data_3ci2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3ci2 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' NZ ' ' CD1' ' A' ' 24' ' ' TRP . 4.0 tmtt? . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 66.5 p -102.96 34.98 2.66 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-O 122.897 1.332 . . . . 0.0 108.771 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' CD ' HH22 ' A' ' 81' ' ' ARG 0.251 0.0 OUTLIER -154.78 151.62 28.89 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.612 -176.736 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.439 ' N ' ' OE1' ' A' ' 23' ' ' GLU . 24.1 m-90 -139.47 81.01 21.01 Favored Pre-proline 0 N--CA 1.517 2.887 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.4 -34.68 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.915 2.41 . . . . 0.0 111.612 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.77 -17.6 9.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.154 -0.966 . . . . 0.0 111.445 -177.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 1.7 pp -107.05 17.63 22.79 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.51 ' CG2' HG21 ' A' ' 79' ' ' VAL . 69.8 t -65.99 169.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.109 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.37 18.18 35.18 Favored Glycine 1 N--CA 1.521 4.354 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -121.05 157.4 30.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.2 p -89.03 159.71 17.45 Favored 'General case' 0 CA--C 1.472 -2.053 0 CA-C-O 127.482 3.515 . . . . 0.0 109.083 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -40.01 -54.18 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.263 1 CA-C-N 105.888 -5.142 . . . . 0.0 118.722 -174.009 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 60.3 mm-40 -55.33 -47.87 75.02 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.936 1.698 . . . . 0.0 110.776 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 1.2 tm-20 -50.96 -47.14 61.29 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.77 -47.78 76.9 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.16 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 66.9 mttm -49.32 -50.55 39.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 76.9 tttt -48.64 -55.33 11.55 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 110.803 -2.908 . . . . 0.0 108.757 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 67.5 t -59.87 -54.27 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.764 0 CA-C-O 125.53 2.586 . . . . 0.0 112.72 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.585 ' CG2' HG23 ' A' ' 66' ' ' VAL . 31.6 mt -57.33 -50.03 78.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 112.151 -2.295 . . . . 0.0 110.663 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 67.8 mt -57.3 -36.42 71.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.1 tt0 -58.78 -44.72 90.76 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 118.05 -1.46 . . . . 0.0 110.935 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.74 -48.39 54.75 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.434 -1.712 . . . . 0.0 114.026 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 25.9 ttpp -127.36 68.31 72.96 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -14.72 -43.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 124.678 3.585 . . . . 0.0 119.949 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -86.97 -5.28 59.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.6 96.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -77.76 93.32 4.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 178.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.483 HD13 ' CG2' ' A' ' 39' ' ' ILE . 73.0 mt -93.14 114.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 121.377 3.843 . . . . 0.0 121.377 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.402 HG12 HE22 ' A' ' 47' ' ' GLN . 36.5 mm -102.27 149.76 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 112.768 -2.014 . . . . 0.0 107.602 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.92 155.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.116 0.96 . . . . 0.0 112.506 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.719 ' HB3' ' CE1' ' A' ' 69' ' ' PHE 0.254 0.6 OUTLIER -142.42 132.19 12.26 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.579 -179.788 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' HD22 ' A' ' 51' ' ' LEU . 52.5 Cg_endo -72.05 113.97 3.84 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.172 1.915 . . . . 0.0 113.994 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 69' ' ' PHE . 36.5 t -41.56 123.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.441 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 119.51 -37.89 2.99 Favored Glycine 0 N--CA 1.507 3.424 2 O-C-N 129.751 4.407 . . . . 0.0 108.651 -175.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.267 52.0 m -60.04 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.031 1.332 . . . . 0.0 108.183 175.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' GLY . 24.9 mm -55.46 147.98 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.87 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.513 HG22 ' NE ' ' A' ' 67' ' ' ARG . 12.4 m -123.01 -147.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.418 ' HG1' ' CD ' ' A' ' 60' ' ' GLU . 1.1 p -87.49 155.33 20.05 Favored 'General case' 0 C--N 1.306 -1.321 1 N-CA-C 124.796 5.11 . . . . 0.0 124.796 -173.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -93.86 34.7 1.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 123.083 1.421 . . . . 0.0 110.865 176.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' CD ' ' HG1' ' A' ' 58' ' ' THR . 24.9 pt-20 -82.02 -176.11 5.97 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.57 56.36 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 123.145 1.45 . . . . 0.0 107.391 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mmm180 -88.96 67.28 8.13 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 126.991 3.282 . . . . 0.0 107.782 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 HD11 HG13 ' A' ' 82' ' ' VAL . 6.5 tp -53.2 -26.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 1 CA-C-N 107.19 -4.55 . . . . 0.0 109.518 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' GLN . 1.3 p30 -60.91 -7.16 2.2 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.811 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.424 ' NH1' ' HB2' ' A' ' 62' ' ' ARG . 6.1 ttp85 -139.55 151.58 46.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 121.768 3.988 . . . . 0.0 121.768 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.585 HG23 ' CG2' ' A' ' 39' ' ' ILE . 21.2 t -115.08 92.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' NE ' HG22 ' A' ' 57' ' ' VAL . 26.8 ttm180 -48.58 123.24 6.43 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 109.826 -3.352 . . . . 0.0 106.05 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HG ' HG21 ' A' ' 32' ' ' VAL 0.271 0.6 OUTLIER -115.16 84.03 2.01 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 125.916 2.01 . . . . 0.0 112.303 -176.965 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.719 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 26.0 m-85 -73.33 108.38 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 124.71 2.195 . . . . 0.0 107.057 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' HG21 ' A' ' 53' ' ' VAL . 14.5 m -113.46 174.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 1 CA-C-N 108.286 -4.052 . . . . 0.0 110.368 -177.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.586 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.2 p-10 -88.69 -146.89 0.16 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 122.941 2.61 . . . . 0.0 111.637 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.586 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 12.0 mptt -90.63 0.34 57.42 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 111.736 -2.484 . . . . 0.0 113.994 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.482 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.375 0.2 OUTLIER -139.15 47.8 1.89 Allowed 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 112.558 -2.11 . . . . 0.0 105.772 178.101 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.71 27.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -100.9 151.68 21.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 123.331 1.539 . . . . 0.0 109.576 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.0 mt -78.72 93.71 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 127.466 3.507 . . . . 0.0 116.125 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.351 . . -73.2 -42.09 63.07 Favored 'General case' 0 C--N 1.291 -1.957 2 CA-C-N 100.292 -7.685 . . . . 0.0 112.958 178.702 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -117.57 156.14 28.61 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.51 HG21 ' CG2' ' A' ' 28' ' ' VAL . 88.5 t -76.34 136.51 68.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 112.75 -3.58 . . . . 0.0 104.981 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -81.48 169.59 15.35 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.518 2.812 . . . . 0.0 111.695 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.508 HH22 ' CD ' ' A' ' 23' ' ' GLU . 2.3 ptp180 -163.69 172.38 14.3 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 116.624 -1.655 . . . . 0.0 111.731 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.534 HG21 HG21 ' A' ' 66' ' ' VAL . 6.1 t -82.58 -111.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' HG11 ' A' ' 82' ' ' VAL . . . . . . . . 0 C--N 1.287 -2.167 3 N-CA-C 96.046 -6.821 . . . . 0.0 96.046 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 13.3 mtpp . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 124.011 1.862 . . . . 0.0 112.444 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.444 ' HA ' HG21 ' A' ' 82' ' ' VAL . 6.5 p -111.42 -6.51 14.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.97 135.08 35.65 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.497 ' CG ' HG12 ' A' ' 39' ' ' ILE . 25.4 m-90 -117.0 72.94 6.24 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 122.983 1.373 . . . . 0.0 114.581 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.45 -31.98 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.643 1.562 . . . . 0.0 110.66 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.475 ' CD ' ' HZ2' ' A' ' 21' ' ' LYS . 33.4 mp0 -52.18 -34.9 47.19 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.167 1.461 . . . . 0.0 109.928 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 24' ' ' TRP 0.25 4.5 pp -102.06 36.48 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 123.704 1.716 . . . . 0.0 113.027 -177.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 79' ' ' VAL . 9.9 t -81.45 155.92 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.767 171.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.65 29.1 17.55 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.469 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.511 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 3.0 mmmp? -120.58 176.49 5.48 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 117.13 -1.414 . . . . 0.0 109.44 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -85.32 160.28 19.85 Favored 'General case' 0 CA--C 1.459 -2.532 0 CA-C-O 126.053 2.835 . . . . 0.0 112.109 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG2' HG13 ' A' ' 70' ' ' VAL 0.251 1.7 p -69.55 -28.31 37.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 1 CA-C-N 107.189 -4.551 . . . . 0.0 111.13 -173.701 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.443 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 18.6 mm-40 -77.23 -38.55 50.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.1 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 32.8 mt-10 -63.08 -50.85 68.94 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 125.889 1.993 . . . . 0.0 105.632 174.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.73 -58.53 3.01 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.79 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 52.1 mttp -49.48 -54.96 14.95 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-O 122.549 1.166 . . . . 0.0 108.425 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' NZ ' ' OE1' ' A' ' 33' ' ' GLU . 57.5 mttp -52.95 -46.65 68.27 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.233 -2.258 . . . . 0.0 112.029 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 27' ' ' LEU . 99.4 t -67.51 -52.51 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 122.559 1.171 . . . . 0.0 110.705 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.551 ' CG2' HG23 ' A' ' 66' ' ' VAL . 17.5 mt -51.74 -48.69 37.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.315 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.595 HD22 ' O ' ' A' ' 46' ' ' ALA . 88.4 mt -60.77 -34.83 75.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 124.988 1.43 . . . . 0.0 107.378 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -84.79 -57.24 3.2 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 114.095 -1.412 . . . . 0.0 113.551 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 45' ' ' GLU . 51.9 tttm -115.54 78.69 6.73 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.338 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -22.71 -52.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 N-CA-C 118.683 2.532 . . . . 0.0 118.683 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.67 9.35 14.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -178.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.595 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -65.15 96.17 0.2 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 117.822 -1.551 . . . . 0.0 113.18 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -77.92 69.86 4.2 Favored 'General case' 0 N--CA 1.513 2.692 0 O-C-N 118.338 -2.726 . . . . 0.0 107.893 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.478 HD13 HG23 ' A' ' 39' ' ' ILE . 32.8 mt -78.04 122.06 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 112.793 -2.003 . . . . 0.0 116.114 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.579 ' H ' ' NH2' ' A' ' 65' ' ' ARG . 1.3 mp -115.47 170.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.453 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 7.7 p -72.79 126.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 123.096 1.427 . . . . 0.0 110.512 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 55' ' ' THR . 0.2 OUTLIER -131.62 104.8 14.39 Favored Pre-proline 0 N--CA 1.492 1.673 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.505 -177.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -56.54 115.05 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.625 0.545 . . . . 0.0 111.015 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.578 ' HA ' ' CG ' ' A' ' 69' ' ' PHE . 14.9 p -39.81 142.31 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 123.679 1.704 . . . . 0.0 112.655 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' N ' ' CE2' ' A' ' 69' ' ' PHE . . . 95.84 -26.09 22.09 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 112.067 -2.333 . . . . 0.0 110.976 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.498 ' CG2' HD21 ' A' ' 51' ' ' LEU 0.321 3.0 m -54.39 -179.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.225 1.012 . . . . 0.0 113.644 176.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.32 99.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 118.646 -2.534 . . . . 0.0 114.388 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.25 -48.18 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.268 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.97 68.54 0.68 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 127.659 3.6 . . . . 0.0 113.603 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.505 ' SD ' ' HG3' ' A' ' 62' ' ' ARG . 18.2 ttm -99.77 -177.96 3.72 Favored 'General case' 0 C--N 1.276 -2.609 1 CA-C-N 104.315 -5.857 . . . . 0.0 107.292 -178.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 11.8 pt-20 -78.53 -163.23 0.43 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 174.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.74 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 67.3 t80 -94.76 81.56 3.82 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.616 -1.303 . . . . 0.0 111.602 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.505 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 8.6 mmt85 -88.65 56.78 3.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.45 -1.7 . . . . 0.0 109.528 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.74 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.27 -27.6 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 111.348 -2.66 . . . . 0.0 116.642 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.07 -14.81 1.73 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 124.008 1.861 . . . . 0.0 108.328 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.579 ' NH2' ' H ' ' A' ' 49' ' ' ILE . 6.2 mtp180 -132.21 157.41 44.41 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 119.443 3.127 . . . . 0.0 119.443 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.551 HG23 ' CG2' ' A' ' 39' ' ' ILE . 2.9 t -115.45 134.44 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 1 N-CA-C 98.5 -4.629 . . . . 0.0 98.5 171.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.478 ' CD ' HD11 ' A' ' 51' ' ' LEU . 9.2 tpp180 -83.13 134.68 34.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.454 HD11 ' CG2' ' A' ' 48' ' ' ILE . 3.2 mt -113.86 82.01 1.62 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.856 1.347 . . . . 0.0 108.475 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CG ' ' HA ' ' A' ' 53' ' ' VAL . 2.6 m-30 -73.46 92.45 1.87 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 126.498 3.047 . . . . 0.0 108.592 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.432 HG13 ' CG2' ' A' ' 32' ' ' VAL . 4.8 m -105.16 171.04 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 1 CA-C-N 105.327 -5.397 . . . . 0.0 104.017 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.616 ' CG ' ' H ' ' A' ' 72' ' ' LYS . 1.5 p-10 -96.75 -138.39 0.27 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 125.373 2.511 . . . . 0.0 112.261 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 22.0 mtmm -85.32 -11.99 53.36 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 109.195 -3.639 . . . . 0.0 114.166 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.306 0.3 OUTLIER -138.05 52.36 1.85 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 112.087 -2.324 . . . . 0.0 107.675 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 36.42 22.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 34.4 m-20 -105.62 138.27 42.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 123.473 1.606 . . . . 0.0 110.608 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.64 122.43 11.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 126.006 2.812 . . . . 0.0 117.211 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.485 . . -104.5 -44.16 4.98 Favored 'General case' 0 C--N 1.289 -2.03 1 CA-C-N 105.362 -5.381 . . . . 0.0 111.016 -171.831 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -115.42 161.7 18.18 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 28' ' ' VAL . 95.4 t -75.79 134.25 72.29 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 113.939 -3.105 . . . . 0.0 109.05 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 31.9 Cg_exo -68.72 131.93 23.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 103.803 -3.191 . . . . 0.0 103.803 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 22' ' ' THR . 4.9 ptm180 -138.67 157.2 46.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.479 1.112 . . . . 0.0 108.703 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 22' ' ' THR . 11.8 t -79.03 152.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.358 1.036 . . . . 0.0 112.697 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.455 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.513 3.824 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.029 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 5.8 tmtt? . . . . . 0 N--CA 1.508 2.467 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 48.2 p -104.55 24.96 10.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 112.608 -2.087 . . . . 0.0 105.401 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.07 151.16 43.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 126.225 2.203 . . . . 0.0 113.202 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.615 ' CG ' HG12 ' A' ' 39' ' ' ILE . 26.9 m-90 -128.67 67.32 76.73 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 123.285 1.517 . . . . 0.0 112.293 174.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -63.42 -37.67 47.62 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 CA-C-N 113.301 -1.357 . . . . 0.0 110.034 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 21' ' ' LYS . 19.6 pm0 -51.01 -31.32 17.73 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.165 0.983 . . . . 0.0 111.934 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.6 pp -105.84 31.9 4.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 79' ' ' VAL . 77.4 t -84.71 124.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 170.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.82 3.46 54.94 Favored Glycine 0 N--CA 1.514 3.868 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 31.9 mmtp -109.53 156.13 20.52 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.367 -0.917 . . . . 0.0 110.306 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 p -85.81 155.07 21.15 Favored 'General case' 0 CA--C 1.474 -1.945 0 CA-C-O 127.386 3.47 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -48.93 -56.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 1 CA-C-N 106.022 -5.081 . . . . 0.0 120.739 -170.259 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 50.0 mm-40 -57.67 -40.43 79.36 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 117.417 -1.713 . . . . 0.0 110.559 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 4.7 tt0 -60.13 -54.39 46.46 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.454 ' CB ' HD11 ' A' ' 27' ' ' LEU . . . -44.58 -52.4 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.964 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mttt -55.77 -58.15 9.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 3.8 tmtm? -47.46 -40.14 17.49 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.798 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.465 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 77.4 t -70.59 -56.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.549 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.615 HG12 ' CG ' ' A' ' 24' ' ' TRP . 47.7 mt -48.19 -39.18 8.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 122.814 1.292 . . . . 0.0 110.836 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 11.7 mt -53.26 -35.9 60.53 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.077 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -62.66 -46.59 87.49 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-O 123.942 1.829 . . . . 0.0 110.455 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' CG ' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -62.78 -49.94 72.99 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.988 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 1.2 mtpp -125.81 81.14 66.04 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.799 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.49 -54.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 118.204 2.348 . . . . 0.0 118.204 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.578 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.36 13.65 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB3' HD13 ' A' ' 48' ' ' ILE . . . -60.22 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.032 0.92 . . . . 0.0 113.293 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -82.74 72.32 9.81 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 124.567 2.127 . . . . 0.0 106.071 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.55 HD13 ' CG2' ' A' ' 39' ' ' ILE . 49.2 mt -73.63 148.95 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 110.617 -2.992 . . . . 0.0 117.37 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.87 162.08 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 112.748 -2.023 . . . . 0.0 112.84 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 133.93 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 112.06 -2.336 . . . . 0.0 105.115 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.6 mt -141.51 113.36 6.62 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.564 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -76.0 130.04 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 CA-C-N 121.818 1.685 . . . . 0.0 108.0 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 69' ' ' PHE . 13.1 t -39.55 130.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.61 -40.69 2.46 Favored Glycine 1 N--CA 1.518 4.144 0 CA-C-N 109.302 -3.59 . . . . 0.0 111.019 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 40.6 m -46.29 125.49 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.721 1.208 . . . . 0.0 108.778 177.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.39 152.28 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -51.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.716 1 N-CA-C 125.002 5.186 . . . . 0.0 125.002 -175.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.08 99.98 5.54 Favored 'General case' 0 C--N 1.288 -2.081 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.407 ' HB2' ' NH2' ' A' ' 62' ' ' ARG . 87.9 mtp -94.11 -117.55 0.1 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 100.809 -3.775 . . . . 0.0 100.809 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HG3' ' NH1' ' A' ' 62' ' ' ARG 0.257 3.1 pp20? -76.54 -167.29 0.78 Allowed 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 111.012 -2.813 . . . . 0.0 106.251 172.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.493 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -79.68 98.73 7.08 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.975 0.893 . . . . 0.0 112.074 -173.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -85.59 58.7 5.19 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 125.758 2.694 . . . . 0.0 109.468 177.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.493 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 7.6 tp -71.47 -9.22 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 109.524 -3.489 . . . . 0.0 116.476 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -96.87 -1.69 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.788 1.28 . . . . 0.0 108.252 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.03 144.61 50.98 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 HG23 ' A' ' 39' ' ' ILE . 3.1 t -116.94 145.86 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -103.66 130.79 51.18 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.746 175.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.437 ' O ' HG12 ' A' ' 70' ' ' VAL . 20.3 mt -103.2 83.05 2.14 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.662 -2.063 . . . . 0.0 107.398 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.68 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.5 m-85 -73.18 100.15 3.0 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 126.478 3.037 . . . . 0.0 108.485 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 68' ' ' LEU . 32.8 m -101.52 171.15 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 1 CA-C-N 106.541 -4.845 . . . . 0.0 108.211 -176.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.514 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.2 p-10 -97.35 -140.87 0.29 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 124.633 2.158 . . . . 0.0 111.689 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.514 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 37.4 tttp -85.88 -0.97 56.77 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 109.199 -3.637 . . . . 0.0 111.451 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.435 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.3 mt -136.08 38.79 2.75 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.624 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.49 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -100.08 134.38 43.09 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.418 HG23 ' HG3' ' A' ' 80' ' ' PRO . 50.8 mt -58.37 122.96 9.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 125.328 2.49 . . . . 0.0 109.651 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.476 . . -105.4 -38.13 6.59 Favored 'General case' 0 C--N 1.284 -2.267 2 CA-C-N 105.19 -5.459 . . . . 0.0 110.261 -172.601 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -118.71 160.08 22.49 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.069 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.46 HG23 HG22 ' A' ' 28' ' ' VAL . 95.4 t -65.55 135.99 95.95 Favored Pre-proline 0 N--CA 1.501 2.089 0 C-N-CA 114.881 -2.728 . . . . 0.0 110.107 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HG2' HD13 ' A' ' 27' ' ' LEU . 4.4 Cg_exo -83.45 142.46 10.54 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 N-CA-C 104.417 -2.955 . . . . 0.0 104.417 -176.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 22' ' ' THR . 6.9 ptm180 -156.56 163.76 39.0 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 116.522 -2.071 . . . . 0.0 113.375 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 83' ' ' GLY . 2.7 t -84.38 155.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 125.924 2.015 . . . . 0.0 111.994 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.542 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.428 0 CA-C-O 114.127 -3.596 . . . . 0.0 112.512 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -98.41 31.22 2.9 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.396 -1.322 . . . . 0.0 111.384 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.63 146.29 31.28 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.913 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.522 ' CZ3' HG22 ' A' ' 82' ' ' VAL . 24.1 m-90 -127.4 67.17 71.1 Favored Pre-proline 0 N--CA 1.498 1.966 0 CA-C-O 124.262 1.982 . . . . 0.0 111.396 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.409 ' HA ' HG23 ' A' ' 79' ' ' VAL . 40.8 Cg_endo -69.29 -41.51 4.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 CA-C-N 111.068 -2.154 . . . . 0.0 110.614 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -67.42 -9.64 43.67 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.786 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -107.78 13.73 26.16 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.488 HG23 HG23 ' A' ' 79' ' ' VAL . 48.6 t -68.01 161.46 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.72 57.15 Favored Glycine 1 N--CA 1.518 4.147 0 C-N-CA 118.475 -1.821 . . . . 0.0 113.829 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 2.9 mtpp -106.48 166.62 10.42 Favored 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 124.122 0.969 . . . . 0.0 111.655 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 p -85.7 154.23 21.79 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 126.249 2.928 . . . . 0.0 115.717 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -48.94 -57.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 1 CA-C-N 107.875 -4.239 . . . . 0.0 114.202 -172.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -53.01 -36.51 60.6 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 121.506 1.957 . . . . 0.0 113.802 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -70.04 -50.68 38.83 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.45 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -46.55 -51.82 14.71 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 123.422 1.582 . . . . 0.0 107.488 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -55.16 -54.2 46.23 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -49.1 -42.03 37.66 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.341 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 85.5 t -67.57 -53.49 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.393 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 66' ' ' VAL . 45.6 mt -60.3 -51.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.084 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp -52.68 -27.75 18.75 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.575 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 39.4 tp60 -68.98 -23.75 64.16 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.1 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.19 -53.37 3.82 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.283 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 18.6 ttpp -116.7 76.69 7.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.24 -45.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 123.387 2.725 . . . . 0.0 117.446 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.25 0.7 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 16.3 mt-30 -77.94 60.74 2.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.511 HD13 ' CG2' ' A' ' 39' ' ' ILE . 65.6 mt -73.22 140.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.502 ' CG2' ' H ' ' A' ' 50' ' ' VAL . 43.1 mm -115.86 175.7 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.607 1.194 . . . . 0.0 112.645 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.502 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 17.2 t -102.52 116.09 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 110.279 -3.146 . . . . 0.0 108.327 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.658 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 13.4 mt -124.04 92.18 48.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.05 127.94 27.76 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 N-CA-C 109.286 -1.082 . . . . 0.0 109.286 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -43.18 127.89 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.877 0 CA-C-O 123.613 1.673 . . . . 0.0 111.186 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 -21.04 35.42 Favored Glycine 1 N--CA 1.517 4.063 0 CA-C-N 109.587 -3.461 . . . . 0.0 112.778 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.448 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.333 23.7 m -68.25 62.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 173.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 mm -51.11 112.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 124.308 2.004 . . . . 0.0 116.382 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 69' ' ' PHE . 30.2 m -103.56 167.82 2.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 110.106 -3.225 . . . . 0.0 104.394 175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 -171.68 2.3 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 108.852 -3.794 . . . . 0.0 111.958 -174.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.3 tpp -92.23 23.76 3.69 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.073 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.406 ' CD ' HH12 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -85.03 166.21 16.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.627 ' CD2' ' HA2' ' A' ' 83' ' ' GLY . 8.3 t80 -145.59 154.19 41.89 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.601 ' N ' ' CD2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -116.43 62.1 0.72 Allowed 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.52 ' N ' ' CD2' ' A' ' 61' ' ' TYR . 5.3 tp -44.54 -27.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.07 -24.37 24.9 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.154 -2.294 . . . . 0.0 108.261 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 62' ' ' ARG 0.269 7.1 ttm-85 -129.38 158.77 38.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 110.375 -3.102 . . . . 0.0 114.434 -168.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.588 HG23 HG23 ' A' ' 39' ' ' ILE . 3.1 t -103.8 140.86 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.406 HH12 ' CD ' ' A' ' 60' ' ' GLU . 4.1 tpp180 -81.34 115.55 20.76 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.3 mp -113.46 84.79 2.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.518 1.136 . . . . 0.0 112.791 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 36.0 m-85 -74.41 104.77 5.27 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 127.238 3.399 . . . . 0.0 106.361 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.51 172.17 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.042 1 CA-C-N 107.166 -4.561 . . . . 0.0 105.833 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.6 p-10 -95.43 -142.4 0.26 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 123.793 2.997 . . . . 0.0 113.688 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.2 ttpp -92.02 9.4 33.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.732 -3.395 . . . . 0.0 110.34 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -142.71 38.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 111.513 -2.585 . . . . 0.0 110.74 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.69 20.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -176.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.5 m-20 -104.61 142.3 34.9 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.943 1.354 . . . . 0.0 108.845 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.7 mt -63.28 113.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 126.518 3.056 . . . . 0.0 112.359 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.488 . . -88.51 -51.34 5.76 Favored 'General case' 0 C--N 1.283 -2.294 2 CA-C-N 103.479 -6.237 . . . . 0.0 107.909 -173.258 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -118.02 157.84 26.06 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG23 HG23 ' A' ' 28' ' ' VAL . 94.4 t -63.66 138.64 97.43 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 115.75 -2.38 . . . . 0.0 112.482 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 3.5 Cg_exo -86.63 157.13 9.09 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.58 2.186 . . . . 0.0 108.26 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.449 HH21 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -154.5 150.24 27.59 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.142 -176.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.522 HG22 ' CZ3' ' A' ' 24' ' ' TRP 0.278 21.9 t -89.13 105.09 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.729 1.268 . . . . 0.0 107.783 175.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.627 ' HA2' ' CD2' ' A' ' 61' ' ' TYR . . . . . . . . 0 C--N 1.27 -3.121 0 C-N-CA 117.7 -2.191 . . . . 0.0 110.853 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -101.29 17.84 21.54 Favored 'General case' 0 N--CA 1.526 3.354 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -140.15 151.89 45.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 125.105 1.503 . . . . 0.0 114.327 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 29.4 m-90 -134.53 73.16 68.72 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 123.762 1.744 . . . . 0.0 112.944 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -77.45 -34.77 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.702 1.601 . . . . 0.0 111.576 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -62.35 -18.89 62.61 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 123.402 1.572 . . . . 0.0 109.429 -177.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -97.94 15.31 24.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 79' ' ' VAL . 99.2 t -73.53 164.45 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.838 -1.164 . . . . 0.0 108.325 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 2.1 89.75 Favored Glycine 1 N--CA 1.518 4.112 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.809 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 14.5 mtmm -130.05 168.51 16.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.312 1.045 . . . . 0.0 108.536 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 10.7 p -87.82 160.08 18.16 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 127.835 3.683 . . . . 0.0 114.319 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -45.76 -50.88 3.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 1 CA-C-N 105.277 -5.42 . . . . 0.0 116.141 -172.738 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 8.8 mm-40 -54.99 -42.41 72.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.082 -1.011 . . . . 0.0 112.162 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.98 -46.59 74.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.64 -49.37 62.42 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.116 -1.434 . . . . 0.0 111.336 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -53.04 -50.2 64.78 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 52.5 mttp -50.9 -46.65 60.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.99 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.1 -56.9 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-O 124.685 2.183 . . . . 0.0 111.309 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.593 ' CG2' HG23 ' A' ' 66' ' ' VAL . 35.3 mt -54.38 -45.84 69.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.011 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 46' ' ' ALA . 91.7 mt -58.13 -36.51 73.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.728 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.55 -39.33 94.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.183 -1.407 . . . . 0.0 110.933 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.41 -45.96 29.31 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.101 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 63.7 tttm -125.18 66.86 53.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -9.83 -57.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 1 C-N-CA 125.466 4.111 . . . . 0.0 121.233 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -82.59 1.49 37.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -57.74 84.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.21 111.01 7.05 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.486 HD12 ' CG2' ' A' ' 39' ' ' ILE . 20.2 mt -107.77 152.37 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.6 mm -124.58 163.06 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 123.752 1.739 . . . . 0.0 114.009 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.417 ' CB ' HG22 ' A' ' 32' ' ' VAL . 7.1 p -106.76 118.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 112.316 -2.22 . . . . 0.0 113.805 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 5.7 mp -128.6 136.58 29.33 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.095 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.79 135.97 20.22 Favored 'Trans proline' 0 N--CA 1.512 2.58 0 C-N-CA 123.017 2.478 . . . . 0.0 109.059 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 69' ' ' PHE . 72.1 t -43.16 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-N 120.437 1.471 . . . . 0.0 114.894 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.32 -39.82 2.47 Favored Glycine 0 N--CA 1.51 3.581 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.902 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.589 ' HB ' ' CE1' ' A' ' 69' ' ' PHE . 22.4 m -47.61 168.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.787 1.28 . . . . 0.0 113.803 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.79 118.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -114.91 -77.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.362 174.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 78.6 9.77 Favored 'General case' 0 C--N 1.283 -2.326 1 N-CA-C 124.172 4.879 . . . . 0.0 124.172 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 tpt -98.99 -128.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 1 CA-C-N 107.153 -4.567 . . . . 0.0 104.098 176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.55 ' CD ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.87 -169.49 2.38 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 172.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.619 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 39.3 t80 -118.04 102.56 9.14 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.72 -1.238 . . . . 0.0 112.311 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 65' ' ' ARG . 2.1 mpt_? -90.83 68.46 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 124.188 1.947 . . . . 0.0 108.739 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.504 HD11 HG12 ' A' ' 82' ' ' VAL . 4.6 tp -42.34 -29.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 112.681 -2.054 . . . . 0.0 116.026 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.04 -17.43 10.1 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 124.16 1.933 . . . . 0.0 111.448 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.611 HH12 ' C ' ' A' ' 83' ' ' GLY . 21.6 ttp85 -132.14 149.7 52.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.593 HG23 ' CG2' ' A' ' 39' ' ' ILE . 3.3 t -106.73 139.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.15 124.69 44.38 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.42 HD13 ' HB3' ' A' ' 80' ' ' PRO . 2.7 mp -109.29 90.39 3.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 125.879 1.987 . . . . 0.0 110.761 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.589 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 12.8 m-85 -70.99 110.96 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 126.155 2.883 . . . . 0.0 110.475 170.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 4.9 m -103.25 170.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-N 108.912 -3.767 . . . . 0.0 109.221 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.7 p-10 -93.43 -140.62 0.22 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 124.285 1.993 . . . . 0.0 112.033 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -92.14 6.82 45.15 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 110.545 -3.025 . . . . 0.0 111.21 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.424 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 72.1 mt -136.74 32.08 2.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.534 -2.121 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 34.96 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.97 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 45.0 m-20 -108.47 137.94 45.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.51 111.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 126.431 3.015 . . . . 0.0 112.796 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.475 . . -90.22 -47.01 8.06 Favored 'General case' 0 C--N 1.288 -2.108 2 CA-C-N 103.27 -6.332 . . . . 0.0 108.657 -173.842 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -117.14 157.15 26.42 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 111.556 -2.565 . . . . 0.0 107.765 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.436 HG23 HG22 ' A' ' 28' ' ' VAL . 94.5 t -75.4 141.03 72.89 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 115.122 -2.631 . . . . 0.0 108.74 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HG2' HD12 ' A' ' 27' ' ' LEU . 6.5 Cg_exo -84.25 158.68 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.56 2.173 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 156.65 32.49 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.032 -1.461 . . . . 0.0 109.195 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 63' ' ' ILE . 23.9 t -74.93 144.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.258 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.619 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . . . . . . 0 N--CA 1.509 3.53 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.63 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 123.584 1.659 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -98.34 1.74 47.34 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HB2' ' NH2' ' A' ' 81' ' ' ARG . 0.6 OUTLIER -139.68 155.9 47.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.635 0.731 . . . . 0.0 111.736 172.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.492 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 30.1 m-90 -118.87 71.93 10.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -70.71 -30.54 17.72 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.054 1.169 . . . . 0.0 109.501 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -66.06 2.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.916 0.865 . . . . 0.0 109.979 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.492 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 31.3 mt -103.97 -8.07 19.9 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.653 -0.654 . . . . 0.0 110.902 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 ' CG2' HG21 ' A' ' 79' ' ' VAL . 53.2 t -66.51 107.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 123.148 1.452 . . . . 0.0 108.846 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.56 5.04 22.94 Favored Glycine 0 N--CA 1.506 3.306 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.639 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' NZ ' ' CD ' ' A' ' 34' ' ' GLU . 1.5 mmmp? -111.69 167.6 10.22 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.736 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -88.28 173.18 8.92 Favored 'General case' 0 CA--C 1.443 -3.14 0 CA-C-O 123.008 1.385 . . . . 0.0 112.791 177.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.558 ' CG2' HG13 ' A' ' 70' ' ' VAL . 1.4 p -80.98 -55.62 7.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 108.903 -3.771 . . . . 0.0 115.641 -171.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' CD ' ' HZ1' ' A' ' 36' ' ' LYS . 35.1 mm-40 -62.83 -21.13 65.7 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 122.362 2.346 . . . . 0.0 109.867 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 38.0 tt0 -75.9 -49.07 18.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -46.33 -52.5 12.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HZ1' ' CD ' ' A' ' 33' ' ' GLU . 82.0 tttt -48.05 -46.58 33.49 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 112.768 -2.015 . . . . 0.0 106.645 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 40.4 tttm -55.54 -54.3 45.65 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.487 -1.285 . . . . 0.0 109.891 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 69.1 t -59.02 -47.88 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 CA-C-O 124.291 1.996 . . . . 0.0 111.734 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.607 ' CG2' HG23 ' A' ' 66' ' ' VAL . 14.7 mt -56.16 -51.8 58.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 112.764 -2.017 . . . . 0.0 109.21 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -61.93 -37.66 85.53 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 29.5 tp60 -58.92 -24.25 62.22 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.205 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' OD2' ' NE1' ' A' ' 24' ' ' TRP . 49.5 t0 -96.2 -51.53 4.37 Favored 'General case' 0 N--CA 1.523 3.194 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.01 75.28 21.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -9.79 -55.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 2 C-N-CA 126.121 4.547 . . . . 0.0 122.717 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -89.67 -0.29 57.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . . . -42.27 97.75 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.437 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 93.4 mm-40 -87.59 65.21 8.44 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 39' ' ' ILE . 46.6 mt -72.26 127.03 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 121.456 3.873 . . . . 0.0 121.456 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -123.14 128.23 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.062 -3.245 . . . . 0.0 106.085 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 51' ' ' LEU . 12.4 p -81.07 158.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 126.411 2.319 . . . . 0.0 113.129 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' CB ' ' CZ ' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -141.1 151.65 62.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -85.48 131.83 4.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.145 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.3 t -42.33 133.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 106.75 -31.27 8.39 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 110.273 -3.149 . . . . 0.0 113.487 -178.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.312 40.2 m -48.62 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.8 1.24 . . . . 0.0 108.186 175.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' GLY . 21.1 mm -53.61 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 125.033 2.349 . . . . 0.0 112.274 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -98.75 -173.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 110.046 -3.252 . . . . 0.0 105.776 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -92.43 144.95 24.85 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 111.68 -2.509 . . . . 0.0 116.231 -174.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.11 40.14 1.06 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.291 1.52 . . . . 0.0 108.388 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.428 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 19.4 pt-20 -83.14 -171.97 3.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.589 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 74.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 123.614 1.673 . . . . 0.0 113.914 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' ASP . 15.5 mmt180 -89.69 68.22 7.55 Favored 'General case' 0 C--N 1.294 -1.843 1 N-CA-C 97.865 -4.865 . . . . 0.0 97.865 176.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.455 HD11 HG13 ' A' ' 82' ' ' VAL . 6.5 tp -43.85 -1.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' ARG . 3.1 p30 -85.67 -9.11 57.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.492 1.917 . . . . 0.0 108.71 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.437 ' NH2' ' O ' ' A' ' 47' ' ' GLN . 38.9 ttm-85 -128.53 148.76 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 -172.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.607 HG23 ' CG2' ' A' ' 39' ' ' ILE . 4.2 t -117.27 120.63 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 1 N-CA-C 99.214 -4.365 . . . . 0.0 99.214 170.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.581 HH21 ' C ' ' A' ' 83' ' ' GLY . 3.1 tpp85 -79.92 117.14 20.5 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.76 93.06 4.34 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 124.533 1.146 . . . . 0.0 110.633 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.592 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 26.5 m-85 -79.43 102.43 8.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 126.124 2.869 . . . . 0.0 109.93 170.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.558 HG13 ' CG2' ' A' ' 32' ' ' VAL . 2.3 m -108.93 177.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 108.475 -3.966 . . . . 0.0 109.47 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.6 p-10 -101.96 -142.77 0.35 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 124.478 2.085 . . . . 0.0 113.533 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -86.67 -2.09 58.24 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 109.021 -3.718 . . . . 0.0 113.09 -178.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 mt -135.84 37.95 2.82 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.915 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.13 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 65.6 m-20 -109.73 149.95 29.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -72.8 121.63 23.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 126.911 3.243 . . . . 0.0 116.983 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.462 . . -106.05 -42.58 5.06 Favored 'General case' 0 C--N 1.295 -1.796 2 CA-C-N 103.671 -6.149 . . . . 0.0 112.559 -173.213 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.4 ' CD ' ' HB3' ' A' ' 69' ' ' PHE . 27.8 mt-30 -111.46 153.97 25.37 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.498 HG21 ' CG2' ' A' ' 28' ' ' VAL . 62.8 t -75.9 139.89 70.09 Favored Pre-proline 0 N--CA 1.508 2.447 0 C-N-CA 112.547 -3.661 . . . . 0.0 106.893 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 9.7 Cg_exo -78.92 152.12 24.67 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 N-CA-C 106.673 -2.087 . . . . 0.0 106.673 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.494 ' NH2' ' HB2' ' A' ' 23' ' ' GLU . 7.7 ptp180 -160.76 159.31 29.91 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.079 -1.048 . . . . 0.0 112.041 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.455 HG13 HD11 ' A' ' 63' ' ' ILE . 5.4 t -78.24 143.66 12.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 124.265 1.983 . . . . 0.0 111.36 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.581 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C--N 1.296 -1.64 0 CA-C-N 110.014 -3.266 . . . . 0.0 110.215 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p -100.87 16.44 25.17 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.599 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.79 153.74 51.5 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 125.253 1.596 . . . . 0.0 110.267 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -128.49 60.44 48.41 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 123.075 1.416 . . . . 0.0 114.714 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -53.47 -35.95 77.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.417 2.078 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -48.05 -31.32 5.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.136 1.446 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.455 HD12 HG13 ' A' ' 39' ' ' ILE . 56.0 mt -79.77 -26.85 40.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.886 -1.961 . . . . 0.0 114.847 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.496 ' CG2' HG21 ' A' ' 79' ' ' VAL . 14.3 t -50.92 137.83 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 117.877 -1.529 . . . . 0.0 107.59 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.23 -13.9 66.54 Favored Glycine 0 N--CA 1.505 3.238 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.305 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -111.34 166.84 10.77 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 117.438 0.619 . . . . 0.0 111.617 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.2 p -90.62 164.32 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 128.273 3.892 . . . . 0.0 115.119 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.69 -31.22 6.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 105.511 -5.313 . . . . 0.0 121.921 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -50.25 13.8 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 123.336 1.541 . . . . 0.0 107.195 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 2.2 tm-20 -50.67 -52.1 43.09 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 102.75 -3.055 . . . . 0.0 102.75 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.71 -60.16 3.14 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.952 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -48.37 -49.07 36.07 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 8.9 ttpp -53.1 -53.45 50.12 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.626 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.64 -55.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 CA-C-O 123.432 1.587 . . . . 0.0 111.607 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.608 ' CG2' HG23 ' A' ' 66' ' ' VAL . 23.0 mt -53.54 -43.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.871 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 46' ' ' ALA . 60.3 mt -64.99 -38.06 89.72 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.387 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -57.79 -48.29 80.14 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.441 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.66 -47.18 73.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.78 -1.555 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HE3' HG13 ' A' ' 82' ' ' VAL . 58.8 tttm -124.74 71.83 60.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 C-N-CA 124.513 1.125 . . . . 0.0 111.617 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -21.58 -50.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 124.35 3.366 . . . . 0.0 118.331 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 0.34 43.19 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.467 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -59.87 92.31 0.02 OUTLIER 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' ASP . 19.3 tt0 -75.72 70.4 2.51 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.475 HD12 ' CG2' ' A' ' 39' ' ' ILE . 47.5 mt -72.68 141.22 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.852 -2.431 . . . . 0.0 117.135 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' HB ' ' HD3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -125.91 156.52 35.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 123.075 1.417 . . . . 0.0 108.063 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.85 142.78 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 111.964 -2.38 . . . . 0.0 106.854 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 1.4 mt -137.17 125.29 14.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.59 135.12 35.03 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.049 1.41 . . . . 0.0 108.857 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -44.02 123.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.957 0.885 . . . . 0.0 112.742 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.22 -35.58 3.85 Favored Glycine 0 N--CA 1.513 3.803 0 O-C-N 128.075 3.359 . . . . 0.0 113.278 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.663 ' HB ' ' CE1' ' A' ' 69' ' ' PHE . 60.1 m -47.61 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.463 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mm -53.4 97.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 124.437 2.065 . . . . 0.0 112.481 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 55' ' ' THR . 14.7 m -97.26 -176.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 110.76 -2.927 . . . . 0.0 105.563 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.33 147.1 24.27 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 112.197 -2.274 . . . . 0.0 115.328 -172.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtp -91.55 34.23 0.98 Allowed 'General case' 0 N--CA 1.515 2.788 0 CA-C-O 124.929 2.299 . . . . 0.0 112.315 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 24.1 pt-20 -83.71 -163.25 0.74 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 109.134 -3.666 . . . . 0.0 115.299 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.65 67.16 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.06 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.39 66.73 7.54 Favored 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 126.608 3.099 . . . . 0.0 105.865 177.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.455 HD11 HG13 ' A' ' 82' ' ' VAL . 4.9 tp -42.8 -8.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 109.717 -3.401 . . . . 0.0 119.446 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' CG ' HH21 ' A' ' 65' ' ' ARG . 45.8 p30 -80.86 -5.7 57.67 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 119.588 1.086 . . . . 0.0 108.166 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 64' ' ' ASP 0.26 15.9 ttm-85 -137.45 147.58 45.44 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -174.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.608 HG23 ' CG2' ' A' ' 39' ' ' ILE . 5.2 t -101.33 140.06 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 1 N-CA-C 99.205 -4.369 . . . . 0.0 99.205 173.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.408 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 1.5 tpp180 -89.44 120.11 30.48 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 mt -111.33 88.15 2.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 126.066 2.104 . . . . 0.0 114.036 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.663 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 38.2 m-85 -81.76 99.62 9.06 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 127.852 3.691 . . . . 0.0 107.734 170.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 5.7 m -100.19 171.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 1 CA-C-N 106.042 -5.072 . . . . 0.0 106.75 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.4 p-10 -87.72 -141.02 0.11 Allowed 'General case' 0 C--N 1.293 -1.874 0 O-C-N 118.818 -2.426 . . . . 0.0 110.72 -175.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 44.3 mmtm -95.88 8.2 44.25 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 110.256 -3.156 . . . . 0.0 112.683 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.1 mt -137.59 32.46 2.51 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.198 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' HA ' ' CG2' ' A' ' 70' ' ' VAL 0.322 3.9 p-10 31.9 41.71 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 m-80 -113.46 151.47 31.4 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 110.93 -2.85 . . . . 0.0 104.968 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -80.69 117.68 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 125.415 2.531 . . . . 0.0 113.695 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.416 . . -105.37 -38.71 6.4 Favored 'General case' 0 C--N 1.298 -1.644 2 CA-C-N 104.062 -5.972 . . . . 0.0 114.344 -174.049 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 155.87 27.23 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.496 HG21 ' CG2' ' A' ' 28' ' ' VAL . 67.2 t -75.46 147.72 82.45 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 113.628 -3.229 . . . . 0.0 109.155 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 25.4 Cg_exo -73.05 139.35 29.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.24 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.377 -1.329 . . . . 0.0 110.281 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG13 ' HE3' ' A' ' 43' ' ' LYS . 14.9 t -82.09 134.09 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 117.374 -1.731 . . . . 0.0 114.522 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.494 2.505 0 C-N-CA 118.957 -1.592 . . . . 0.0 113.968 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.59 ' HE3' ' NE1' ' A' ' 24' ' ' TRP . 4.4 tmtm? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -120.95 20.02 11.62 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 109.066 -3.697 . . . . 0.0 111.028 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.566 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -153.11 159.38 42.76 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 126.327 1.851 . . . . 0.0 113.33 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.59 ' NE1' ' HE3' ' A' ' 21' ' ' LYS . 11.6 m-90 -139.32 64.91 33.45 Favored Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HA ' HG13 ' A' ' 79' ' ' VAL . 75.6 Cg_exo -53.85 -40.05 81.92 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.407 2.738 . . . . 0.0 111.184 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 14.6 mp0 -50.5 -27.88 7.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 123.767 1.746 . . . . 0.0 109.671 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 29.4 mt -79.46 -24.09 42.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 116.542 -1.694 . . . . 0.0 113.514 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 ' CG2' ' A' ' 79' ' ' VAL . 95.7 t -47.97 136.72 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -17.49 55.16 Favored Glycine 0 N--CA 1.51 3.591 0 C-N-CA 119.371 -1.395 . . . . 0.0 112.487 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -113.73 161.76 17.12 Favored 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.759 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.5 p -86.55 153.82 21.54 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 126.548 3.07 . . . . 0.0 115.102 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.298 4.3 p -38.9 -56.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 1 CA-C-N 107.128 -4.578 . . . . 0.0 117.446 -174.131 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.39 -23.8 65.61 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 120.508 1.504 . . . . 0.0 113.833 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -77.46 -48.94 15.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -51.46 -44.13 62.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' CG ' HD13 ' A' ' 40' ' ' LEU . 36.7 ttmt -54.53 -47.2 73.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.084 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -54.13 -48.81 70.38 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 124.901 1.376 . . . . 0.0 110.758 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.3 t -64.99 -48.0 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 124.133 1.92 . . . . 0.0 112.029 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.601 ' CG2' HG23 ' A' ' 66' ' ' VAL . 31.4 mt -55.89 -55.39 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.961 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' CG ' ' A' ' 36' ' ' LYS . 3.8 mt -64.74 -22.86 67.08 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.131 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 17.5 tp60 -66.46 -29.04 69.08 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.742 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -97.02 -53.47 3.49 Favored 'General case' 0 N--CA 1.517 2.914 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 20.0 tptp -118.75 72.15 10.79 Favored Pre-proline 0 N--CA 1.506 2.342 0 O-C-N 120.168 -1.583 . . . . 0.0 112.04 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -20.03 -50.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 124.684 3.589 . . . . 0.0 120.144 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.1 mp0 -63.8 -22.21 66.8 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.49 84.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 120.084 3.364 . . . . 0.0 120.084 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -75.33 74.59 2.43 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 39' ' ' ILE . 23.9 mt -76.47 121.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 3.9 mp -119.29 163.05 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 173.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.43 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 8.6 p -85.01 130.2 36.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 111.153 -2.748 . . . . 0.0 106.982 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.633 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -129.12 102.02 19.15 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.58 118.39 5.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 120.912 1.075 . . . . 0.0 113.686 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG21 ' C ' ' A' ' 69' ' ' PHE . 2.4 t -38.81 134.3 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 118.186 2.662 . . . . 0.0 118.186 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 113.61 -37.28 3.66 Favored Glycine 0 N--CA 1.506 3.362 1 CA-C-N 108.232 -4.076 . . . . 0.0 107.13 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.431 ' O ' HG11 ' A' ' 57' ' ' VAL 0.297 80.7 m -56.07 69.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.91 1.684 . . . . 0.0 108.235 174.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' GLY . 11.5 mm -62.63 116.76 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.445 1.593 . . . . 0.0 109.832 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.442 HG23 ' HD3' ' A' ' 67' ' ' ARG . 18.4 m -98.67 -168.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 111.325 -2.671 . . . . 0.0 112.428 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.17 150.37 24.0 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 117.824 2.528 . . . . 0.0 117.824 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.7 mmm -91.71 47.61 1.38 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 123.044 1.402 . . . . 0.0 107.336 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 62' ' ' ARG . 13.0 pt-20 -81.16 -179.55 7.4 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.488 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 1.1 t80 -127.57 41.91 3.42 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 125.479 2.561 . . . . 0.0 107.817 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 64' ' ' ASP . 3.6 mpt_? -88.43 77.42 8.1 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' HA ' HG13 ' A' ' 82' ' ' VAL . 8.7 tp -67.23 22.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.747 1 CA-C-N 107.835 -4.257 . . . . 0.0 116.931 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 62' ' ' ARG . 2.3 p-10 -95.93 -11.82 26.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 110.195 -3.184 . . . . 0.0 108.971 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.438 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 6.3 mtm180 -129.46 88.1 2.64 Favored 'General case' 0 N--CA 1.503 2.194 1 N-CA-C 128.496 6.48 . . . . 0.0 128.496 -173.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.601 HG23 ' CG2' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.83 83.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 121.898 2.135 . . . . 0.0 107.072 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HD3' HG23 ' A' ' 57' ' ' VAL . 2.2 ptp180 -59.32 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 111.23 -2.714 . . . . 0.0 111.088 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . 53.9 mt -73.99 100.17 3.49 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 116.993 -1.883 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.7 m-85 -74.63 98.86 3.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 127.624 3.583 . . . . 0.0 107.268 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.1 m -100.9 165.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 1 CA-C-N 107.267 -4.515 . . . . 0.0 107.21 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.9 p-10 -89.91 -140.61 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 115.935 -2.306 . . . . 0.0 107.973 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 11.3 mptt -95.78 8.98 42.01 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 111.12 -2.763 . . . . 0.0 113.906 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.1 mt -137.6 39.32 2.42 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 112.242 -2.254 . . . . 0.0 107.164 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 33.91 28.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 118.86 2.911 . . . . 0.0 118.86 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.0 m-20 -104.76 148.59 26.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.0 mt -74.93 120.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 126.446 3.022 . . . . 0.0 111.14 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.48 . . -104.54 -52.81 2.82 Favored 'General case' 0 C--N 1.285 -2.227 2 CA-C-N 102.468 -6.697 . . . . 0.0 107.794 -173.592 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -119.98 84.91 2.29 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.761 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.589 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.2 t -42.2 147.71 0.55 Allowed Pre-proline 0 N--CA 1.503 2.18 0 C-N-CA 117.079 -1.848 . . . . 0.0 115.69 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD2' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -89.19 -170.79 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.473 3.449 . . . . 0.0 119.51 -175.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.536 HH11 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -156.46 136.35 12.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.961 -3.291 . . . . 0.0 105.556 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG13 ' HA ' ' A' ' 63' ' ' ILE . 96.7 t -53.65 -63.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 125.888 2.756 . . . . 0.0 109.67 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.536 ' C ' HH11 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.291 -1.919 1 CA-C-N 107.705 -4.316 . . . . 0.0 105.459 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 7.4 tmtm? . . . . . 0 N--CA 1.483 1.185 1 N-CA-C 99.302 -4.332 . . . . 0.0 99.302 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -98.78 13.29 32.87 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.214 -2.721 . . . . 0.0 111.839 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.4 146.56 40.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 126.27 2.231 . . . . 0.0 113.625 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.588 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 19.6 m-90 -131.16 64.7 74.51 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.412 ' HA ' HG11 ' A' ' 79' ' ' VAL . 98.9 Cg_endo -60.08 -33.96 94.89 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.951 2.434 . . . . 0.0 111.234 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.05 -12.1 3.09 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.201 1.477 . . . . 0.0 109.336 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.588 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 17.9 mt -99.31 2.86 45.8 Favored 'General case' 0 CA--C 1.56 1.36 0 O-C-N 121.123 -0.986 . . . . 0.0 112.365 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.507 ' CG2' HG23 ' A' ' 79' ' ' VAL . 88.6 t -73.4 127.07 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-N 120.652 1.569 . . . . 0.0 107.068 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.6 4.04 57.18 Favored Glycine 0 N--CA 1.505 3.298 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' HZ1' ' CB ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -117.63 160.83 20.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -89.6 153.21 20.93 Favored 'General case' 0 CA--C 1.474 -1.967 0 CA-C-O 125.989 2.804 . . . . 0.0 114.696 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.464 ' HB ' HG13 ' A' ' 70' ' ' VAL 0.318 11.6 p -42.37 -62.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.415 1 CA-C-N 107.533 -4.394 . . . . 0.0 118.215 -172.265 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.23 -18.51 63.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.514 -1.674 . . . . 0.0 111.356 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 36.7 tt0 -76.61 -45.75 28.88 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.461 ' CA ' HD12 ' A' ' 27' ' ' LEU . . . -54.38 -55.64 26.58 Favored 'General case' 0 C--O 1.205 -1.251 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -48.5 -49.6 35.17 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.717 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 3.2 ttpp -52.94 -44.29 66.96 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.555 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.66 -47.08 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 CA-C-O 122.156 0.979 . . . . 0.0 112.252 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.549 ' CG2' HG23 ' A' ' 66' ' ' VAL . 40.5 mt -48.24 -48.27 13.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 122.932 1.348 . . . . 0.0 109.691 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.91 -22.27 62.18 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.364 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -16.16 57.31 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.451 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.39 -52.54 3.93 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.749 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mmmp? -119.08 77.99 16.76 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -19.06 -56.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.503 4.135 . . . . 0.0 120.728 -177.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.48 8.27 19.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB3' HD13 ' A' ' 48' ' ' ILE . . . -52.83 87.05 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 70.71 3.67 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.47 HD13 ' CG2' ' A' ' 39' ' ' ILE . 62.1 mt -74.3 148.04 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 112.383 -2.19 . . . . 0.0 116.794 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.11 152.76 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.969 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.4 HG21 HG22 ' A' ' 32' ' ' VAL . 3.5 p -93.6 122.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 112.84 -1.982 . . . . 0.0 113.404 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.535 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 1.4 mp -136.77 141.58 35.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.5 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -80.38 139.54 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.369 1.38 . . . . 0.0 108.769 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -43.81 127.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.98 -34.82 4.67 Favored Glycine 1 N--CA 1.523 4.448 0 CA-C-N 111.179 -2.737 . . . . 0.0 115.613 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.626 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.253 50.2 m -45.03 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.981 1.312 . . . . 0.0 112.695 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.45 106.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 CA-C-O 122.58 1.181 . . . . 0.0 111.545 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.411 ' HB ' ' HD3' ' A' ' 67' ' ' ARG . 1.7 m -111.38 -106.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 85.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 1 N-CA-C 123.297 4.554 . . . . 0.0 123.297 -173.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 18.5 mmm -95.11 -47.57 6.32 Favored 'General case' 0 N--CA 1.501 2.116 1 CA-C-N 106.874 -4.694 . . . . 0.0 105.426 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.499 ' CD ' HH21 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -82.94 -175.9 6.06 Favored 'General case' 0 C--N 1.284 -2.279 3 CA-C-N 103.161 -6.381 . . . . 0.0 112.062 179.385 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.487 ' CE2' HD11 ' A' ' 63' ' ' ILE . 20.8 t80 -157.97 85.66 0.89 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.586 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -100.84 81.76 2.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 175.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.529 ' O ' ' NZ ' ' A' ' 43' ' ' LYS 0.262 6.0 tp -42.54 -6.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.136 1 CA-C-N 108.341 -4.027 . . . . 0.0 117.007 177.711 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.1 p30 -93.88 7.27 45.6 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.228 1.011 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HD2' ' CZ ' ' A' ' 67' ' ' ARG . 20.0 ttp180 -129.78 140.38 51.06 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.549 HG23 ' CG2' ' A' ' 39' ' ' ILE . 9.6 t -111.52 150.68 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 122.918 2.599 . . . . 0.0 106.073 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.556 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.77 112.77 24.48 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.326 -177.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.58 85.14 2.4 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.343 1.652 . . . . 0.0 109.458 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.626 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 29.6 m-85 -83.54 97.42 9.02 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 127.335 3.445 . . . . 0.0 109.965 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.464 HG13 ' HB ' ' A' ' 32' ' ' VAL . 4.4 m -104.24 174.09 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 1 CA-C-N 105.746 -5.206 . . . . 0.0 109.392 -175.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.6 p-10 -99.74 -148.77 0.35 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 124.163 1.935 . . . . 0.0 109.28 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.454 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -95.33 17.17 14.95 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 111.26 -2.7 . . . . 0.0 113.641 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -133.8 26.16 3.99 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 111.222 -2.717 . . . . 0.0 103.715 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.28 0.0 OUTLIER 33.36 35.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.61 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.7 m-20 -113.42 154.91 26.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.6 mt -78.21 119.85 27.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 126.483 3.039 . . . . 0.0 115.423 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.474 . . -98.51 -45.61 6.04 Favored 'General case' 0 C--N 1.293 -1.874 2 CA-C-N 103.662 -6.154 . . . . 0.0 111.696 -173.668 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -117.72 160.66 20.96 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.507 HG23 ' CG2' ' A' ' 28' ' ' VAL . 89.4 t -71.68 146.56 91.2 Favored Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 114.052 -3.059 . . . . 0.0 110.282 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -79.13 159.28 26.79 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.331 2.021 . . . . 0.0 109.6 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 79' ' ' VAL . 8.7 ptp85 -160.38 162.11 33.27 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 117.376 -1.297 . . . . 0.0 113.659 -176.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.503 HG12 HD13 ' A' ' 63' ' ' ILE . 2.9 t -84.55 150.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.197 0 C-N-CA 126.6 2.048 . . . . 0.0 114.427 176.239 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -100.0 19.59 15.97 Favored 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 112.079 -2.328 . . . . 0.0 112.292 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -142.63 151.41 41.43 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.204 176.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.521 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 30.5 m-90 -127.84 75.37 78.19 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.616 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.2 -18.02 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.352 2.035 . . . . 0.0 111.071 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -77.58 -28.68 51.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 2.0 pp -92.27 23.48 3.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.391 1.091 . . . . 0.0 113.918 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.472 ' CG2' HG21 ' A' ' 79' ' ' VAL . 55.7 t -72.53 167.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.83 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.01 36.58 20.94 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-O 123.209 1.449 . . . . 0.0 112.799 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 50.2 mttp -138.1 174.58 10.41 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 112.203 -1.999 . . . . 0.0 110.534 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 p -85.51 159.85 19.82 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 125.321 2.486 . . . . 0.0 114.331 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -32.35 57.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 1 CA-C-N 108.324 -4.035 . . . . 0.0 109.719 -175.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 44.5 mm-40 -63.81 -46.41 85.24 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.024 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.36 -54.93 41.47 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 126.327 2.267 . . . . 0.0 105.079 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -45.69 -54.85 7.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.354 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.5 mtpt -49.43 -56.44 9.69 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -54.45 -48.43 71.75 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.05 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 94.2 t -57.71 -56.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 CA-C-O 124.787 2.232 . . . . 0.0 110.646 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.597 ' CG2' HG23 ' A' ' 66' ' ' VAL . 37.9 mt -55.32 -45.68 77.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.57 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 26.1 mt -56.49 -38.72 72.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 8.7 tt0 -59.0 -44.77 91.71 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.816 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.04 -47.74 60.81 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.782 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.493 ' HZ2' ' CD ' ' A' ' 45' ' ' GLU . 63.6 tttm -125.23 74.84 67.98 Favored Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -7.77 -65.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 1 C-N-CA 125.487 4.125 . . . . 0.0 120.139 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.493 ' CD ' ' HZ2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -88.34 7.12 33.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 -177.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -43.95 103.23 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -85.24 83.47 7.98 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.476 HD13 ' CG2' ' A' ' 39' ' ' ILE . 68.5 mt -80.31 135.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 111.581 -2.554 . . . . 0.0 115.809 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.4 HD13 ' C ' ' A' ' 48' ' ' ILE . 1.8 mp -125.95 137.68 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 111.956 -2.384 . . . . 0.0 111.522 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.42 ' C ' HD13 ' A' ' 51' ' ' LEU . 12.1 p -95.81 145.51 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 5.5 mp -141.12 149.62 56.1 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -81.55 135.38 9.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 N-CA-C 105.474 -2.548 . . . . 0.0 105.474 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 69' ' ' PHE . 87.4 t -42.91 130.48 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.31 -41.1 2.11 Favored Glycine 1 N--CA 1.519 4.214 0 CA-C-N 111.528 -2.578 . . . . 0.0 112.977 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.614 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.258 11.4 m -50.02 165.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 125.279 1.432 . . . . 0.0 111.338 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mm -61.14 136.05 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.581 HG21 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -123.69 -77.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.015 176.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 83.73 6.41 Favored 'General case' 0 C--N 1.295 -1.78 1 N-CA-C 122.698 4.333 . . . . 0.0 122.698 -179.115 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 tpt -97.44 -137.11 0.27 Allowed 'General case' 0 C--N 1.29 -2.003 1 CA-C-N 107.769 -4.287 . . . . 0.0 103.273 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.277 0.1 OUTLIER -78.4 -174.07 3.6 Favored 'General case' 0 C--N 1.288 -2.105 1 N-CA-C 98.843 -4.503 . . . . 0.0 98.843 170.168 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.481 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 7.9 t80 -120.33 135.85 54.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.015 -2.303 . . . . 0.0 117.059 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -115.56 64.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 124.074 1.892 . . . . 0.0 106.844 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.494 HD11 HG12 ' A' ' 82' ' ' VAL . 5.8 tp -42.83 -7.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.8 p30 -81.66 -9.83 59.56 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 124.207 1.003 . . . . 0.0 110.035 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -129.07 149.3 50.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 120.562 3.541 . . . . 0.0 120.562 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 39' ' ' ILE . 5.0 t -110.18 132.21 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 101.962 -3.347 . . . . 0.0 101.962 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.517 HH21 ' C ' ' A' ' 83' ' ' GLY . 16.8 tpp85 -89.83 116.21 27.74 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.779 -2.01 . . . . 0.0 108.098 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 80' ' ' PRO . 7.6 mp -107.92 90.97 3.46 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 124.816 1.323 . . . . 0.0 113.996 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 22.5 m-85 -76.34 103.52 6.4 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 125.588 2.613 . . . . 0.0 112.153 169.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 4.5 m -109.77 171.78 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-N 109.077 -3.692 . . . . 0.0 109.074 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -93.62 -140.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.494 -2.004 . . . . 0.0 111.818 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.4 mmtm -88.51 0.91 55.81 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 110.911 -2.859 . . . . 0.0 112.303 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -136.97 39.52 2.55 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 111.62 -2.537 . . . . 0.0 109.846 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.434 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.57 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -178.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 53.7 m-20 -105.27 142.31 35.27 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 80' ' ' PRO . 79.9 mt -67.18 116.98 7.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 126.69 3.138 . . . . 0.0 114.561 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 53' ' ' VAL 0.468 . . -102.82 -40.61 6.49 Favored 'General case' 0 C--N 1.289 -2.057 1 CA-C-N 104.414 -5.812 . . . . 0.0 111.815 -172.198 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.2 163.72 15.87 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 102.266 -3.235 . . . . 0.0 102.266 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG21 ' CG2' ' A' ' 28' ' ' VAL . 78.1 t -77.3 141.22 66.06 Favored Pre-proline 0 N--CA 1.499 1.998 0 C-N-CA 114.092 -3.043 . . . . 0.0 110.235 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HG2' HD12 ' A' ' 76' ' ' ILE . 14.6 Cg_exo -80.84 145.49 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.544 2.829 . . . . 0.0 106.464 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -153.28 168.45 25.98 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.502 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.494 HG12 HD11 ' A' ' 63' ' ' ILE . 25.0 t -82.64 154.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 116.731 -1.987 . . . . 0.0 113.105 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.517 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.511 3.636 0 C-N-CA 125.937 1.732 . . . . 0.0 114.01 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' CG ' ' A' ' 42' ' ' ASP . 37.3 mtpt . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 122.968 1.366 . . . . 0.0 112.517 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 45.6 p -128.94 19.26 6.04 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.331 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -156.88 150.58 24.57 Favored 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.731 178.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.542 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 20.3 m-90 -133.77 59.89 42.39 Favored Pre-proline 0 N--CA 1.516 2.83 0 N-CA-C 121.118 3.747 . . . . 0.0 121.118 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 24' ' ' TRP . 52.8 Cg_exo -48.98 -40.3 40.58 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 124.098 3.198 . . . . 0.0 110.983 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 4.8 mp0 -46.38 -30.41 2.11 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.621 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.425 HD12 ' CG1' ' A' ' 39' ' ' ILE . 32.6 mt -79.65 -27.37 40.88 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.665 ' CG2' HG23 ' A' ' 79' ' ' VAL . 30.8 t -48.05 137.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.85 -4.12 71.79 Favored Glycine 0 N--CA 1.508 3.446 0 CA-C-N 114.566 -1.197 . . . . 0.0 113.255 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 32.4 mtmm -114.27 178.42 4.29 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.504 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.7 p -85.71 171.56 11.53 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 127.518 3.533 . . . . 0.0 116.867 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.1 p -72.15 -18.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 1 CA-C-N 104.863 -5.608 . . . . 0.0 112.752 -176.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -85.42 -49.09 8.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -50.06 -52.78 31.73 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.91 -44.21 60.0 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.406 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' ILE . 61.1 mttm -62.05 -49.14 77.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.082 1.765 . . . . 0.0 108.24 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.43 ' NZ ' ' OE1' ' A' ' 33' ' ' GLU . 80.5 mttt -54.97 -52.76 62.04 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.976 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.8 -54.99 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.239 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 66' ' ' VAL . 32.2 mt -55.34 -51.0 60.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.095 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 44' ' ' PRO . 96.9 mt -57.37 -33.28 67.64 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -59.81 -43.76 94.35 Favored 'General case' 0 N--CA 1.516 2.871 0 C-N-CA 117.432 -1.707 . . . . 0.0 110.137 175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' CG ' ' NZ ' ' A' ' 21' ' ' LYS . 52.0 m-20 -72.63 -53.06 12.86 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.41 ' N ' ' CD ' ' A' ' 44' ' ' PRO . 26.3 tptp -121.43 57.17 6.79 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 112.347 -2.206 . . . . 0.0 108.389 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 12.5 Cg_exo -12.48 -65.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 125.198 3.932 . . . . 0.0 120.414 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.74 24.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -71.22 124.67 25.01 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-O 122.442 1.115 . . . . 0.0 111.203 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -91.71 67.9 5.46 Favored 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.536 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 20.6 mt -72.37 134.4 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 119.359 3.096 . . . . 0.0 119.359 -173.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 40.5 mm -103.53 175.22 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 113.385 -1.734 . . . . 0.0 111.569 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.427 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 4.6 p -106.4 118.19 53.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 126.516 1.926 . . . . 0.0 111.516 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 16.7 mt -136.29 119.41 12.21 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.399 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -70.45 138.44 35.62 Favored 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 123.51 2.807 . . . . 0.0 110.465 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.7 t -42.28 131.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.45 99.07 1.92 Allowed Glycine 0 N--CA 1.509 3.555 2 N-CA-C 96.215 -6.754 . . . . 0.0 96.215 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.713 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -68.24 116.2 8.57 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -171.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -83.14 -0.24 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 126.036 2.827 . . . . 0.0 111.036 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -110.62 -173.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 108.592 -3.913 . . . . 0.0 111.61 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.489 ' OG1' ' NH1' ' A' ' 62' ' ' ARG . 2.8 p -87.09 -178.53 6.28 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.9 tpt -91.03 -38.08 13.03 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 125.961 2.791 . . . . 0.0 115.345 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 9.5 pt-20 -49.82 -160.68 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.34 1 CA-C-N 105.061 -5.518 . . . . 0.0 117.24 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.699 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 57.8 t80 -114.76 70.84 0.74 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.695 1.247 . . . . 0.0 113.376 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.536 ' H ' ' CD ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -88.22 66.13 8.34 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 126.718 3.152 . . . . 0.0 109.602 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.699 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.23 -31.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 2 N-CA-C 125.652 5.427 . . . . 0.0 125.652 -179.079 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' CG ' HH22 ' A' ' 65' ' ' ARG . 6.4 p-10 -55.09 -18.11 5.03 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 123.458 1.599 . . . . 0.0 108.058 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.531 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 14.8 ttp-105 -135.45 104.37 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.644 HG22 ' CG2' ' A' ' 39' ' ' ILE . 18.4 t -62.04 136.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 123.495 2.861 . . . . 0.0 104.193 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.728 ' CZ ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -96.57 134.89 39.22 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.038 -1.865 . . . . 0.0 112.577 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.728 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 80.5 mt -114.96 81.3 1.54 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.855 -1.975 . . . . 0.0 111.432 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.713 ' CZ ' ' HA ' ' A' ' 55' ' ' THR . 9.4 m-85 -73.7 102.93 4.1 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 126.713 3.149 . . . . 0.0 105.26 167.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -100.75 167.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 1 CA-C-N 107.481 -4.418 . . . . 0.0 106.301 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.5 p-10 -91.39 -141.44 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 123.386 2.812 . . . . 0.0 112.424 -177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.547 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 9.9 mptt -91.66 5.22 50.52 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 111.055 -2.793 . . . . 0.0 114.939 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 73' ' ' LEU 0.264 0.5 OUTLIER -138.6 34.52 2.23 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.6 176.893 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.62 48.03 0.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 124.665 2.174 . . . . 0.0 110.005 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -115.0 142.71 46.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 172.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.63 119.55 15.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 124.359 2.028 . . . . 0.0 112.846 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.477 . . -103.21 -35.67 8.37 Favored 'General case' 0 C--N 1.297 -1.707 2 CA-C-N 104.687 -5.688 . . . . 0.0 110.726 -174.875 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.53 126.63 53.6 Favored 'General case' 0 N--CA 1.52 3.049 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.12 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.727 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 94.2 t -78.38 -75.83 0.07 OUTLIER Pre-proline 0 N--CA 1.516 2.831 1 N-CA-C 124.997 5.184 . . . . 0.0 124.997 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.727 ' CD ' ' CB ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -66.6 51.3 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.613 2 N-CA-C 133.547 8.249 . . . . 0.0 133.547 -171.795 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 80' ' ' PRO 0.262 0.0 OUTLIER -170.69 120.65 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 2 N-CA-C 131.144 7.461 . . . . 0.0 131.144 172.956 . . . . . . . . 5 4 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG21 ' CZ3' ' A' ' 24' ' ' TRP . 4.4 t -51.26 -23.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 111.939 -2.391 . . . . 0.0 113.853 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' C ' HH21 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.28 -2.569 0 O-C-N 128.786 3.804 . . . . 0.0 103.605 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 42.5 tptt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.659 0.742 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -112.37 24.53 12.44 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-O 122.733 1.254 . . . . 0.0 110.601 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -136.77 146.03 45.27 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 112.729 -2.032 . . . . 0.0 108.999 175.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 15.6 m-90 -129.95 62.78 65.77 Favored Pre-proline 0 N--CA 1.522 3.156 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HA ' HG13 ' A' ' 79' ' ' VAL . 77.9 Cg_exo -53.68 -38.92 84.88 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.978 3.118 . . . . 0.0 111.586 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 30.4 mp0 -49.58 -28.65 5.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.919 1.343 . . . . 0.0 110.333 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.483 HD12 ' CB ' ' A' ' 35' ' ' ALA . 74.4 mt -79.92 -19.99 46.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.671 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 ' CG2' ' A' ' 79' ' ' VAL . 59.9 t -49.73 137.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 121.625 2.011 . . . . 0.0 107.831 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.65 -9.03 66.36 Favored Glycine 0 N--CA 1.515 3.922 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.27 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 35.0 mmtm -106.45 166.92 10.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.404 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.9 p -88.46 165.81 14.64 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 126.679 3.133 . . . . 0.0 116.533 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.255 0.3 OUTLIER -60.84 -50.51 80.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 1 CA-C-N 107.174 -4.557 . . . . 0.0 116.569 -174.241 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 41.1 mm-40 -68.17 -37.55 81.11 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.572 -1.651 . . . . 0.0 111.127 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -58.98 -51.09 71.58 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.406 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.483 ' CB ' HD12 ' A' ' 27' ' ' LEU . . . -49.82 -59.08 4.17 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.293 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.303 21.7 tttm -44.55 -53.78 6.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 54.5 mttp -53.47 -53.93 44.3 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.6 -2.091 . . . . 0.0 111.072 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.6 t -59.53 -52.3 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 123.941 1.829 . . . . 0.0 113.193 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 66' ' ' VAL . 15.8 mt -54.17 -50.94 51.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.101 -2.318 . . . . 0.0 107.864 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.64 -14.12 56.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 124.294 0.996 . . . . 0.0 112.675 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -80.27 -21.13 43.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -97.0 -52.12 3.98 Favored 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 10.7 tptp -118.35 72.94 10.19 Favored Pre-proline 0 N--CA 1.514 2.754 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -9.76 -51.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 1 C-N-CA 125.421 4.081 . . . . 0.0 120.495 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 3.4 mp0 -71.89 -23.28 61.47 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.27 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.479 1.133 . . . . 0.0 113.713 -177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -87.57 71.3 9.77 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 39' ' ' ILE . 56.0 mt -74.03 142.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.35 160.92 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 1 CA-C-N 107.687 -4.324 . . . . 0.0 110.053 -179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.04 119.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 112.254 -2.248 . . . . 0.0 106.83 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.507 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 1.5 mt -135.2 121.24 14.3 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 117.249 2.314 . . . . 0.0 117.249 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.66 127.84 19.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 N-CA-C 108.438 -1.408 . . . . 0.0 108.438 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.545 HG21 ' HB3' ' A' ' 69' ' ' PHE . 5.2 p -57.77 139.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 123.876 1.798 . . . . 0.0 113.58 177.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.19 -15.55 27.86 Favored Glycine 1 N--CA 1.521 4.309 0 CA-C-N 110.747 -2.933 . . . . 0.0 113.049 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.485 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.304 17.6 m -45.56 139.28 3.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 176.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.0 mm -80.54 82.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 CA-C-N 123.156 2.707 . . . . 0.0 111.773 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.699 HG23 ' CE2' ' A' ' 69' ' ' PHE . 1.5 m -127.27 156.56 38.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.986 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.57 178.05 5.73 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 109.275 -3.602 . . . . 0.0 115.049 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.584 ' SD ' ' CD ' ' A' ' 81' ' ' ARG . 1.2 tpt -89.41 67.13 7.63 Favored 'General case' 0 N--CA 1.494 1.741 1 N-CA-C 96.432 -5.396 . . . . 0.0 96.432 173.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' CD ' ' NH1' ' A' ' 62' ' ' ARG . 10.3 pt-20 -78.44 154.24 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.83 50.81 0.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.956 1.836 . . . . 0.0 111.783 -176.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NH1' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mpt_? -90.88 72.76 6.54 Favored 'General case' 0 N--CA 1.491 1.595 1 N-CA-C 94.973 -5.936 . . . . 0.0 94.973 175.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 HD13 ' CG1' ' A' ' 82' ' ' VAL . 6.6 tp -40.87 -4.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' NH2' ' A' ' 65' ' ' ARG . 3.9 p-10 -99.3 2.86 45.84 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.426 ' NH2' ' OD2' ' A' ' 64' ' ' ASP . 8.7 tpp180 -123.95 95.51 4.59 Favored 'General case' 0 N--CA 1.498 1.969 1 N-CA-C 124.97 5.174 . . . . 0.0 124.97 -170.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.611 HG23 ' CG2' ' A' ' 39' ' ' ILE . 0.8 OUTLIER -89.2 52.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 115.264 -2.574 . . . . 0.0 105.62 177.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.512 HH11 ' CD ' ' A' ' 60' ' ' GLU . 9.9 ptm180 -48.0 116.46 1.52 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 123.714 1.721 . . . . 0.0 111.703 -174.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' CD1' HG22 ' A' ' 48' ' ' ILE . 67.3 mt -82.15 93.08 6.98 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 109.341 -3.572 . . . . 0.0 115.668 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.699 ' CE2' HG23 ' A' ' 57' ' ' VAL . 37.0 m-85 -74.39 96.06 2.81 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 126.811 3.196 . . . . 0.0 108.45 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 m -106.82 174.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.304 1 CA-C-N 106.937 -4.665 . . . . 0.0 110.422 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.5 p-10 -95.95 -141.55 0.27 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 124.919 2.295 . . . . 0.0 112.769 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 58.6 mttp -83.98 -8.11 59.24 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 108.971 -3.741 . . . . 0.0 113.457 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.423 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.287 0.5 OUTLIER -137.41 48.13 2.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 124.924 2.297 . . . . 0.0 109.677 178.73 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.82 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 2.5 m120 -99.71 142.57 31.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.752 1.263 . . . . 0.0 108.222 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.37 117.7 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 126.389 2.995 . . . . 0.0 115.279 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.459 . . -98.48 -44.27 6.56 Favored 'General case' 0 C--N 1.283 -2.306 2 CA-C-N 103.905 -6.043 . . . . 0.0 109.86 -172.273 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -117.43 118.88 33.43 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 101.073 -3.677 . . . . 0.0 101.073 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.587 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -73.1 137.65 79.03 Favored Pre-proline 0 N--CA 1.501 2.106 1 C-N-CA 110.947 -4.301 . . . . 0.0 109.818 -178.455 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 68' ' ' LEU . 5.8 Cg_exo -82.16 169.75 14.13 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 123.901 3.067 . . . . 0.0 113.836 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.584 ' CD ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -145.87 154.18 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG21 ' CZ3' ' A' ' 24' ' ' TRP . 70.8 t -71.97 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.734 2 CA-C-N 107.048 -4.615 . . . . 0.0 102.923 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 31.3 tttp . . . . . 0 N--CA 1.485 1.3 1 N-CA-C 99.634 -4.21 . . . . 0.0 99.634 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 8.3 p -106.42 -6.29 18.33 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 118.264 -1.374 . . . . 0.0 108.386 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.69 136.01 48.37 Favored 'General case' 0 N--CA 1.523 3.214 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.552 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 29.6 m-90 -126.45 71.62 72.14 Favored Pre-proline 0 N--CA 1.513 2.71 1 N-CA-C 126.553 5.76 . . . . 0.0 126.553 -176.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.08 -35.41 19.99 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.143 1.229 . . . . 0.0 113.828 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 23.0 mp0 -57.61 -37.88 74.02 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 126.344 2.973 . . . . 0.0 114.097 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 4.2 pp -78.57 -16.06 57.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.239 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.481 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 93.3 t -49.51 157.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.913 0 O-C-N 123.22 0.325 . . . . 0.0 110.554 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.74 -13.76 46.08 Favored Glycine 1 N--CA 1.518 4.151 0 O-C-N 120.347 -1.47 . . . . 0.0 113.901 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.08 167.88 10.59 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 117.203 -1.379 . . . . 0.0 112.671 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.5 p -86.52 159.62 19.23 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 127.039 3.304 . . . . 0.0 114.747 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.8 p -45.46 -23.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 1 CA-C-N 106.847 -4.706 . . . . 0.0 119.015 -174.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.62 ' CG ' ' H ' ' A' ' 34' ' ' GLU . 14.3 pt-20 -67.2 -58.67 4.41 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.796 0.808 . . . . 0.0 109.293 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.62 ' H ' ' CG ' ' A' ' 33' ' ' GLU . 2.5 tt0 -56.97 -50.43 72.71 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -47.77 -51.58 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 117.573 -1.651 . . . . 0.0 112.711 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 17.5 mtpp -58.36 -52.8 64.07 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.55 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 4.3 tmtm? -48.6 -41.1 29.77 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.926 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 62.3 t -69.11 -60.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.925 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.54 HG23 HD12 ' A' ' 48' ' ' ILE . 42.9 mt -56.05 -53.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.186 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mp -56.92 -23.74 47.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.419 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.55 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 57.3 tp60 -67.65 -33.5 75.07 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.119 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 51.0 m-20 -92.59 -49.49 6.08 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -120.75 80.45 32.39 Favored Pre-proline 0 N--CA 1.515 2.82 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -35.19 -31.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.574 0 N-CA-C 120.408 3.195 . . . . 0.0 120.408 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.569 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -88.72 -0.23 57.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.843 0.714 . . . . 0.0 112.289 -177.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.46 99.32 0.14 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.699 1.238 . . . . 0.0 111.738 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.26 113.7 25.97 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.54 HD12 HG23 ' A' ' 39' ' ' ILE . 21.8 mt -105.47 155.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.406 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 42.4 mm -125.19 169.74 16.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.581 -3.009 . . . . 0.0 105.899 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 70' ' ' VAL . 8.7 p -107.25 142.43 20.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.481 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -139.51 122.27 10.37 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 178.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' HD21 ' A' ' 51' ' ' LEU . 55.1 Cg_endo -72.7 129.14 14.15 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.27 1.98 . . . . 0.0 112.319 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG2' ' HB3' ' A' ' 69' ' ' PHE . 6.7 t -42.2 133.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.52 -27.0 19.73 Favored Glycine 0 N--CA 1.512 3.72 0 CA-C-N 109.552 -3.476 . . . . 0.0 112.683 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.305 51.8 m -60.66 178.38 0.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 126.28 1.832 . . . . 0.0 112.928 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG21 ' N ' ' A' ' 57' ' ' VAL . 14.1 mt -86.46 154.18 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' CG1' ' HG2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -140.45 -59.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.972 1 N-CA-C 122.666 4.321 . . . . 0.0 122.666 177.113 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 78.14 6.89 Favored 'General case' 0 C--N 1.288 -2.093 1 N-CA-C 123.098 4.481 . . . . 0.0 123.098 -177.5 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 88.9 mtp -97.13 -144.14 0.29 Allowed 'General case' 0 C--N 1.291 -1.942 1 CA-C-N 104.459 -5.791 . . . . 0.0 104.352 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -60.5 -142.31 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 O-C-N 124.854 1.346 . . . . 0.0 112.393 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.627 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -100.25 113.46 26.17 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.339 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.578 ' NH2' ' HB2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -105.54 39.66 1.71 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 123.925 1.821 . . . . 0.0 110.056 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.627 ' HB ' ' CE1' ' A' ' 61' ' ' TYR . 8.6 tp -56.37 -25.64 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 110.098 -3.228 . . . . 0.0 117.351 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -70.44 -11.12 60.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 63' ' ' ILE . 23.0 ttp180 -135.06 163.13 30.59 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -176.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG23 ' CG2' ' A' ' 39' ' ' ILE . 16.1 t -117.08 128.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' NE ' ' HA ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -102.47 110.11 21.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 114.03 -3.068 . . . . 0.0 114.207 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.47 HD13 ' CD1' ' A' ' 39' ' ' ILE . 6.1 mt -107.49 104.79 14.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 111.515 -2.584 . . . . 0.0 106.65 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 8.9 m-85 -69.18 122.24 18.4 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.875 -1.93 . . . . 0.0 107.861 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' CG2' ' A' ' 50' ' ' VAL . 8.3 m -102.46 170.97 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 110.642 -2.981 . . . . 0.0 105.948 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -96.45 -135.88 0.24 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 117.144 -1.823 . . . . 0.0 112.129 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -91.34 3.01 55.97 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 110.405 -3.089 . . . . 0.0 112.306 177.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.5 mt -135.78 34.43 2.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.769 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.29 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -178.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -102.98 139.05 39.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 30' ' ' LYS . 13.1 mt -64.37 115.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.219 0 CA-C-O 126.491 3.043 . . . . 0.0 112.177 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.579 . . -97.98 -39.3 9.02 Favored 'General case' 0 C--N 1.281 -2.394 1 CA-C-N 105.158 -5.474 . . . . 0.0 101.979 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -115.95 129.24 56.3 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.669 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 98.8 t -44.6 -61.83 1.93 Allowed Pre-proline 0 N--CA 1.514 2.765 1 N-CA-C 125.148 5.24 . . . . 0.0 125.148 177.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.261 0.0 OUTLIER 4.8 -161.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 2 C-N-CA 131.114 7.876 . . . . 0.0 128.61 -168.582 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.449 ' C ' HG12 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -145.78 175.19 10.59 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -161.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.444 ' CG2' HG21 ' A' ' 66' ' ' VAL . 21.6 t -68.22 137.34 24.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 109.099 -3.682 . . . . 0.0 108.416 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.503 3.139 0 CA-C-O 114.911 -3.16 . . . . 0.0 117.92 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HZ3' ' CD ' ' A' ' 26' ' ' GLU . 8.9 mtpm? . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -107.16 7.25 29.43 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.515 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -142.74 150.72 40.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 126.15 2.156 . . . . 0.0 112.096 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.556 ' CE3' HG13 ' A' ' 66' ' ' VAL . 25.4 m-90 -132.45 79.51 65.12 Favored Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.48 -30.85 3.76 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 120.872 1.048 . . . . 0.0 110.021 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.485 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 3.0 pm0 -51.8 -20.88 2.42 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 122.501 1.143 . . . . 0.0 113.459 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 35' ' ' ALA . 3.1 pp -107.93 16.19 23.7 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 79' ' ' VAL . 22.3 t -70.64 155.92 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-O 122.343 1.068 . . . . 0.0 112.104 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.29 18.05 70.95 Favored Glycine 0 N--CA 1.512 3.735 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.927 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -128.69 167.48 17.17 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 116.843 -1.551 . . . . 0.0 110.278 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -91.01 166.18 13.14 Favored 'General case' 0 CA--C 1.472 -2.045 1 CA-C-O 128.573 4.035 . . . . 0.0 115.508 179.81 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 50' ' ' VAL . 1.4 p -53.92 -29.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 1 CA-C-N 103.175 -6.375 . . . . 0.0 115.435 -174.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.03 -37.54 23.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.718 -1.239 . . . . 0.0 111.992 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 46.5 mt-10 -61.02 -48.09 83.42 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -47.14 -50.78 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.683 -1.607 . . . . 0.0 112.962 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -51.2 -51.46 53.63 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.682 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.3 -47.41 69.25 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.04 -2.345 . . . . 0.0 108.868 -178.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.2 t -59.16 -57.64 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 CA-C-O 123.555 1.645 . . . . 0.0 111.944 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.53 ' CG2' HG23 ' A' ' 66' ' ' VAL . 14.0 mt -54.98 -46.44 76.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.221 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.18 -33.55 67.59 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.42 -19.6 65.62 Favored 'General case' 0 N--CA 1.519 3.023 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.457 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -96.07 -58.59 2.05 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.24 1.416 . . . . 0.0 110.457 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -121.94 67.8 24.24 Favored Pre-proline 0 N--CA 1.499 1.997 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.328 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.96 -45.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 125.107 3.872 . . . . 0.0 120.271 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.14 -5.26 57.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.64 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -76.44 77.74 3.17 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.481 HG12 ' HB ' ' A' ' 66' ' ' VAL . 44.2 mt -74.89 133.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.7 mp -117.43 162.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 112.463 -2.153 . . . . 0.0 113.119 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.7 p -106.02 131.47 55.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 112.913 -1.949 . . . . 0.0 114.488 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 5.1 mp -138.94 155.87 72.81 Favored Pre-proline 0 N--CA 1.508 2.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -81.38 130.49 7.11 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 121.737 1.624 . . . . 0.0 109.794 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 69' ' ' PHE . 93.7 t -40.44 132.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.43 1.97 Allowed Glycine 0 N--CA 1.505 3.265 0 CA-C-N 110.353 -3.112 . . . . 0.0 108.168 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.431 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 43.3 m -47.09 131.35 12.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.871 1.32 . . . . 0.0 109.264 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.539 ' H ' ' CD1' ' A' ' 56' ' ' ILE . 1.9 mp -52.01 113.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.517 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -104.1 -70.57 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.32 66.54 4.8 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 127.345 3.45 . . . . 0.0 118.757 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -99.66 -119.39 0.15 Allowed 'General case' 0 C--N 1.288 -2.095 1 CA-C-N 104.405 -5.816 . . . . 0.0 106.245 -179.085 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -72.51 -152.22 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 108.998 -3.728 . . . . 0.0 105.461 171.145 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.516 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -128.84 91.59 3.25 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -176.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -94.77 66.22 3.12 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 127.496 3.522 . . . . 0.0 105.937 175.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.516 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 2.7 tp -59.91 -25.13 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 1 CA-C-N 106.549 -4.841 . . . . 0.0 114.019 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.51 24.93 1.55 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.8 ttm-85 -158.16 131.64 7.66 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.556 HG13 ' CE3' ' A' ' 24' ' ' TRP . 12.4 t -104.86 70.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 C-N-CA 116.543 -2.063 . . . . 0.0 105.979 173.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -45.98 138.11 5.3 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.119 1.914 . . . . 0.0 112.157 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.23 116.65 33.1 Favored 'General case' 0 C--N 1.295 -1.786 1 CA-C-N 108.304 -4.044 . . . . 0.0 112.775 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 42.8 m-85 -93.14 99.56 12.12 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 125.721 2.677 . . . . 0.0 110.162 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.442 HG13 ' CG2' ' A' ' 32' ' ' VAL . 1.1 m -111.01 177.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 1 CA-C-N 107.787 -4.279 . . . . 0.0 113.508 -174.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -106.67 -141.87 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 124.177 1.942 . . . . 0.0 113.906 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -83.99 -5.41 59.22 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 110.338 -3.119 . . . . 0.0 113.091 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.5 mt -136.12 43.18 2.54 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 111.075 -2.784 . . . . 0.0 111.171 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 33.15 30.26 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.1 m-20 -106.83 141.0 38.76 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 123.455 1.598 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.61 93.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 127.756 3.646 . . . . 0.0 116.329 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.44 . . -74.41 -40.72 61.83 Favored 'General case' 0 C--N 1.289 -2.053 2 CA-C-N 100.718 -7.492 . . . . 0.0 110.516 -179.273 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -119.52 158.71 25.74 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' A' ' 28' ' ' VAL . 97.2 t -76.92 138.39 65.7 Favored Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 114.506 -2.877 . . . . 0.0 110.71 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.6 Cg_exo -75.89 165.73 29.43 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.773 2.315 . . . . 0.0 110.193 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -162.77 167.94 22.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 63' ' ' ILE . 37.5 t -82.61 133.53 28.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 C-N-CA 118.964 -1.095 . . . . 0.0 109.69 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.138 0 O-C-N 125.32 1.638 . . . . 0.0 112.428 177.178 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.606 ' HZ3' ' CD ' ' A' ' 26' ' ' GLU . 81.2 tttt . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 122.273 1.035 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -97.41 26.55 4.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.62 156.4 47.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.822 1.326 . . . . 0.0 112.743 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.644 ' NE1' ' HA ' ' A' ' 39' ' ' ILE . 11.7 m-90 -134.56 78.61 55.9 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HA ' HG21 ' A' ' 28' ' ' VAL . 66.8 Cg_endo -75.2 -26.21 10.82 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 120.598 0.865 . . . . 0.0 113.993 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 16.1 mp0 -51.33 -29.62 15.76 Favored 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 124.845 2.26 . . . . 0.0 110.11 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.572 HD23 ' CG1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.98 -27.9 49.23 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.035 -177.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.58 ' CG2' HG23 ' A' ' 79' ' ' VAL . 58.5 t -49.02 136.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 CA-C-N 119.97 1.259 . . . . 0.0 112.335 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.83 2.01 69.92 Favored Glycine 0 N--CA 1.507 3.407 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.169 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -126.09 169.49 12.73 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.65 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -87.59 177.13 7.15 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 125.331 2.491 . . . . 0.0 113.829 176.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.58 -37.4 77.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 109.863 -3.335 . . . . 0.0 115.716 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.66 -48.32 69.74 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.509 -1.276 . . . . 0.0 111.162 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.521 ' CD ' ' HZ1' ' A' ' 37' ' ' LYS . 58.5 mm-40 -60.07 -42.1 93.83 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.473 ' HB2' HD22 ' A' ' 27' ' ' LEU . . . -53.52 -60.94 2.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.74 -1.225 . . . . 0.0 110.419 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 55.2 mtpt -45.68 -50.22 13.75 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.339 1.066 . . . . 0.0 108.806 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 73.3 tttt -48.99 -47.64 44.04 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.031 -2.804 . . . . 0.0 109.142 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.64 -49.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 124.731 1.269 . . . . 0.0 112.686 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.644 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 11.1 mt -48.11 -47.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.476 0.655 . . . . 0.0 111.448 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.439 HD22 ' O ' ' A' ' 46' ' ' ALA 0.252 96.0 mt -63.88 -12.81 39.97 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.921 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.99 -47.31 18.78 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.96 -52.72 26.05 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 124.831 2.253 . . . . 0.0 110.773 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 57.6 tttm -122.76 70.06 36.96 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.137 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -28.44 -45.19 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.844 3.029 . . . . 0.0 119.603 178.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.93 8.85 24.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.439 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -64.96 113.14 3.66 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 116.953 -1.899 . . . . 0.0 115.483 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -82.44 67.77 8.62 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.735 -1.853 . . . . 0.0 106.273 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.523 HD13 HG23 ' A' ' 39' ' ' ILE . 2.8 mp -80.77 137.7 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 124.19 1.948 . . . . 0.0 115.528 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.3 mp -120.27 177.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 109.908 -3.315 . . . . 0.0 109.628 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 12.1 p -98.33 125.26 51.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.58 1.181 . . . . 0.0 109.48 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 9.7 mt -122.47 89.06 49.46 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.412 ' HG2' ' OG1' ' A' ' 55' ' ' THR . 37.8 Cg_endo -53.39 130.39 38.29 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 O-C-N 119.005 -1.103 . . . . 0.0 113.436 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.432 HG21 ' C ' ' A' ' 69' ' ' PHE . 54.8 t -45.36 115.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 123.133 1.444 . . . . 0.0 111.157 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.36 8.1 Favored Glycine 0 N--CA 1.513 3.78 1 CA-C-N 107.779 -4.282 . . . . 0.0 115.039 -173.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.472 HG23 HD21 ' A' ' 51' ' ' LEU 0.284 1.4 m -56.94 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 118.945 1.372 . . . . 0.0 107.908 177.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.31 110.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 120.085 3.365 . . . . 0.0 120.085 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.41 HG22 ' HE2' ' A' ' 69' ' ' PHE . 35.3 m -124.12 177.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 108.473 -3.967 . . . . 0.0 110.672 176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -94.89 142.87 26.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 109.759 -3.382 . . . . 0.0 112.574 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.3 tpt -93.28 57.9 2.75 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 123.399 2.818 . . . . 0.0 104.419 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -80.49 -169.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 111.18 -2.736 . . . . 0.0 113.208 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 12.8 t80 -140.21 63.33 1.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.634 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.28 74.61 7.0 Favored 'General case' 0 N--CA 1.486 1.331 1 N-CA-C 97.91 -4.848 . . . . 0.0 97.91 174.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -43.07 -20.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 109.899 -3.319 . . . . 0.0 116.334 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -62.52 4.24 0.16 Allowed 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.904 1.335 . . . . 0.0 109.466 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.613 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.5 ttm-85 -149.87 154.71 38.81 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.602 HG23 ' CG2' ' A' ' 39' ' ' ILE . 3.2 t -115.99 135.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 1 N-CA-C 99.454 -4.276 . . . . 0.0 99.454 176.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.447 ' C ' HD13 ' A' ' 68' ' ' LEU . 8.9 ttm-85 -94.49 126.19 39.61 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.837 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.447 HD13 ' C ' ' A' ' 67' ' ' ARG . 11.1 mp -110.59 76.81 1.0 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.526 2.391 . . . . 0.0 112.048 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 26.1 m-85 -74.98 102.44 4.81 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 126.996 3.284 . . . . 0.0 105.468 168.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 18.7 m -100.77 179.75 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.326 1 CA-C-N 106.055 -5.066 . . . . 0.0 109.975 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.616 ' CG ' ' H ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -89.43 -145.49 0.16 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 117.438 -3.289 . . . . 0.0 111.425 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.6 -4.95 59.25 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 111.336 -2.666 . . . . 0.0 115.62 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.437 HD11 ' O ' ' A' ' 73' ' ' LEU 0.266 0.6 OUTLIER -138.02 48.47 1.98 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 126.875 3.226 . . . . 0.0 106.959 176.938 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 34.58 37.02 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.302 -3.135 . . . . 0.0 116.663 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -106.9 147.73 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 124.14 1.924 . . . . 0.0 107.633 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.92 97.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 127.176 3.369 . . . . 0.0 116.623 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.374 . . -73.1 -48.81 32.55 Favored 'General case' 0 C--N 1.29 -2.016 2 CA-C-N 100.257 -7.701 . . . . 0.0 111.767 179.71 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -119.1 155.85 30.8 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.58 HG23 ' CG2' ' A' ' 28' ' ' VAL . 89.2 t -72.47 142.89 84.64 Favored Pre-proline 0 N--CA 1.507 2.392 0 C-N-CA 114.312 -2.955 . . . . 0.0 108.505 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -82.11 159.03 17.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 123.549 2.833 . . . . 0.0 108.725 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -162.57 171.81 16.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 108.257 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 t -79.5 140.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.15 0 CA-C-O 116.399 -2.334 . . . . 0.0 109.946 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' A' ' 23' ' ' GLU . 81.9 tttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -113.78 21.03 15.36 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.151 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -143.94 132.52 22.31 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 118.381 2.734 . . . . 0.0 118.381 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.562 ' CZ2' HG21 ' A' ' 39' ' ' ILE . 21.3 m-90 -119.1 67.73 8.83 Favored Pre-proline 0 N--CA 1.504 2.234 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -61.9 -36.25 73.44 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 120.867 1.045 . . . . 0.0 110.889 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 21' ' ' LYS . 8.1 pm0 -49.8 -25.02 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.677 1.227 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 52.1 mt -77.07 -34.19 57.09 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.657 -177.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.407 ' CG2' HG21 ' A' ' 79' ' ' VAL . 60.5 t -45.91 135.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.545 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 -177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.84 -15.5 59.47 Favored Glycine 0 N--CA 1.513 3.803 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.129 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.49 176.02 5.56 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -87.97 156.43 19.34 Favored 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.787 3.184 . . . . 0.0 118.314 176.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -46.76 70.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 1 CA-C-N 107.426 -4.443 . . . . 0.0 116.545 -175.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 63.1 mm-40 -54.46 -49.38 70.19 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 116.883 -1.927 . . . . 0.0 111.203 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -49.88 -53.61 24.75 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 124.333 2.016 . . . . 0.0 106.012 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -54.02 -54.91 32.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.275 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.431 ' HA ' HG12 ' A' ' 48' ' ' ILE . 9.5 mtpm? -46.27 -52.02 13.38 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 125.416 1.487 . . . . 0.0 107.72 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 21.1 ttpp -56.98 -57.59 11.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 110.78 -2.918 . . . . 0.0 108.98 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 72.2 t -55.0 -46.44 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 122.85 1.31 . . . . 0.0 112.955 -178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.607 ' CG2' HD12 ' A' ' 48' ' ' ILE . 96.9 mt -66.59 -49.41 75.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.227 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.46 -39.89 73.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 33.4 mt-30 -57.69 -37.37 73.35 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.438 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 21' ' ' LYS . 5.1 t0 -98.16 21.57 10.68 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 126.978 2.111 . . . . 0.0 115.955 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.582 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 65.7 tttt -98.72 105.91 33.68 Favored Pre-proline 0 N--CA 1.526 3.374 1 N-CA-C 128.299 6.407 . . . . 0.0 128.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 4.0 Cg_exo -90.95 -63.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.594 3.479 0 N-CA-C 104.132 -3.064 . . . . 0.0 104.132 161.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' C ' ' HE3' ' A' ' 43' ' ' LYS . 19.8 mp0 -88.81 -27.0 21.39 Favored 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' N ' ' HG3' ' A' ' 43' ' ' LYS . . . -62.35 67.58 0.01 OUTLIER 'General case' 1 N--CA 1.541 4.115 1 N-CA-C 132.85 8.092 . . . . 0.0 132.85 -179.064 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 60.7 tp60 -89.81 113.08 24.59 Favored 'General case' 1 N--CA 1.541 4.078 0 CA-C-N 124.965 3.53 . . . . 0.0 108.21 178.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.607 HD12 ' CG2' ' A' ' 39' ' ' ILE . 1.1 mp -78.48 144.65 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 48' ' ' ILE . 42.9 mm -139.3 142.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 110.433 -3.076 . . . . 0.0 105.402 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.8 141.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.621 HD11 ' CE2' ' A' ' 69' ' ' PHE . 5.9 mt -132.0 128.66 21.55 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 116.88 -1.533 . . . . 0.0 107.675 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.27 135.89 23.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 104.058 -3.093 . . . . 0.0 104.058 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.445 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -41.41 124.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.12 -20.21 38.64 Favored Glycine 0 N--CA 1.505 3.256 0 CA-C-N 109.055 -3.702 . . . . 0.0 118.172 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.489 ' OG1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -48.79 143.94 4.91 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.466 2.133 . . . . 0.0 112.587 -175.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.3 121.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.538 ' CG2' ' HD2' ' A' ' 67' ' ' ARG . 1.8 m -115.89 -87.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -175.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.47 107.64 16.09 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 119.487 3.143 . . . . 0.0 119.487 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.6 mtm -96.14 -58.56 2.05 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 127.649 3.595 . . . . 0.0 108.82 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.61 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -84.36 -145.92 0.09 Allowed 'General case' 0 C--N 1.273 -2.743 1 CA-C-N 104.05 -5.977 . . . . 0.0 105.7 175.173 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.566 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -126.07 94.61 4.14 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.438 172.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.61 ' HE ' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -77.84 50.97 0.9 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 124.911 2.291 . . . . 0.0 112.466 175.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.566 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 10.4 tp -76.66 31.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-O 125.234 2.445 . . . . 0.0 117.321 -176.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 62' ' ' ARG . 23.5 p30 -98.5 -30.63 12.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 111.212 -2.722 . . . . 0.0 109.386 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.572 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 3.8 ttp85 -127.5 158.62 36.92 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 118.923 2.934 . . . . 0.0 118.923 -171.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 39' ' ' ILE . 2.2 t -107.09 127.34 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.538 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.6 ttp180 -87.1 102.03 14.04 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 108.693 -3.867 . . . . 0.0 104.917 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 80' ' ' PRO . 10.9 mp -103.09 90.47 3.75 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 125.398 1.686 . . . . 0.0 111.307 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CE2' HD11 ' A' ' 51' ' ' LEU . 13.0 m-85 -73.28 105.75 4.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 124.762 2.22 . . . . 0.0 109.744 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -106.69 173.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 109.062 -3.699 . . . . 0.0 107.829 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.575 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.7 p-10 -98.39 -139.19 0.3 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 124.575 2.131 . . . . 0.0 111.885 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.575 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.6 mtmm -83.79 -13.52 53.62 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 109.477 -3.511 . . . . 0.0 114.83 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.323 0.3 OUTLIER -136.35 51.13 2.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-O 124.447 2.07 . . . . 0.0 107.197 -178.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.75 25.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 178.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -102.73 156.98 17.27 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.4 mt -78.86 116.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 126.465 3.031 . . . . 0.0 115.563 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.478 . . -94.53 -47.29 6.61 Favored 'General case' 0 C--N 1.287 -2.135 2 CA-C-N 103.381 -6.282 . . . . 0.0 110.065 -174.18 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -114.7 159.62 20.32 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 94.6 t -72.29 132.44 84.11 Favored Pre-proline 0 N--CA 1.499 2.018 0 C-N-CA 114.022 -3.071 . . . . 0.0 110.12 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 38.0 Cg_exo -67.05 144.25 68.9 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.811 2.341 . . . . 0.0 107.88 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.86 153.07 31.43 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.246 -1.359 . . . . 0.0 112.134 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' A' ' 63' ' ' ILE . 13.1 t -82.32 102.64 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.55 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.286 -2.22 0 C-N-CA 118.767 -1.683 . . . . 0.0 110.056 176.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' VAL . 12.8 p -114.89 9.27 16.14 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.255 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.38 150.4 45.26 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.528 -179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.416 ' CG ' HG12 ' A' ' 39' ' ' ILE . 16.3 m-90 -127.86 65.78 69.2 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 123.477 1.608 . . . . 0.0 112.444 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 27' ' ' LEU . 54.2 Cg_endo -67.74 -32.95 28.94 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.596 1.531 . . . . 0.0 109.481 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -65.5 0.49 1.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 39' ' ' ILE . 40.9 mt -99.17 -17.68 18.04 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.986 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.466 ' CG2' HG23 ' A' ' 79' ' ' VAL . 64.0 t -63.11 116.06 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 116.821 -1.952 . . . . 0.0 108.596 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.46 -5.68 24.76 Favored Glycine 0 N--CA 1.508 3.479 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.8 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -101.63 171.72 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.47 1.108 . . . . 0.0 108.564 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -87.19 168.75 12.95 Favored 'General case' 0 CA--C 1.445 -3.079 0 CA-C-O 124.942 2.306 . . . . 0.0 111.688 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.5 HG21 HG13 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -70.39 -39.57 76.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 108.566 -3.925 . . . . 0.0 109.066 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 2.1 pp20? -65.32 -49.74 68.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.287 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 tt0 -58.82 -46.08 88.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 27' ' ' LEU . . . -50.44 -58.51 5.58 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 116.721 -1.609 . . . . 0.0 109.809 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -47.69 -55.17 10.06 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 120.994 1.724 . . . . 0.0 107.481 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -48.04 -51.33 24.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 110.394 -3.094 . . . . 0.0 109.894 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.49 -52.92 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.066 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.622 ' CG2' HG23 ' A' ' 66' ' ' VAL . 22.5 mt -51.34 -47.79 34.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 123.021 1.391 . . . . 0.0 109.832 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.6 -28.79 57.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.01 -34.81 79.33 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 123.313 1.53 . . . . 0.0 109.679 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 36.8 m-20 -88.82 -49.53 6.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 119.661 3.208 . . . . 0.0 119.661 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 24.1 tptp -116.06 72.1 4.46 Favored Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -10.98 -38.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 2 C-N-CA 127.289 5.326 . . . . 0.0 122.773 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.9 mp0 -91.42 -25.11 19.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB3' HD13 ' A' ' 48' ' ' ILE . . . -38.17 80.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 1 N-CA-C 123.353 4.575 . . . . 0.0 123.353 -171.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -76.64 69.88 3.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.532 HD13 HG23 ' A' ' 39' ' ' ILE . 4.6 mt -72.46 131.69 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.352 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.57 162.01 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.77 113.19 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.36 1.076 . . . . 0.0 109.803 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.692 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -114.16 100.85 53.42 Favored Pre-proline 0 N--CA 1.501 2.1 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.616 -178.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.3 131.83 29.56 Favored 'Trans proline' 0 N--CA 1.509 2.416 0 CA-C-N 122.035 1.763 . . . . 0.0 108.926 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 70' ' ' VAL . 78.1 t -46.57 121.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 120.371 -1.455 . . . . 0.0 113.223 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.07 -30.19 6.42 Favored Glycine 1 N--CA 1.517 4.098 0 CA-C-N 110.512 -3.04 . . . . 0.0 114.849 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.573 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.289 91.6 m -47.21 92.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 124.742 1.217 . . . . 0.0 109.205 176.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mm -52.06 101.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 124.046 1.879 . . . . 0.0 115.804 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -103.65 -178.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.44 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.448 ' HG1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -91.16 158.76 16.44 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -174.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.459 ' N ' ' SD ' ' A' ' 59' ' ' MET . 3.6 mpp? -92.13 37.26 0.98 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 123.876 1.798 . . . . 0.0 108.237 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' CD ' ' HG1' ' A' ' 58' ' ' THR . 18.2 pt-20 -81.89 -171.67 3.49 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.757 -2.928 . . . . 0.0 111.773 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.482 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -133.98 82.42 1.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.738 1.256 . . . . 0.0 108.771 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -88.3 78.21 8.05 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 101.291 -3.596 . . . . 0.0 101.291 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.482 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 7.4 tp -69.77 -3.61 3.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 109.412 -3.54 . . . . 0.0 112.659 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.5 -6.7 58.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 110.047 -3.252 . . . . 0.0 106.755 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.292 5.3 ttm-85 -145.33 150.83 37.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 120.265 3.432 . . . . 0.0 120.265 -171.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.622 HG23 ' CG2' ' A' ' 39' ' ' ILE . 4.4 t -111.67 108.64 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.15 125.35 23.77 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 tp -115.12 74.55 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 O-C-N 124.905 1.378 . . . . 0.0 111.641 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.692 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 24.4 m-85 -72.76 104.94 4.13 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 126.593 3.092 . . . . 0.0 111.344 169.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 3.6 m -107.36 171.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 CA-C-N 108.724 -3.853 . . . . 0.0 112.156 -175.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.1 p-10 -83.0 -147.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 123.738 2.972 . . . . 0.0 112.889 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.8 ttpp -91.55 8.5 36.29 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.389 -3.096 . . . . 0.0 112.031 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.445 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.7 mt -141.7 36.45 1.63 Allowed 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 111.458 -2.61 . . . . 0.0 110.245 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.517 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.13 26.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 -177.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -103.62 135.47 45.15 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.64 118.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 127.542 3.544 . . . . 0.0 114.039 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.443 . . -94.68 -51.24 4.81 Favored 'General case' 0 C--N 1.288 -2.105 2 CA-C-N 103.159 -6.382 . . . . 0.0 112.064 -173.023 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.41 161.78 18.55 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.466 HG23 ' CG2' ' A' ' 28' ' ' VAL . 95.0 t -73.46 137.68 77.84 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 113.819 -3.152 . . . . 0.0 108.757 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 13.1 Cg_exo -78.36 152.71 27.07 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.421 ' NH2' ' O ' ' A' ' 82' ' ' VAL . 2.6 ptm180 -156.43 157.83 36.23 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 117.748 -1.581 . . . . 0.0 112.391 -176.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.472 HG21 HG21 ' A' ' 66' ' ' VAL . 3.5 t -81.49 131.5 33.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.401 -1.319 . . . . 0.0 108.104 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.593 0 CA-C-O 114.538 -3.368 . . . . 0.0 112.804 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 49.0 tttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 125.736 2.684 . . . . 0.0 115.041 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -111.94 33.77 4.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 100.458 -3.904 . . . . 0.0 100.458 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -142.31 156.08 45.24 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 126.671 2.482 . . . . 0.0 113.56 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.496 ' CE3' HG13 ' A' ' 66' ' ' VAL . 22.4 m-90 -140.77 62.78 18.47 Favored Pre-proline 0 N--CA 1.509 2.522 0 CA-C-O 123.73 1.729 . . . . 0.0 115.09 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -63.3 -13.02 33.31 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.293 1.995 . . . . 0.0 113.125 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' CD ' ' HZ2' ' A' ' 21' ' ' LYS . 12.0 mp0 -77.43 -20.43 54.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD1' HG13 ' A' ' 39' ' ' ILE . 69.8 mt -87.46 -19.62 27.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.427 ' CG2' HG23 ' A' ' 79' ' ' VAL . 45.4 t -49.51 130.57 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.22 -10.88 60.08 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.637 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -110.11 161.7 15.29 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.7 p -74.5 162.7 28.56 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-O 126.867 3.222 . . . . 0.0 110.961 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 70' ' ' VAL 0.279 9.1 p -62.89 -47.39 93.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 1 CA-C-N 107.199 -4.546 . . . . 0.0 112.163 -173.573 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -68.42 -34.2 75.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.343 -1.743 . . . . 0.0 110.954 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -62.94 -51.1 68.21 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -62.41 -44.19 97.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.398 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 85.7 mttt -45.85 -50.49 14.24 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.236 1.017 . . . . 0.0 108.518 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 5.7 ttpm? -48.14 -54.19 14.16 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 111.876 -2.42 . . . . 0.0 110.932 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 71.4 t -65.76 -47.34 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 112.768 -2.015 . . . . 0.0 111.898 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.628 ' CG2' HG23 ' A' ' 66' ' ' VAL . 17.1 mt -52.92 -53.57 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.886 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.257 34.7 mt -58.2 -19.62 34.92 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 125.154 1.534 . . . . 0.0 110.999 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -75.54 -25.88 57.55 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -96.45 -53.86 3.45 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -118.87 55.05 2.46 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.671 -0.643 . . . . 0.0 110.844 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -17.91 -40.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 125.131 3.888 . . . . 0.0 119.507 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.51 -30.37 68.53 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.518 0.675 . . . . 0.0 112.301 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.0 76.32 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 120.86 3.652 . . . . 0.0 120.86 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.43 74.84 4.96 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.532 HD13 HG23 ' A' ' 39' ' ' ILE . 55.6 mt -73.03 141.84 15.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.645 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.36 170.43 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.047 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.11 122.65 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.616 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 40.9 mt -118.51 77.47 13.98 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -50.79 129.88 28.87 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 106.927 -1.99 . . . . 0.0 106.927 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.485 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 1.3 t -40.86 130.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 123.885 1.802 . . . . 0.0 115.725 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.75 -29.61 12.14 Favored Glycine 0 N--CA 1.508 3.489 0 CA-C-N 110.652 -2.976 . . . . 0.0 113.811 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.513 ' CG2' HD21 ' A' ' 51' ' ' LEU 0.298 3.2 m -45.76 162.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.03 136.63 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.595 HG23 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -141.79 -70.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.873 0 N-CA-C 121.249 3.796 . . . . 0.0 121.249 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 93.33 8.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -98.64 -86.97 0.35 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 108.922 -3.763 . . . . 0.0 102.35 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' CD ' HH21 ' A' ' 62' ' ' ARG . 20.2 pt-20 -81.73 -167.91 1.69 Allowed 'General case' 0 C--N 1.277 -2.557 1 CA-C-N 107.263 -4.517 . . . . 0.0 106.321 173.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.37 95.99 8.44 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.405 HH21 ' CD ' ' A' ' 60' ' ' GLU . 3.0 mpt_? -83.74 66.24 8.95 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 125.088 2.375 . . . . 0.0 104.863 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.616 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.6 tp -74.8 -23.46 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.922 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.56 6.4 5.9 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 109.445 -3.525 . . . . 0.0 108.583 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.303 12.6 ttm-85 -154.87 149.38 26.31 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.628 HG23 ' CG2' ' A' ' 39' ' ' ILE . 2.9 t -117.17 126.44 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-N 120.647 1.567 . . . . 0.0 112.393 174.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 2.3 mtp180 -56.25 104.04 0.13 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 117.1 -1.429 . . . . 0.0 113.035 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 70' ' ' VAL . 10.3 mp -106.48 74.27 1.01 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 123.208 2.731 . . . . 0.0 104.496 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.616 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 16.7 m-85 -72.82 108.64 5.89 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 127.42 3.486 . . . . 0.0 109.262 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 68' ' ' LEU . 32.7 m -106.03 170.33 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 1 CA-C-N 106.647 -4.797 . . . . 0.0 110.088 -173.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 72' ' ' LYS . 5.3 p-10 -94.83 -138.15 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 124.096 1.903 . . . . 0.0 111.082 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 30.0 mmtp -83.57 -11.83 56.88 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 109.74 -3.391 . . . . 0.0 112.447 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.302 0.4 OUTLIER -136.53 52.2 1.97 Allowed 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 124.144 1.926 . . . . 0.0 108.955 -179.202 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' C ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.47 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 110.735 -2.938 . . . . 0.0 118.547 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -99.38 134.56 42.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.641 1.21 . . . . 0.0 110.274 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 mt -52.28 117.9 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 126.326 2.965 . . . . 0.0 111.877 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.435 . . -102.37 -39.19 7.28 Favored 'General case' 0 C--N 1.286 -2.168 1 CA-C-N 104.633 -5.712 . . . . 0.0 112.348 -170.913 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -114.47 160.25 19.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 102.831 -3.025 . . . . 0.0 102.831 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG23 ' CG2' ' A' ' 28' ' ' VAL . 88.3 t -76.88 145.03 73.54 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 114.273 -2.971 . . . . 0.0 109.405 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 14.5 Cg_exo -78.42 151.33 25.86 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.297 -1.463 . . . . 0.0 108.297 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.594 HH22 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -153.63 155.73 36.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.501 HG23 HG21 ' A' ' 66' ' ' VAL . 45.2 t -75.53 -83.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 124.01 1.862 . . . . 0.0 108.454 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.594 ' C ' HH22 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.285 -2.276 1 N-CA-C 102.304 -4.318 . . . . 0.0 102.304 -175.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.621 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 14.6 pttp . . . . . 0 CA--C 1.488 -1.416 0 CA-C-O 124.397 2.046 . . . . 0.0 107.874 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 36.2 p -106.92 -3.7 19.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 110.596 -3.002 . . . . 0.0 111.034 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.621 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -129.77 142.84 50.63 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.575 ' CZ2' HG22 ' A' ' 39' ' ' ILE . 25.5 m-90 -134.23 76.55 62.86 Favored Pre-proline 0 N--CA 1.52 3.068 1 N-CA-C 123.363 4.579 . . . . 0.0 123.363 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -79.84 -35.69 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.873 1.716 . . . . 0.0 111.985 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.13 -18.19 9.23 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -176.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 1.2 pp -104.09 2.05 31.59 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.282 1.433 . . . . 0.0 114.389 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.474 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 49.0 t -70.55 141.67 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.754 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.84 7.6 59.83 Favored Glycine 0 N--CA 1.515 3.941 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -125.96 167.38 15.37 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.525 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 3.2 p -88.17 155.01 19.99 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 126.354 2.978 . . . . 0.0 114.033 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 p -40.97 -49.62 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 1 CA-C-N 106.411 -4.904 . . . . 0.0 120.14 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 57.6 mm-40 -59.88 -49.02 79.35 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.211 -1.395 . . . . 0.0 109.605 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -51.3 -51.82 50.86 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.414 ' HB3' ' CD1' ' A' ' 76' ' ' ILE . . . -52.6 -58.02 8.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.547 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 49.1 mtpt -45.99 -52.45 11.74 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 123.364 1.554 . . . . 0.0 107.107 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.8 -54.05 43.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.483 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.4 t -54.33 -54.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-O 124.896 2.284 . . . . 0.0 109.778 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.575 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 9.3 mt -54.26 -43.88 63.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 110.526 -3.033 . . . . 0.0 112.216 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 46' ' ' ALA . 57.7 mt -73.22 -32.87 65.02 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 125.655 1.847 . . . . 0.0 110.866 175.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -64.81 -18.54 65.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.36 -64.15 1.08 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.277 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -104.65 62.62 0.11 Allowed Pre-proline 0 C--N 1.29 -1.979 0 C-N-CA 127.873 2.469 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -18.86 -49.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 123.983 3.122 . . . . 0.0 120.052 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.53 14.91 13.59 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 48' ' ' ILE . . . -59.56 97.87 0.04 OUTLIER 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.762 1.268 . . . . 0.0 113.626 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.51 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 3.3 tt0 -73.59 77.33 1.49 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.514 HD13 ' CG2' ' A' ' 39' ' ' ILE . 66.8 mt -74.52 135.06 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 123.153 1.454 . . . . 0.0 113.524 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.51 137.58 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 111.514 -2.585 . . . . 0.0 108.758 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.27 141.37 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 123.117 1.437 . . . . 0.0 110.541 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.538 HD22 ' CG2' ' A' ' 55' ' ' THR . 2.5 mp -137.43 140.19 29.77 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.01 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.413 ' O ' ' HB ' ' A' ' 55' ' ' THR . 32.3 Cg_endo -74.82 141.79 27.63 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 t -42.14 128.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.12 20.63 Favored Glycine 0 N--CA 1.507 3.396 0 CA-C-N 111.213 -2.721 . . . . 0.0 112.543 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.538 ' CG2' HD22 ' A' ' 51' ' ' LEU 0.28 0.9 OUTLIER -69.02 177.05 2.82 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 123.76 1.743 . . . . 0.0 112.428 179.106 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.3 mm -59.18 105.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 124.037 4.829 . . . . 0.0 124.037 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -105.18 -50.84 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.613 0 CA-C-N 111.207 -2.724 . . . . 0.0 111.682 173.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 62.95 4.53 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 128.284 3.897 . . . . 0.0 119.156 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.524 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 3.5 ttt -98.65 -162.38 0.95 Allowed 'General case' 0 C--N 1.279 -2.475 1 CA-C-N 103.038 -6.437 . . . . 0.0 108.687 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.524 ' H ' ' HG2' ' A' ' 59' ' ' MET . 0.4 OUTLIER -73.87 -141.69 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.226 172.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.513 ' CE2' HD11 ' A' ' 63' ' ' ILE . 12.1 t80 -136.49 83.35 2.0 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -87.41 76.61 9.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.513 HD11 ' CE2' ' A' ' 61' ' ' TYR . 5.9 tp -52.2 -19.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 110.952 -2.84 . . . . 0.0 112.808 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 47' ' ' GLN 0.263 2.2 p30 -81.43 15.96 1.85 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.975 177.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.476 HH21 ' C ' ' A' ' 83' ' ' GLY . 53.0 ttp180 -153.64 122.65 6.46 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.558 HG12 HD12 ' A' ' 39' ' ' ILE . 24.0 t -91.12 146.79 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 C-N-CA 114.467 -2.893 . . . . 0.0 105.016 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.641 HH21 ' C ' ' A' ' 83' ' ' GLY . 14.9 tpp85 -99.94 114.08 27.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.076 -2.784 . . . . 0.0 105.527 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 HD23 ' CD1' ' A' ' 39' ' ' ILE . 84.3 mt -113.74 105.21 13.03 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.46 -1.296 . . . . 0.0 114.094 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 57' ' ' VAL . 25.7 m-85 -80.14 102.91 9.66 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 125.697 2.665 . . . . 0.0 112.174 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.99 173.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 108.593 -3.912 . . . . 0.0 110.018 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -99.72 -141.75 0.33 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 124.53 2.109 . . . . 0.0 111.935 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.553 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.64 8.54 43.11 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.054 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 75' ' ' ASN . 65.2 mt -135.46 39.95 2.84 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 111.075 -2.784 . . . . 0.0 108.627 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.78 28.0 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 64.0 m-20 -104.8 146.9 28.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.174 1.94 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 35' ' ' ALA . 15.6 mt -77.8 95.33 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-O 127.245 3.403 . . . . 0.0 114.402 -177.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.507 . . -72.3 -45.47 59.87 Favored 'General case' 0 C--N 1.289 -2.045 2 CA-C-N 100.608 -7.542 . . . . 0.0 102.437 178.838 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -119.19 135.14 54.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.74 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 87.2 t -42.72 -56.19 6.27 Favored Pre-proline 0 N--CA 1.519 2.98 1 N-CA-C 124.623 5.046 . . . . 0.0 124.623 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.74 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.255 0.0 OUTLIER 7.01 -152.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 2 C-N-CA 130.714 7.609 . . . . 0.0 127.837 -168.309 . . . . . . . . 5 4 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -155.53 -173.23 4.45 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -158.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 66' ' ' VAL . 5.0 t -81.88 148.55 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.289 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.641 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.988 0 O-C-N 126.392 2.307 . . . . 0.0 114.464 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 1.7 tmtm? . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -123.75 16.51 9.46 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 111.56 -2.564 . . . . 0.0 106.846 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -133.74 150.12 51.48 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.085 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.517 ' CD1' ' HE3' ' A' ' 21' ' ' LYS . 26.8 m-90 -133.22 74.56 72.47 Favored Pre-proline 0 N--CA 1.507 2.388 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -74.14 -33.91 5.43 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.704 2.269 . . . . 0.0 110.486 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -48.43 -34.85 11.66 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.739 2.209 . . . . 0.0 109.945 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.7 pp -98.51 23.08 8.96 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.556 ' CG2' HG21 ' A' ' 79' ' ' VAL . 64.5 t -73.32 163.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.85 17.17 60.33 Favored Glycine 0 N--CA 1.512 3.709 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.949 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.23 163.89 25.74 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-O 116.568 -1.682 . . . . 0.0 109.59 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.5 p -88.42 158.13 18.47 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 126.575 3.083 . . . . 0.0 113.908 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.49 -27.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 1 CA-C-N 106.41 -4.905 . . . . 0.0 114.76 -176.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 34' ' ' GLU . 16.8 pt-20 -66.67 -52.16 47.92 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 123.87 1.795 . . . . 0.0 109.429 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' ' 33' ' ' GLU . 9.6 tm-20 -62.48 -51.04 69.02 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -50.72 -48.92 58.73 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.06 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -57.95 -53.12 61.81 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 3.8 tmtm? -48.2 -35.91 12.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 113.382 -1.736 . . . . 0.0 114.775 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.1 t -85.25 -59.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.229 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 66' ' ' VAL . 40.2 mt -49.25 -48.91 17.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.679 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.94 -23.18 62.19 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.126 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -96.38 -63.27 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 8.2 tptp -111.13 67.23 0.59 Allowed Pre-proline 0 N--CA 1.499 2.007 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -18.62 -46.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 124.599 3.533 . . . . 0.0 120.096 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.3 mp0 -59.28 -35.07 73.07 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.86 79.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.678 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 43.9 tt0 -78.09 65.37 3.46 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.875 1.797 . . . . 0.0 107.269 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 39' ' ' ILE . 32.6 mt -70.46 142.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.442 ' CG2' ' H ' ' A' ' 50' ' ' VAL . 32.9 mm -125.86 -166.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 110.668 -2.969 . . . . 0.0 106.418 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 4.8 p -106.02 142.05 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 0.0 112.56 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' CD1' ' CG2' ' A' ' 55' ' ' THR . 0.0 OUTLIER -139.39 102.81 7.24 Favored Pre-proline 0 N--CA 1.513 2.723 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.55 129.06 15.17 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 122.799 2.035 . . . . 0.0 109.435 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 t -41.94 130.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 123.383 1.563 . . . . 0.0 114.476 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.62 -21.49 45.83 Favored Glycine 0 N--CA 1.503 3.144 0 CA-C-N 111.095 -2.775 . . . . 0.0 114.613 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -58.24 156.36 9.98 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 119.261 1.531 . . . . 0.0 113.416 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.04 127.46 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.124 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG22 ' HE2' ' A' ' 69' ' ' PHE . 30.0 m -131.21 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 112.645 -2.071 . . . . 0.0 109.473 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -155.67 0.31 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.466 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 50.2 mtp -58.1 -149.91 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -18.68 44.36 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 125.27 2.462 . . . . 0.0 116.318 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -116.54 107.15 14.38 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 109.488 -3.506 . . . . 0.0 106.706 178.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.617 ' H ' ' C ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -107.45 43.72 1.16 Allowed 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 125.277 2.465 . . . . 0.0 109.758 179.073 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.2 tp -42.73 -27.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.444 1 CA-C-N 107.295 -4.502 . . . . 0.0 120.058 -177.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.23 -17.62 20.45 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 47' ' ' GLN 0.255 0.1 OUTLIER -142.81 -170.84 3.32 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.863 -2.426 . . . . 0.0 114.017 -176.973 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 39' ' ' ILE . 3.0 t -115.64 111.49 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 1 N-CA-C 88.032 -8.507 . . . . 0.0 88.032 169.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HD3' ' CG1' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -81.04 101.83 9.82 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 122.515 2.416 . . . . 0.0 111.013 -176.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' HG11 ' A' ' 70' ' ' VAL . 8.9 mp -79.9 80.18 6.33 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.507 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 13.6 m-85 -70.12 106.67 3.35 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 125.96 2.79 . . . . 0.0 108.95 166.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 14.9 m -105.9 175.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.766 1 CA-C-N 108.234 -4.075 . . . . 0.0 109.607 -176.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.486 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 6.5 p-10 -91.89 -140.21 0.18 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.232 -2.167 . . . . 0.0 113.194 -177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 43.8 mtmt -89.3 0.87 56.47 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 110.673 -2.967 . . . . 0.0 112.072 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.1 mt -135.77 32.66 2.98 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.874 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.16 28.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -177.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -103.2 148.83 25.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.0 mt -74.88 106.46 4.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 126.843 3.211 . . . . 0.0 114.18 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.399 . . -81.34 -51.88 7.88 Favored 'General case' 0 C--N 1.287 -2.152 2 CA-C-N 101.692 -7.049 . . . . 0.0 110.042 -177.744 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.49 148.33 39.59 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.556 HG21 ' CG2' ' A' ' 28' ' ' VAL . 88.8 t -70.45 141.73 88.47 Favored Pre-proline 0 N--CA 1.502 2.132 0 C-N-CA 114.193 -3.003 . . . . 0.0 108.113 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 6.2 Cg_exo -89.27 159.16 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.765 2.31 . . . . 0.0 108.26 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.41 ' C ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -154.29 157.27 38.41 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -177.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 HG21 ' CH2' ' A' ' 24' ' ' TRP . 55.6 t -75.26 109.79 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 176.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.276 -2.768 0 CA-C-N 110.869 -2.878 . . . . 0.0 107.032 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.688 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.551 1.006 0 CA-C-O 124.31 2.005 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' NZ ' ' CD1' ' A' ' 24' ' ' TRP . 4.0 tmtt? -100.47 56.13 0.9 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 66.5 p -102.96 34.98 2.66 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-O 122.897 1.332 . . . . 0.0 108.771 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' CD ' HH22 ' A' ' 81' ' ' ARG 0.251 0.0 OUTLIER -154.78 151.62 28.89 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.612 -176.736 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.439 ' N ' ' OE1' ' A' ' 23' ' ' GLU . 24.1 m-90 -139.47 81.01 21.01 Favored Pre-proline 0 N--CA 1.517 2.887 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.4 -34.68 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.915 2.41 . . . . 0.0 111.612 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.77 -17.6 9.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.154 -0.966 . . . . 0.0 111.445 -177.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 1.7 pp -107.05 17.63 22.79 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.51 ' CG2' HG21 ' A' ' 79' ' ' VAL . 69.8 t -65.99 169.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.109 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.37 18.18 35.18 Favored Glycine 1 N--CA 1.521 4.354 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -121.05 157.4 30.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.2 p -89.03 159.71 17.45 Favored 'General case' 0 CA--C 1.472 -2.053 0 CA-C-O 127.482 3.515 . . . . 0.0 109.083 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -40.01 -54.18 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.263 1 CA-C-N 105.888 -5.142 . . . . 0.0 118.722 -174.009 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 60.3 mm-40 -55.33 -47.87 75.02 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.936 1.698 . . . . 0.0 110.776 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 1.2 tm-20 -50.96 -47.14 61.29 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.77 -47.78 76.9 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.16 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 66.9 mttm -49.32 -50.55 39.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 76.9 tttt -48.64 -55.33 11.55 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 110.803 -2.908 . . . . 0.0 108.757 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 67.5 t -59.87 -54.27 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.764 0 CA-C-O 125.53 2.586 . . . . 0.0 112.72 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.585 ' CG2' HG23 ' A' ' 66' ' ' VAL . 31.6 mt -57.33 -50.03 78.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 112.151 -2.295 . . . . 0.0 110.663 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 67.8 mt -57.3 -36.42 71.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.1 tt0 -58.78 -44.72 90.76 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 118.05 -1.46 . . . . 0.0 110.935 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.74 -48.39 54.75 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.434 -1.712 . . . . 0.0 114.026 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 25.9 ttpp -127.36 68.31 72.96 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -14.72 -43.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 124.678 3.585 . . . . 0.0 119.949 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -86.97 -5.28 59.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.6 96.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -77.76 93.32 4.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 178.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.483 HD13 ' CG2' ' A' ' 39' ' ' ILE . 73.0 mt -93.14 114.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 121.377 3.843 . . . . 0.0 121.377 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.402 HG12 HE22 ' A' ' 47' ' ' GLN . 36.5 mm -102.27 149.76 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 112.768 -2.014 . . . . 0.0 107.602 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.92 155.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.116 0.96 . . . . 0.0 112.506 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.719 ' HB3' ' CE1' ' A' ' 69' ' ' PHE 0.254 0.6 OUTLIER -142.42 132.19 12.26 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.579 -179.788 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' HD22 ' A' ' 51' ' ' LEU . 52.5 Cg_endo -72.05 113.97 3.84 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.172 1.915 . . . . 0.0 113.994 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 69' ' ' PHE . 36.5 t -41.56 123.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.441 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 119.51 -37.89 2.99 Favored Glycine 0 N--CA 1.507 3.424 2 O-C-N 129.751 4.407 . . . . 0.0 108.651 -175.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.267 52.0 m -60.04 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.031 1.332 . . . . 0.0 108.183 175.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' GLY . 24.9 mm -55.46 147.98 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.87 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.513 HG22 ' NE ' ' A' ' 67' ' ' ARG . 12.4 m -123.01 -147.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.418 ' HG1' ' CD ' ' A' ' 60' ' ' GLU . 1.1 p -87.49 155.33 20.05 Favored 'General case' 0 C--N 1.306 -1.321 1 N-CA-C 124.796 5.11 . . . . 0.0 124.796 -173.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -93.86 34.7 1.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 123.083 1.421 . . . . 0.0 110.865 176.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' CD ' ' HG1' ' A' ' 58' ' ' THR . 24.9 pt-20 -82.02 -176.11 5.97 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.57 56.36 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 123.145 1.45 . . . . 0.0 107.391 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mmm180 -88.96 67.28 8.13 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 126.991 3.282 . . . . 0.0 107.782 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 HD11 HG13 ' A' ' 82' ' ' VAL . 6.5 tp -53.2 -26.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 1 CA-C-N 107.19 -4.55 . . . . 0.0 109.518 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' GLN . 1.3 p30 -60.91 -7.16 2.2 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.811 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' NH1' ' HB2' ' A' ' 62' ' ' ARG . 6.1 ttp85 -139.55 151.58 46.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 121.768 3.988 . . . . 0.0 121.768 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.585 HG23 ' CG2' ' A' ' 39' ' ' ILE . 21.2 t -115.08 92.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' NE ' HG22 ' A' ' 57' ' ' VAL . 26.8 ttm180 -48.58 123.24 6.43 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 109.826 -3.352 . . . . 0.0 106.05 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HG ' HG21 ' A' ' 32' ' ' VAL 0.271 0.6 OUTLIER -115.16 84.03 2.01 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 125.916 2.01 . . . . 0.0 112.303 -176.965 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.719 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 26.0 m-85 -73.33 108.38 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 124.71 2.195 . . . . 0.0 107.057 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' HG21 ' A' ' 53' ' ' VAL . 14.5 m -113.46 174.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 1 CA-C-N 108.286 -4.052 . . . . 0.0 110.368 -177.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.586 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.2 p-10 -88.69 -146.89 0.16 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 122.941 2.61 . . . . 0.0 111.637 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.586 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 12.0 mptt -90.63 0.34 57.42 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 111.736 -2.484 . . . . 0.0 113.994 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.482 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.375 0.2 OUTLIER -139.15 47.8 1.89 Allowed 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 112.558 -2.11 . . . . 0.0 105.772 178.101 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.71 27.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -100.9 151.68 21.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 123.331 1.539 . . . . 0.0 109.576 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.0 mt -78.72 93.71 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 127.466 3.507 . . . . 0.0 116.125 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.351 . . -73.2 -42.09 63.07 Favored 'General case' 0 C--N 1.291 -1.957 2 CA-C-N 100.292 -7.685 . . . . 0.0 112.958 178.702 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -117.57 156.14 28.61 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.51 HG21 ' CG2' ' A' ' 28' ' ' VAL . 88.5 t -76.34 136.51 68.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 112.75 -3.58 . . . . 0.0 104.981 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -81.48 169.59 15.35 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.518 2.812 . . . . 0.0 111.695 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.508 HH22 ' CD ' ' A' ' 23' ' ' GLU . 2.3 ptp180 -163.69 172.38 14.3 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 116.624 -1.655 . . . . 0.0 111.731 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.534 HG21 HG21 ' A' ' 66' ' ' VAL . 6.1 t -82.58 -111.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' HG11 ' A' ' 82' ' ' VAL . . . . . . . . 0 C--N 1.287 -2.167 3 N-CA-C 96.046 -6.821 . . . . 0.0 96.046 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.704 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 120.926 0.393 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 13.3 mtpp -102.07 156.83 17.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 124.011 1.862 . . . . 0.0 112.444 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 ' HA ' HG21 ' A' ' 82' ' ' VAL . 6.5 p -111.42 -6.51 14.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.97 135.08 35.65 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.497 ' CG ' HG12 ' A' ' 39' ' ' ILE . 25.4 m-90 -117.0 72.94 6.24 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 122.983 1.373 . . . . 0.0 114.581 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.45 -31.98 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.643 1.562 . . . . 0.0 110.66 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.475 ' CD ' ' HZ2' ' A' ' 21' ' ' LYS . 33.4 mp0 -52.18 -34.9 47.19 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.167 1.461 . . . . 0.0 109.928 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 24' ' ' TRP 0.25 4.5 pp -102.06 36.48 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 123.704 1.716 . . . . 0.0 113.027 -177.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 79' ' ' VAL . 9.9 t -81.45 155.92 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.767 171.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.65 29.1 17.55 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.469 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.511 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 3.0 mmmp? -120.58 176.49 5.48 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 117.13 -1.414 . . . . 0.0 109.44 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -85.32 160.28 19.85 Favored 'General case' 0 CA--C 1.459 -2.532 0 CA-C-O 126.053 2.835 . . . . 0.0 112.109 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG2' HG13 ' A' ' 70' ' ' VAL 0.251 1.7 p -69.55 -28.31 37.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 1 CA-C-N 107.189 -4.551 . . . . 0.0 111.13 -173.701 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.443 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 18.6 mm-40 -77.23 -38.55 50.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.1 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 32.8 mt-10 -63.08 -50.85 68.94 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 125.889 1.993 . . . . 0.0 105.632 174.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.73 -58.53 3.01 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.79 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 52.1 mttp -49.48 -54.96 14.95 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-O 122.549 1.166 . . . . 0.0 108.425 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' NZ ' ' OE1' ' A' ' 33' ' ' GLU . 57.5 mttp -52.95 -46.65 68.27 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.233 -2.258 . . . . 0.0 112.029 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 27' ' ' LEU . 99.4 t -67.51 -52.51 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 122.559 1.171 . . . . 0.0 110.705 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.551 ' CG2' HG23 ' A' ' 66' ' ' VAL . 17.5 mt -51.74 -48.69 37.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.315 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.595 HD22 ' O ' ' A' ' 46' ' ' ALA . 88.4 mt -60.77 -34.83 75.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 124.988 1.43 . . . . 0.0 107.378 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -84.79 -57.24 3.2 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 114.095 -1.412 . . . . 0.0 113.551 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 45' ' ' GLU . 51.9 tttm -115.54 78.69 6.73 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.338 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -22.71 -52.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 N-CA-C 118.683 2.532 . . . . 0.0 118.683 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.67 9.35 14.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -178.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -65.15 96.17 0.2 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 117.822 -1.551 . . . . 0.0 113.18 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -77.92 69.86 4.2 Favored 'General case' 0 N--CA 1.513 2.692 0 O-C-N 118.338 -2.726 . . . . 0.0 107.893 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.478 HD13 HG23 ' A' ' 39' ' ' ILE . 32.8 mt -78.04 122.06 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 112.793 -2.003 . . . . 0.0 116.114 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.579 ' H ' ' NH2' ' A' ' 65' ' ' ARG . 1.3 mp -115.47 170.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.453 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 7.7 p -72.79 126.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 123.096 1.427 . . . . 0.0 110.512 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.498 HD21 ' CG2' ' A' ' 55' ' ' THR . 0.2 OUTLIER -131.62 104.8 14.39 Favored Pre-proline 0 N--CA 1.492 1.673 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.505 -177.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -56.54 115.05 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.625 0.545 . . . . 0.0 111.015 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.578 ' HA ' ' CG ' ' A' ' 69' ' ' PHE . 14.9 p -39.81 142.31 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 123.679 1.704 . . . . 0.0 112.655 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' N ' ' CE2' ' A' ' 69' ' ' PHE . . . 95.84 -26.09 22.09 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 112.067 -2.333 . . . . 0.0 110.976 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.498 ' CG2' HD21 ' A' ' 51' ' ' LEU 0.321 3.0 m -54.39 -179.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.225 1.012 . . . . 0.0 113.644 176.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.32 99.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 118.646 -2.534 . . . . 0.0 114.388 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.25 -48.18 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.268 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.97 68.54 0.68 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 127.659 3.6 . . . . 0.0 113.603 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.505 ' SD ' ' HG3' ' A' ' 62' ' ' ARG . 18.2 ttm -99.77 -177.96 3.72 Favored 'General case' 0 C--N 1.276 -2.609 1 CA-C-N 104.315 -5.857 . . . . 0.0 107.292 -178.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 11.8 pt-20 -78.53 -163.23 0.43 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 174.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.74 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 67.3 t80 -94.76 81.56 3.82 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.616 -1.303 . . . . 0.0 111.602 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.505 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 8.6 mmt85 -88.65 56.78 3.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.45 -1.7 . . . . 0.0 109.528 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.74 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.27 -27.6 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 111.348 -2.66 . . . . 0.0 116.642 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.07 -14.81 1.73 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 124.008 1.861 . . . . 0.0 108.328 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.579 ' NH2' ' H ' ' A' ' 49' ' ' ILE . 6.2 mtp180 -132.21 157.41 44.41 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 119.443 3.127 . . . . 0.0 119.443 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.551 HG23 ' CG2' ' A' ' 39' ' ' ILE . 2.9 t -115.45 134.44 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 1 N-CA-C 98.5 -4.629 . . . . 0.0 98.5 171.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.478 ' CD ' HD11 ' A' ' 51' ' ' LEU . 9.2 tpp180 -83.13 134.68 34.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.454 HD11 ' CG2' ' A' ' 48' ' ' ILE . 3.2 mt -113.86 82.01 1.62 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.856 1.347 . . . . 0.0 108.475 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CG ' ' HA ' ' A' ' 53' ' ' VAL . 2.6 m-30 -73.46 92.45 1.87 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 126.498 3.047 . . . . 0.0 108.592 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.432 HG13 ' CG2' ' A' ' 32' ' ' VAL . 4.8 m -105.16 171.04 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 1 CA-C-N 105.327 -5.397 . . . . 0.0 104.017 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.616 ' CG ' ' H ' ' A' ' 72' ' ' LYS . 1.5 p-10 -96.75 -138.39 0.27 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 125.373 2.511 . . . . 0.0 112.261 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 22.0 mtmm -85.32 -11.99 53.36 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 109.195 -3.639 . . . . 0.0 114.166 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.306 0.3 OUTLIER -138.05 52.36 1.85 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 112.087 -2.324 . . . . 0.0 107.675 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 36.42 22.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 34.4 m-20 -105.62 138.27 42.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 123.473 1.606 . . . . 0.0 110.608 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.64 122.43 11.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 126.006 2.812 . . . . 0.0 117.211 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.485 . . -104.5 -44.16 4.98 Favored 'General case' 0 C--N 1.289 -2.03 1 CA-C-N 105.362 -5.381 . . . . 0.0 111.016 -171.831 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -115.42 161.7 18.18 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 28' ' ' VAL . 95.4 t -75.79 134.25 72.29 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 113.939 -3.105 . . . . 0.0 109.05 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 31.9 Cg_exo -68.72 131.93 23.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 103.803 -3.191 . . . . 0.0 103.803 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 22' ' ' THR . 4.9 ptm180 -138.67 157.2 46.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.479 1.112 . . . . 0.0 108.703 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 22' ' ' THR . 11.8 t -79.03 152.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.358 1.036 . . . . 0.0 112.697 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.455 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.513 3.824 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.029 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.7 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.217 -0.628 0 CA-C-O 120.841 0.353 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 5.8 tmtt? -77.24 59.94 1.86 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 48.2 p -104.55 24.96 10.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 112.608 -2.087 . . . . 0.0 105.401 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.07 151.16 43.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 126.225 2.203 . . . . 0.0 113.202 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.615 ' CG ' HG12 ' A' ' 39' ' ' ILE . 26.9 m-90 -128.67 67.32 76.73 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 123.285 1.517 . . . . 0.0 112.293 174.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -63.42 -37.67 47.62 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 CA-C-N 113.301 -1.357 . . . . 0.0 110.034 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 21' ' ' LYS . 19.6 pm0 -51.01 -31.32 17.73 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.165 0.983 . . . . 0.0 111.934 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.6 pp -105.84 31.9 4.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 79' ' ' VAL . 77.4 t -84.71 124.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 170.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.82 3.46 54.94 Favored Glycine 0 N--CA 1.514 3.868 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 31.9 mmtp -109.53 156.13 20.52 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.367 -0.917 . . . . 0.0 110.306 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 p -85.81 155.07 21.15 Favored 'General case' 0 CA--C 1.474 -1.945 0 CA-C-O 127.386 3.47 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -48.93 -56.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 1 CA-C-N 106.022 -5.081 . . . . 0.0 120.739 -170.259 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 50.0 mm-40 -57.67 -40.43 79.36 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 117.417 -1.713 . . . . 0.0 110.559 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 4.7 tt0 -60.13 -54.39 46.46 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' CB ' HD11 ' A' ' 27' ' ' LEU . . . -44.58 -52.4 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.964 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mttt -55.77 -58.15 9.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 3.8 tmtm? -47.46 -40.14 17.49 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.798 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 77.4 t -70.59 -56.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.549 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.615 HG12 ' CG ' ' A' ' 24' ' ' TRP . 47.7 mt -48.19 -39.18 8.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 122.814 1.292 . . . . 0.0 110.836 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 11.7 mt -53.26 -35.9 60.53 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.077 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -62.66 -46.59 87.49 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-O 123.942 1.829 . . . . 0.0 110.455 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' CG ' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -62.78 -49.94 72.99 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.988 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 1.2 mtpp -125.81 81.14 66.04 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.799 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.49 -54.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 118.204 2.348 . . . . 0.0 118.204 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.578 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -90.36 13.65 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB3' HD13 ' A' ' 48' ' ' ILE . . . -60.22 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.032 0.92 . . . . 0.0 113.293 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -82.74 72.32 9.81 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 124.567 2.127 . . . . 0.0 106.071 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.55 HD13 ' CG2' ' A' ' 39' ' ' ILE . 49.2 mt -73.63 148.95 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 110.617 -2.992 . . . . 0.0 117.37 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.87 162.08 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 112.748 -2.023 . . . . 0.0 112.84 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 133.93 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 112.06 -2.336 . . . . 0.0 105.115 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.68 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.6 mt -141.51 113.36 6.62 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.564 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -76.0 130.04 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 CA-C-N 121.818 1.685 . . . . 0.0 108.0 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 69' ' ' PHE . 13.1 t -39.55 130.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.61 -40.69 2.46 Favored Glycine 1 N--CA 1.518 4.144 0 CA-C-N 109.302 -3.59 . . . . 0.0 111.019 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 40.6 m -46.29 125.49 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.721 1.208 . . . . 0.0 108.778 177.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.39 152.28 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -51.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.716 1 N-CA-C 125.002 5.186 . . . . 0.0 125.002 -175.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.08 99.98 5.54 Favored 'General case' 0 C--N 1.288 -2.081 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.407 ' HB2' ' NH2' ' A' ' 62' ' ' ARG . 87.9 mtp -94.11 -117.55 0.1 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 100.809 -3.775 . . . . 0.0 100.809 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HG3' ' NH1' ' A' ' 62' ' ' ARG 0.257 3.1 pp20? -76.54 -167.29 0.78 Allowed 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 111.012 -2.813 . . . . 0.0 106.251 172.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.493 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -79.68 98.73 7.08 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.975 0.893 . . . . 0.0 112.074 -173.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -85.59 58.7 5.19 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 125.758 2.694 . . . . 0.0 109.468 177.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.493 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 7.6 tp -71.47 -9.22 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 109.524 -3.489 . . . . 0.0 116.476 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -96.87 -1.69 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.788 1.28 . . . . 0.0 108.252 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.03 144.61 50.98 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 HG23 ' A' ' 39' ' ' ILE . 3.1 t -116.94 145.86 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -103.66 130.79 51.18 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.746 175.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' O ' HG12 ' A' ' 70' ' ' VAL . 20.3 mt -103.2 83.05 2.14 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.662 -2.063 . . . . 0.0 107.398 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.68 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.5 m-85 -73.18 100.15 3.0 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 126.478 3.037 . . . . 0.0 108.485 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 68' ' ' LEU . 32.8 m -101.52 171.15 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 1 CA-C-N 106.541 -4.845 . . . . 0.0 108.211 -176.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.514 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.2 p-10 -97.35 -140.87 0.29 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 124.633 2.158 . . . . 0.0 111.689 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.514 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 37.4 tttp -85.88 -0.97 56.77 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 109.199 -3.637 . . . . 0.0 111.451 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.435 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.3 mt -136.08 38.79 2.75 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.624 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.49 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -100.08 134.38 43.09 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.418 HG23 ' HG3' ' A' ' 80' ' ' PRO . 50.8 mt -58.37 122.96 9.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 125.328 2.49 . . . . 0.0 109.651 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.476 . . -105.4 -38.13 6.59 Favored 'General case' 0 C--N 1.284 -2.267 2 CA-C-N 105.19 -5.459 . . . . 0.0 110.261 -172.601 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -118.71 160.08 22.49 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.069 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.46 HG23 HG22 ' A' ' 28' ' ' VAL . 95.4 t -65.55 135.99 95.95 Favored Pre-proline 0 N--CA 1.501 2.089 0 C-N-CA 114.881 -2.728 . . . . 0.0 110.107 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HG2' HD13 ' A' ' 27' ' ' LEU . 4.4 Cg_exo -83.45 142.46 10.54 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 N-CA-C 104.417 -2.955 . . . . 0.0 104.417 -176.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 22' ' ' THR . 6.9 ptm180 -156.56 163.76 39.0 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 116.522 -2.071 . . . . 0.0 113.375 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 83' ' ' GLY . 2.7 t -84.38 155.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 125.924 2.015 . . . . 0.0 111.994 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.542 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.428 0 CA-C-O 114.127 -3.596 . . . . 0.0 112.512 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.705 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.215 -0.758 0 CA-C-O 120.856 0.36 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -102.19 45.63 0.96 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -98.41 31.22 2.9 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.396 -1.322 . . . . 0.0 111.384 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.63 146.29 31.28 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.913 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.522 ' CZ3' HG22 ' A' ' 82' ' ' VAL . 24.1 m-90 -127.4 67.17 71.1 Favored Pre-proline 0 N--CA 1.498 1.966 0 CA-C-O 124.262 1.982 . . . . 0.0 111.396 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' HA ' HG23 ' A' ' 79' ' ' VAL . 40.8 Cg_endo -69.29 -41.51 4.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 CA-C-N 111.068 -2.154 . . . . 0.0 110.614 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -67.42 -9.64 43.67 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.786 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -107.78 13.73 26.16 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.488 HG23 HG23 ' A' ' 79' ' ' VAL . 48.6 t -68.01 161.46 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.72 57.15 Favored Glycine 1 N--CA 1.518 4.147 0 C-N-CA 118.475 -1.821 . . . . 0.0 113.829 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 2.9 mtpp -106.48 166.62 10.42 Favored 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 124.122 0.969 . . . . 0.0 111.655 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 p -85.7 154.23 21.79 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 126.249 2.928 . . . . 0.0 115.717 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -48.94 -57.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 1 CA-C-N 107.875 -4.239 . . . . 0.0 114.202 -172.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -53.01 -36.51 60.6 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 121.506 1.957 . . . . 0.0 113.802 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -70.04 -50.68 38.83 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.45 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -46.55 -51.82 14.71 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 123.422 1.582 . . . . 0.0 107.488 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -55.16 -54.2 46.23 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -49.1 -42.03 37.66 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.341 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 85.5 t -67.57 -53.49 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.393 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 66' ' ' VAL . 45.6 mt -60.3 -51.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.084 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp -52.68 -27.75 18.75 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.575 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 39.4 tp60 -68.98 -23.75 64.16 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.1 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.19 -53.37 3.82 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.283 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 18.6 ttpp -116.7 76.69 7.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.24 -45.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 123.387 2.725 . . . . 0.0 117.446 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.25 0.7 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 16.3 mt-30 -77.94 60.74 2.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.511 HD13 ' CG2' ' A' ' 39' ' ' ILE . 65.6 mt -73.22 140.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.502 ' CG2' ' H ' ' A' ' 50' ' ' VAL . 43.1 mm -115.86 175.7 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.607 1.194 . . . . 0.0 112.645 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.502 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 17.2 t -102.52 116.09 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 110.279 -3.146 . . . . 0.0 108.327 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.658 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 13.4 mt -124.04 92.18 48.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.05 127.94 27.76 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 N-CA-C 109.286 -1.082 . . . . 0.0 109.286 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -43.18 127.89 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.877 0 CA-C-O 123.613 1.673 . . . . 0.0 111.186 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 -21.04 35.42 Favored Glycine 1 N--CA 1.517 4.063 0 CA-C-N 109.587 -3.461 . . . . 0.0 112.778 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.448 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.333 23.7 m -68.25 62.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 173.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 mm -51.11 112.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 124.308 2.004 . . . . 0.0 116.382 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 69' ' ' PHE . 30.2 m -103.56 167.82 2.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 110.106 -3.225 . . . . 0.0 104.394 175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 -171.68 2.3 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 108.852 -3.794 . . . . 0.0 111.958 -174.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.3 tpp -92.23 23.76 3.69 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.073 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.406 ' CD ' HH12 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -85.03 166.21 16.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.627 ' CD2' ' HA2' ' A' ' 83' ' ' GLY . 8.3 t80 -145.59 154.19 41.89 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.601 ' N ' ' CD2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -116.43 62.1 0.72 Allowed 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.52 ' N ' ' CD2' ' A' ' 61' ' ' TYR . 5.3 tp -44.54 -27.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.07 -24.37 24.9 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.154 -2.294 . . . . 0.0 108.261 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 62' ' ' ARG 0.269 7.1 ttm-85 -129.38 158.77 38.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 110.375 -3.102 . . . . 0.0 114.434 -168.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.588 HG23 HG23 ' A' ' 39' ' ' ILE . 3.1 t -103.8 140.86 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.406 HH12 ' CD ' ' A' ' 60' ' ' GLU . 4.1 tpp180 -81.34 115.55 20.76 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.3 mp -113.46 84.79 2.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.518 1.136 . . . . 0.0 112.791 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 36.0 m-85 -74.41 104.77 5.27 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 127.238 3.399 . . . . 0.0 106.361 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.51 172.17 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.042 1 CA-C-N 107.166 -4.561 . . . . 0.0 105.833 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.6 p-10 -95.43 -142.4 0.26 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 123.793 2.997 . . . . 0.0 113.688 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.2 ttpp -92.02 9.4 33.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.732 -3.395 . . . . 0.0 110.34 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.4 mt -142.71 38.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 111.513 -2.585 . . . . 0.0 110.74 177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.69 20.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -176.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.5 m-20 -104.61 142.3 34.9 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.943 1.354 . . . . 0.0 108.845 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.7 mt -63.28 113.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 126.518 3.056 . . . . 0.0 112.359 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.488 . . -88.51 -51.34 5.76 Favored 'General case' 0 C--N 1.283 -2.294 2 CA-C-N 103.479 -6.237 . . . . 0.0 107.909 -173.258 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -118.02 157.84 26.06 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG23 HG23 ' A' ' 28' ' ' VAL . 94.4 t -63.66 138.64 97.43 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 115.75 -2.38 . . . . 0.0 112.482 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 3.5 Cg_exo -86.63 157.13 9.09 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.58 2.186 . . . . 0.0 108.26 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.449 HH21 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -154.5 150.24 27.59 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.142 -176.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.522 HG22 ' CZ3' ' A' ' 24' ' ' TRP 0.278 21.9 t -89.13 105.09 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.729 1.268 . . . . 0.0 107.783 175.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.627 ' HA2' ' CD2' ' A' ' 61' ' ' TYR . . . . . . . . 0 C--N 1.27 -3.121 0 C-N-CA 117.7 -2.191 . . . . 0.0 110.853 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.691 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 121.625 0.726 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.07 49.59 2.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.848 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -101.29 17.84 21.54 Favored 'General case' 0 N--CA 1.526 3.354 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -140.15 151.89 45.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 125.105 1.503 . . . . 0.0 114.327 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 29.4 m-90 -134.53 73.16 68.72 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 123.762 1.744 . . . . 0.0 112.944 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -77.45 -34.77 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.702 1.601 . . . . 0.0 111.576 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -62.35 -18.89 62.61 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 123.402 1.572 . . . . 0.0 109.429 -177.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -97.94 15.31 24.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 79' ' ' VAL . 99.2 t -73.53 164.45 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.838 -1.164 . . . . 0.0 108.325 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 2.1 89.75 Favored Glycine 1 N--CA 1.518 4.112 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.809 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 14.5 mtmm -130.05 168.51 16.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.312 1.045 . . . . 0.0 108.536 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 10.7 p -87.82 160.08 18.16 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 127.835 3.683 . . . . 0.0 114.319 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -45.76 -50.88 3.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 1 CA-C-N 105.277 -5.42 . . . . 0.0 116.141 -172.738 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 8.8 mm-40 -54.99 -42.41 72.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.082 -1.011 . . . . 0.0 112.162 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.98 -46.59 74.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.64 -49.37 62.42 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.116 -1.434 . . . . 0.0 111.336 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -53.04 -50.2 64.78 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 52.5 mttp -50.9 -46.65 60.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.99 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.1 -56.9 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-O 124.685 2.183 . . . . 0.0 111.309 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.593 ' CG2' HG23 ' A' ' 66' ' ' VAL . 35.3 mt -54.38 -45.84 69.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.011 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 46' ' ' ALA . 91.7 mt -58.13 -36.51 73.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.728 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.55 -39.33 94.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.183 -1.407 . . . . 0.0 110.933 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.41 -45.96 29.31 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.101 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 63.7 tttm -125.18 66.86 53.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -9.83 -57.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 1 C-N-CA 125.466 4.111 . . . . 0.0 121.233 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -82.59 1.49 37.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.449 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -57.74 84.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.21 111.01 7.05 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.486 HD12 ' CG2' ' A' ' 39' ' ' ILE . 20.2 mt -107.77 152.37 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.6 mm -124.58 163.06 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 123.752 1.739 . . . . 0.0 114.009 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.417 ' CB ' HG22 ' A' ' 32' ' ' VAL . 7.1 p -106.76 118.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 112.316 -2.22 . . . . 0.0 113.805 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 5.7 mp -128.6 136.58 29.33 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.095 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.79 135.97 20.22 Favored 'Trans proline' 0 N--CA 1.512 2.58 0 C-N-CA 123.017 2.478 . . . . 0.0 109.059 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 69' ' ' PHE . 72.1 t -43.16 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-N 120.437 1.471 . . . . 0.0 114.894 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.32 -39.82 2.47 Favored Glycine 0 N--CA 1.51 3.581 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.902 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.589 ' HB ' ' CE1' ' A' ' 69' ' ' PHE . 22.4 m -47.61 168.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.787 1.28 . . . . 0.0 113.803 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.79 118.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.572 HG21 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -114.91 -77.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.362 174.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 78.6 9.77 Favored 'General case' 0 C--N 1.283 -2.326 1 N-CA-C 124.172 4.879 . . . . 0.0 124.172 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 tpt -98.99 -128.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 1 CA-C-N 107.153 -4.567 . . . . 0.0 104.098 176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.55 ' CD ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.87 -169.49 2.38 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 172.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.619 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 39.3 t80 -118.04 102.56 9.14 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.72 -1.238 . . . . 0.0 112.311 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 65' ' ' ARG . 2.1 mpt_? -90.83 68.46 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 124.188 1.947 . . . . 0.0 108.739 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.504 HD11 HG12 ' A' ' 82' ' ' VAL . 4.6 tp -42.34 -29.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 112.681 -2.054 . . . . 0.0 116.026 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.04 -17.43 10.1 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 124.16 1.933 . . . . 0.0 111.448 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.611 HH12 ' C ' ' A' ' 83' ' ' GLY . 21.6 ttp85 -132.14 149.7 52.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.593 HG23 ' CG2' ' A' ' 39' ' ' ILE . 3.3 t -106.73 139.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.15 124.69 44.38 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.42 HD13 ' HB3' ' A' ' 80' ' ' PRO . 2.7 mp -109.29 90.39 3.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 125.879 1.987 . . . . 0.0 110.761 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.589 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 12.8 m-85 -70.99 110.96 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 126.155 2.883 . . . . 0.0 110.475 170.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 4.9 m -103.25 170.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-N 108.912 -3.767 . . . . 0.0 109.221 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.7 p-10 -93.43 -140.62 0.22 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 124.285 1.993 . . . . 0.0 112.033 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -92.14 6.82 45.15 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 110.545 -3.025 . . . . 0.0 111.21 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.424 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 72.1 mt -136.74 32.08 2.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.534 -2.121 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.465 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 34.96 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.97 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 45.0 m-20 -108.47 137.94 45.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.51 111.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 126.431 3.015 . . . . 0.0 112.796 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.475 . . -90.22 -47.01 8.06 Favored 'General case' 0 C--N 1.288 -2.108 2 CA-C-N 103.27 -6.332 . . . . 0.0 108.657 -173.842 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -117.14 157.15 26.42 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 111.556 -2.565 . . . . 0.0 107.765 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.436 HG23 HG22 ' A' ' 28' ' ' VAL . 94.5 t -75.4 141.03 72.89 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 115.122 -2.631 . . . . 0.0 108.74 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HG2' HD12 ' A' ' 27' ' ' LEU . 6.5 Cg_exo -84.25 158.68 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.56 2.173 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 156.65 32.49 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.032 -1.461 . . . . 0.0 109.195 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 63' ' ' ILE . 23.9 t -74.93 144.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.258 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.619 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . . . . . . 0 N--CA 1.509 3.53 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.63 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.675 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.556 1.178 0 CA-C-O 122.7 1.238 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -100.45 76.9 1.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 123.584 1.659 . . . . 0.0 113.241 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -98.34 1.74 47.34 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HB2' ' NH2' ' A' ' 81' ' ' ARG . 0.6 OUTLIER -139.68 155.9 47.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.635 0.731 . . . . 0.0 111.736 172.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.492 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 30.1 m-90 -118.87 71.93 10.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -70.71 -30.54 17.72 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.054 1.169 . . . . 0.0 109.501 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -66.06 2.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.916 0.865 . . . . 0.0 109.979 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.492 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 31.3 mt -103.97 -8.07 19.9 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.653 -0.654 . . . . 0.0 110.902 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.498 ' CG2' HG21 ' A' ' 79' ' ' VAL . 53.2 t -66.51 107.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 123.148 1.452 . . . . 0.0 108.846 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.56 5.04 22.94 Favored Glycine 0 N--CA 1.506 3.306 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.639 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' NZ ' ' CD ' ' A' ' 34' ' ' GLU . 1.5 mmmp? -111.69 167.6 10.22 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.736 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -88.28 173.18 8.92 Favored 'General case' 0 CA--C 1.443 -3.14 0 CA-C-O 123.008 1.385 . . . . 0.0 112.791 177.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.558 ' CG2' HG13 ' A' ' 70' ' ' VAL . 1.4 p -80.98 -55.62 7.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 108.903 -3.771 . . . . 0.0 115.641 -171.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' CD ' ' HZ1' ' A' ' 36' ' ' LYS . 35.1 mm-40 -62.83 -21.13 65.7 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 122.362 2.346 . . . . 0.0 109.867 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 38.0 tt0 -75.9 -49.07 18.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -46.33 -52.5 12.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HZ1' ' CD ' ' A' ' 33' ' ' GLU . 82.0 tttt -48.05 -46.58 33.49 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 112.768 -2.015 . . . . 0.0 106.645 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 40.4 tttm -55.54 -54.3 45.65 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.487 -1.285 . . . . 0.0 109.891 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 69.1 t -59.02 -47.88 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 CA-C-O 124.291 1.996 . . . . 0.0 111.734 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.607 ' CG2' HG23 ' A' ' 66' ' ' VAL . 14.7 mt -56.16 -51.8 58.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 112.764 -2.017 . . . . 0.0 109.21 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -61.93 -37.66 85.53 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 29.5 tp60 -58.92 -24.25 62.22 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.205 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' OD2' ' NE1' ' A' ' 24' ' ' TRP . 49.5 t0 -96.2 -51.53 4.37 Favored 'General case' 0 N--CA 1.523 3.194 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.01 75.28 21.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -9.79 -55.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 2 C-N-CA 126.121 4.547 . . . . 0.0 122.717 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -89.67 -0.29 57.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . . . -42.27 97.75 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.437 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 93.4 mm-40 -87.59 65.21 8.44 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 39' ' ' ILE . 46.6 mt -72.26 127.03 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 121.456 3.873 . . . . 0.0 121.456 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -123.14 128.23 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.062 -3.245 . . . . 0.0 106.085 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 51' ' ' LEU . 12.4 p -81.07 158.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 126.411 2.319 . . . . 0.0 113.129 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' CB ' ' CZ ' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -141.1 151.65 62.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -85.48 131.83 4.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.145 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.3 t -42.33 133.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 106.75 -31.27 8.39 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 110.273 -3.149 . . . . 0.0 113.487 -178.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.312 40.2 m -48.62 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.8 1.24 . . . . 0.0 108.186 175.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' GLY . 21.1 mm -53.61 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 125.033 2.349 . . . . 0.0 112.274 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 m -98.75 -173.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 110.046 -3.252 . . . . 0.0 105.776 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -92.43 144.95 24.85 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 111.68 -2.509 . . . . 0.0 116.231 -174.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.11 40.14 1.06 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.291 1.52 . . . . 0.0 108.388 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 19.4 pt-20 -83.14 -171.97 3.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.589 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 74.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 123.614 1.673 . . . . 0.0 113.914 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' ASP . 15.5 mmt180 -89.69 68.22 7.55 Favored 'General case' 0 C--N 1.294 -1.843 1 N-CA-C 97.865 -4.865 . . . . 0.0 97.865 176.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.455 HD11 HG13 ' A' ' 82' ' ' VAL . 6.5 tp -43.85 -1.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' ARG . 3.1 p30 -85.67 -9.11 57.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.492 1.917 . . . . 0.0 108.71 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.437 ' NH2' ' O ' ' A' ' 47' ' ' GLN . 38.9 ttm-85 -128.53 148.76 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 -172.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.607 HG23 ' CG2' ' A' ' 39' ' ' ILE . 4.2 t -117.27 120.63 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 1 N-CA-C 99.214 -4.365 . . . . 0.0 99.214 170.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.581 HH21 ' C ' ' A' ' 83' ' ' GLY . 3.1 tpp85 -79.92 117.14 20.5 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.76 93.06 4.34 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 124.533 1.146 . . . . 0.0 110.633 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.592 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 26.5 m-85 -79.43 102.43 8.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 126.124 2.869 . . . . 0.0 109.93 170.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.558 HG13 ' CG2' ' A' ' 32' ' ' VAL . 2.3 m -108.93 177.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 108.475 -3.966 . . . . 0.0 109.47 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.6 p-10 -101.96 -142.77 0.35 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 124.478 2.085 . . . . 0.0 113.533 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -86.67 -2.09 58.24 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 109.021 -3.718 . . . . 0.0 113.09 -178.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.3 mt -135.84 37.95 2.82 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.915 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.13 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 65.6 m-20 -109.73 149.95 29.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -72.8 121.63 23.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 126.911 3.243 . . . . 0.0 116.983 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.462 . . -106.05 -42.58 5.06 Favored 'General case' 0 C--N 1.295 -1.796 2 CA-C-N 103.671 -6.149 . . . . 0.0 112.559 -173.213 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.4 ' CD ' ' HB3' ' A' ' 69' ' ' PHE . 27.8 mt-30 -111.46 153.97 25.37 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.498 HG21 ' CG2' ' A' ' 28' ' ' VAL . 62.8 t -75.9 139.89 70.09 Favored Pre-proline 0 N--CA 1.508 2.447 0 C-N-CA 112.547 -3.661 . . . . 0.0 106.893 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 9.7 Cg_exo -78.92 152.12 24.67 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 N-CA-C 106.673 -2.087 . . . . 0.0 106.673 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.494 ' NH2' ' HB2' ' A' ' 23' ' ' GLU . 7.7 ptp180 -160.76 159.31 29.91 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.079 -1.048 . . . . 0.0 112.041 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.455 HG13 HD11 ' A' ' 63' ' ' ILE . 5.4 t -78.24 143.66 12.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 124.265 1.983 . . . . 0.0 111.36 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.581 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C--N 1.296 -1.64 0 CA-C-N 110.014 -3.266 . . . . 0.0 110.215 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.689 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.212 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -124.9 49.57 1.84 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p -100.87 16.44 25.17 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.599 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.79 153.74 51.5 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 125.253 1.596 . . . . 0.0 110.267 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -128.49 60.44 48.41 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 123.075 1.416 . . . . 0.0 114.714 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -53.47 -35.95 77.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.417 2.078 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -48.05 -31.32 5.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.136 1.446 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.455 HD12 HG13 ' A' ' 39' ' ' ILE . 56.0 mt -79.77 -26.85 40.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.886 -1.961 . . . . 0.0 114.847 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.496 ' CG2' HG21 ' A' ' 79' ' ' VAL . 14.3 t -50.92 137.83 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 117.877 -1.529 . . . . 0.0 107.59 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.23 -13.9 66.54 Favored Glycine 0 N--CA 1.505 3.238 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.305 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -111.34 166.84 10.77 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 117.438 0.619 . . . . 0.0 111.617 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.2 p -90.62 164.32 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 128.273 3.892 . . . . 0.0 115.119 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.69 -31.22 6.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 105.511 -5.313 . . . . 0.0 121.921 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -50.25 13.8 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 123.336 1.541 . . . . 0.0 107.195 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 2.2 tm-20 -50.67 -52.1 43.09 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 102.75 -3.055 . . . . 0.0 102.75 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.71 -60.16 3.14 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.952 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -48.37 -49.07 36.07 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 8.9 ttpp -53.1 -53.45 50.12 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.626 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.64 -55.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 CA-C-O 123.432 1.587 . . . . 0.0 111.607 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.608 ' CG2' HG23 ' A' ' 66' ' ' VAL . 23.0 mt -53.54 -43.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.871 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 46' ' ' ALA . 60.3 mt -64.99 -38.06 89.72 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.387 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -57.79 -48.29 80.14 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.441 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.66 -47.18 73.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.78 -1.555 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HE3' HG13 ' A' ' 82' ' ' VAL . 58.8 tttm -124.74 71.83 60.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 C-N-CA 124.513 1.125 . . . . 0.0 111.617 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -21.58 -50.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 124.35 3.366 . . . . 0.0 118.331 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 0.34 43.19 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.467 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -59.87 92.31 0.02 OUTLIER 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' ASP . 19.3 tt0 -75.72 70.4 2.51 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.475 HD12 ' CG2' ' A' ' 39' ' ' ILE . 47.5 mt -72.68 141.22 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.852 -2.431 . . . . 0.0 117.135 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' HB ' ' HD3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -125.91 156.52 35.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 123.075 1.417 . . . . 0.0 108.063 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.85 142.78 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 111.964 -2.38 . . . . 0.0 106.854 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 1.4 mt -137.17 125.29 14.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.59 135.12 35.03 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.049 1.41 . . . . 0.0 108.857 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -44.02 123.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.957 0.885 . . . . 0.0 112.742 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.22 -35.58 3.85 Favored Glycine 0 N--CA 1.513 3.803 0 O-C-N 128.075 3.359 . . . . 0.0 113.278 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.663 ' HB ' ' CE1' ' A' ' 69' ' ' PHE . 60.1 m -47.61 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.463 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mm -53.4 97.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 124.437 2.065 . . . . 0.0 112.481 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 55' ' ' THR . 14.7 m -97.26 -176.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 110.76 -2.927 . . . . 0.0 105.563 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.33 147.1 24.27 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 112.197 -2.274 . . . . 0.0 115.328 -172.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtp -91.55 34.23 0.98 Allowed 'General case' 0 N--CA 1.515 2.788 0 CA-C-O 124.929 2.299 . . . . 0.0 112.315 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 24.1 pt-20 -83.71 -163.25 0.74 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 109.134 -3.666 . . . . 0.0 115.299 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.65 67.16 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.06 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.39 66.73 7.54 Favored 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 126.608 3.099 . . . . 0.0 105.865 177.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.455 HD11 HG13 ' A' ' 82' ' ' VAL . 4.9 tp -42.8 -8.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 109.717 -3.401 . . . . 0.0 119.446 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' CG ' HH21 ' A' ' 65' ' ' ARG . 45.8 p30 -80.86 -5.7 57.67 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 119.588 1.086 . . . . 0.0 108.166 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 64' ' ' ASP 0.26 15.9 ttm-85 -137.45 147.58 45.44 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -174.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.608 HG23 ' CG2' ' A' ' 39' ' ' ILE . 5.2 t -101.33 140.06 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 1 N-CA-C 99.205 -4.369 . . . . 0.0 99.205 173.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.408 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 1.5 tpp180 -89.44 120.11 30.48 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 mt -111.33 88.15 2.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 126.066 2.104 . . . . 0.0 114.036 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.663 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 38.2 m-85 -81.76 99.62 9.06 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 127.852 3.691 . . . . 0.0 107.734 170.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 5.7 m -100.19 171.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 1 CA-C-N 106.042 -5.072 . . . . 0.0 106.75 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.4 p-10 -87.72 -141.02 0.11 Allowed 'General case' 0 C--N 1.293 -1.874 0 O-C-N 118.818 -2.426 . . . . 0.0 110.72 -175.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 44.3 mmtm -95.88 8.2 44.25 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 110.256 -3.156 . . . . 0.0 112.683 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.1 mt -137.59 32.46 2.51 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.198 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.456 ' HA ' ' CG2' ' A' ' 70' ' ' VAL 0.322 3.9 p-10 31.9 41.71 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 m-80 -113.46 151.47 31.4 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 110.93 -2.85 . . . . 0.0 104.968 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -80.69 117.68 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 125.415 2.531 . . . . 0.0 113.695 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.416 . . -105.37 -38.71 6.4 Favored 'General case' 0 C--N 1.298 -1.644 2 CA-C-N 104.062 -5.972 . . . . 0.0 114.344 -174.049 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 155.87 27.23 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.496 HG21 ' CG2' ' A' ' 28' ' ' VAL . 67.2 t -75.46 147.72 82.45 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 113.628 -3.229 . . . . 0.0 109.155 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 25.4 Cg_exo -73.05 139.35 29.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.24 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.377 -1.329 . . . . 0.0 110.281 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG13 ' HE3' ' A' ' 43' ' ' LYS . 14.9 t -82.09 134.09 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 117.374 -1.731 . . . . 0.0 114.522 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.494 2.505 0 C-N-CA 118.957 -1.592 . . . . 0.0 113.968 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.706 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.214 -0.803 0 CA-C-O 122.413 1.101 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.59 ' HE3' ' NE1' ' A' ' 24' ' ' TRP . 4.4 tmtm? -116.16 72.93 0.83 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -120.95 20.02 11.62 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 109.066 -3.697 . . . . 0.0 111.028 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.566 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -153.11 159.38 42.76 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 126.327 1.851 . . . . 0.0 113.33 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.59 ' NE1' ' HE3' ' A' ' 21' ' ' LYS . 11.6 m-90 -139.32 64.91 33.45 Favored Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HA ' HG13 ' A' ' 79' ' ' VAL . 75.6 Cg_exo -53.85 -40.05 81.92 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.407 2.738 . . . . 0.0 111.184 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 14.6 mp0 -50.5 -27.88 7.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 123.767 1.746 . . . . 0.0 109.671 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 29.4 mt -79.46 -24.09 42.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 116.542 -1.694 . . . . 0.0 113.514 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 ' CG2' ' A' ' 79' ' ' VAL . 95.7 t -47.97 136.72 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -17.49 55.16 Favored Glycine 0 N--CA 1.51 3.591 0 C-N-CA 119.371 -1.395 . . . . 0.0 112.487 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -113.73 161.76 17.12 Favored 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.759 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.5 p -86.55 153.82 21.54 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 126.548 3.07 . . . . 0.0 115.102 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.298 4.3 p -38.9 -56.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 1 CA-C-N 107.128 -4.578 . . . . 0.0 117.446 -174.131 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.39 -23.8 65.61 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 120.508 1.504 . . . . 0.0 113.833 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -77.46 -48.94 15.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -51.46 -44.13 62.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' CG ' HD13 ' A' ' 40' ' ' LEU . 36.7 ttmt -54.53 -47.2 73.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.084 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -54.13 -48.81 70.38 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 124.901 1.376 . . . . 0.0 110.758 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.3 t -64.99 -48.0 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 124.133 1.92 . . . . 0.0 112.029 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.601 ' CG2' HG23 ' A' ' 66' ' ' VAL . 31.4 mt -55.89 -55.39 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.961 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' CG ' ' A' ' 36' ' ' LYS . 3.8 mt -64.74 -22.86 67.08 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.131 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 17.5 tp60 -66.46 -29.04 69.08 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.742 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -97.02 -53.47 3.49 Favored 'General case' 0 N--CA 1.517 2.914 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 20.0 tptp -118.75 72.15 10.79 Favored Pre-proline 0 N--CA 1.506 2.342 0 O-C-N 120.168 -1.583 . . . . 0.0 112.04 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -20.03 -50.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 124.684 3.589 . . . . 0.0 120.144 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.1 mp0 -63.8 -22.21 66.8 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.49 84.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 120.084 3.364 . . . . 0.0 120.084 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -75.33 74.59 2.43 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 39' ' ' ILE . 23.9 mt -76.47 121.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 3.9 mp -119.29 163.05 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 173.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.43 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 8.6 p -85.01 130.2 36.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 111.153 -2.748 . . . . 0.0 106.982 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.633 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -129.12 102.02 19.15 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.58 118.39 5.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 120.912 1.075 . . . . 0.0 113.686 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG21 ' C ' ' A' ' 69' ' ' PHE . 2.4 t -38.81 134.3 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 118.186 2.662 . . . . 0.0 118.186 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 113.61 -37.28 3.66 Favored Glycine 0 N--CA 1.506 3.362 1 CA-C-N 108.232 -4.076 . . . . 0.0 107.13 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.431 ' O ' HG11 ' A' ' 57' ' ' VAL 0.297 80.7 m -56.07 69.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.91 1.684 . . . . 0.0 108.235 174.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' GLY . 11.5 mm -62.63 116.76 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.445 1.593 . . . . 0.0 109.832 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.442 HG23 ' HD3' ' A' ' 67' ' ' ARG . 18.4 m -98.67 -168.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 111.325 -2.671 . . . . 0.0 112.428 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.17 150.37 24.0 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 117.824 2.528 . . . . 0.0 117.824 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.7 mmm -91.71 47.61 1.38 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 123.044 1.402 . . . . 0.0 107.336 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' CD ' ' HB2' ' A' ' 62' ' ' ARG . 13.0 pt-20 -81.16 -179.55 7.4 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.488 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 1.1 t80 -127.57 41.91 3.42 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 125.479 2.561 . . . . 0.0 107.817 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 64' ' ' ASP . 3.6 mpt_? -88.43 77.42 8.1 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' HA ' HG13 ' A' ' 82' ' ' VAL . 8.7 tp -67.23 22.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.747 1 CA-C-N 107.835 -4.257 . . . . 0.0 116.931 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 62' ' ' ARG . 2.3 p-10 -95.93 -11.82 26.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 110.195 -3.184 . . . . 0.0 108.971 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 6.3 mtm180 -129.46 88.1 2.64 Favored 'General case' 0 N--CA 1.503 2.194 1 N-CA-C 128.496 6.48 . . . . 0.0 128.496 -173.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.601 HG23 ' CG2' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.83 83.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 121.898 2.135 . . . . 0.0 107.072 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HD3' HG23 ' A' ' 57' ' ' VAL . 2.2 ptp180 -59.32 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 111.23 -2.714 . . . . 0.0 111.088 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . 53.9 mt -73.99 100.17 3.49 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 116.993 -1.883 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.7 m-85 -74.63 98.86 3.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 127.624 3.583 . . . . 0.0 107.268 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.1 m -100.9 165.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 1 CA-C-N 107.267 -4.515 . . . . 0.0 107.21 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.9 p-10 -89.91 -140.61 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 115.935 -2.306 . . . . 0.0 107.973 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 11.3 mptt -95.78 8.98 42.01 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 111.12 -2.763 . . . . 0.0 113.906 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.1 mt -137.6 39.32 2.42 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 112.242 -2.254 . . . . 0.0 107.164 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 33.91 28.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 118.86 2.911 . . . . 0.0 118.86 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.0 m-20 -104.76 148.59 26.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.0 mt -74.93 120.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 126.446 3.022 . . . . 0.0 111.14 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.48 . . -104.54 -52.81 2.82 Favored 'General case' 0 C--N 1.285 -2.227 2 CA-C-N 102.468 -6.697 . . . . 0.0 107.794 -173.592 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -119.98 84.91 2.29 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.761 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.589 ' CG2' HG22 ' A' ' 28' ' ' VAL . 1.2 t -42.2 147.71 0.55 Allowed Pre-proline 0 N--CA 1.503 2.18 0 C-N-CA 117.079 -1.848 . . . . 0.0 115.69 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD2' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -89.19 -170.79 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.473 3.449 . . . . 0.0 119.51 -175.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.536 HH11 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -156.46 136.35 12.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.961 -3.291 . . . . 0.0 105.556 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG13 ' HA ' ' A' ' 63' ' ' ILE . 96.7 t -53.65 -63.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 125.888 2.756 . . . . 0.0 109.67 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.536 ' C ' HH11 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.291 -1.919 1 CA-C-N 107.705 -4.316 . . . . 0.0 105.459 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.688 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.551 1.003 0 CA-C-O 123.049 1.405 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 7.4 tmtm? -102.16 70.56 1.2 Allowed 'General case' 0 C--N 1.305 -1.368 1 N-CA-C 99.302 -4.332 . . . . 0.0 99.302 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -98.78 13.29 32.87 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.214 -2.721 . . . . 0.0 111.839 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.4 146.56 40.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 126.27 2.231 . . . . 0.0 113.625 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.588 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 19.6 m-90 -131.16 64.7 74.51 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.412 ' HA ' HG11 ' A' ' 79' ' ' VAL . 98.9 Cg_endo -60.08 -33.96 94.89 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.951 2.434 . . . . 0.0 111.234 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.05 -12.1 3.09 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.201 1.477 . . . . 0.0 109.336 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 17.9 mt -99.31 2.86 45.8 Favored 'General case' 0 CA--C 1.56 1.36 0 O-C-N 121.123 -0.986 . . . . 0.0 112.365 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.507 ' CG2' HG23 ' A' ' 79' ' ' VAL . 88.6 t -73.4 127.07 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-N 120.652 1.569 . . . . 0.0 107.068 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.6 4.04 57.18 Favored Glycine 0 N--CA 1.505 3.298 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' HZ1' ' CB ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -117.63 160.83 20.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -89.6 153.21 20.93 Favored 'General case' 0 CA--C 1.474 -1.967 0 CA-C-O 125.989 2.804 . . . . 0.0 114.696 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.464 ' HB ' HG13 ' A' ' 70' ' ' VAL 0.318 11.6 p -42.37 -62.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.415 1 CA-C-N 107.533 -4.394 . . . . 0.0 118.215 -172.265 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.23 -18.51 63.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.514 -1.674 . . . . 0.0 111.356 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 36.7 tt0 -76.61 -45.75 28.88 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' CA ' HD12 ' A' ' 27' ' ' LEU . . . -54.38 -55.64 26.58 Favored 'General case' 0 C--O 1.205 -1.251 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -48.5 -49.6 35.17 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.717 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 3.2 ttpp -52.94 -44.29 66.96 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.555 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.66 -47.08 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 CA-C-O 122.156 0.979 . . . . 0.0 112.252 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.549 ' CG2' HG23 ' A' ' 66' ' ' VAL . 40.5 mt -48.24 -48.27 13.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 122.932 1.348 . . . . 0.0 109.691 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.91 -22.27 62.18 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.364 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -16.16 57.31 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.451 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.39 -52.54 3.93 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.749 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mmmp? -119.08 77.99 16.76 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -19.06 -56.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.503 4.135 . . . . 0.0 120.728 -177.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.48 8.27 19.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB3' HD13 ' A' ' 48' ' ' ILE . . . -52.83 87.05 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 70.71 3.67 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.47 HD13 ' CG2' ' A' ' 39' ' ' ILE . 62.1 mt -74.3 148.04 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 112.383 -2.19 . . . . 0.0 116.794 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.11 152.76 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.969 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.4 HG21 HG22 ' A' ' 32' ' ' VAL . 3.5 p -93.6 122.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 112.84 -1.982 . . . . 0.0 113.404 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.535 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 1.4 mp -136.77 141.58 35.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.5 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -80.38 139.54 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.369 1.38 . . . . 0.0 108.769 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -43.81 127.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.98 -34.82 4.67 Favored Glycine 1 N--CA 1.523 4.448 0 CA-C-N 111.179 -2.737 . . . . 0.0 115.613 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.626 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.253 50.2 m -45.03 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.981 1.312 . . . . 0.0 112.695 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.45 106.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 CA-C-O 122.58 1.181 . . . . 0.0 111.545 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.411 ' HB ' ' HD3' ' A' ' 67' ' ' ARG . 1.7 m -111.38 -106.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 85.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 1 N-CA-C 123.297 4.554 . . . . 0.0 123.297 -173.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 18.5 mmm -95.11 -47.57 6.32 Favored 'General case' 0 N--CA 1.501 2.116 1 CA-C-N 106.874 -4.694 . . . . 0.0 105.426 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.499 ' CD ' HH21 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -82.94 -175.9 6.06 Favored 'General case' 0 C--N 1.284 -2.279 3 CA-C-N 103.161 -6.381 . . . . 0.0 112.062 179.385 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.487 ' CE2' HD11 ' A' ' 63' ' ' ILE . 20.8 t80 -157.97 85.66 0.89 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.586 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HB2' ' NH2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -100.84 81.76 2.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 175.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.529 ' O ' ' NZ ' ' A' ' 43' ' ' LYS 0.262 6.0 tp -42.54 -6.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.136 1 CA-C-N 108.341 -4.027 . . . . 0.0 117.007 177.711 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.1 p30 -93.88 7.27 45.6 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.228 1.011 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HD2' ' CZ ' ' A' ' 67' ' ' ARG . 20.0 ttp180 -129.78 140.38 51.06 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.549 HG23 ' CG2' ' A' ' 39' ' ' ILE . 9.6 t -111.52 150.68 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 122.918 2.599 . . . . 0.0 106.073 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.556 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.77 112.77 24.48 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.326 -177.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.58 85.14 2.4 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.343 1.652 . . . . 0.0 109.458 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.626 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 29.6 m-85 -83.54 97.42 9.02 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 127.335 3.445 . . . . 0.0 109.965 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.464 HG13 ' HB ' ' A' ' 32' ' ' VAL . 4.4 m -104.24 174.09 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 1 CA-C-N 105.746 -5.206 . . . . 0.0 109.392 -175.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.6 p-10 -99.74 -148.77 0.35 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 124.163 1.935 . . . . 0.0 109.28 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.454 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -95.33 17.17 14.95 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 111.26 -2.7 . . . . 0.0 113.641 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -133.8 26.16 3.99 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 111.222 -2.717 . . . . 0.0 103.715 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.28 0.0 OUTLIER 33.36 35.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.61 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.7 m-20 -113.42 154.91 26.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.6 mt -78.21 119.85 27.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 126.483 3.039 . . . . 0.0 115.423 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.474 . . -98.51 -45.61 6.04 Favored 'General case' 0 C--N 1.293 -1.874 2 CA-C-N 103.662 -6.154 . . . . 0.0 111.696 -173.668 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -117.72 160.66 20.96 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.507 HG23 ' CG2' ' A' ' 28' ' ' VAL . 89.4 t -71.68 146.56 91.2 Favored Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 114.052 -3.059 . . . . 0.0 110.282 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -79.13 159.28 26.79 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.331 2.021 . . . . 0.0 109.6 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 79' ' ' VAL . 8.7 ptp85 -160.38 162.11 33.27 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 117.376 -1.297 . . . . 0.0 113.659 -176.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.503 HG12 HD13 ' A' ' 63' ' ' ILE . 2.9 t -84.55 150.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.197 0 C-N-CA 126.6 2.048 . . . . 0.0 114.427 176.239 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.704 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 122.473 1.13 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -119.36 60.75 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -100.0 19.59 15.97 Favored 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 112.079 -2.328 . . . . 0.0 112.292 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -142.63 151.41 41.43 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.204 176.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.521 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 30.5 m-90 -127.84 75.37 78.19 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.616 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.2 -18.02 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.352 2.035 . . . . 0.0 111.071 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -77.58 -28.68 51.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 2.0 pp -92.27 23.48 3.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.391 1.091 . . . . 0.0 113.918 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.472 ' CG2' HG21 ' A' ' 79' ' ' VAL . 55.7 t -72.53 167.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.83 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.01 36.58 20.94 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-O 123.209 1.449 . . . . 0.0 112.799 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 50.2 mttp -138.1 174.58 10.41 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 112.203 -1.999 . . . . 0.0 110.534 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 p -85.51 159.85 19.82 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 125.321 2.486 . . . . 0.0 114.331 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -32.35 57.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 1 CA-C-N 108.324 -4.035 . . . . 0.0 109.719 -175.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 44.5 mm-40 -63.81 -46.41 85.24 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.024 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.36 -54.93 41.47 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 126.327 2.267 . . . . 0.0 105.079 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.449 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -45.69 -54.85 7.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.354 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.5 mtpt -49.43 -56.44 9.69 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -54.45 -48.43 71.75 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.05 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 94.2 t -57.71 -56.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 CA-C-O 124.787 2.232 . . . . 0.0 110.646 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.597 ' CG2' HG23 ' A' ' 66' ' ' VAL . 37.9 mt -55.32 -45.68 77.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.57 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 26.1 mt -56.49 -38.72 72.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 8.7 tt0 -59.0 -44.77 91.71 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.816 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.04 -47.74 60.81 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.782 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.493 ' HZ2' ' CD ' ' A' ' 45' ' ' GLU . 63.6 tttm -125.23 74.84 67.98 Favored Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -7.77 -65.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 1 C-N-CA 125.487 4.125 . . . . 0.0 120.139 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.493 ' CD ' ' HZ2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -88.34 7.12 33.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 -177.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -43.95 103.23 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -85.24 83.47 7.98 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.476 HD13 ' CG2' ' A' ' 39' ' ' ILE . 68.5 mt -80.31 135.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 111.581 -2.554 . . . . 0.0 115.809 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.4 HD13 ' C ' ' A' ' 48' ' ' ILE . 1.8 mp -125.95 137.68 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 111.956 -2.384 . . . . 0.0 111.522 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.42 ' C ' HD13 ' A' ' 51' ' ' LEU . 12.1 p -95.81 145.51 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 5.5 mp -141.12 149.62 56.1 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -81.55 135.38 9.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 N-CA-C 105.474 -2.548 . . . . 0.0 105.474 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 69' ' ' PHE . 87.4 t -42.91 130.48 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.31 -41.1 2.11 Favored Glycine 1 N--CA 1.519 4.214 0 CA-C-N 111.528 -2.578 . . . . 0.0 112.977 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.614 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.258 11.4 m -50.02 165.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 125.279 1.432 . . . . 0.0 111.338 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mm -61.14 136.05 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.581 HG21 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -123.69 -77.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.015 176.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 83.73 6.41 Favored 'General case' 0 C--N 1.295 -1.78 1 N-CA-C 122.698 4.333 . . . . 0.0 122.698 -179.115 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 tpt -97.44 -137.11 0.27 Allowed 'General case' 0 C--N 1.29 -2.003 1 CA-C-N 107.769 -4.287 . . . . 0.0 103.273 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.277 0.1 OUTLIER -78.4 -174.07 3.6 Favored 'General case' 0 C--N 1.288 -2.105 1 N-CA-C 98.843 -4.503 . . . . 0.0 98.843 170.168 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.481 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 7.9 t80 -120.33 135.85 54.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.015 -2.303 . . . . 0.0 117.059 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -115.56 64.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 124.074 1.892 . . . . 0.0 106.844 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.494 HD11 HG12 ' A' ' 82' ' ' VAL . 5.8 tp -42.83 -7.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.8 p30 -81.66 -9.83 59.56 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 124.207 1.003 . . . . 0.0 110.035 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -129.07 149.3 50.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 120.562 3.541 . . . . 0.0 120.562 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 39' ' ' ILE . 5.0 t -110.18 132.21 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 101.962 -3.347 . . . . 0.0 101.962 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.517 HH21 ' C ' ' A' ' 83' ' ' GLY . 16.8 tpp85 -89.83 116.21 27.74 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.779 -2.01 . . . . 0.0 108.098 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 80' ' ' PRO . 7.6 mp -107.92 90.97 3.46 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 124.816 1.323 . . . . 0.0 113.996 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 22.5 m-85 -76.34 103.52 6.4 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 125.588 2.613 . . . . 0.0 112.153 169.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 4.5 m -109.77 171.78 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-N 109.077 -3.692 . . . . 0.0 109.074 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -93.62 -140.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.494 -2.004 . . . . 0.0 111.818 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.4 mmtm -88.51 0.91 55.81 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 110.911 -2.859 . . . . 0.0 112.303 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -136.97 39.52 2.55 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 111.62 -2.537 . . . . 0.0 109.846 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.57 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -178.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 53.7 m-20 -105.27 142.31 35.27 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 80' ' ' PRO . 79.9 mt -67.18 116.98 7.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 126.69 3.138 . . . . 0.0 114.561 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 53' ' ' VAL 0.468 . . -102.82 -40.61 6.49 Favored 'General case' 0 C--N 1.289 -2.057 1 CA-C-N 104.414 -5.812 . . . . 0.0 111.815 -172.198 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.2 163.72 15.87 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 102.266 -3.235 . . . . 0.0 102.266 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG21 ' CG2' ' A' ' 28' ' ' VAL . 78.1 t -77.3 141.22 66.06 Favored Pre-proline 0 N--CA 1.499 1.998 0 C-N-CA 114.092 -3.043 . . . . 0.0 110.235 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HG2' HD12 ' A' ' 76' ' ' ILE . 14.6 Cg_exo -80.84 145.49 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.544 2.829 . . . . 0.0 106.464 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -153.28 168.45 25.98 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.502 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.494 HG12 HD11 ' A' ' 63' ' ' ILE . 25.0 t -82.64 154.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 116.731 -1.987 . . . . 0.0 113.105 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.517 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.511 3.636 0 C-N-CA 125.937 1.732 . . . . 0.0 114.01 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.641 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.55 0.944 0 CA-C-O 121.453 0.644 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' CG ' ' A' ' 42' ' ' ASP . 37.3 mtpt -118.68 152.3 36.36 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.517 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 45.6 p -128.94 19.26 6.04 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.331 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -156.88 150.58 24.57 Favored 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.731 178.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.542 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 20.3 m-90 -133.77 59.89 42.39 Favored Pre-proline 0 N--CA 1.516 2.83 0 N-CA-C 121.118 3.747 . . . . 0.0 121.118 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 24' ' ' TRP . 52.8 Cg_exo -48.98 -40.3 40.58 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 124.098 3.198 . . . . 0.0 110.983 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 4.8 mp0 -46.38 -30.41 2.11 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.621 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.425 HD12 ' CG1' ' A' ' 39' ' ' ILE . 32.6 mt -79.65 -27.37 40.88 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.665 ' CG2' HG23 ' A' ' 79' ' ' VAL . 30.8 t -48.05 137.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.85 -4.12 71.79 Favored Glycine 0 N--CA 1.508 3.446 0 CA-C-N 114.566 -1.197 . . . . 0.0 113.255 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 32.4 mtmm -114.27 178.42 4.29 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.504 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.7 p -85.71 171.56 11.53 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 127.518 3.533 . . . . 0.0 116.867 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.1 p -72.15 -18.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 1 CA-C-N 104.863 -5.608 . . . . 0.0 112.752 -176.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -85.42 -49.09 8.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -50.06 -52.78 31.73 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.91 -44.21 60.0 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.406 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' ILE . 61.1 mttm -62.05 -49.14 77.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.082 1.765 . . . . 0.0 108.24 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.43 ' NZ ' ' OE1' ' A' ' 33' ' ' GLU . 80.5 mttt -54.97 -52.76 62.04 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.976 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.8 -54.99 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.239 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 66' ' ' VAL . 32.2 mt -55.34 -51.0 60.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.095 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 44' ' ' PRO . 96.9 mt -57.37 -33.28 67.64 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -59.81 -43.76 94.35 Favored 'General case' 0 N--CA 1.516 2.871 0 C-N-CA 117.432 -1.707 . . . . 0.0 110.137 175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' CG ' ' NZ ' ' A' ' 21' ' ' LYS . 52.0 m-20 -72.63 -53.06 12.86 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' N ' ' CD ' ' A' ' 44' ' ' PRO . 26.3 tptp -121.43 57.17 6.79 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 112.347 -2.206 . . . . 0.0 108.389 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 12.5 Cg_exo -12.48 -65.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 125.198 3.932 . . . . 0.0 120.414 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.74 24.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -71.22 124.67 25.01 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-O 122.442 1.115 . . . . 0.0 111.203 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -91.71 67.9 5.46 Favored 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.536 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 20.6 mt -72.37 134.4 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 119.359 3.096 . . . . 0.0 119.359 -173.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 40.5 mm -103.53 175.22 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 113.385 -1.734 . . . . 0.0 111.569 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.427 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 4.6 p -106.4 118.19 53.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 126.516 1.926 . . . . 0.0 111.516 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 16.7 mt -136.29 119.41 12.21 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.399 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -70.45 138.44 35.62 Favored 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 123.51 2.807 . . . . 0.0 110.465 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.7 t -42.28 131.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.45 99.07 1.92 Allowed Glycine 0 N--CA 1.509 3.555 2 N-CA-C 96.215 -6.754 . . . . 0.0 96.215 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.713 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -68.24 116.2 8.57 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -171.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -83.14 -0.24 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 126.036 2.827 . . . . 0.0 111.036 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -110.62 -173.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 108.592 -3.913 . . . . 0.0 111.61 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.489 ' OG1' ' NH1' ' A' ' 62' ' ' ARG . 2.8 p -87.09 -178.53 6.28 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.9 tpt -91.03 -38.08 13.03 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 125.961 2.791 . . . . 0.0 115.345 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 9.5 pt-20 -49.82 -160.68 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.34 1 CA-C-N 105.061 -5.518 . . . . 0.0 117.24 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.699 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 57.8 t80 -114.76 70.84 0.74 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.695 1.247 . . . . 0.0 113.376 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.536 ' H ' ' CD ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -88.22 66.13 8.34 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 126.718 3.152 . . . . 0.0 109.602 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.699 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.23 -31.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 2 N-CA-C 125.652 5.427 . . . . 0.0 125.652 -179.079 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' CG ' HH22 ' A' ' 65' ' ' ARG . 6.4 p-10 -55.09 -18.11 5.03 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 123.458 1.599 . . . . 0.0 108.058 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.531 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 14.8 ttp-105 -135.45 104.37 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.644 HG22 ' CG2' ' A' ' 39' ' ' ILE . 18.4 t -62.04 136.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 123.495 2.861 . . . . 0.0 104.193 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.728 ' CZ ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -96.57 134.89 39.22 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.038 -1.865 . . . . 0.0 112.577 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.728 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 80.5 mt -114.96 81.3 1.54 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.855 -1.975 . . . . 0.0 111.432 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.713 ' CZ ' ' HA ' ' A' ' 55' ' ' THR . 9.4 m-85 -73.7 102.93 4.1 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 126.713 3.149 . . . . 0.0 105.26 167.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -100.75 167.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 1 CA-C-N 107.481 -4.418 . . . . 0.0 106.301 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.5 p-10 -91.39 -141.44 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 123.386 2.812 . . . . 0.0 112.424 -177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.547 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 9.9 mptt -91.66 5.22 50.52 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 111.055 -2.793 . . . . 0.0 114.939 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 73' ' ' LEU 0.264 0.5 OUTLIER -138.6 34.52 2.23 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.6 176.893 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.62 48.03 0.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 124.665 2.174 . . . . 0.0 110.005 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -115.0 142.71 46.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 172.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.63 119.55 15.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 124.359 2.028 . . . . 0.0 112.846 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.477 . . -103.21 -35.67 8.37 Favored 'General case' 0 C--N 1.297 -1.707 2 CA-C-N 104.687 -5.688 . . . . 0.0 110.726 -174.875 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.53 126.63 53.6 Favored 'General case' 0 N--CA 1.52 3.049 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.12 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.727 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 94.2 t -78.38 -75.83 0.07 OUTLIER Pre-proline 0 N--CA 1.516 2.831 1 N-CA-C 124.997 5.184 . . . . 0.0 124.997 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.727 ' CD ' ' CB ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -66.6 51.3 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.613 2 N-CA-C 133.547 8.249 . . . . 0.0 133.547 -171.795 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 80' ' ' PRO 0.262 0.0 OUTLIER -170.69 120.65 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 2 N-CA-C 131.144 7.461 . . . . 0.0 131.144 172.956 . . . . . . . . 5 4 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG21 ' CZ3' ' A' ' 24' ' ' TRP . 4.4 t -51.26 -23.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 111.939 -2.391 . . . . 0.0 113.853 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' C ' HH21 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.28 -2.569 0 O-C-N 128.786 3.804 . . . . 0.0 103.605 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.693 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 120.186 0.041 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 42.5 tptt -131.42 58.57 1.72 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.659 0.742 . . . . 0.0 109.341 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -112.37 24.53 12.44 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-O 122.733 1.254 . . . . 0.0 110.601 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -136.77 146.03 45.27 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 112.729 -2.032 . . . . 0.0 108.999 175.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 15.6 m-90 -129.95 62.78 65.77 Favored Pre-proline 0 N--CA 1.522 3.156 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HA ' HG13 ' A' ' 79' ' ' VAL . 77.9 Cg_exo -53.68 -38.92 84.88 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.978 3.118 . . . . 0.0 111.586 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 30.4 mp0 -49.58 -28.65 5.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.919 1.343 . . . . 0.0 110.333 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.483 HD12 ' CB ' ' A' ' 35' ' ' ALA . 74.4 mt -79.92 -19.99 46.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.671 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 ' CG2' ' A' ' 79' ' ' VAL . 59.9 t -49.73 137.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 121.625 2.011 . . . . 0.0 107.831 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.65 -9.03 66.36 Favored Glycine 0 N--CA 1.515 3.922 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.27 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 35.0 mmtm -106.45 166.92 10.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.404 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.9 p -88.46 165.81 14.64 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 126.679 3.133 . . . . 0.0 116.533 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.255 0.3 OUTLIER -60.84 -50.51 80.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 1 CA-C-N 107.174 -4.557 . . . . 0.0 116.569 -174.241 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 41.1 mm-40 -68.17 -37.55 81.11 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.572 -1.651 . . . . 0.0 111.127 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -58.98 -51.09 71.58 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.406 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.483 ' CB ' HD12 ' A' ' 27' ' ' LEU . . . -49.82 -59.08 4.17 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.293 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . 0.303 21.7 tttm -44.55 -53.78 6.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 54.5 mttp -53.47 -53.93 44.3 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.6 -2.091 . . . . 0.0 111.072 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.6 t -59.53 -52.3 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 123.941 1.829 . . . . 0.0 113.193 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 66' ' ' VAL . 15.8 mt -54.17 -50.94 51.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.101 -2.318 . . . . 0.0 107.864 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.64 -14.12 56.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 124.294 0.996 . . . . 0.0 112.675 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -80.27 -21.13 43.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -97.0 -52.12 3.98 Favored 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 10.7 tptp -118.35 72.94 10.19 Favored Pre-proline 0 N--CA 1.514 2.754 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -9.76 -51.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 1 C-N-CA 125.421 4.081 . . . . 0.0 120.495 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 3.4 mp0 -71.89 -23.28 61.47 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.27 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.479 1.133 . . . . 0.0 113.713 -177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -87.57 71.3 9.77 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 39' ' ' ILE . 56.0 mt -74.03 142.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.35 160.92 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 1 CA-C-N 107.687 -4.324 . . . . 0.0 110.053 -179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.04 119.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 112.254 -2.248 . . . . 0.0 106.83 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.507 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 1.5 mt -135.2 121.24 14.3 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 117.249 2.314 . . . . 0.0 117.249 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.66 127.84 19.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 N-CA-C 108.438 -1.408 . . . . 0.0 108.438 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.545 HG21 ' HB3' ' A' ' 69' ' ' PHE . 5.2 p -57.77 139.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 123.876 1.798 . . . . 0.0 113.58 177.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.19 -15.55 27.86 Favored Glycine 1 N--CA 1.521 4.309 0 CA-C-N 110.747 -2.933 . . . . 0.0 113.049 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.485 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.304 17.6 m -45.56 139.28 3.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 176.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.0 mm -80.54 82.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 CA-C-N 123.156 2.707 . . . . 0.0 111.773 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.699 HG23 ' CE2' ' A' ' 69' ' ' PHE . 1.5 m -127.27 156.56 38.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.986 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.57 178.05 5.73 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 109.275 -3.602 . . . . 0.0 115.049 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.584 ' SD ' ' CD ' ' A' ' 81' ' ' ARG . 1.2 tpt -89.41 67.13 7.63 Favored 'General case' 0 N--CA 1.494 1.741 1 N-CA-C 96.432 -5.396 . . . . 0.0 96.432 173.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' CD ' ' NH1' ' A' ' 62' ' ' ARG . 10.3 pt-20 -78.44 154.24 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.83 50.81 0.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.956 1.836 . . . . 0.0 111.783 -176.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NH1' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mpt_? -90.88 72.76 6.54 Favored 'General case' 0 N--CA 1.491 1.595 1 N-CA-C 94.973 -5.936 . . . . 0.0 94.973 175.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 HD13 ' CG1' ' A' ' 82' ' ' VAL . 6.6 tp -40.87 -4.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' NH2' ' A' ' 65' ' ' ARG . 3.9 p-10 -99.3 2.86 45.84 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.426 ' NH2' ' OD2' ' A' ' 64' ' ' ASP . 8.7 tpp180 -123.95 95.51 4.59 Favored 'General case' 0 N--CA 1.498 1.969 1 N-CA-C 124.97 5.174 . . . . 0.0 124.97 -170.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.611 HG23 ' CG2' ' A' ' 39' ' ' ILE . 0.8 OUTLIER -89.2 52.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 115.264 -2.574 . . . . 0.0 105.62 177.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.512 HH11 ' CD ' ' A' ' 60' ' ' GLU . 9.9 ptm180 -48.0 116.46 1.52 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 123.714 1.721 . . . . 0.0 111.703 -174.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' CD1' HG22 ' A' ' 48' ' ' ILE . 67.3 mt -82.15 93.08 6.98 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 109.341 -3.572 . . . . 0.0 115.668 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.699 ' CE2' HG23 ' A' ' 57' ' ' VAL . 37.0 m-85 -74.39 96.06 2.81 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 126.811 3.196 . . . . 0.0 108.45 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 m -106.82 174.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.304 1 CA-C-N 106.937 -4.665 . . . . 0.0 110.422 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.5 p-10 -95.95 -141.55 0.27 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 124.919 2.295 . . . . 0.0 112.769 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 58.6 mttp -83.98 -8.11 59.24 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 108.971 -3.741 . . . . 0.0 113.457 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.287 0.5 OUTLIER -137.41 48.13 2.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 124.924 2.297 . . . . 0.0 109.677 178.73 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.82 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 2.5 m120 -99.71 142.57 31.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.752 1.263 . . . . 0.0 108.222 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.37 117.7 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 126.389 2.995 . . . . 0.0 115.279 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.459 . . -98.48 -44.27 6.56 Favored 'General case' 0 C--N 1.283 -2.306 2 CA-C-N 103.905 -6.043 . . . . 0.0 109.86 -172.273 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -117.43 118.88 33.43 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 101.073 -3.677 . . . . 0.0 101.073 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.587 ' CG2' HG22 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -73.1 137.65 79.03 Favored Pre-proline 0 N--CA 1.501 2.106 1 C-N-CA 110.947 -4.301 . . . . 0.0 109.818 -178.455 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 68' ' ' LEU . 5.8 Cg_exo -82.16 169.75 14.13 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 123.901 3.067 . . . . 0.0 113.836 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.584 ' CD ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -145.87 154.18 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG21 ' CZ3' ' A' ' 24' ' ' TRP . 70.8 t -71.97 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.734 2 CA-C-N 107.048 -4.615 . . . . 0.0 102.923 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.743 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 122.975 1.369 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 31.3 tttp -106.3 136.49 45.94 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.634 -4.21 . . . . 0.0 99.634 178.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 8.3 p -106.42 -6.29 18.33 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 118.264 -1.374 . . . . 0.0 108.386 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.69 136.01 48.37 Favored 'General case' 0 N--CA 1.523 3.214 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.552 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 29.6 m-90 -126.45 71.62 72.14 Favored Pre-proline 0 N--CA 1.513 2.71 1 N-CA-C 126.553 5.76 . . . . 0.0 126.553 -176.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.08 -35.41 19.99 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.143 1.229 . . . . 0.0 113.828 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 23.0 mp0 -57.61 -37.88 74.02 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 126.344 2.973 . . . . 0.0 114.097 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 4.2 pp -78.57 -16.06 57.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.239 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.481 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 93.3 t -49.51 157.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.913 0 O-C-N 123.22 0.325 . . . . 0.0 110.554 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.74 -13.76 46.08 Favored Glycine 1 N--CA 1.518 4.151 0 O-C-N 120.347 -1.47 . . . . 0.0 113.901 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.08 167.88 10.59 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 117.203 -1.379 . . . . 0.0 112.671 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.5 p -86.52 159.62 19.23 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 127.039 3.304 . . . . 0.0 114.747 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.8 p -45.46 -23.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 1 CA-C-N 106.847 -4.706 . . . . 0.0 119.015 -174.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.62 ' CG ' ' H ' ' A' ' 34' ' ' GLU . 14.3 pt-20 -67.2 -58.67 4.41 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.796 0.808 . . . . 0.0 109.293 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.62 ' H ' ' CG ' ' A' ' 33' ' ' GLU . 2.5 tt0 -56.97 -50.43 72.71 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -47.77 -51.58 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 117.573 -1.651 . . . . 0.0 112.711 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 17.5 mtpp -58.36 -52.8 64.07 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.55 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 4.3 tmtm? -48.6 -41.1 29.77 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.926 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 62.3 t -69.11 -60.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.925 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.54 HG23 HD12 ' A' ' 48' ' ' ILE . 42.9 mt -56.05 -53.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.186 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mp -56.92 -23.74 47.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.419 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.55 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 57.3 tp60 -67.65 -33.5 75.07 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.119 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 51.0 m-20 -92.59 -49.49 6.08 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -120.75 80.45 32.39 Favored Pre-proline 0 N--CA 1.515 2.82 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -35.19 -31.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.574 0 N-CA-C 120.408 3.195 . . . . 0.0 120.408 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.569 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -88.72 -0.23 57.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.843 0.714 . . . . 0.0 112.289 -177.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.46 99.32 0.14 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.699 1.238 . . . . 0.0 111.738 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.26 113.7 25.97 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.54 HD12 HG23 ' A' ' 39' ' ' ILE . 21.8 mt -105.47 155.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.406 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 42.4 mm -125.19 169.74 16.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.581 -3.009 . . . . 0.0 105.899 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 70' ' ' VAL . 8.7 p -107.25 142.43 20.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.481 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -139.51 122.27 10.37 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 178.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' HD21 ' A' ' 51' ' ' LEU . 55.1 Cg_endo -72.7 129.14 14.15 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.27 1.98 . . . . 0.0 112.319 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG2' ' HB3' ' A' ' 69' ' ' PHE . 6.7 t -42.2 133.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.52 -27.0 19.73 Favored Glycine 0 N--CA 1.512 3.72 0 CA-C-N 109.552 -3.476 . . . . 0.0 112.683 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.305 51.8 m -60.66 178.38 0.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 126.28 1.832 . . . . 0.0 112.928 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG21 ' N ' ' A' ' 57' ' ' VAL . 14.1 mt -86.46 154.18 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' CG1' ' HG2' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -140.45 -59.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.972 1 N-CA-C 122.666 4.321 . . . . 0.0 122.666 177.113 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 78.14 6.89 Favored 'General case' 0 C--N 1.288 -2.093 1 N-CA-C 123.098 4.481 . . . . 0.0 123.098 -177.5 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 88.9 mtp -97.13 -144.14 0.29 Allowed 'General case' 0 C--N 1.291 -1.942 1 CA-C-N 104.459 -5.791 . . . . 0.0 104.352 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -60.5 -142.31 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 O-C-N 124.854 1.346 . . . . 0.0 112.393 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.627 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -100.25 113.46 26.17 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.339 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.578 ' NH2' ' HB2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -105.54 39.66 1.71 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 123.925 1.821 . . . . 0.0 110.056 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.627 ' HB ' ' CE1' ' A' ' 61' ' ' TYR . 8.6 tp -56.37 -25.64 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 110.098 -3.228 . . . . 0.0 117.351 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -70.44 -11.12 60.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 63' ' ' ILE . 23.0 ttp180 -135.06 163.13 30.59 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -176.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG23 ' CG2' ' A' ' 39' ' ' ILE . 16.1 t -117.08 128.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' NE ' ' HA ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -102.47 110.11 21.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 114.03 -3.068 . . . . 0.0 114.207 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.47 HD13 ' CD1' ' A' ' 39' ' ' ILE . 6.1 mt -107.49 104.79 14.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 111.515 -2.584 . . . . 0.0 106.65 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 8.9 m-85 -69.18 122.24 18.4 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.875 -1.93 . . . . 0.0 107.861 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' CG2' ' A' ' 50' ' ' VAL . 8.3 m -102.46 170.97 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 110.642 -2.981 . . . . 0.0 105.948 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -96.45 -135.88 0.24 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 117.144 -1.823 . . . . 0.0 112.129 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -91.34 3.01 55.97 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 110.405 -3.089 . . . . 0.0 112.306 177.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.5 mt -135.78 34.43 2.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.769 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.29 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -178.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -102.98 139.05 39.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 30' ' ' LYS . 13.1 mt -64.37 115.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.219 0 CA-C-O 126.491 3.043 . . . . 0.0 112.177 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.579 . . -97.98 -39.3 9.02 Favored 'General case' 0 C--N 1.281 -2.394 1 CA-C-N 105.158 -5.474 . . . . 0.0 101.979 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -115.95 129.24 56.3 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.669 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 98.8 t -44.6 -61.83 1.93 Allowed Pre-proline 0 N--CA 1.514 2.765 1 N-CA-C 125.148 5.24 . . . . 0.0 125.148 177.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.261 0.0 OUTLIER 4.8 -161.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 2 C-N-CA 131.114 7.876 . . . . 0.0 128.61 -168.582 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.449 ' C ' HG12 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -145.78 175.19 10.59 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -161.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.444 ' CG2' HG21 ' A' ' 66' ' ' VAL . 21.6 t -68.22 137.34 24.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 109.099 -3.682 . . . . 0.0 108.416 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.503 3.139 0 CA-C-O 114.911 -3.16 . . . . 0.0 117.92 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.725 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 121.99 0.9 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HZ3' ' CD ' ' A' ' 26' ' ' GLU . 8.9 mtpm? -99.08 144.5 28.15 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.377 -1.283 . . . . 0.0 107.907 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -107.16 7.25 29.43 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.515 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -142.74 150.72 40.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 126.15 2.156 . . . . 0.0 112.096 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.556 ' CE3' HG13 ' A' ' 66' ' ' VAL . 25.4 m-90 -132.45 79.51 65.12 Favored Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.48 -30.85 3.76 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 120.872 1.048 . . . . 0.0 110.021 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.485 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 3.0 pm0 -51.8 -20.88 2.42 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 122.501 1.143 . . . . 0.0 113.459 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 35' ' ' ALA . 3.1 pp -107.93 16.19 23.7 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 79' ' ' VAL . 22.3 t -70.64 155.92 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-O 122.343 1.068 . . . . 0.0 112.104 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.29 18.05 70.95 Favored Glycine 0 N--CA 1.512 3.735 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.927 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -128.69 167.48 17.17 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 116.843 -1.551 . . . . 0.0 110.278 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -91.01 166.18 13.14 Favored 'General case' 0 CA--C 1.472 -2.045 1 CA-C-O 128.573 4.035 . . . . 0.0 115.508 179.81 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 50' ' ' VAL . 1.4 p -53.92 -29.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 1 CA-C-N 103.175 -6.375 . . . . 0.0 115.435 -174.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.03 -37.54 23.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.718 -1.239 . . . . 0.0 111.992 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 46.5 mt-10 -61.02 -48.09 83.42 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -47.14 -50.78 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.683 -1.607 . . . . 0.0 112.962 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -51.2 -51.46 53.63 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.682 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.3 -47.41 69.25 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.04 -2.345 . . . . 0.0 108.868 -178.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.2 t -59.16 -57.64 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 CA-C-O 123.555 1.645 . . . . 0.0 111.944 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.53 ' CG2' HG23 ' A' ' 66' ' ' VAL . 14.0 mt -54.98 -46.44 76.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.221 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.18 -33.55 67.59 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.42 -19.6 65.62 Favored 'General case' 0 N--CA 1.519 3.023 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.457 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -96.07 -58.59 2.05 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.24 1.416 . . . . 0.0 110.457 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -121.94 67.8 24.24 Favored Pre-proline 0 N--CA 1.499 1.997 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.328 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.96 -45.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 125.107 3.872 . . . . 0.0 120.271 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.14 -5.26 57.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.64 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -76.44 77.74 3.17 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.481 HG12 ' HB ' ' A' ' 66' ' ' VAL . 44.2 mt -74.89 133.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.7 mp -117.43 162.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 112.463 -2.153 . . . . 0.0 113.119 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.7 p -106.02 131.47 55.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 112.913 -1.949 . . . . 0.0 114.488 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 5.1 mp -138.94 155.87 72.81 Favored Pre-proline 0 N--CA 1.508 2.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -81.38 130.49 7.11 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 121.737 1.624 . . . . 0.0 109.794 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 69' ' ' PHE . 93.7 t -40.44 132.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.43 1.97 Allowed Glycine 0 N--CA 1.505 3.265 0 CA-C-N 110.353 -3.112 . . . . 0.0 108.168 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.431 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 43.3 m -47.09 131.35 12.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.871 1.32 . . . . 0.0 109.264 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.539 ' H ' ' CD1' ' A' ' 56' ' ' ILE . 1.9 mp -52.01 113.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.517 ' HA ' ' NH1' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -104.1 -70.57 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.32 66.54 4.8 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 127.345 3.45 . . . . 0.0 118.757 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -99.66 -119.39 0.15 Allowed 'General case' 0 C--N 1.288 -2.095 1 CA-C-N 104.405 -5.816 . . . . 0.0 106.245 -179.085 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -72.51 -152.22 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 108.998 -3.728 . . . . 0.0 105.461 171.145 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.516 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -128.84 91.59 3.25 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -176.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -94.77 66.22 3.12 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 127.496 3.522 . . . . 0.0 105.937 175.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.516 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 2.7 tp -59.91 -25.13 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 1 CA-C-N 106.549 -4.841 . . . . 0.0 114.019 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.51 24.93 1.55 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.8 ttm-85 -158.16 131.64 7.66 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.556 HG13 ' CE3' ' A' ' 24' ' ' TRP . 12.4 t -104.86 70.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 C-N-CA 116.543 -2.063 . . . . 0.0 105.979 173.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -45.98 138.11 5.3 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.119 1.914 . . . . 0.0 112.157 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.23 116.65 33.1 Favored 'General case' 0 C--N 1.295 -1.786 1 CA-C-N 108.304 -4.044 . . . . 0.0 112.775 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.522 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 42.8 m-85 -93.14 99.56 12.12 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 125.721 2.677 . . . . 0.0 110.162 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.442 HG13 ' CG2' ' A' ' 32' ' ' VAL . 1.1 m -111.01 177.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 1 CA-C-N 107.787 -4.279 . . . . 0.0 113.508 -174.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -106.67 -141.87 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 124.177 1.942 . . . . 0.0 113.906 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -83.99 -5.41 59.22 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 110.338 -3.119 . . . . 0.0 113.091 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.5 mt -136.12 43.18 2.54 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 111.075 -2.784 . . . . 0.0 111.171 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 33.15 30.26 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.1 m-20 -106.83 141.0 38.76 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 123.455 1.598 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.61 93.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 127.756 3.646 . . . . 0.0 116.329 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.44 . . -74.41 -40.72 61.83 Favored 'General case' 0 C--N 1.289 -2.053 2 CA-C-N 100.718 -7.492 . . . . 0.0 110.516 -179.273 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -119.52 158.71 25.74 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' A' ' 28' ' ' VAL . 97.2 t -76.92 138.39 65.7 Favored Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 114.506 -2.877 . . . . 0.0 110.71 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.6 Cg_exo -75.89 165.73 29.43 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.773 2.315 . . . . 0.0 110.193 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -162.77 167.94 22.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 63' ' ' ILE . 37.5 t -82.61 133.53 28.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 C-N-CA 118.964 -1.095 . . . . 0.0 109.69 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.138 0 O-C-N 125.32 1.638 . . . . 0.0 112.428 177.178 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.689 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.213 -0.863 0 CA-C-O 122.326 1.06 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.606 ' HZ3' ' CD ' ' A' ' 26' ' ' GLU . 81.2 tttt -114.22 86.45 2.42 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.469 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -97.41 26.55 4.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.62 156.4 47.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.822 1.326 . . . . 0.0 112.743 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.644 ' NE1' ' HA ' ' A' ' 39' ' ' ILE . 11.7 m-90 -134.56 78.61 55.9 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HA ' HG21 ' A' ' 28' ' ' VAL . 66.8 Cg_endo -75.2 -26.21 10.82 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 120.598 0.865 . . . . 0.0 113.993 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 16.1 mp0 -51.33 -29.62 15.76 Favored 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 124.845 2.26 . . . . 0.0 110.11 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.572 HD23 ' CG1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.98 -27.9 49.23 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.035 -177.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.58 ' CG2' HG23 ' A' ' 79' ' ' VAL . 58.5 t -49.02 136.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 CA-C-N 119.97 1.259 . . . . 0.0 112.335 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.83 2.01 69.92 Favored Glycine 0 N--CA 1.507 3.407 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.169 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -126.09 169.49 12.73 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.65 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -87.59 177.13 7.15 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 125.331 2.491 . . . . 0.0 113.829 176.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.58 -37.4 77.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 109.863 -3.335 . . . . 0.0 115.716 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.66 -48.32 69.74 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.509 -1.276 . . . . 0.0 111.162 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.521 ' CD ' ' HZ1' ' A' ' 37' ' ' LYS . 58.5 mm-40 -60.07 -42.1 93.83 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.473 ' HB2' HD22 ' A' ' 27' ' ' LEU . . . -53.52 -60.94 2.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.74 -1.225 . . . . 0.0 110.419 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 55.2 mtpt -45.68 -50.22 13.75 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.339 1.066 . . . . 0.0 108.806 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 73.3 tttt -48.99 -47.64 44.04 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.031 -2.804 . . . . 0.0 109.142 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.64 -49.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 124.731 1.269 . . . . 0.0 112.686 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.644 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 11.1 mt -48.11 -47.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.476 0.655 . . . . 0.0 111.448 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.439 HD22 ' O ' ' A' ' 46' ' ' ALA 0.252 96.0 mt -63.88 -12.81 39.97 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.921 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.99 -47.31 18.78 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.96 -52.72 26.05 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 124.831 2.253 . . . . 0.0 110.773 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 57.6 tttm -122.76 70.06 36.96 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.137 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -28.44 -45.19 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.844 3.029 . . . . 0.0 119.603 178.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.93 8.85 24.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.439 ' O ' HD22 ' A' ' 40' ' ' LEU . . . -64.96 113.14 3.66 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 116.953 -1.899 . . . . 0.0 115.483 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -82.44 67.77 8.62 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.735 -1.853 . . . . 0.0 106.273 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.523 HD13 HG23 ' A' ' 39' ' ' ILE . 2.8 mp -80.77 137.7 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 124.19 1.948 . . . . 0.0 115.528 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.3 mp -120.27 177.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 109.908 -3.315 . . . . 0.0 109.628 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 12.1 p -98.33 125.26 51.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.58 1.181 . . . . 0.0 109.48 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 9.7 mt -122.47 89.06 49.46 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.412 ' HG2' ' OG1' ' A' ' 55' ' ' THR . 37.8 Cg_endo -53.39 130.39 38.29 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 O-C-N 119.005 -1.103 . . . . 0.0 113.436 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.432 HG21 ' C ' ' A' ' 69' ' ' PHE . 54.8 t -45.36 115.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 123.133 1.444 . . . . 0.0 111.157 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.36 8.1 Favored Glycine 0 N--CA 1.513 3.78 1 CA-C-N 107.779 -4.282 . . . . 0.0 115.039 -173.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.472 HG23 HD21 ' A' ' 51' ' ' LEU 0.284 1.4 m -56.94 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 118.945 1.372 . . . . 0.0 107.908 177.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.31 110.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 120.085 3.365 . . . . 0.0 120.085 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.41 HG22 ' HE2' ' A' ' 69' ' ' PHE . 35.3 m -124.12 177.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 108.473 -3.967 . . . . 0.0 110.672 176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -94.89 142.87 26.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 109.759 -3.382 . . . . 0.0 112.574 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.3 tpt -93.28 57.9 2.75 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 123.399 2.818 . . . . 0.0 104.419 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -80.49 -169.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 111.18 -2.736 . . . . 0.0 113.208 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 12.8 t80 -140.21 63.33 1.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.634 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.28 74.61 7.0 Favored 'General case' 0 N--CA 1.486 1.331 1 N-CA-C 97.91 -4.848 . . . . 0.0 97.91 174.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -43.07 -20.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 109.899 -3.319 . . . . 0.0 116.334 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -62.52 4.24 0.16 Allowed 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.904 1.335 . . . . 0.0 109.466 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.613 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.5 ttm-85 -149.87 154.71 38.81 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.602 HG23 ' CG2' ' A' ' 39' ' ' ILE . 3.2 t -115.99 135.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 1 N-CA-C 99.454 -4.276 . . . . 0.0 99.454 176.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.447 ' C ' HD13 ' A' ' 68' ' ' LEU . 8.9 ttm-85 -94.49 126.19 39.61 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.837 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.447 HD13 ' C ' ' A' ' 67' ' ' ARG . 11.1 mp -110.59 76.81 1.0 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.526 2.391 . . . . 0.0 112.048 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 26.1 m-85 -74.98 102.44 4.81 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 126.996 3.284 . . . . 0.0 105.468 168.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 18.7 m -100.77 179.75 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.326 1 CA-C-N 106.055 -5.066 . . . . 0.0 109.975 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.616 ' CG ' ' H ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -89.43 -145.49 0.16 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 117.438 -3.289 . . . . 0.0 111.425 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.6 -4.95 59.25 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 111.336 -2.666 . . . . 0.0 115.62 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.437 HD11 ' O ' ' A' ' 73' ' ' LEU 0.266 0.6 OUTLIER -138.02 48.47 1.98 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 126.875 3.226 . . . . 0.0 106.959 176.938 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 34.58 37.02 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.302 -3.135 . . . . 0.0 116.663 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -106.9 147.73 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 124.14 1.924 . . . . 0.0 107.633 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.92 97.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 127.176 3.369 . . . . 0.0 116.623 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.374 . . -73.1 -48.81 32.55 Favored 'General case' 0 C--N 1.29 -2.016 2 CA-C-N 100.257 -7.701 . . . . 0.0 111.767 179.71 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -119.1 155.85 30.8 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.58 HG23 ' CG2' ' A' ' 28' ' ' VAL . 89.2 t -72.47 142.89 84.64 Favored Pre-proline 0 N--CA 1.507 2.392 0 C-N-CA 114.312 -2.955 . . . . 0.0 108.505 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -82.11 159.03 17.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 123.549 2.833 . . . . 0.0 108.725 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ptp85 -162.57 171.81 16.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 108.257 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 t -79.5 140.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.15 0 CA-C-O 116.399 -2.334 . . . . 0.0 109.946 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.704 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.555 1.138 0 CA-C-O 121.24 0.543 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' A' ' 23' ' ' GLU . 81.9 tttt -139.94 118.27 12.08 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.171 1.388 . . . . 0.0 108.934 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -113.78 21.03 15.36 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.151 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -143.94 132.52 22.31 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 118.381 2.734 . . . . 0.0 118.381 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.562 ' CZ2' HG21 ' A' ' 39' ' ' ILE . 21.3 m-90 -119.1 67.73 8.83 Favored Pre-proline 0 N--CA 1.504 2.234 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -61.9 -36.25 73.44 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 120.867 1.045 . . . . 0.0 110.889 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 21' ' ' LYS . 8.1 pm0 -49.8 -25.02 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.677 1.227 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 52.1 mt -77.07 -34.19 57.09 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.657 -177.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.407 ' CG2' HG21 ' A' ' 79' ' ' VAL . 60.5 t -45.91 135.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.545 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 -177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.84 -15.5 59.47 Favored Glycine 0 N--CA 1.513 3.803 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.129 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.49 176.02 5.56 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.3 OUTLIER -87.97 156.43 19.34 Favored 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.787 3.184 . . . . 0.0 118.314 176.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -46.76 70.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 1 CA-C-N 107.426 -4.443 . . . . 0.0 116.545 -175.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 63.1 mm-40 -54.46 -49.38 70.19 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 116.883 -1.927 . . . . 0.0 111.203 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -49.88 -53.61 24.75 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 124.333 2.016 . . . . 0.0 106.012 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -54.02 -54.91 32.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.275 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.431 ' HA ' HG12 ' A' ' 48' ' ' ILE . 9.5 mtpm? -46.27 -52.02 13.38 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 125.416 1.487 . . . . 0.0 107.72 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 21.1 ttpp -56.98 -57.59 11.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 110.78 -2.918 . . . . 0.0 108.98 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 72.2 t -55.0 -46.44 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 122.85 1.31 . . . . 0.0 112.955 -178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.607 ' CG2' HD12 ' A' ' 48' ' ' ILE . 96.9 mt -66.59 -49.41 75.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.227 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.46 -39.89 73.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 33.4 mt-30 -57.69 -37.37 73.35 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.438 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.442 ' OD2' ' NZ ' ' A' ' 21' ' ' LYS . 5.1 t0 -98.16 21.57 10.68 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 126.978 2.111 . . . . 0.0 115.955 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.582 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 65.7 tttt -98.72 105.91 33.68 Favored Pre-proline 0 N--CA 1.526 3.374 1 N-CA-C 128.299 6.407 . . . . 0.0 128.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 4.0 Cg_exo -90.95 -63.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.594 3.479 0 N-CA-C 104.132 -3.064 . . . . 0.0 104.132 161.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' C ' ' HE3' ' A' ' 43' ' ' LYS . 19.8 mp0 -88.81 -27.0 21.39 Favored 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' N ' ' HG3' ' A' ' 43' ' ' LYS . . . -62.35 67.58 0.01 OUTLIER 'General case' 1 N--CA 1.541 4.115 1 N-CA-C 132.85 8.092 . . . . 0.0 132.85 -179.064 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 60.7 tp60 -89.81 113.08 24.59 Favored 'General case' 1 N--CA 1.541 4.078 0 CA-C-N 124.965 3.53 . . . . 0.0 108.21 178.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.607 HD12 ' CG2' ' A' ' 39' ' ' ILE . 1.1 mp -78.48 144.65 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 48' ' ' ILE . 42.9 mm -139.3 142.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 110.433 -3.076 . . . . 0.0 105.402 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.8 141.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.621 HD11 ' CE2' ' A' ' 69' ' ' PHE . 5.9 mt -132.0 128.66 21.55 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 116.88 -1.533 . . . . 0.0 107.675 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.27 135.89 23.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 104.058 -3.093 . . . . 0.0 104.058 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.445 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -41.41 124.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.12 -20.21 38.64 Favored Glycine 0 N--CA 1.505 3.256 0 CA-C-N 109.055 -3.702 . . . . 0.0 118.172 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.489 ' OG1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -48.79 143.94 4.91 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.466 2.133 . . . . 0.0 112.587 -175.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.3 121.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.538 ' CG2' ' HD2' ' A' ' 67' ' ' ARG . 1.8 m -115.89 -87.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -175.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.47 107.64 16.09 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 119.487 3.143 . . . . 0.0 119.487 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.6 mtm -96.14 -58.56 2.05 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 127.649 3.595 . . . . 0.0 108.82 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.61 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -84.36 -145.92 0.09 Allowed 'General case' 0 C--N 1.273 -2.743 1 CA-C-N 104.05 -5.977 . . . . 0.0 105.7 175.173 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.566 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -126.07 94.61 4.14 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.438 172.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.61 ' HE ' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -77.84 50.97 0.9 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 124.911 2.291 . . . . 0.0 112.466 175.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.566 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 10.4 tp -76.66 31.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-O 125.234 2.445 . . . . 0.0 117.321 -176.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 62' ' ' ARG . 23.5 p30 -98.5 -30.63 12.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 111.212 -2.722 . . . . 0.0 109.386 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.572 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 3.8 ttp85 -127.5 158.62 36.92 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 118.923 2.934 . . . . 0.0 118.923 -171.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 39' ' ' ILE . 2.2 t -107.09 127.34 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.538 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.6 ttp180 -87.1 102.03 14.04 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 108.693 -3.867 . . . . 0.0 104.917 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 80' ' ' PRO . 10.9 mp -103.09 90.47 3.75 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 125.398 1.686 . . . . 0.0 111.307 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CE2' HD11 ' A' ' 51' ' ' LEU . 13.0 m-85 -73.28 105.75 4.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 124.762 2.22 . . . . 0.0 109.744 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -106.69 173.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 109.062 -3.699 . . . . 0.0 107.829 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.575 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.7 p-10 -98.39 -139.19 0.3 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 124.575 2.131 . . . . 0.0 111.885 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.575 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.6 mtmm -83.79 -13.52 53.62 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 109.477 -3.511 . . . . 0.0 114.83 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.323 0.3 OUTLIER -136.35 51.13 2.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-O 124.447 2.07 . . . . 0.0 107.197 -178.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.75 25.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 178.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -102.73 156.98 17.27 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.4 mt -78.86 116.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 126.465 3.031 . . . . 0.0 115.563 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.478 . . -94.53 -47.29 6.61 Favored 'General case' 0 C--N 1.287 -2.135 2 CA-C-N 103.381 -6.282 . . . . 0.0 110.065 -174.18 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -114.7 159.62 20.32 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 94.6 t -72.29 132.44 84.11 Favored Pre-proline 0 N--CA 1.499 2.018 0 C-N-CA 114.022 -3.071 . . . . 0.0 110.12 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 38.0 Cg_exo -67.05 144.25 68.9 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.811 2.341 . . . . 0.0 107.88 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.86 153.07 31.43 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.246 -1.359 . . . . 0.0 112.134 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' A' ' 63' ' ' ILE . 13.1 t -82.32 102.64 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.55 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.286 -2.22 0 C-N-CA 118.767 -1.683 . . . . 0.0 110.056 176.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.707 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.214 -0.766 0 CA-C-O 122.716 1.246 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -122.36 65.97 0.94 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 177.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' VAL . 12.8 p -114.89 9.27 16.14 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.255 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.38 150.4 45.26 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.528 -179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.416 ' CG ' HG12 ' A' ' 39' ' ' ILE . 16.3 m-90 -127.86 65.78 69.2 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 123.477 1.608 . . . . 0.0 112.444 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 27' ' ' LEU . 54.2 Cg_endo -67.74 -32.95 28.94 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.596 1.531 . . . . 0.0 109.481 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -65.5 0.49 1.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 39' ' ' ILE . 40.9 mt -99.17 -17.68 18.04 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.986 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.466 ' CG2' HG23 ' A' ' 79' ' ' VAL . 64.0 t -63.11 116.06 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 116.821 -1.952 . . . . 0.0 108.596 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.46 -5.68 24.76 Favored Glycine 0 N--CA 1.508 3.479 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.8 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -101.63 171.72 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.47 1.108 . . . . 0.0 108.564 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -87.19 168.75 12.95 Favored 'General case' 0 CA--C 1.445 -3.079 0 CA-C-O 124.942 2.306 . . . . 0.0 111.688 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.5 HG21 HG13 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -70.39 -39.57 76.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 108.566 -3.925 . . . . 0.0 109.066 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 2.1 pp20? -65.32 -49.74 68.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.287 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 tt0 -58.82 -46.08 88.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 27' ' ' LEU . . . -50.44 -58.51 5.58 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 116.721 -1.609 . . . . 0.0 109.809 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -47.69 -55.17 10.06 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 120.994 1.724 . . . . 0.0 107.481 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -48.04 -51.33 24.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 110.394 -3.094 . . . . 0.0 109.894 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.49 -52.92 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.066 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.622 ' CG2' HG23 ' A' ' 66' ' ' VAL . 22.5 mt -51.34 -47.79 34.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 123.021 1.391 . . . . 0.0 109.832 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.6 -28.79 57.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.01 -34.81 79.33 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 123.313 1.53 . . . . 0.0 109.679 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 36.8 m-20 -88.82 -49.53 6.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 119.661 3.208 . . . . 0.0 119.661 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 24.1 tptp -116.06 72.1 4.46 Favored Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -10.98 -38.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 2 C-N-CA 127.289 5.326 . . . . 0.0 122.773 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.9 mp0 -91.42 -25.11 19.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB3' HD13 ' A' ' 48' ' ' ILE . . . -38.17 80.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 1 N-CA-C 123.353 4.575 . . . . 0.0 123.353 -171.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -76.64 69.88 3.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.532 HD13 HG23 ' A' ' 39' ' ' ILE . 4.6 mt -72.46 131.69 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.352 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.57 162.01 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.77 113.19 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.36 1.076 . . . . 0.0 109.803 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.692 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -114.16 100.85 53.42 Favored Pre-proline 0 N--CA 1.501 2.1 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.616 -178.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.3 131.83 29.56 Favored 'Trans proline' 0 N--CA 1.509 2.416 0 CA-C-N 122.035 1.763 . . . . 0.0 108.926 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 70' ' ' VAL . 78.1 t -46.57 121.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 120.371 -1.455 . . . . 0.0 113.223 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.07 -30.19 6.42 Favored Glycine 1 N--CA 1.517 4.098 0 CA-C-N 110.512 -3.04 . . . . 0.0 114.849 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.573 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.289 91.6 m -47.21 92.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 124.742 1.217 . . . . 0.0 109.205 176.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mm -52.06 101.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 124.046 1.879 . . . . 0.0 115.804 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -103.65 -178.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.44 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.448 ' HG1' ' CD ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -91.16 158.76 16.44 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -174.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.459 ' N ' ' SD ' ' A' ' 59' ' ' MET . 3.6 mpp? -92.13 37.26 0.98 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 123.876 1.798 . . . . 0.0 108.237 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' CD ' ' HG1' ' A' ' 58' ' ' THR . 18.2 pt-20 -81.89 -171.67 3.49 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.757 -2.928 . . . . 0.0 111.773 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.482 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -133.98 82.42 1.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.738 1.256 . . . . 0.0 108.771 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -88.3 78.21 8.05 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 101.291 -3.596 . . . . 0.0 101.291 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.482 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 7.4 tp -69.77 -3.61 3.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 109.412 -3.54 . . . . 0.0 112.659 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.5 -6.7 58.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 110.047 -3.252 . . . . 0.0 106.755 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.292 5.3 ttm-85 -145.33 150.83 37.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 120.265 3.432 . . . . 0.0 120.265 -171.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.622 HG23 ' CG2' ' A' ' 39' ' ' ILE . 4.4 t -111.67 108.64 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.15 125.35 23.77 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 tp -115.12 74.55 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 O-C-N 124.905 1.378 . . . . 0.0 111.641 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.692 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 24.4 m-85 -72.76 104.94 4.13 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 126.593 3.092 . . . . 0.0 111.344 169.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 3.6 m -107.36 171.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 CA-C-N 108.724 -3.853 . . . . 0.0 112.156 -175.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.1 p-10 -83.0 -147.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 123.738 2.972 . . . . 0.0 112.889 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.8 ttpp -91.55 8.5 36.29 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.389 -3.096 . . . . 0.0 112.031 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.445 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.7 mt -141.7 36.45 1.63 Allowed 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 111.458 -2.61 . . . . 0.0 110.245 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.517 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.13 26.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 -177.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -103.62 135.47 45.15 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.64 118.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 127.542 3.544 . . . . 0.0 114.039 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.443 . . -94.68 -51.24 4.81 Favored 'General case' 0 C--N 1.288 -2.105 2 CA-C-N 103.159 -6.382 . . . . 0.0 112.064 -173.023 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.41 161.78 18.55 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.466 HG23 ' CG2' ' A' ' 28' ' ' VAL . 95.0 t -73.46 137.68 77.84 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 113.819 -3.152 . . . . 0.0 108.757 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 13.1 Cg_exo -78.36 152.71 27.07 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.421 ' NH2' ' O ' ' A' ' 82' ' ' VAL . 2.6 ptm180 -156.43 157.83 36.23 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 117.748 -1.581 . . . . 0.0 112.391 -176.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.472 HG21 HG21 ' A' ' 66' ' ' VAL . 3.5 t -81.49 131.5 33.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.401 -1.319 . . . . 0.0 108.104 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.593 0 CA-C-O 114.538 -3.368 . . . . 0.0 112.804 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.7 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 120.923 0.392 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 49.0 tttp -57.75 73.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 125.736 2.684 . . . . 0.0 115.041 -178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LEU . 17.1 p -111.94 33.77 4.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 100.458 -3.904 . . . . 0.0 100.458 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -142.31 156.08 45.24 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 126.671 2.482 . . . . 0.0 113.56 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.496 ' CE3' HG13 ' A' ' 66' ' ' VAL . 22.4 m-90 -140.77 62.78 18.47 Favored Pre-proline 0 N--CA 1.509 2.522 0 CA-C-O 123.73 1.729 . . . . 0.0 115.09 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -63.3 -13.02 33.31 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.293 1.995 . . . . 0.0 113.125 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' CD ' ' HZ2' ' A' ' 21' ' ' LYS . 12.0 mp0 -77.43 -20.43 54.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD1' HG13 ' A' ' 39' ' ' ILE . 69.8 mt -87.46 -19.62 27.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.427 ' CG2' HG23 ' A' ' 79' ' ' VAL . 45.4 t -49.51 130.57 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.22 -10.88 60.08 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.637 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -110.11 161.7 15.29 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.7 p -74.5 162.7 28.56 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-O 126.867 3.222 . . . . 0.0 110.961 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 70' ' ' VAL 0.279 9.1 p -62.89 -47.39 93.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 1 CA-C-N 107.199 -4.546 . . . . 0.0 112.163 -173.573 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -68.42 -34.2 75.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.343 -1.743 . . . . 0.0 110.954 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -62.94 -51.1 68.21 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -62.41 -44.19 97.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.398 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 85.7 mttt -45.85 -50.49 14.24 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.236 1.017 . . . . 0.0 108.518 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 5.7 ttpm? -48.14 -54.19 14.16 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 111.876 -2.42 . . . . 0.0 110.932 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 71.4 t -65.76 -47.34 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 112.768 -2.015 . . . . 0.0 111.898 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.628 ' CG2' HG23 ' A' ' 66' ' ' VAL . 17.1 mt -52.92 -53.57 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.886 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.257 34.7 mt -58.2 -19.62 34.92 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 125.154 1.534 . . . . 0.0 110.999 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -75.54 -25.88 57.55 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -96.45 -53.86 3.45 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -118.87 55.05 2.46 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.671 -0.643 . . . . 0.0 110.844 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -17.91 -40.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 125.131 3.888 . . . . 0.0 119.507 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.51 -30.37 68.53 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.518 0.675 . . . . 0.0 112.301 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.0 76.32 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 120.86 3.652 . . . . 0.0 120.86 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.43 74.84 4.96 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.532 HD13 HG23 ' A' ' 39' ' ' ILE . 55.6 mt -73.03 141.84 15.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.645 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.36 170.43 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.047 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.11 122.65 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.616 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 40.9 mt -118.51 77.47 13.98 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -50.79 129.88 28.87 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 106.927 -1.99 . . . . 0.0 106.927 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.485 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 1.3 t -40.86 130.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 123.885 1.802 . . . . 0.0 115.725 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.75 -29.61 12.14 Favored Glycine 0 N--CA 1.508 3.489 0 CA-C-N 110.652 -2.976 . . . . 0.0 113.811 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.513 ' CG2' HD21 ' A' ' 51' ' ' LEU 0.298 3.2 m -45.76 162.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.03 136.63 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.595 HG23 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -141.79 -70.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.873 0 N-CA-C 121.249 3.796 . . . . 0.0 121.249 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 93.33 8.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -98.64 -86.97 0.35 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 108.922 -3.763 . . . . 0.0 102.35 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' CD ' HH21 ' A' ' 62' ' ' ARG . 20.2 pt-20 -81.73 -167.91 1.69 Allowed 'General case' 0 C--N 1.277 -2.557 1 CA-C-N 107.263 -4.517 . . . . 0.0 106.321 173.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.37 95.99 8.44 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.405 HH21 ' CD ' ' A' ' 60' ' ' GLU . 3.0 mpt_? -83.74 66.24 8.95 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 125.088 2.375 . . . . 0.0 104.863 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.616 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.6 tp -74.8 -23.46 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.922 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.56 6.4 5.9 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 109.445 -3.525 . . . . 0.0 108.583 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.303 12.6 ttm-85 -154.87 149.38 26.31 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.628 HG23 ' CG2' ' A' ' 39' ' ' ILE . 2.9 t -117.17 126.44 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-N 120.647 1.567 . . . . 0.0 112.393 174.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 2.3 mtp180 -56.25 104.04 0.13 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 117.1 -1.429 . . . . 0.0 113.035 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 70' ' ' VAL . 10.3 mp -106.48 74.27 1.01 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 123.208 2.731 . . . . 0.0 104.496 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.616 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 16.7 m-85 -72.82 108.64 5.89 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 127.42 3.486 . . . . 0.0 109.262 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 68' ' ' LEU . 32.7 m -106.03 170.33 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 1 CA-C-N 106.647 -4.797 . . . . 0.0 110.088 -173.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 72' ' ' LYS . 5.3 p-10 -94.83 -138.15 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 124.096 1.903 . . . . 0.0 111.082 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 30.0 mmtp -83.57 -11.83 56.88 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 109.74 -3.391 . . . . 0.0 112.447 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.302 0.4 OUTLIER -136.53 52.2 1.97 Allowed 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 124.144 1.926 . . . . 0.0 108.955 -179.202 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' C ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.47 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 110.735 -2.938 . . . . 0.0 118.547 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -99.38 134.56 42.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.641 1.21 . . . . 0.0 110.274 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 mt -52.28 117.9 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 126.326 2.965 . . . . 0.0 111.877 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.435 . . -102.37 -39.19 7.28 Favored 'General case' 0 C--N 1.286 -2.168 1 CA-C-N 104.633 -5.712 . . . . 0.0 112.348 -170.913 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -114.47 160.25 19.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 102.831 -3.025 . . . . 0.0 102.831 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG23 ' CG2' ' A' ' 28' ' ' VAL . 88.3 t -76.88 145.03 73.54 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 114.273 -2.971 . . . . 0.0 109.405 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 14.5 Cg_exo -78.42 151.33 25.86 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.297 -1.463 . . . . 0.0 108.297 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.594 HH22 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -153.63 155.73 36.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.501 HG23 HG21 ' A' ' 66' ' ' VAL . 45.2 t -75.53 -83.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 124.01 1.862 . . . . 0.0 108.454 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.594 ' C ' HH22 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.285 -2.276 1 N-CA-C 102.304 -4.318 . . . . 0.0 102.304 -175.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.74 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.217 -0.657 0 CA-C-O 121.609 0.719 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.621 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 14.6 pttp -102.23 165.77 10.95 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 124.397 2.046 . . . . 0.0 107.874 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 36.2 p -106.92 -3.7 19.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 110.596 -3.002 . . . . 0.0 111.034 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.621 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -129.77 142.84 50.63 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.575 ' CZ2' HG22 ' A' ' 39' ' ' ILE . 25.5 m-90 -134.23 76.55 62.86 Favored Pre-proline 0 N--CA 1.52 3.068 1 N-CA-C 123.363 4.579 . . . . 0.0 123.363 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -79.84 -35.69 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.873 1.716 . . . . 0.0 111.985 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.13 -18.19 9.23 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -176.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 1.2 pp -104.09 2.05 31.59 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.282 1.433 . . . . 0.0 114.389 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.474 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 49.0 t -70.55 141.67 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.754 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.84 7.6 59.83 Favored Glycine 0 N--CA 1.515 3.941 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -125.96 167.38 15.37 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.525 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 3.2 p -88.17 155.01 19.99 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 126.354 2.978 . . . . 0.0 114.033 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 p -40.97 -49.62 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 1 CA-C-N 106.411 -4.904 . . . . 0.0 120.14 -175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 57.6 mm-40 -59.88 -49.02 79.35 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.211 -1.395 . . . . 0.0 109.605 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -51.3 -51.82 50.86 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.414 ' HB3' ' CD1' ' A' ' 76' ' ' ILE . . . -52.6 -58.02 8.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.547 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 49.1 mtpt -45.99 -52.45 11.74 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 123.364 1.554 . . . . 0.0 107.107 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.8 -54.05 43.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.483 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.4 t -54.33 -54.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-O 124.896 2.284 . . . . 0.0 109.778 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.575 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 9.3 mt -54.26 -43.88 63.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 110.526 -3.033 . . . . 0.0 112.216 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 46' ' ' ALA . 57.7 mt -73.22 -32.87 65.02 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 125.655 1.847 . . . . 0.0 110.866 175.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -64.81 -18.54 65.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.36 -64.15 1.08 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.277 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -104.65 62.62 0.11 Allowed Pre-proline 0 C--N 1.29 -1.979 0 C-N-CA 127.873 2.469 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -18.86 -49.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 123.983 3.122 . . . . 0.0 120.052 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.53 14.91 13.59 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 48' ' ' ILE . . . -59.56 97.87 0.04 OUTLIER 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.762 1.268 . . . . 0.0 113.626 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.51 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 3.3 tt0 -73.59 77.33 1.49 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.514 HD13 ' CG2' ' A' ' 39' ' ' ILE . 66.8 mt -74.52 135.06 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 123.153 1.454 . . . . 0.0 113.524 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.51 137.58 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 111.514 -2.585 . . . . 0.0 108.758 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.27 141.37 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 123.117 1.437 . . . . 0.0 110.541 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.538 HD22 ' CG2' ' A' ' 55' ' ' THR . 2.5 mp -137.43 140.19 29.77 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.01 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.413 ' O ' ' HB ' ' A' ' 55' ' ' THR . 32.3 Cg_endo -74.82 141.79 27.63 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 t -42.14 128.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.12 20.63 Favored Glycine 0 N--CA 1.507 3.396 0 CA-C-N 111.213 -2.721 . . . . 0.0 112.543 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.538 ' CG2' HD22 ' A' ' 51' ' ' LEU 0.28 0.9 OUTLIER -69.02 177.05 2.82 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 123.76 1.743 . . . . 0.0 112.428 179.106 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.3 mm -59.18 105.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 124.037 4.829 . . . . 0.0 124.037 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -105.18 -50.84 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.613 0 CA-C-N 111.207 -2.724 . . . . 0.0 111.682 173.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 62.95 4.53 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 128.284 3.897 . . . . 0.0 119.156 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.524 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 3.5 ttt -98.65 -162.38 0.95 Allowed 'General case' 0 C--N 1.279 -2.475 1 CA-C-N 103.038 -6.437 . . . . 0.0 108.687 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.524 ' H ' ' HG2' ' A' ' 59' ' ' MET . 0.4 OUTLIER -73.87 -141.69 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.226 172.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.513 ' CE2' HD11 ' A' ' 63' ' ' ILE . 12.1 t80 -136.49 83.35 2.0 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -87.41 76.61 9.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.513 HD11 ' CE2' ' A' ' 61' ' ' TYR . 5.9 tp -52.2 -19.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 110.952 -2.84 . . . . 0.0 112.808 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 47' ' ' GLN 0.263 2.2 p30 -81.43 15.96 1.85 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.975 177.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.476 HH21 ' C ' ' A' ' 83' ' ' GLY . 53.0 ttp180 -153.64 122.65 6.46 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.558 HG12 HD12 ' A' ' 39' ' ' ILE . 24.0 t -91.12 146.79 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 C-N-CA 114.467 -2.893 . . . . 0.0 105.016 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.641 HH21 ' C ' ' A' ' 83' ' ' GLY . 14.9 tpp85 -99.94 114.08 27.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.076 -2.784 . . . . 0.0 105.527 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 HD23 ' CD1' ' A' ' 39' ' ' ILE . 84.3 mt -113.74 105.21 13.03 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.46 -1.296 . . . . 0.0 114.094 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 57' ' ' VAL . 25.7 m-85 -80.14 102.91 9.66 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 125.697 2.665 . . . . 0.0 112.174 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.99 173.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 108.593 -3.912 . . . . 0.0 110.018 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -99.72 -141.75 0.33 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 124.53 2.109 . . . . 0.0 111.935 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.553 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.64 8.54 43.11 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.054 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 75' ' ' ASN . 65.2 mt -135.46 39.95 2.84 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 111.075 -2.784 . . . . 0.0 108.627 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.78 28.0 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 64.0 m-20 -104.8 146.9 28.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.174 1.94 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 35' ' ' ALA . 15.6 mt -77.8 95.33 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-O 127.245 3.403 . . . . 0.0 114.402 -177.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.507 . . -72.3 -45.47 59.87 Favored 'General case' 0 C--N 1.289 -2.045 2 CA-C-N 100.608 -7.542 . . . . 0.0 102.437 178.838 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -119.19 135.14 54.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.74 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 87.2 t -42.72 -56.19 6.27 Favored Pre-proline 0 N--CA 1.519 2.98 1 N-CA-C 124.623 5.046 . . . . 0.0 124.623 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.74 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.255 0.0 OUTLIER 7.01 -152.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 2 C-N-CA 130.714 7.609 . . . . 0.0 127.837 -168.309 . . . . . . . . 5 4 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -155.53 -173.23 4.45 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -158.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 66' ' ' VAL . 5.0 t -81.88 148.55 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.289 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.641 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.988 0 O-C-N 126.392 2.307 . . . . 0.0 114.464 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.682 ' CA ' ' H ' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.217 -0.632 0 CA-C-O 120.991 0.424 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 1.7 tmtm? -14.2 76.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -123.75 16.51 9.46 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 111.56 -2.564 . . . . 0.0 106.846 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -133.74 150.12 51.48 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.085 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.517 ' CD1' ' HE3' ' A' ' 21' ' ' LYS . 26.8 m-90 -133.22 74.56 72.47 Favored Pre-proline 0 N--CA 1.507 2.388 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -74.14 -33.91 5.43 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.704 2.269 . . . . 0.0 110.486 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -48.43 -34.85 11.66 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.739 2.209 . . . . 0.0 109.945 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.7 pp -98.51 23.08 8.96 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.556 ' CG2' HG21 ' A' ' 79' ' ' VAL . 64.5 t -73.32 163.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.85 17.17 60.33 Favored Glycine 0 N--CA 1.512 3.709 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.949 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.23 163.89 25.74 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-O 116.568 -1.682 . . . . 0.0 109.59 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.5 p -88.42 158.13 18.47 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 126.575 3.083 . . . . 0.0 113.908 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.49 -27.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 1 CA-C-N 106.41 -4.905 . . . . 0.0 114.76 -176.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 34' ' ' GLU . 16.8 pt-20 -66.67 -52.16 47.92 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 123.87 1.795 . . . . 0.0 109.429 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' ' 33' ' ' GLU . 9.6 tm-20 -62.48 -51.04 69.02 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -50.72 -48.92 58.73 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.06 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -57.95 -53.12 61.81 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 3.8 tmtm? -48.2 -35.91 12.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 113.382 -1.736 . . . . 0.0 114.775 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.1 t -85.25 -59.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.229 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 66' ' ' VAL . 40.2 mt -49.25 -48.91 17.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.679 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.94 -23.18 62.19 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.126 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -96.38 -63.27 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 8.2 tptp -111.13 67.23 0.59 Allowed Pre-proline 0 N--CA 1.499 2.007 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -18.62 -46.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 124.599 3.533 . . . . 0.0 120.096 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.3 mp0 -59.28 -35.07 73.07 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.86 79.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.678 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 43.9 tt0 -78.09 65.37 3.46 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.875 1.797 . . . . 0.0 107.269 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 39' ' ' ILE . 32.6 mt -70.46 142.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.442 ' CG2' ' H ' ' A' ' 50' ' ' VAL . 32.9 mm -125.86 -166.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 110.668 -2.969 . . . . 0.0 106.418 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 4.8 p -106.02 142.05 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 0.0 112.56 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' CD1' ' CG2' ' A' ' 55' ' ' THR . 0.0 OUTLIER -139.39 102.81 7.24 Favored Pre-proline 0 N--CA 1.513 2.723 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.55 129.06 15.17 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 122.799 2.035 . . . . 0.0 109.435 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 t -41.94 130.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 123.383 1.563 . . . . 0.0 114.476 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.62 -21.49 45.83 Favored Glycine 0 N--CA 1.503 3.144 0 CA-C-N 111.095 -2.775 . . . . 0.0 114.613 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -58.24 156.36 9.98 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 119.261 1.531 . . . . 0.0 113.416 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.04 127.46 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.124 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG22 ' HE2' ' A' ' 69' ' ' PHE . 30.0 m -131.21 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 112.645 -2.071 . . . . 0.0 109.473 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -155.67 0.31 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.466 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 50.2 mtp -58.1 -149.91 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -18.68 44.36 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 125.27 2.462 . . . . 0.0 116.318 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -116.54 107.15 14.38 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 109.488 -3.506 . . . . 0.0 106.706 178.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.617 ' H ' ' C ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -107.45 43.72 1.16 Allowed 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 125.277 2.465 . . . . 0.0 109.758 179.073 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.2 tp -42.73 -27.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.444 1 CA-C-N 107.295 -4.502 . . . . 0.0 120.058 -177.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.23 -17.62 20.45 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 47' ' ' GLN 0.255 0.1 OUTLIER -142.81 -170.84 3.32 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.863 -2.426 . . . . 0.0 114.017 -176.973 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 39' ' ' ILE . 3.0 t -115.64 111.49 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 1 N-CA-C 88.032 -8.507 . . . . 0.0 88.032 169.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HD3' ' CG1' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -81.04 101.83 9.82 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 122.515 2.416 . . . . 0.0 111.013 -176.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' HG11 ' A' ' 70' ' ' VAL . 8.9 mp -79.9 80.18 6.33 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.507 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 13.6 m-85 -70.12 106.67 3.35 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 125.96 2.79 . . . . 0.0 108.95 166.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 14.9 m -105.9 175.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.766 1 CA-C-N 108.234 -4.075 . . . . 0.0 109.607 -176.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.486 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 6.5 p-10 -91.89 -140.21 0.18 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.232 -2.167 . . . . 0.0 113.194 -177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 43.8 mtmt -89.3 0.87 56.47 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 110.673 -2.967 . . . . 0.0 112.072 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.1 mt -135.77 32.66 2.98 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.874 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.16 28.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -177.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -103.2 148.83 25.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.0 mt -74.88 106.46 4.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 126.843 3.211 . . . . 0.0 114.18 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.399 . . -81.34 -51.88 7.88 Favored 'General case' 0 C--N 1.287 -2.152 2 CA-C-N 101.692 -7.049 . . . . 0.0 110.042 -177.744 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.49 148.33 39.59 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG21 ' CG2' ' A' ' 28' ' ' VAL . 88.8 t -70.45 141.73 88.47 Favored Pre-proline 0 N--CA 1.502 2.132 0 C-N-CA 114.193 -3.003 . . . . 0.0 108.113 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 6.2 Cg_exo -89.27 159.16 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.765 2.31 . . . . 0.0 108.26 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.41 ' C ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -154.29 157.27 38.41 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -177.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 HG21 ' CH2' ' A' ' 24' ' ' TRP . 55.6 t -75.26 109.79 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 176.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.276 -2.768 0 CA-C-N 110.869 -2.878 . . . . 0.0 107.032 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' NZ ' ' CD1' ' A' ' 24' ' ' TRP . 4.0 tmtt? . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.469 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 66.5 p -102.96 34.98 2.66 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-O 122.897 1.332 . . . . 0.0 108.771 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' CD ' HH22 ' A' ' 81' ' ' ARG 0.251 0.0 OUTLIER -154.78 151.62 28.89 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.612 -176.736 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 24.1 m-90 -139.47 81.01 21.01 Favored Pre-proline 0 N--CA 1.517 2.887 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.4 -34.68 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.915 2.41 . . . . 0.0 111.612 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.77 -17.6 9.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.154 -0.966 . . . . 0.0 111.445 -177.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 1.7 pp -107.05 17.63 22.79 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 79' ' ' VAL . 69.8 t -65.99 169.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.109 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.37 18.18 35.18 Favored Glycine 1 N--CA 1.521 4.354 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -121.05 157.4 30.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.2 p -89.03 159.71 17.45 Favored 'General case' 0 CA--C 1.472 -2.053 0 CA-C-O 127.482 3.515 . . . . 0.0 109.083 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -40.01 -54.18 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.263 1 CA-C-N 105.888 -5.142 . . . . 0.0 118.722 -174.009 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 60.3 mm-40 -55.33 -47.87 75.02 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.936 1.698 . . . . 0.0 110.776 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 1.2 tm-20 -50.96 -47.14 61.29 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.77 -47.78 76.9 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.16 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 66.9 mttm -49.32 -50.55 39.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 76.9 tttt -48.64 -55.33 11.55 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 110.803 -2.908 . . . . 0.0 108.757 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 67.5 t -59.87 -54.27 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.764 0 CA-C-O 125.53 2.586 . . . . 0.0 112.72 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.686 ' CG2' HG21 ' A' ' 66' ' ' VAL . 31.6 mt -57.33 -50.03 78.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 112.151 -2.295 . . . . 0.0 110.663 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 67.8 mt -57.3 -36.42 71.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.1 tt0 -58.78 -44.72 90.76 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 118.05 -1.46 . . . . 0.0 110.935 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.74 -48.39 54.75 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.434 -1.712 . . . . 0.0 114.026 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 25.9 ttpp -127.36 68.31 72.96 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -14.72 -43.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 124.678 3.585 . . . . 0.0 119.949 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -86.97 -5.28 59.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -46.6 96.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.641 HE22 HD11 ' A' ' 49' ' ' ILE . 12.1 tm0? -77.76 93.32 4.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.598 HD11 ' CG2' ' A' ' 39' ' ' ILE . 73.0 mt -93.14 114.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 121.377 3.843 . . . . 0.0 121.377 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.641 HD11 HE22 ' A' ' 47' ' ' GLN . 36.5 mm -102.27 149.76 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 112.768 -2.014 . . . . 0.0 107.602 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.92 155.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.116 0.96 . . . . 0.0 112.506 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.769 ' HB3' ' CE1' ' A' ' 69' ' ' PHE 0.254 0.6 OUTLIER -142.42 132.19 12.26 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.579 -179.788 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.452 ' HD2' HD23 ' A' ' 51' ' ' LEU . 52.5 Cg_endo -72.05 113.97 3.84 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.172 1.915 . . . . 0.0 113.994 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 69' ' ' PHE . 36.5 t -41.56 123.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.441 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 119.51 -37.89 2.99 Favored Glycine 0 N--CA 1.507 3.424 2 O-C-N 129.751 4.407 . . . . 0.0 108.651 -175.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.517 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.267 52.0 m -60.04 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.031 1.332 . . . . 0.0 108.183 175.332 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' GLY . 24.9 mm -55.46 147.98 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.87 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' NE ' ' A' ' 67' ' ' ARG . 12.4 m -123.01 -147.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.42 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -87.49 155.33 20.05 Favored 'General case' 0 C--N 1.306 -1.321 1 N-CA-C 124.796 5.11 . . . . 0.0 124.796 -173.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -93.86 34.7 1.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 123.083 1.421 . . . . 0.0 110.865 176.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.02 -176.11 5.97 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.57 56.36 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 123.145 1.45 . . . . 0.0 107.391 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.48 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mmm180 -88.96 67.28 8.13 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 126.991 3.282 . . . . 0.0 107.782 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.537 HD12 HG11 ' A' ' 82' ' ' VAL . 6.5 tp -53.2 -26.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 1 CA-C-N 107.19 -4.55 . . . . 0.0 109.518 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' GLN . 1.3 p30 -60.91 -7.16 2.2 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.811 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 62' ' ' ARG . 6.1 ttp85 -139.55 151.58 46.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 121.768 3.988 . . . . 0.0 121.768 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.686 HG21 ' CG2' ' A' ' 39' ' ' ILE . 21.2 t -115.08 92.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' NE ' HG21 ' A' ' 57' ' ' VAL . 26.8 ttm180 -48.58 123.24 6.43 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 109.826 -3.352 . . . . 0.0 106.05 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 76' ' ' ILE 0.271 0.6 OUTLIER -115.16 84.03 2.01 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 125.916 2.01 . . . . 0.0 112.303 -176.965 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.769 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 26.0 m-85 -73.33 108.38 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 124.71 2.195 . . . . 0.0 107.057 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 53' ' ' VAL . 14.5 m -113.46 174.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 1 CA-C-N 108.286 -4.052 . . . . 0.0 110.368 -177.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.586 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.2 p-10 -88.69 -146.89 0.16 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 122.941 2.61 . . . . 0.0 111.637 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.586 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 12.0 mptt -90.63 0.34 57.42 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 111.736 -2.484 . . . . 0.0 113.994 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.375 0.2 OUTLIER -139.15 47.8 1.89 Allowed 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 112.558 -2.11 . . . . 0.0 105.772 178.101 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.71 27.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 58.6 m-80 -100.9 151.68 21.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 123.331 1.539 . . . . 0.0 109.576 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.423 HD11 HD11 ' A' ' 68' ' ' LEU . 82.0 mt -78.72 93.71 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 127.466 3.507 . . . . 0.0 116.125 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.351 . . -73.2 -42.09 63.07 Favored 'General case' 0 C--N 1.291 -1.957 2 CA-C-N 100.292 -7.685 . . . . 0.0 112.958 178.702 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 10.1 tt0 -117.57 156.14 28.61 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 28' ' ' VAL . 88.5 t -76.34 136.51 68.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 112.75 -3.58 . . . . 0.0 104.981 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_exo -81.48 169.59 15.35 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.518 2.812 . . . . 0.0 111.695 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.527 HH22 ' CD ' ' A' ' 23' ' ' GLU . 2.3 ptp180 -163.69 172.38 14.3 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 116.624 -1.655 . . . . 0.0 111.731 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.578 HG22 HG22 ' A' ' 66' ' ' VAL . 6.1 t -82.58 -111.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 82' ' ' VAL . . . . . . . . 0 C--N 1.287 -2.167 3 N-CA-C 96.046 -6.821 . . . . 0.0 96.046 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 13.3 mtpp . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 124.011 1.862 . . . . 0.0 112.444 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.5 p -111.42 -6.51 14.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.97 135.08 35.65 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.591 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 25.4 m-90 -117.0 72.94 6.24 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 122.983 1.373 . . . . 0.0 114.581 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HA ' HG23 ' A' ' 28' ' ' VAL . 40.5 Cg_endo -69.45 -31.98 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.643 1.562 . . . . 0.0 110.66 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' ' HZ1' ' A' ' 21' ' ' LYS . 33.4 mp0 -52.18 -34.9 47.19 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.167 1.461 . . . . 0.0 109.928 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 24' ' ' TRP 0.25 4.5 pp -102.06 36.48 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 123.704 1.716 . . . . 0.0 113.027 -177.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.58 ' CG2' HG22 ' A' ' 79' ' ' VAL . 9.9 t -81.45 155.92 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.767 171.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.65 29.1 17.55 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.469 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.0 mmmp? -120.58 176.49 5.48 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 117.13 -1.414 . . . . 0.0 109.44 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -85.32 160.28 19.85 Favored 'General case' 0 CA--C 1.459 -2.532 0 CA-C-O 126.053 2.835 . . . . 0.0 112.109 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.549 ' CG2' HG11 ' A' ' 70' ' ' VAL 0.251 1.7 p -69.55 -28.31 37.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 1 CA-C-N 107.189 -4.551 . . . . 0.0 111.13 -173.701 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.432 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 18.6 mm-40 -77.23 -38.55 50.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.1 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 32.8 mt-10 -63.08 -50.85 68.94 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 125.889 1.993 . . . . 0.0 105.632 174.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.73 -58.53 3.01 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.79 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.1 mttp -49.48 -54.96 14.95 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-O 122.549 1.166 . . . . 0.0 108.425 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' NZ ' ' OE1' ' A' ' 33' ' ' GLU . 57.5 mttp -52.95 -46.65 68.27 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.233 -2.258 . . . . 0.0 112.029 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' CD2' ' A' ' 27' ' ' LEU . 99.4 t -67.51 -52.51 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 122.559 1.171 . . . . 0.0 110.705 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 66' ' ' VAL . 17.5 mt -51.74 -48.69 37.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.315 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD21 ' O ' ' A' ' 46' ' ' ALA . 88.4 mt -60.77 -34.83 75.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 124.988 1.43 . . . . 0.0 107.378 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -84.79 -57.24 3.2 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 114.095 -1.412 . . . . 0.0 113.551 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 51.9 tttm -115.54 78.69 6.73 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.338 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -22.71 -52.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 N-CA-C 118.683 2.532 . . . . 0.0 118.683 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.67 9.35 14.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -178.221 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.696 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -65.15 96.17 0.2 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 117.822 -1.551 . . . . 0.0 113.18 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.92 69.86 4.2 Favored 'General case' 0 N--CA 1.513 2.692 0 O-C-N 118.338 -2.726 . . . . 0.0 107.893 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' HD12 ' A' ' 68' ' ' LEU . 32.8 mt -78.04 122.06 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 112.793 -2.003 . . . . 0.0 116.114 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.638 ' H ' ' CZ ' ' A' ' 65' ' ' ARG . 1.3 mp -115.47 170.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.453 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 7.7 p -72.79 126.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 123.096 1.427 . . . . 0.0 110.512 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 55' ' ' THR . 0.2 OUTLIER -131.62 104.8 14.39 Favored Pre-proline 0 N--CA 1.492 1.673 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.505 -177.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -56.54 115.05 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.625 0.545 . . . . 0.0 111.015 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.597 ' HA ' ' CG ' ' A' ' 69' ' ' PHE . 14.9 p -39.81 142.31 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 123.679 1.704 . . . . 0.0 112.655 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' N ' ' CE2' ' A' ' 69' ' ' PHE . . . 95.84 -26.09 22.09 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 112.067 -2.333 . . . . 0.0 110.976 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.582 HG21 HD23 ' A' ' 51' ' ' LEU 0.321 3.0 m -54.39 -179.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.225 1.012 . . . . 0.0 113.644 176.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.32 99.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 118.646 -2.534 . . . . 0.0 114.388 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -99.25 -48.18 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.268 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.97 68.54 0.68 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 127.659 3.6 . . . . 0.0 113.603 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.483 ' SD ' ' HG3' ' A' ' 62' ' ' ARG . 18.2 ttm -99.77 -177.96 3.72 Favored 'General case' 0 C--N 1.276 -2.609 1 CA-C-N 104.315 -5.857 . . . . 0.0 107.292 -178.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 11.8 pt-20 -78.53 -163.23 0.43 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 174.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.924 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 67.3 t80 -94.76 81.56 3.82 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.616 -1.303 . . . . 0.0 111.602 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.483 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 8.6 mmt85 -88.65 56.78 3.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.45 -1.7 . . . . 0.0 109.528 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.924 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.27 -27.6 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 111.348 -2.66 . . . . 0.0 116.642 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.07 -14.81 1.73 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 124.008 1.861 . . . . 0.0 108.328 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.638 ' CZ ' ' H ' ' A' ' 49' ' ' ILE . 6.2 mtp180 -132.21 157.41 44.41 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 119.443 3.127 . . . . 0.0 119.443 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.71 HG21 HG21 ' A' ' 39' ' ' ILE . 2.9 t -115.45 134.44 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 1 N-CA-C 98.5 -4.629 . . . . 0.0 98.5 171.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CD ' HD13 ' A' ' 51' ' ' LEU . 9.2 tpp180 -83.13 134.68 34.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD12 ' CG2' ' A' ' 48' ' ' ILE . 3.2 mt -113.86 82.01 1.62 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.856 1.347 . . . . 0.0 108.475 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.597 ' CG ' ' HA ' ' A' ' 53' ' ' VAL . 2.6 m-30 -73.46 92.45 1.87 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 126.498 3.047 . . . . 0.0 108.592 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 32' ' ' VAL . 4.8 m -105.16 171.04 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 1 CA-C-N 105.327 -5.397 . . . . 0.0 104.017 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.5 p-10 -96.75 -138.39 0.27 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 125.373 2.511 . . . . 0.0 112.261 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.549 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.0 mtmm -85.32 -11.99 53.36 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 109.195 -3.639 . . . . 0.0 114.166 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.609 ' CD1' HD22 ' A' ' 75' ' ' ASN 0.306 0.3 OUTLIER -138.05 52.36 1.85 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 112.087 -2.324 . . . . 0.0 107.675 -178.816 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 36.42 22.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.609 HD22 ' CD1' ' A' ' 73' ' ' LEU . 34.4 m-20 -105.62 138.27 42.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 123.473 1.606 . . . . 0.0 110.608 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.64 122.43 11.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 126.006 2.812 . . . . 0.0 117.211 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.485 . . -104.5 -44.16 4.98 Favored 'General case' 0 C--N 1.289 -2.03 1 CA-C-N 105.362 -5.381 . . . . 0.0 111.016 -171.831 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . 11.0 tp60 -115.42 161.7 18.18 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.58 HG22 ' CG2' ' A' ' 28' ' ' VAL . 95.4 t -75.79 134.25 72.29 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 113.939 -3.105 . . . . 0.0 109.05 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 31.9 Cg_exo -68.72 131.93 23.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 103.803 -3.191 . . . . 0.0 103.803 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' THR . 4.9 ptm180 -138.67 157.2 46.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.479 1.112 . . . . 0.0 108.703 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.8 t -79.03 152.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.358 1.036 . . . . 0.0 112.697 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.455 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.513 3.824 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.029 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 5.8 tmtt? . . . . . 0 N--CA 1.508 2.467 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 48.2 p -104.55 24.96 10.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 112.608 -2.087 . . . . 0.0 105.401 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.07 151.16 43.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 126.225 2.203 . . . . 0.0 113.202 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.649 ' CG ' HG12 ' A' ' 39' ' ' ILE . 26.9 m-90 -128.67 67.32 76.73 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 123.285 1.517 . . . . 0.0 112.293 174.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -63.42 -37.67 47.62 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 CA-C-N 113.301 -1.357 . . . . 0.0 110.034 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 27' ' ' LEU . 19.6 pm0 -51.01 -31.32 17.73 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.165 0.983 . . . . 0.0 111.934 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.6 pp -105.84 31.9 4.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.556 HG21 HG22 ' A' ' 79' ' ' VAL . 77.4 t -84.71 124.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 170.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.82 3.46 54.94 Favored Glycine 0 N--CA 1.514 3.868 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -109.53 156.13 20.52 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.367 -0.917 . . . . 0.0 110.306 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 p -85.81 155.07 21.15 Favored 'General case' 0 CA--C 1.474 -1.945 0 CA-C-O 127.386 3.47 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -48.93 -56.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 1 CA-C-N 106.022 -5.081 . . . . 0.0 120.739 -170.259 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 50.0 mm-40 -57.67 -40.43 79.36 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 117.417 -1.713 . . . . 0.0 110.559 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.13 -54.39 46.46 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -44.58 -52.4 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.964 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mttt -55.77 -58.15 9.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 3.8 tmtm? -47.46 -40.14 17.49 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.798 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 77.4 t -70.59 -56.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.549 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HG21 ' A' ' 66' ' ' VAL . 47.7 mt -48.19 -39.18 8.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 122.814 1.292 . . . . 0.0 110.836 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 11.7 mt -53.26 -35.9 60.53 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.077 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -62.66 -46.59 87.49 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-O 123.942 1.829 . . . . 0.0 110.455 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.543 ' CG ' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -62.78 -49.94 72.99 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.988 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 1.2 mtpp -125.81 81.14 66.04 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.799 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.49 -54.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 118.204 2.348 . . . . 0.0 118.204 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.36 13.65 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 64' ' ' ASP . . . -60.22 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.032 0.92 . . . . 0.0 113.293 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -82.74 72.32 9.81 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 124.567 2.127 . . . . 0.0 106.071 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.67 HD11 ' CG2' ' A' ' 39' ' ' ILE . 49.2 mt -73.63 148.95 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 110.617 -2.992 . . . . 0.0 117.37 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.87 162.08 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 112.748 -2.023 . . . . 0.0 112.84 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 133.93 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 112.06 -2.336 . . . . 0.0 105.115 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.722 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.6 mt -141.51 113.36 6.62 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.564 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -76.0 130.04 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 CA-C-N 121.818 1.685 . . . . 0.0 108.0 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 69' ' ' PHE . 13.1 t -39.55 130.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.61 -40.69 2.46 Favored Glycine 1 N--CA 1.518 4.144 0 CA-C-N 109.302 -3.59 . . . . 0.0 111.019 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.56 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 40.6 m -46.29 125.49 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.721 1.208 . . . . 0.0 108.778 177.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.39 152.28 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.502 HG21 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -128.62 -51.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.716 1 N-CA-C 125.002 5.186 . . . . 0.0 125.002 -175.653 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.08 99.98 5.54 Favored 'General case' 0 C--N 1.288 -2.081 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.431 ' HB2' ' NH2' ' A' ' 62' ' ' ARG . 87.9 mtp -94.11 -117.55 0.1 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 100.809 -3.775 . . . . 0.0 100.809 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.257 3.1 pp20? -76.54 -167.29 0.78 Allowed 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 111.012 -2.813 . . . . 0.0 106.251 172.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -79.68 98.73 7.08 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.975 0.893 . . . . 0.0 112.074 -173.148 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -85.59 58.7 5.19 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 125.758 2.694 . . . . 0.0 109.468 177.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.515 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 7.6 tp -71.47 -9.22 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 109.524 -3.489 . . . . 0.0 116.476 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 11.5 p-10 -96.87 -1.69 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.788 1.28 . . . . 0.0 108.252 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.03 144.61 50.98 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.721 HG21 HG21 ' A' ' 39' ' ' ILE . 3.1 t -116.94 145.86 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -103.66 130.79 51.18 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.746 175.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 35' ' ' ALA . 20.3 mt -103.2 83.05 2.14 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.662 -2.063 . . . . 0.0 107.398 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.722 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.5 m-85 -73.18 100.15 3.0 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 126.478 3.037 . . . . 0.0 108.485 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 68' ' ' LEU . 32.8 m -101.52 171.15 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 1 CA-C-N 106.541 -4.845 . . . . 0.0 108.211 -176.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.514 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.2 p-10 -97.35 -140.87 0.29 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 124.633 2.158 . . . . 0.0 111.689 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.514 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 37.4 tttp -85.88 -0.97 56.77 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 109.199 -3.637 . . . . 0.0 111.451 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.492 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.3 mt -136.08 38.79 2.75 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.624 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.49 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -100.08 134.38 43.09 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.616 HG21 ' HG3' ' A' ' 80' ' ' PRO . 50.8 mt -58.37 122.96 9.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 125.328 2.49 . . . . 0.0 109.651 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.476 . . -105.4 -38.13 6.59 Favored 'General case' 0 C--N 1.284 -2.267 2 CA-C-N 105.19 -5.459 . . . . 0.0 110.261 -172.601 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -118.71 160.08 22.49 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.069 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.556 HG22 HG21 ' A' ' 28' ' ' VAL . 95.4 t -65.55 135.99 95.95 Favored Pre-proline 0 N--CA 1.501 2.089 0 C-N-CA 114.881 -2.728 . . . . 0.0 110.107 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HG3' HG21 ' A' ' 76' ' ' ILE . 4.4 Cg_exo -83.45 142.46 10.54 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 N-CA-C 104.417 -2.955 . . . . 0.0 104.417 -176.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 22' ' ' THR . 6.9 ptm180 -156.56 163.76 39.0 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 116.522 -2.071 . . . . 0.0 113.375 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 83' ' ' GLY . 2.7 t -84.38 155.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 125.924 2.015 . . . . 0.0 111.994 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.542 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.428 0 CA-C-O 114.127 -3.596 . . . . 0.0 112.512 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -98.41 31.22 2.9 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.396 -1.322 . . . . 0.0 111.384 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.63 146.29 31.28 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.913 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.637 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 24.1 m-90 -127.4 67.17 71.1 Favored Pre-proline 0 N--CA 1.498 1.966 0 CA-C-O 124.262 1.982 . . . . 0.0 111.396 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' HG22 ' A' ' 79' ' ' VAL . 40.8 Cg_endo -69.29 -41.51 4.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 CA-C-N 111.068 -2.154 . . . . 0.0 110.614 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.7 pm0 -67.42 -9.64 43.67 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.786 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.637 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -107.78 13.73 26.16 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.645 HG21 HG22 ' A' ' 79' ' ' VAL . 48.6 t -68.01 161.46 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.72 57.15 Favored Glycine 1 N--CA 1.518 4.147 0 C-N-CA 118.475 -1.821 . . . . 0.0 113.829 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 2.9 mtpp -106.48 166.62 10.42 Favored 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 124.122 0.969 . . . . 0.0 111.655 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 p -85.7 154.23 21.79 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 126.249 2.928 . . . . 0.0 115.717 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.479 ' CG2' HG11 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -48.94 -57.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 1 CA-C-N 107.875 -4.239 . . . . 0.0 114.202 -172.081 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -53.01 -36.51 60.6 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 121.506 1.957 . . . . 0.0 113.802 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -50.68 38.83 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -46.55 -51.82 14.71 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 123.422 1.582 . . . . 0.0 107.488 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 40' ' ' LEU . 15.5 mtpp -55.16 -54.2 46.23 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -49.1 -42.03 37.66 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.341 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 85.5 t -67.57 -53.49 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.393 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.813 HG21 HG21 ' A' ' 66' ' ' VAL . 45.6 mt -60.3 -51.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.084 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 36' ' ' LYS . 1.3 mp -52.68 -27.75 18.75 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.575 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 39.4 tp60 -68.98 -23.75 64.16 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.1 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.19 -53.37 3.82 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.283 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 18.6 ttpp -116.7 76.69 7.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.24 -45.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 123.387 2.725 . . . . 0.0 117.446 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.25 0.7 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 16.3 mt-30 -77.94 60.74 2.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.651 ' HA ' ' HG3' ' A' ' 65' ' ' ARG . 65.6 mt -73.22 140.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 43.1 mm -115.86 175.7 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.607 1.194 . . . . 0.0 112.645 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.477 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 17.2 t -102.52 116.09 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 110.279 -3.146 . . . . 0.0 108.327 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 13.4 mt -124.04 92.18 48.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.05 127.94 27.76 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 N-CA-C 109.286 -1.082 . . . . 0.0 109.286 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.429 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -43.18 127.89 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.877 0 CA-C-O 123.613 1.673 . . . . 0.0 111.186 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 -21.04 35.42 Favored Glycine 1 N--CA 1.517 4.063 0 CA-C-N 109.587 -3.461 . . . . 0.0 112.778 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.626 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.333 23.7 m -68.25 62.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 173.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 mm -51.11 112.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 124.308 2.004 . . . . 0.0 116.382 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' CG2' ' HE2' ' A' ' 69' ' ' PHE . 30.2 m -103.56 167.82 2.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 110.106 -3.225 . . . . 0.0 104.394 175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 -171.68 2.3 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 108.852 -3.794 . . . . 0.0 111.958 -174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.3 tpp -92.23 23.76 3.69 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.073 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.03 166.21 16.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.631 ' CD2' ' HA2' ' A' ' 83' ' ' GLY . 8.3 t80 -145.59 154.19 41.89 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.601 ' N ' ' CD2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -116.43 62.1 0.72 Allowed 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.619 HD12 HG12 ' A' ' 82' ' ' VAL . 5.3 tp -44.54 -27.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.07 -24.37 24.9 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.154 -2.294 . . . . 0.0 108.261 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HG3' ' HA ' ' A' ' 48' ' ' ILE 0.269 7.1 ttm-85 -129.38 158.77 38.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 110.375 -3.102 . . . . 0.0 114.434 -168.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 39' ' ' ILE . 3.1 t -103.8 140.86 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -81.34 115.55 20.76 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 80' ' ' PRO . 10.3 mp -113.46 84.79 2.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.518 1.136 . . . . 0.0 112.791 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 36.0 m-85 -74.41 104.77 5.27 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 127.238 3.399 . . . . 0.0 106.361 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 32' ' ' VAL . 21.3 m -99.51 172.17 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.042 1 CA-C-N 107.166 -4.561 . . . . 0.0 105.833 -177.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.6 p-10 -95.43 -142.4 0.26 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 123.793 2.997 . . . . 0.0 113.688 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.2 ttpp -92.02 9.4 33.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.732 -3.395 . . . . 0.0 110.34 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.4 mt -142.71 38.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 111.513 -2.585 . . . . 0.0 110.74 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.69 20.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -176.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.5 m-20 -104.61 142.3 34.9 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.943 1.354 . . . . 0.0 108.845 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 44.7 mt -63.28 113.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 126.518 3.056 . . . . 0.0 112.359 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.488 . . -88.51 -51.34 5.76 Favored 'General case' 0 C--N 1.283 -2.294 2 CA-C-N 103.479 -6.237 . . . . 0.0 107.909 -173.258 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -118.02 157.84 26.06 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 28' ' ' VAL . 94.4 t -63.66 138.64 97.43 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 115.75 -2.38 . . . . 0.0 112.482 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 3.5 Cg_exo -86.63 157.13 9.09 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.58 2.186 . . . . 0.0 108.26 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.44 HH21 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -154.5 150.24 27.59 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.142 -176.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG12 HD12 ' A' ' 63' ' ' ILE 0.278 21.9 t -89.13 105.09 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.729 1.268 . . . . 0.0 107.783 175.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.631 ' HA2' ' CD2' ' A' ' 61' ' ' TYR . . . . . . . . 0 C--N 1.27 -3.121 0 C-N-CA 117.7 -2.191 . . . . 0.0 110.853 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -101.29 17.84 21.54 Favored 'General case' 0 N--CA 1.526 3.354 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -140.15 151.89 45.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 125.105 1.503 . . . . 0.0 114.327 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.565 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 29.4 m-90 -134.53 73.16 68.72 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 123.762 1.744 . . . . 0.0 112.944 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' A' ' 28' ' ' VAL . 13.1 Cg_endo -77.45 -34.77 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.702 1.601 . . . . 0.0 111.576 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -62.35 -18.89 62.61 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 123.402 1.572 . . . . 0.0 109.429 -177.232 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -97.94 15.31 24.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.528 HG21 HG22 ' A' ' 79' ' ' VAL . 99.2 t -73.53 164.45 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.838 -1.164 . . . . 0.0 108.325 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 2.1 89.75 Favored Glycine 1 N--CA 1.518 4.112 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.809 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.582 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 14.5 mtmm -130.05 168.51 16.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.312 1.045 . . . . 0.0 108.536 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 10.7 p -87.82 160.08 18.16 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 127.835 3.683 . . . . 0.0 114.319 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -45.76 -50.88 3.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 1 CA-C-N 105.277 -5.42 . . . . 0.0 116.141 -172.738 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 8.8 mm-40 -54.99 -42.41 72.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.082 -1.011 . . . . 0.0 112.162 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.98 -46.59 74.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.448 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -51.64 -49.37 62.42 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.116 -1.434 . . . . 0.0 111.336 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 57.5 mtpt -53.04 -50.2 64.78 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 52.5 mttp -50.9 -46.65 60.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.99 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 84.2 t -61.1 -56.9 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-O 124.685 2.183 . . . . 0.0 111.309 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.71 ' CG2' HG21 ' A' ' 66' ' ' VAL . 35.3 mt -54.38 -45.84 69.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.011 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 46' ' ' ALA . 91.7 mt -58.13 -36.51 73.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.728 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 55.9 tt0 -63.55 -39.33 94.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.183 -1.407 . . . . 0.0 110.933 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.41 -45.96 29.31 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.101 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 63.7 tttm -125.18 66.86 53.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -9.83 -57.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 1 C-N-CA 125.466 4.111 . . . . 0.0 121.233 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -82.59 1.49 37.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -57.74 84.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.21 111.01 7.05 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.58 HG12 ' H ' ' A' ' 66' ' ' VAL . 20.2 mt -107.77 152.37 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 50' ' ' VAL . 18.6 mm -124.58 163.06 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 123.752 1.739 . . . . 0.0 114.009 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.457 ' CB ' HG21 ' A' ' 32' ' ' VAL . 7.1 p -106.76 118.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 112.316 -2.22 . . . . 0.0 113.805 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 5.7 mp -128.6 136.58 29.33 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.095 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.79 135.97 20.22 Favored 'Trans proline' 0 N--CA 1.512 2.58 0 C-N-CA 123.017 2.478 . . . . 0.0 109.059 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 72.1 t -43.16 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-N 120.437 1.471 . . . . 0.0 114.894 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.32 -39.82 2.47 Favored Glycine 0 N--CA 1.51 3.581 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.902 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.653 ' HB ' ' CZ ' ' A' ' 69' ' ' PHE . 22.4 m -47.61 168.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.787 1.28 . . . . 0.0 113.803 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.79 118.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.638 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -114.91 -77.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.362 174.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 78.6 9.77 Favored 'General case' 0 C--N 1.283 -2.326 1 N-CA-C 124.172 4.879 . . . . 0.0 124.172 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' A' ' 60' ' ' GLU . 1.9 tpt -98.99 -128.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 1 CA-C-N 107.153 -4.567 . . . . 0.0 104.098 176.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.545 ' CD ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.87 -169.49 2.38 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 172.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.652 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 39.3 t80 -118.04 102.56 9.14 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.72 -1.238 . . . . 0.0 112.311 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 65' ' ' ARG . 2.1 mpt_? -90.83 68.46 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 124.188 1.947 . . . . 0.0 108.739 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.749 HD12 HG11 ' A' ' 82' ' ' VAL . 4.6 tp -42.34 -29.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 112.681 -2.054 . . . . 0.0 116.026 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 2.2 p30 -57.04 -17.43 10.1 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 124.16 1.933 . . . . 0.0 111.448 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 62' ' ' ARG . 21.6 ttp85 -132.14 149.7 52.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.71 HG21 ' CG2' ' A' ' 39' ' ' ILE . 3.3 t -106.73 139.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' CZ ' ' HA ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.15 124.69 44.38 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 67' ' ' ARG . 2.7 mp -109.29 90.39 3.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 125.879 1.987 . . . . 0.0 110.761 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.653 ' CZ ' ' HB ' ' A' ' 55' ' ' THR . 12.8 m-85 -70.99 110.96 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 126.155 2.883 . . . . 0.0 110.475 170.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.9 m -103.25 170.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-N 108.912 -3.767 . . . . 0.0 109.221 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.7 p-10 -93.43 -140.62 0.22 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 124.285 1.993 . . . . 0.0 112.033 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -92.14 6.82 45.15 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 110.545 -3.025 . . . . 0.0 111.21 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 72.1 mt -136.74 32.08 2.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.534 -2.121 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 34.96 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.97 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 45.0 m-20 -108.47 137.94 45.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.4 mt -61.51 111.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 126.431 3.015 . . . . 0.0 112.796 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.475 . . -90.22 -47.01 8.06 Favored 'General case' 0 C--N 1.288 -2.108 2 CA-C-N 103.27 -6.332 . . . . 0.0 108.657 -173.842 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -117.14 157.15 26.42 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 111.556 -2.565 . . . . 0.0 107.765 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.528 HG22 HG21 ' A' ' 28' ' ' VAL . 94.5 t -75.4 141.03 72.89 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 115.122 -2.631 . . . . 0.0 108.74 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.573 ' HG2' HD11 ' A' ' 27' ' ' LEU . 6.5 Cg_exo -84.25 158.68 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.56 2.173 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 156.65 32.49 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.032 -1.461 . . . . 0.0 109.195 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG11 HD12 ' A' ' 63' ' ' ILE . 23.9 t -74.93 144.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.258 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.652 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . . . . . . 0 N--CA 1.509 3.53 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.63 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 123.584 1.659 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -98.34 1.74 47.34 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.554 ' HB2' ' NH2' ' A' ' 81' ' ' ARG . 0.6 OUTLIER -139.68 155.9 47.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.635 0.731 . . . . 0.0 111.736 172.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.498 ' CG ' HG12 ' A' ' 39' ' ' ILE . 30.1 m-90 -118.87 71.93 10.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -70.71 -30.54 17.72 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.054 1.169 . . . . 0.0 109.501 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -66.06 2.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.916 0.865 . . . . 0.0 109.979 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.521 HD13 ' HB1' ' A' ' 35' ' ' ALA . 31.3 mt -103.97 -8.07 19.9 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.653 -0.654 . . . . 0.0 110.902 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 79' ' ' VAL . 53.2 t -66.51 107.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 123.148 1.452 . . . . 0.0 108.846 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.56 5.04 22.94 Favored Glycine 0 N--CA 1.506 3.306 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.639 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' NZ ' ' CD ' ' A' ' 34' ' ' GLU . 1.5 mmmp? -111.69 167.6 10.22 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.736 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -88.28 173.18 8.92 Favored 'General case' 0 CA--C 1.443 -3.14 0 CA-C-O 123.008 1.385 . . . . 0.0 112.791 177.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.709 ' CG2' HG11 ' A' ' 70' ' ' VAL . 1.4 p -80.98 -55.62 7.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 108.903 -3.771 . . . . 0.0 115.641 -171.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 35.1 mm-40 -62.83 -21.13 65.7 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 122.362 2.346 . . . . 0.0 109.867 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 38.0 tt0 -75.9 -49.07 18.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.521 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -46.33 -52.5 12.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 82.0 tttt -48.05 -46.58 33.49 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 112.768 -2.015 . . . . 0.0 106.645 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 40.4 tttm -55.54 -54.3 45.65 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.487 -1.285 . . . . 0.0 109.891 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 69.1 t -59.02 -47.88 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 CA-C-O 124.291 1.996 . . . . 0.0 111.734 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 66' ' ' VAL . 14.7 mt -56.16 -51.8 58.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 112.764 -2.017 . . . . 0.0 109.21 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -61.93 -37.66 85.53 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 29.5 tp60 -58.92 -24.25 62.22 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.205 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' OD2' ' NE1' ' A' ' 24' ' ' TRP . 49.5 t0 -96.2 -51.53 4.37 Favored 'General case' 0 N--CA 1.523 3.194 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.01 75.28 21.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -9.79 -55.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 2 C-N-CA 126.121 4.547 . . . . 0.0 122.717 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -89.67 -0.29 57.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . . . -42.27 97.75 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.437 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 93.4 mm-40 -87.59 65.21 8.44 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 39' ' ' ILE . 46.6 mt -72.26 127.03 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 121.456 3.873 . . . . 0.0 121.456 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.441 HD13 HH12 ' A' ' 65' ' ' ARG . 1.7 mp -123.14 128.23 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.062 -3.245 . . . . 0.0 106.085 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 51' ' ' LEU . 12.4 p -81.07 158.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 126.411 2.319 . . . . 0.0 113.129 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 HG21 ' A' ' 55' ' ' THR . 0.8 OUTLIER -141.1 151.65 62.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -85.48 131.83 4.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.145 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 70' ' ' VAL . 13.3 t -42.33 133.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 106.75 -31.27 8.39 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 110.273 -3.149 . . . . 0.0 113.487 -178.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.624 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.312 40.2 m -48.62 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.8 1.24 . . . . 0.0 108.186 175.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' GLY . 21.1 mm -53.61 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 125.033 2.349 . . . . 0.0 112.274 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.619 HG21 ' HE2' ' A' ' 69' ' ' PHE . 7.0 m -98.75 -173.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 110.046 -3.252 . . . . 0.0 105.776 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -92.43 144.95 24.85 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 111.68 -2.509 . . . . 0.0 116.231 -174.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.11 40.14 1.06 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.291 1.52 . . . . 0.0 108.388 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 19.4 pt-20 -83.14 -171.97 3.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.589 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -137.47 74.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 123.614 1.673 . . . . 0.0 113.914 178.016 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' ASP . 15.5 mmt180 -89.69 68.22 7.55 Favored 'General case' 0 C--N 1.294 -1.843 1 N-CA-C 97.865 -4.865 . . . . 0.0 97.865 176.351 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 HG11 ' A' ' 82' ' ' VAL . 6.5 tp -43.85 -1.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' ARG . 3.1 p30 -85.67 -9.11 57.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.492 1.917 . . . . 0.0 108.71 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.441 HH12 HD13 ' A' ' 49' ' ' ILE . 38.9 ttm-85 -128.53 148.76 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 -172.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.723 HG21 HG21 ' A' ' 39' ' ' ILE . 4.2 t -117.27 120.63 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 1 N-CA-C 99.214 -4.365 . . . . 0.0 99.214 170.131 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.595 HH21 ' C ' ' A' ' 83' ' ' GLY . 3.1 tpp85 -79.92 117.14 20.5 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD23 HG23 ' A' ' 32' ' ' VAL . 10.0 mp -107.76 93.06 4.34 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 124.533 1.146 . . . . 0.0 110.633 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.624 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 26.5 m-85 -79.43 102.43 8.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 126.124 2.869 . . . . 0.0 109.93 170.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.709 HG11 ' CG2' ' A' ' 32' ' ' VAL . 2.3 m -108.93 177.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 108.475 -3.966 . . . . 0.0 109.47 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.6 p-10 -101.96 -142.77 0.35 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 124.478 2.085 . . . . 0.0 113.533 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -86.67 -2.09 58.24 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 109.021 -3.718 . . . . 0.0 113.09 -178.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 54.3 mt -135.84 37.95 2.82 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 37.13 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 65.6 m-20 -109.73 149.95 29.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -72.8 121.63 23.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 126.911 3.243 . . . . 0.0 116.983 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.462 . . -106.05 -42.58 5.06 Favored 'General case' 0 C--N 1.295 -1.796 2 CA-C-N 103.671 -6.149 . . . . 0.0 112.559 -173.213 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 27.8 mt-30 -111.46 153.97 25.37 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.524 HG22 ' CG2' ' A' ' 28' ' ' VAL . 62.8 t -75.9 139.89 70.09 Favored Pre-proline 0 N--CA 1.508 2.447 0 C-N-CA 112.547 -3.661 . . . . 0.0 106.893 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 9.7 Cg_exo -78.92 152.12 24.67 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 N-CA-C 106.673 -2.087 . . . . 0.0 106.673 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.554 ' NH2' ' HB2' ' A' ' 23' ' ' GLU . 7.7 ptp180 -160.76 159.31 29.91 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.079 -1.048 . . . . 0.0 112.041 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.55 HG11 HD12 ' A' ' 63' ' ' ILE . 5.4 t -78.24 143.66 12.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 124.265 1.983 . . . . 0.0 111.36 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.595 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C--N 1.296 -1.64 0 CA-C-N 110.014 -3.266 . . . . 0.0 110.215 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p -100.87 16.44 25.17 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.599 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.79 153.74 51.5 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 125.253 1.596 . . . . 0.0 110.267 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -128.49 60.44 48.41 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 123.075 1.416 . . . . 0.0 114.714 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -53.47 -35.95 77.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.417 2.078 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -48.05 -31.32 5.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.136 1.446 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.56 HD11 HG13 ' A' ' 39' ' ' ILE . 56.0 mt -79.77 -26.85 40.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.886 -1.961 . . . . 0.0 114.847 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG2' HG22 ' A' ' 79' ' ' VAL . 14.3 t -50.92 137.83 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 117.877 -1.529 . . . . 0.0 107.59 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.23 -13.9 66.54 Favored Glycine 0 N--CA 1.505 3.238 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.305 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -111.34 166.84 10.77 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 117.438 0.619 . . . . 0.0 111.617 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.2 p -90.62 164.32 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 128.273 3.892 . . . . 0.0 115.119 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.69 -31.22 6.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 105.511 -5.313 . . . . 0.0 121.921 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -50.25 13.8 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 123.336 1.541 . . . . 0.0 107.195 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.673 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 2.2 tm-20 -50.67 -52.1 43.09 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 102.75 -3.055 . . . . 0.0 102.75 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.71 -60.16 3.14 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.952 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -48.37 -49.07 36.07 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.673 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 8.9 ttpp -53.1 -53.45 50.12 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.626 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.456 HG23 ' HZ1' ' A' ' 37' ' ' LYS . 90.5 t -60.64 -55.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 CA-C-O 123.432 1.587 . . . . 0.0 111.607 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.779 HG21 HG21 ' A' ' 66' ' ' VAL . 23.0 mt -53.54 -43.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.871 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 46' ' ' ALA . 60.3 mt -64.99 -38.06 89.72 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.387 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -57.79 -48.29 80.14 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.441 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.66 -47.18 73.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.78 -1.555 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HE3' HG11 ' A' ' 82' ' ' VAL . 58.8 tttm -124.74 71.83 60.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 C-N-CA 124.513 1.125 . . . . 0.0 111.617 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -21.58 -50.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 124.35 3.366 . . . . 0.0 118.331 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 0.34 43.19 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -59.87 92.31 0.02 OUTLIER 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' ASP . 19.3 tt0 -75.72 70.4 2.51 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.571 HG12 ' H ' ' A' ' 66' ' ' VAL . 47.5 mt -72.68 141.22 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.852 -2.431 . . . . 0.0 117.135 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.451 ' HB ' ' HD3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -125.91 156.52 35.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 123.075 1.417 . . . . 0.0 108.063 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.85 142.78 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 111.964 -2.38 . . . . 0.0 106.854 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 1.4 mt -137.17 125.29 14.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.59 135.12 35.03 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.049 1.41 . . . . 0.0 108.857 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 70' ' ' VAL . 2.6 t -44.02 123.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.957 0.885 . . . . 0.0 112.742 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.22 -35.58 3.85 Favored Glycine 0 N--CA 1.513 3.803 0 O-C-N 128.075 3.359 . . . . 0.0 113.278 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.701 ' HB ' ' CE1' ' A' ' 69' ' ' PHE . 60.1 m -47.61 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.463 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mm -53.4 97.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 124.437 2.065 . . . . 0.0 112.481 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.564 HG21 ' HE2' ' A' ' 69' ' ' PHE . 14.7 m -97.26 -176.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 110.76 -2.927 . . . . 0.0 105.563 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.33 147.1 24.27 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 112.197 -2.274 . . . . 0.0 115.328 -172.04 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtp -91.55 34.23 0.98 Allowed 'General case' 0 N--CA 1.515 2.788 0 CA-C-O 124.929 2.299 . . . . 0.0 112.315 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.444 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 24.1 pt-20 -83.71 -163.25 0.74 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 109.134 -3.666 . . . . 0.0 115.299 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.65 67.16 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.06 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.444 ' HE ' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.39 66.73 7.54 Favored 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 126.608 3.099 . . . . 0.0 105.865 177.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.582 HD12 HG11 ' A' ' 82' ' ' VAL . 4.9 tp -42.8 -8.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 109.717 -3.401 . . . . 0.0 119.446 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 65' ' ' ARG . 45.8 p30 -80.86 -5.7 57.67 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 119.588 1.086 . . . . 0.0 108.166 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.465 HH21 ' CG ' ' A' ' 64' ' ' ASP 0.26 15.9 ttm-85 -137.45 147.58 45.44 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -174.163 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.779 HG21 HG21 ' A' ' 39' ' ' ILE . 5.2 t -101.33 140.06 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 1 N-CA-C 99.205 -4.369 . . . . 0.0 99.205 173.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.408 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 1.5 tpp180 -89.44 120.11 30.48 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.9 mt -111.33 88.15 2.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 126.066 2.104 . . . . 0.0 114.036 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.701 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 38.2 m-85 -81.76 99.62 9.06 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 127.852 3.691 . . . . 0.0 107.734 170.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 5.7 m -100.19 171.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 1 CA-C-N 106.042 -5.072 . . . . 0.0 106.75 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.4 p-10 -87.72 -141.02 0.11 Allowed 'General case' 0 C--N 1.293 -1.874 0 O-C-N 118.818 -2.426 . . . . 0.0 110.72 -175.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 44.3 mmtm -95.88 8.2 44.25 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 110.256 -3.156 . . . . 0.0 112.683 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.1 mt -137.59 32.46 2.51 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.198 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' HA ' ' CG2' ' A' ' 70' ' ' VAL 0.322 3.9 p-10 31.9 41.71 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 m-80 -113.46 151.47 31.4 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 110.93 -2.85 . . . . 0.0 104.968 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -80.69 117.68 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 125.415 2.531 . . . . 0.0 113.695 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 71' ' ' ASP 0.416 . . -105.37 -38.71 6.4 Favored 'General case' 0 C--N 1.298 -1.644 2 CA-C-N 104.062 -5.972 . . . . 0.0 114.344 -174.049 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 155.87 27.23 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.533 HG22 ' CG2' ' A' ' 28' ' ' VAL . 67.2 t -75.46 147.72 82.45 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 113.628 -3.229 . . . . 0.0 109.155 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HG2' HD12 ' A' ' 27' ' ' LEU . 25.4 Cg_exo -73.05 139.35 29.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.24 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.377 -1.329 . . . . 0.0 110.281 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 63' ' ' ILE . 14.9 t -82.09 134.09 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 117.374 -1.731 . . . . 0.0 114.522 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.494 2.505 0 C-N-CA 118.957 -1.592 . . . . 0.0 113.968 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HE3' ' NE1' ' A' ' 24' ' ' TRP . 4.4 tmtm? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 68.1 p -120.95 20.02 11.62 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 109.066 -3.697 . . . . 0.0 111.028 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.566 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -153.11 159.38 42.76 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 126.327 1.851 . . . . 0.0 113.33 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.62 ' NE1' ' HE3' ' A' ' 21' ' ' LYS . 11.6 m-90 -139.32 64.91 33.45 Favored Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.596 ' HA ' HG21 ' A' ' 79' ' ' VAL . 75.6 Cg_exo -53.85 -40.05 81.92 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.407 2.738 . . . . 0.0 111.184 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 14.6 mp0 -50.5 -27.88 7.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 123.767 1.746 . . . . 0.0 109.671 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CD1' HG13 ' A' ' 39' ' ' ILE . 29.4 mt -79.46 -24.09 42.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 116.542 -1.694 . . . . 0.0 113.514 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.742 HG23 ' CG2' ' A' ' 79' ' ' VAL . 95.7 t -47.97 136.72 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -17.49 55.16 Favored Glycine 0 N--CA 1.51 3.591 0 C-N-CA 119.371 -1.395 . . . . 0.0 112.487 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -113.73 161.76 17.12 Favored 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.759 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.5 p -86.55 153.82 21.54 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 126.548 3.07 . . . . 0.0 115.102 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.298 4.3 p -38.9 -56.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 1 CA-C-N 107.128 -4.578 . . . . 0.0 117.446 -174.131 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.39 -23.8 65.61 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 120.508 1.504 . . . . 0.0 113.833 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -77.46 -48.94 15.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.46 -44.13 62.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' CG ' HD12 ' A' ' 40' ' ' LEU . 36.7 ttmt -54.53 -47.2 73.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.084 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -54.13 -48.81 70.38 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 124.901 1.376 . . . . 0.0 110.758 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.3 t -64.99 -48.0 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 124.133 1.92 . . . . 0.0 112.029 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.78 HG21 HG21 ' A' ' 66' ' ' VAL . 31.4 mt -55.89 -55.39 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.961 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD12 ' CG ' ' A' ' 36' ' ' LYS . 3.8 mt -64.74 -22.86 67.08 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.131 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 17.5 tp60 -66.46 -29.04 69.08 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.742 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -97.02 -53.47 3.49 Favored 'General case' 0 N--CA 1.517 2.914 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 20.0 tptp -118.75 72.15 10.79 Favored Pre-proline 0 N--CA 1.506 2.342 0 O-C-N 120.168 -1.583 . . . . 0.0 112.04 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -20.03 -50.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 124.684 3.589 . . . . 0.0 120.144 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.1 mp0 -63.8 -22.21 66.8 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.49 84.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 120.084 3.364 . . . . 0.0 120.084 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -75.33 74.59 2.43 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.521 HD11 HG21 ' A' ' 39' ' ' ILE . 23.9 mt -76.47 121.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 50' ' ' VAL . 3.9 mp -119.29 163.05 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 173.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.6 p -85.01 130.2 36.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 111.153 -2.748 . . . . 0.0 106.982 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.688 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -129.12 102.02 19.15 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.58 118.39 5.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 120.912 1.075 . . . . 0.0 113.686 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 69' ' ' PHE . 2.4 t -38.81 134.3 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 118.186 2.662 . . . . 0.0 118.186 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 113.61 -37.28 3.66 Favored Glycine 0 N--CA 1.506 3.362 1 CA-C-N 108.232 -4.076 . . . . 0.0 107.13 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' VAL 0.297 80.7 m -56.07 69.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.91 1.684 . . . . 0.0 108.235 174.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' GLY . 11.5 mm -62.63 116.76 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.445 1.593 . . . . 0.0 109.832 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.469 HG21 ' HD3' ' A' ' 67' ' ' ARG . 18.4 m -98.67 -168.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 111.325 -2.671 . . . . 0.0 112.428 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.17 150.37 24.0 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 117.824 2.528 . . . . 0.0 117.824 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.7 mmm -91.71 47.61 1.38 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 123.044 1.402 . . . . 0.0 107.336 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' CD ' ' HB2' ' A' ' 62' ' ' ARG . 13.0 pt-20 -81.16 -179.55 7.4 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.488 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.559 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 1.1 t80 -127.57 41.91 3.42 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 125.479 2.561 . . . . 0.0 107.817 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 64' ' ' ASP . 3.6 mpt_? -88.43 77.42 8.1 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.744 ' HA ' HG12 ' A' ' 82' ' ' VAL . 8.7 tp -67.23 22.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.747 1 CA-C-N 107.835 -4.257 . . . . 0.0 116.931 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 62' ' ' ARG . 2.3 p-10 -95.93 -11.82 26.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 110.195 -3.184 . . . . 0.0 108.971 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 6.3 mtm180 -129.46 88.1 2.64 Favored 'General case' 0 N--CA 1.503 2.194 1 N-CA-C 128.496 6.48 . . . . 0.0 128.496 -173.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.78 HG21 HG21 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.83 83.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 121.898 2.135 . . . . 0.0 107.072 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.469 ' HD3' HG21 ' A' ' 57' ' ' VAL . 2.2 ptp180 -59.32 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 111.23 -2.714 . . . . 0.0 111.088 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 80' ' ' PRO . 53.9 mt -73.99 100.17 3.49 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 116.993 -1.883 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.7 m-85 -74.63 98.86 3.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 127.624 3.583 . . . . 0.0 107.268 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.1 m -100.9 165.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 1 CA-C-N 107.267 -4.515 . . . . 0.0 107.21 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.9 p-10 -89.91 -140.61 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 115.935 -2.306 . . . . 0.0 107.973 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 11.3 mptt -95.78 8.98 42.01 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 111.12 -2.763 . . . . 0.0 113.906 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.431 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 31.1 mt -137.6 39.32 2.42 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 112.242 -2.254 . . . . 0.0 107.164 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 33.91 28.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 118.86 2.911 . . . . 0.0 118.86 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.0 m-20 -104.76 148.59 26.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.443 HG21 HG23 ' A' ' 79' ' ' VAL . 23.0 mt -74.93 120.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 126.446 3.022 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.48 . . -104.54 -52.81 2.82 Favored 'General case' 0 C--N 1.285 -2.227 2 CA-C-N 102.468 -6.697 . . . . 0.0 107.794 -173.592 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 69' ' ' PHE . 6.3 mp0 -119.98 84.91 2.29 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.761 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.742 ' CG2' HG23 ' A' ' 28' ' ' VAL . 1.2 t -42.2 147.71 0.55 Allowed Pre-proline 0 N--CA 1.503 2.18 0 C-N-CA 117.079 -1.848 . . . . 0.0 115.69 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -89.19 -170.79 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.473 3.449 . . . . 0.0 119.51 -175.393 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.532 HH11 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -156.46 136.35 12.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.961 -3.291 . . . . 0.0 105.556 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 63' ' ' ILE . 96.7 t -53.65 -63.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 125.888 2.756 . . . . 0.0 109.67 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.532 ' C ' HH11 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.291 -1.919 1 CA-C-N 107.705 -4.316 . . . . 0.0 105.459 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 7.4 tmtm? . . . . . 0 N--CA 1.483 1.185 1 N-CA-C 99.302 -4.332 . . . . 0.0 99.302 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -98.78 13.29 32.87 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.214 -2.721 . . . . 0.0 111.839 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.4 146.56 40.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 126.27 2.231 . . . . 0.0 113.625 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.603 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 19.6 m-90 -131.16 64.7 74.51 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -60.08 -33.96 94.89 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.951 2.434 . . . . 0.0 111.234 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.05 -12.1 3.09 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.201 1.477 . . . . 0.0 109.336 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.603 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 17.9 mt -99.31 2.86 45.8 Favored 'General case' 0 CA--C 1.56 1.36 0 O-C-N 121.123 -0.986 . . . . 0.0 112.365 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG2' HG22 ' A' ' 79' ' ' VAL . 88.6 t -73.4 127.07 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-N 120.652 1.569 . . . . 0.0 107.068 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.6 4.04 57.18 Favored Glycine 0 N--CA 1.505 3.298 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -117.63 160.83 20.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -89.6 153.21 20.93 Favored 'General case' 0 CA--C 1.474 -1.967 0 CA-C-O 125.989 2.804 . . . . 0.0 114.696 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.576 ' HB ' HG11 ' A' ' 70' ' ' VAL 0.318 11.6 p -42.37 -62.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.415 1 CA-C-N 107.533 -4.394 . . . . 0.0 118.215 -172.265 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.23 -18.51 63.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.514 -1.674 . . . . 0.0 111.356 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 36.7 tt0 -76.61 -45.75 28.88 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.501 ' CA ' HD13 ' A' ' 27' ' ' LEU . . . -54.38 -55.64 26.58 Favored 'General case' 0 C--O 1.205 -1.251 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -48.5 -49.6 35.17 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.717 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 3.2 ttpp -52.94 -44.29 66.96 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.555 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' N ' ' HZ2' ' A' ' 37' ' ' LYS . 78.4 t -70.66 -47.08 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 CA-C-O 122.156 0.979 . . . . 0.0 112.252 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.712 HG21 HG21 ' A' ' 66' ' ' VAL . 40.5 mt -48.24 -48.27 13.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 122.932 1.348 . . . . 0.0 109.691 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 46' ' ' ALA . 31.1 mt -59.91 -22.27 62.18 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.364 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -16.16 57.31 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.451 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.39 -52.54 3.93 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.749 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mmmp? -119.08 77.99 16.76 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -19.06 -56.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.503 4.135 . . . . 0.0 120.728 -177.49 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.48 8.27 19.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.494 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -52.83 87.05 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.24 70.71 3.67 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.527 HD11 ' CG2' ' A' ' 39' ' ' ILE . 62.1 mt -74.3 148.04 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 112.383 -2.19 . . . . 0.0 116.794 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.11 152.76 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.969 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 32' ' ' VAL . 3.5 p -93.6 122.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 112.84 -1.982 . . . . 0.0 113.404 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.618 HD23 HG21 ' A' ' 55' ' ' THR . 1.4 mp -136.77 141.58 35.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.5 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -80.38 139.54 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.369 1.38 . . . . 0.0 108.769 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 69' ' ' PHE . 41.7 t -43.81 127.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.98 -34.82 4.67 Favored Glycine 1 N--CA 1.523 4.448 0 CA-C-N 111.179 -2.737 . . . . 0.0 115.613 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.618 HG21 HD23 ' A' ' 51' ' ' LEU 0.253 50.2 m -45.03 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.981 1.312 . . . . 0.0 112.695 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.45 106.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 CA-C-O 122.58 1.181 . . . . 0.0 111.545 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.617 HG21 ' HE2' ' A' ' 69' ' ' PHE . 1.7 m -111.38 -106.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 85.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 1 N-CA-C 123.297 4.554 . . . . 0.0 123.297 -173.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 18.5 mmm -95.11 -47.57 6.32 Favored 'General case' 0 N--CA 1.501 2.116 1 CA-C-N 106.874 -4.694 . . . . 0.0 105.426 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' HB2' HH21 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -82.94 -175.9 6.06 Favored 'General case' 0 C--N 1.284 -2.279 3 CA-C-N 103.161 -6.381 . . . . 0.0 112.062 179.385 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.535 ' CE2' HD13 ' A' ' 63' ' ' ILE . 20.8 t80 -157.97 85.66 0.89 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.586 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.542 HH21 ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -100.84 81.76 2.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 175.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.668 HD12 HG11 ' A' ' 82' ' ' VAL 0.262 6.0 tp -42.54 -6.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.136 1 CA-C-N 108.341 -4.027 . . . . 0.0 117.007 177.711 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.1 p30 -93.88 7.27 45.6 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.228 1.011 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.572 ' HD2' ' CZ ' ' A' ' 67' ' ' ARG . 20.0 ttp180 -129.78 140.38 51.06 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 39' ' ' ILE . 9.6 t -111.52 150.68 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 122.918 2.599 . . . . 0.0 106.073 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.77 112.77 24.48 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.326 -177.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.58 85.14 2.4 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.343 1.652 . . . . 0.0 109.458 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.617 ' HE2' HG21 ' A' ' 57' ' ' VAL . 29.6 m-85 -83.54 97.42 9.02 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 127.335 3.445 . . . . 0.0 109.965 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.576 HG11 ' HB ' ' A' ' 32' ' ' VAL . 4.4 m -104.24 174.09 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 1 CA-C-N 105.746 -5.206 . . . . 0.0 109.392 -175.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.6 p-10 -99.74 -148.77 0.35 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 124.163 1.935 . . . . 0.0 109.28 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.33 17.17 14.95 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 111.26 -2.7 . . . . 0.0 113.641 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -133.8 26.16 3.99 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 111.222 -2.717 . . . . 0.0 103.715 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.28 0.0 OUTLIER 33.36 35.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.61 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.7 m-20 -113.42 154.91 26.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.6 mt -78.21 119.85 27.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 126.483 3.039 . . . . 0.0 115.423 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.474 . . -98.51 -45.61 6.04 Favored 'General case' 0 C--N 1.293 -1.874 2 CA-C-N 103.662 -6.154 . . . . 0.0 111.696 -173.668 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -117.72 160.66 20.96 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.549 HG22 ' CG2' ' A' ' 28' ' ' VAL . 89.4 t -71.68 146.56 91.2 Favored Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 114.052 -3.059 . . . . 0.0 110.282 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 8.1 Cg_exo -79.13 159.28 26.79 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.331 2.021 . . . . 0.0 109.6 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 79' ' ' VAL . 8.7 ptp85 -160.38 162.11 33.27 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 117.376 -1.297 . . . . 0.0 113.659 -176.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 63' ' ' ILE . 2.9 t -84.55 150.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.197 0 C-N-CA 126.6 2.048 . . . . 0.0 114.427 176.239 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -100.0 19.59 15.97 Favored 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 112.079 -2.328 . . . . 0.0 112.292 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -142.63 151.41 41.43 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.204 176.384 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.578 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 30.5 m-90 -127.84 75.37 78.19 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.616 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.2 -18.02 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.352 2.035 . . . . 0.0 111.071 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -77.58 -28.68 51.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 2.0 pp -92.27 23.48 3.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.391 1.091 . . . . 0.0 113.918 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 79' ' ' VAL . 55.7 t -72.53 167.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.83 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.01 36.58 20.94 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-O 123.209 1.449 . . . . 0.0 112.799 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 50.2 mttp -138.1 174.58 10.41 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 112.203 -1.999 . . . . 0.0 110.534 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 p -85.51 159.85 19.82 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 125.321 2.486 . . . . 0.0 114.331 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG2' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -64.25 -32.35 57.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 1 CA-C-N 108.324 -4.035 . . . . 0.0 109.719 -175.739 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 44.5 mm-40 -63.81 -46.41 85.24 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.024 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.36 -54.93 41.47 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 126.327 2.267 . . . . 0.0 105.079 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -45.69 -54.85 7.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.354 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.5 mtpt -49.43 -56.44 9.69 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -54.45 -48.43 71.75 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.05 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 94.2 t -57.71 -56.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 CA-C-O 124.787 2.232 . . . . 0.0 110.646 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.772 HG21 HG21 ' A' ' 66' ' ' VAL . 37.9 mt -55.32 -45.68 77.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.57 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 26.1 mt -56.49 -38.72 72.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 8.7 tt0 -59.0 -44.77 91.71 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.816 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.04 -47.74 60.81 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.782 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 63.6 tttm -125.23 74.84 67.98 Favored Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -7.77 -65.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 1 C-N-CA 125.487 4.125 . . . . 0.0 120.139 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.575 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -88.34 7.12 33.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 -177.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.517 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -43.95 103.23 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -85.24 83.47 7.98 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.586 HD11 ' CG2' ' A' ' 39' ' ' ILE . 68.5 mt -80.31 135.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 111.581 -2.554 . . . . 0.0 115.809 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 48' ' ' ILE . 1.8 mp -125.95 137.68 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 111.956 -2.384 . . . . 0.0 111.522 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.481 ' C ' HD12 ' A' ' 51' ' ' LEU . 12.1 p -95.81 145.51 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 5.5 mp -141.12 149.62 56.1 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -81.55 135.38 9.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 N-CA-C 105.474 -2.548 . . . . 0.0 105.474 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 69' ' ' PHE . 87.4 t -42.91 130.48 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.31 -41.1 2.11 Favored Glycine 1 N--CA 1.519 4.214 0 CA-C-N 111.528 -2.578 . . . . 0.0 112.977 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.636 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.258 11.4 m -50.02 165.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 125.279 1.432 . . . . 0.0 111.338 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mm -61.14 136.05 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.68 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -123.69 -77.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.015 176.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 83.73 6.41 Favored 'General case' 0 C--N 1.295 -1.78 1 N-CA-C 122.698 4.333 . . . . 0.0 122.698 -179.115 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 tpt -97.44 -137.11 0.27 Allowed 'General case' 0 C--N 1.29 -2.003 1 CA-C-N 107.769 -4.287 . . . . 0.0 103.273 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 60' ' ' GLU 0.277 0.1 OUTLIER -78.4 -174.07 3.6 Favored 'General case' 0 C--N 1.288 -2.105 1 N-CA-C 98.843 -4.503 . . . . 0.0 98.843 170.168 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 7.9 t80 -120.33 135.85 54.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.015 -2.303 . . . . 0.0 117.059 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -115.56 64.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 124.074 1.892 . . . . 0.0 106.844 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.638 HD12 HG11 ' A' ' 82' ' ' VAL . 5.8 tp -42.83 -7.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.8 p30 -81.66 -9.83 59.56 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 124.207 1.003 . . . . 0.0 110.035 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -129.07 149.3 50.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 120.562 3.541 . . . . 0.0 120.562 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.772 HG21 HG21 ' A' ' 39' ' ' ILE . 5.0 t -110.18 132.21 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 101.962 -3.347 . . . . 0.0 101.962 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.64 ' NH1' ' HA ' ' A' ' 57' ' ' VAL . 16.8 tpp85 -89.83 116.21 27.74 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.779 -2.01 . . . . 0.0 108.098 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 80' ' ' PRO . 7.6 mp -107.92 90.97 3.46 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 124.816 1.323 . . . . 0.0 113.996 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 57' ' ' VAL . 22.5 m-85 -76.34 103.52 6.4 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 125.588 2.613 . . . . 0.0 112.153 169.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 4.5 m -109.77 171.78 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-N 109.077 -3.692 . . . . 0.0 109.074 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -93.62 -140.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.494 -2.004 . . . . 0.0 111.818 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.4 mmtm -88.51 0.91 55.81 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 110.911 -2.859 . . . . 0.0 112.303 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 38.5 mt -136.97 39.52 2.55 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 111.62 -2.537 . . . . 0.0 109.846 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.57 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -178.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 53.7 m-20 -105.27 142.31 35.27 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.532 HD13 ' HG2' ' A' ' 80' ' ' PRO . 79.9 mt -67.18 116.98 7.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 126.69 3.138 . . . . 0.0 114.561 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 53' ' ' VAL 0.468 . . -102.82 -40.61 6.49 Favored 'General case' 0 C--N 1.289 -2.057 1 CA-C-N 104.414 -5.812 . . . . 0.0 111.815 -172.198 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.2 163.72 15.87 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 102.266 -3.235 . . . . 0.0 102.266 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 28' ' ' VAL . 78.1 t -77.3 141.22 66.06 Favored Pre-proline 0 N--CA 1.499 1.998 0 C-N-CA 114.092 -3.043 . . . . 0.0 110.235 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.532 ' HG2' HD13 ' A' ' 76' ' ' ILE . 14.6 Cg_exo -80.84 145.49 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.544 2.829 . . . . 0.0 106.464 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -153.28 168.45 25.98 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.502 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.638 HG11 HD12 ' A' ' 63' ' ' ILE . 25.0 t -82.64 154.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 116.731 -1.987 . . . . 0.0 113.105 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.561 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.511 3.636 0 C-N-CA 125.937 1.732 . . . . 0.0 114.01 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' CG ' ' A' ' 42' ' ' ASP . 37.3 mtpt . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 122.968 1.366 . . . . 0.0 112.517 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 45.6 p -128.94 19.26 6.04 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.331 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -156.88 150.58 24.57 Favored 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.731 178.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CE3' ' C ' ' A' ' 23' ' ' GLU . 20.3 m-90 -133.77 59.89 42.39 Favored Pre-proline 0 N--CA 1.516 2.83 0 N-CA-C 121.118 3.747 . . . . 0.0 121.118 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' N ' HG13 ' A' ' 79' ' ' VAL . 52.8 Cg_exo -48.98 -40.3 40.58 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 124.098 3.198 . . . . 0.0 110.983 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 4.8 mp0 -46.38 -30.41 2.11 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.621 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 32.6 mt -79.65 -27.37 40.88 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.775 ' CG2' HG22 ' A' ' 79' ' ' VAL . 30.8 t -48.05 137.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.85 -4.12 71.79 Favored Glycine 0 N--CA 1.508 3.446 0 CA-C-N 114.566 -1.197 . . . . 0.0 113.255 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 32.4 mtmm -114.27 178.42 4.29 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.504 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.7 p -85.71 171.56 11.53 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 127.518 3.533 . . . . 0.0 116.867 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.1 p -72.15 -18.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 1 CA-C-N 104.863 -5.608 . . . . 0.0 112.752 -176.195 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -85.42 -49.09 8.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 24.4 mt-10 -50.06 -52.78 31.73 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' CB ' HD13 ' A' ' 27' ' ' LEU . . . -50.91 -44.21 60.0 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.406 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' ILE . 61.1 mttm -62.05 -49.14 77.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.082 1.765 . . . . 0.0 108.24 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -54.97 -52.76 62.04 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.976 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 84.9 t -61.8 -54.99 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.239 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.662 ' CG2' HG21 ' A' ' 66' ' ' VAL . 32.2 mt -55.34 -51.0 60.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.095 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' PRO . 96.9 mt -57.37 -33.28 67.64 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 24.1 mt-30 -59.81 -43.76 94.35 Favored 'General case' 0 N--CA 1.516 2.871 0 C-N-CA 117.432 -1.707 . . . . 0.0 110.137 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' CG ' ' NZ ' ' A' ' 21' ' ' LYS . 52.0 m-20 -72.63 -53.06 12.86 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 82' ' ' VAL . 26.3 tptp -121.43 57.17 6.79 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 112.347 -2.206 . . . . 0.0 108.389 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 12.5 Cg_exo -12.48 -65.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 125.198 3.932 . . . . 0.0 120.414 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.74 24.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -71.22 124.67 25.01 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-O 122.442 1.115 . . . . 0.0 111.203 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -91.71 67.9 5.46 Favored 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.543 HG12 ' HB ' ' A' ' 66' ' ' VAL . 20.6 mt -72.37 134.4 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 119.359 3.096 . . . . 0.0 119.359 -173.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 50' ' ' VAL . 40.5 mm -103.53 175.22 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 113.385 -1.734 . . . . 0.0 111.569 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.6 p -106.4 118.19 53.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 126.516 1.926 . . . . 0.0 111.516 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.786 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 16.7 mt -136.29 119.41 12.21 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.399 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 27.3 Cg_exo -70.45 138.44 35.62 Favored 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 123.51 2.807 . . . . 0.0 110.465 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.459 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 32.7 t -42.28 131.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.45 99.07 1.92 Allowed Glycine 0 N--CA 1.509 3.555 2 N-CA-C 96.215 -6.754 . . . . 0.0 96.215 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.717 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -68.24 116.2 8.57 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -171.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -83.14 -0.24 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 126.036 2.827 . . . . 0.0 111.036 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' CG2' ' HE2' ' A' ' 69' ' ' PHE . 24.9 m -110.62 -173.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 108.592 -3.913 . . . . 0.0 111.61 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.489 ' OG1' ' NH1' ' A' ' 62' ' ' ARG . 2.8 p -87.09 -178.53 6.28 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.9 tpt -91.03 -38.08 13.03 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 125.961 2.791 . . . . 0.0 115.345 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 9.5 pt-20 -49.82 -160.68 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.34 1 CA-C-N 105.061 -5.518 . . . . 0.0 117.24 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.824 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 57.8 t80 -114.76 70.84 0.74 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.695 1.247 . . . . 0.0 113.376 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.655 ' H ' ' CD ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -88.22 66.13 8.34 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 126.718 3.152 . . . . 0.0 109.602 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.824 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.23 -31.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 2 N-CA-C 125.652 5.427 . . . . 0.0 125.652 -179.079 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.543 ' CG ' HH22 ' A' ' 65' ' ' ARG . 6.4 p-10 -55.09 -18.11 5.03 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 123.458 1.599 . . . . 0.0 108.058 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.738 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 14.8 ttp-105 -135.45 104.37 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 82' ' ' VAL . 18.4 t -62.04 136.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 123.495 2.861 . . . . 0.0 104.193 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.771 ' CZ ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -96.57 134.89 39.22 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.038 -1.865 . . . . 0.0 112.577 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.771 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 80.5 mt -114.96 81.3 1.54 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.855 -1.975 . . . . 0.0 111.432 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.786 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 9.4 m-85 -73.7 102.93 4.1 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 126.713 3.149 . . . . 0.0 105.26 167.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -100.75 167.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 1 CA-C-N 107.481 -4.418 . . . . 0.0 106.301 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.5 p-10 -91.39 -141.44 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 123.386 2.812 . . . . 0.0 112.424 -177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.547 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 9.9 mptt -91.66 5.22 50.52 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 111.055 -2.793 . . . . 0.0 114.939 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 73' ' ' LEU 0.264 0.5 OUTLIER -138.6 34.52 2.23 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.6 176.893 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.62 48.03 0.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 124.665 2.174 . . . . 0.0 110.005 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 4.1 m-20 -115.0 142.71 46.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.63 119.55 15.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 124.359 2.028 . . . . 0.0 112.846 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.477 . . -103.21 -35.67 8.37 Favored 'General case' 0 C--N 1.297 -1.707 2 CA-C-N 104.687 -5.688 . . . . 0.0 110.726 -174.875 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.53 126.63 53.6 Favored 'General case' 0 N--CA 1.52 3.049 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.12 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.87 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 94.2 t -78.38 -75.83 0.07 OUTLIER Pre-proline 0 N--CA 1.516 2.831 1 N-CA-C 124.997 5.184 . . . . 0.0 124.997 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.87 ' HD3' ' HB ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -66.6 51.3 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.613 2 N-CA-C 133.547 8.249 . . . . 0.0 133.547 -171.795 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.501 HH21 ' C ' ' A' ' 83' ' ' GLY 0.262 0.0 OUTLIER -170.69 120.65 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 2 N-CA-C 131.144 7.461 . . . . 0.0 131.144 172.956 . . . . . . . . 5 4 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.666 ' HA ' HG22 ' A' ' 66' ' ' VAL . 4.4 t -51.26 -23.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 111.939 -2.391 . . . . 0.0 113.853 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.501 ' C ' HH21 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.28 -2.569 0 O-C-N 128.786 3.804 . . . . 0.0 103.605 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 42.5 tptt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.659 0.742 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -112.37 24.53 12.44 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-O 122.733 1.254 . . . . 0.0 110.601 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -136.77 146.03 45.27 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 112.729 -2.032 . . . . 0.0 108.999 175.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.585 ' CZ3' HG23 ' A' ' 82' ' ' VAL . 15.6 m-90 -129.95 62.78 65.77 Favored Pre-proline 0 N--CA 1.522 3.156 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.624 ' HA ' HG21 ' A' ' 79' ' ' VAL . 77.9 Cg_exo -53.68 -38.92 84.88 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.978 3.118 . . . . 0.0 111.586 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 30.4 mp0 -49.58 -28.65 5.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.919 1.343 . . . . 0.0 110.333 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' A' ' 35' ' ' ALA . 74.4 mt -79.92 -19.99 46.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.671 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.677 HG23 ' CG2' ' A' ' 79' ' ' VAL . 59.9 t -49.73 137.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 121.625 2.011 . . . . 0.0 107.831 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.65 -9.03 66.36 Favored Glycine 0 N--CA 1.515 3.922 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.27 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 35.0 mmtm -106.45 166.92 10.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.404 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -88.46 165.81 14.64 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 126.679 3.133 . . . . 0.0 116.533 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 68' ' ' LEU 0.255 0.3 OUTLIER -60.84 -50.51 80.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 1 CA-C-N 107.174 -4.557 . . . . 0.0 116.569 -174.241 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 41.1 mm-40 -68.17 -37.55 81.11 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.572 -1.651 . . . . 0.0 111.127 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -58.98 -51.09 71.58 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.406 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -49.82 -59.08 4.17 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.293 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 48' ' ' ILE 0.303 21.7 tttm -44.55 -53.78 6.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.311 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 54.5 mttp -53.47 -53.93 44.3 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.6 -2.091 . . . . 0.0 111.072 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.6 t -59.53 -52.3 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 123.941 1.829 . . . . 0.0 113.193 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 66' ' ' VAL . 15.8 mt -54.17 -50.94 51.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.101 -2.318 . . . . 0.0 107.864 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.64 -14.12 56.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 124.294 0.996 . . . . 0.0 112.675 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 2.6 tm0? -80.27 -21.13 43.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -97.0 -52.12 3.98 Favored 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 82' ' ' VAL . 10.7 tptp -118.35 72.94 10.19 Favored Pre-proline 0 N--CA 1.514 2.754 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -9.76 -51.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 1 C-N-CA 125.421 4.081 . . . . 0.0 120.495 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.4 mp0 -71.89 -23.28 61.47 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.27 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.479 1.133 . . . . 0.0 113.713 -177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' GLU . 8.2 tp60 -87.57 71.3 9.77 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -175.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 39' ' ' ILE . 56.0 mt -74.03 142.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.35 160.92 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 1 CA-C-N 107.687 -4.324 . . . . 0.0 110.053 -179.302 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.04 119.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 112.254 -2.248 . . . . 0.0 106.83 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.538 HD13 ' CZ ' ' A' ' 69' ' ' PHE . 1.5 mt -135.2 121.24 14.3 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 117.249 2.314 . . . . 0.0 117.249 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 32.5 Cg_exo -64.66 127.84 19.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 N-CA-C 108.438 -1.408 . . . . 0.0 108.438 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 69' ' ' PHE . 5.2 p -57.77 139.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 123.876 1.798 . . . . 0.0 113.58 177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.19 -15.55 27.86 Favored Glycine 1 N--CA 1.521 4.309 0 CA-C-N 110.747 -2.933 . . . . 0.0 113.049 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.304 17.6 m -45.56 139.28 3.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.0 mm -80.54 82.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 CA-C-N 123.156 2.707 . . . . 0.0 111.773 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.675 HG21 ' CE2' ' A' ' 69' ' ' PHE . 1.5 m -127.27 156.56 38.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.986 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.57 178.05 5.73 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 109.275 -3.602 . . . . 0.0 115.049 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.584 ' SD ' ' CD ' ' A' ' 81' ' ' ARG . 1.2 tpt -89.41 67.13 7.63 Favored 'General case' 0 N--CA 1.494 1.741 1 N-CA-C 96.432 -5.396 . . . . 0.0 96.432 173.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' CD ' ' NH1' ' A' ' 62' ' ' ARG . 10.3 pt-20 -78.44 154.24 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.417 ' HE1' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -111.83 50.81 0.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.956 1.836 . . . . 0.0 111.783 -176.324 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NH1' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mpt_? -90.88 72.76 6.54 Favored 'General case' 0 N--CA 1.491 1.595 1 N-CA-C 94.973 -5.936 . . . . 0.0 94.973 175.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' HA ' HG12 ' A' ' 82' ' ' VAL . 6.6 tp -40.87 -4.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' NH2' ' A' ' 65' ' ' ARG . 3.9 p-10 -99.3 2.86 45.84 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HG3' ' H ' ' A' ' 67' ' ' ARG . 8.7 tpp180 -123.95 95.51 4.59 Favored 'General case' 0 N--CA 1.498 1.969 1 N-CA-C 124.97 5.174 . . . . 0.0 124.97 -170.304 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -89.2 52.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 115.264 -2.574 . . . . 0.0 105.62 177.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.496 HH11 ' CD ' ' A' ' 60' ' ' GLU . 9.9 ptm180 -48.0 116.46 1.52 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 123.714 1.721 . . . . 0.0 111.703 -174.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' CD2' ' HG2' ' A' ' 80' ' ' PRO . 67.3 mt -82.15 93.08 6.98 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 109.341 -3.572 . . . . 0.0 115.668 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 57' ' ' VAL . 37.0 m-85 -74.39 96.06 2.81 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 126.811 3.196 . . . . 0.0 108.45 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 18.1 m -106.82 174.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.304 1 CA-C-N 106.937 -4.665 . . . . 0.0 110.422 -174.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.5 p-10 -95.95 -141.55 0.27 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 124.919 2.295 . . . . 0.0 112.769 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 58.6 mttp -83.98 -8.11 59.24 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 108.971 -3.741 . . . . 0.0 113.457 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.287 0.5 OUTLIER -137.41 48.13 2.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 124.924 2.297 . . . . 0.0 109.677 178.73 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.82 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 42.0 m-20 -99.71 142.57 31.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.752 1.263 . . . . 0.0 108.222 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.37 117.7 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 126.389 2.995 . . . . 0.0 115.279 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.459 . . -98.48 -44.27 6.56 Favored 'General case' 0 C--N 1.283 -2.306 2 CA-C-N 103.905 -6.043 . . . . 0.0 109.86 -172.273 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -117.43 118.88 33.43 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 101.073 -3.677 . . . . 0.0 101.073 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.677 ' CG2' HG23 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -73.1 137.65 79.03 Favored Pre-proline 0 N--CA 1.501 2.106 1 C-N-CA 110.947 -4.301 . . . . 0.0 109.818 -178.455 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HG2' ' CD2' ' A' ' 68' ' ' LEU . 5.8 Cg_exo -82.16 169.75 14.13 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 123.901 3.067 . . . . 0.0 113.836 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.584 ' CD ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -145.87 154.18 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.294 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.592 ' CG2' HG22 ' A' ' 66' ' ' VAL . 70.8 t -71.97 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.734 2 CA-C-N 107.048 -4.615 . . . . 0.0 102.923 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 31.3 tttp . . . . . 0 N--CA 1.485 1.3 1 N-CA-C 99.634 -4.21 . . . . 0.0 99.634 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 8.3 p -106.42 -6.29 18.33 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 118.264 -1.374 . . . . 0.0 108.386 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' OE2' ' HG3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -130.69 136.01 48.37 Favored 'General case' 0 N--CA 1.523 3.214 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -176.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.721 ' CZ2' HG23 ' A' ' 39' ' ' ILE . 29.6 m-90 -126.45 71.62 72.14 Favored Pre-proline 0 N--CA 1.513 2.71 1 N-CA-C 126.553 5.76 . . . . 0.0 126.553 -176.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' TRP . 70.5 Cg_endo -68.08 -35.41 19.99 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.143 1.229 . . . . 0.0 113.828 176.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 23.0 mp0 -57.61 -37.88 74.02 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 126.344 2.973 . . . . 0.0 114.097 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.568 ' HA ' ' NZ ' ' A' ' 30' ' ' LYS . 4.2 pp -78.57 -16.06 57.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.239 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 79' ' ' VAL . 93.3 t -49.51 157.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.913 0 O-C-N 123.22 0.325 . . . . 0.0 110.554 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.74 -13.76 46.08 Favored Glycine 1 N--CA 1.518 4.151 0 O-C-N 120.347 -1.47 . . . . 0.0 113.901 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.568 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.08 167.88 10.59 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 117.203 -1.379 . . . . 0.0 112.671 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.5 p -86.52 159.62 19.23 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 127.039 3.304 . . . . 0.0 114.747 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.8 p -45.46 -23.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 1 CA-C-N 106.847 -4.706 . . . . 0.0 119.015 -174.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.565 ' CG ' ' H ' ' A' ' 34' ' ' GLU . 14.3 pt-20 -67.2 -58.67 4.41 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.796 0.808 . . . . 0.0 109.293 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.565 ' H ' ' CG ' ' A' ' 33' ' ' GLU . 2.5 tt0 -56.97 -50.43 72.71 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB1' ' CD1' ' A' ' 68' ' ' LEU . . . -47.77 -51.58 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 117.573 -1.651 . . . . 0.0 112.711 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.679 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 17.5 mtpp -58.36 -52.8 64.07 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 4.3 tmtm? -48.6 -41.1 29.77 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.926 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 62.3 t -69.11 -60.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.925 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.721 HG23 ' CZ2' ' A' ' 24' ' ' TRP . 42.9 mt -56.05 -53.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.186 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mp -56.92 -23.74 47.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.419 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 57.3 tp60 -67.65 -33.5 75.07 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.119 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 51.0 m-20 -92.59 -49.49 6.08 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 80.45 32.39 Favored Pre-proline 0 N--CA 1.515 2.82 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -35.19 -31.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.574 0 N-CA-C 120.408 3.195 . . . . 0.0 120.408 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.72 -0.23 57.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.843 0.714 . . . . 0.0 112.289 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.46 99.32 0.14 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.699 1.238 . . . . 0.0 111.738 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.26 113.7 25.97 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.679 ' HB ' ' HG2' ' A' ' 36' ' ' LYS . 21.8 mt -105.47 155.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.406 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 42.4 mm -125.19 169.74 16.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.581 -3.009 . . . . 0.0 105.899 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' CG2' HG21 ' A' ' 70' ' ' VAL . 8.7 p -107.25 142.43 20.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -139.51 122.27 10.37 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 178.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HD2' HD23 ' A' ' 51' ' ' LEU . 55.1 Cg_endo -72.7 129.14 14.15 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.27 1.98 . . . . 0.0 112.319 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 69' ' ' PHE . 6.7 t -42.2 133.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.52 -27.0 19.73 Favored Glycine 0 N--CA 1.512 3.72 0 CA-C-N 109.552 -3.476 . . . . 0.0 112.683 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.45 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.305 51.8 m -60.66 178.38 0.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 126.28 1.832 . . . . 0.0 112.928 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 57' ' ' VAL . 14.1 mt -86.46 154.18 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -140.45 -59.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.972 1 N-CA-C 122.666 4.321 . . . . 0.0 122.666 177.113 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 78.14 6.89 Favored 'General case' 0 C--N 1.288 -2.093 1 N-CA-C 123.098 4.481 . . . . 0.0 123.098 -177.5 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 88.9 mtp -97.13 -144.14 0.29 Allowed 'General case' 0 C--N 1.291 -1.942 1 CA-C-N 104.459 -5.791 . . . . 0.0 104.352 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.3 pm0 -60.5 -142.31 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 O-C-N 124.854 1.346 . . . . 0.0 112.393 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.673 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -100.25 113.46 26.17 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.339 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.635 ' NH2' ' HB2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -105.54 39.66 1.71 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 123.925 1.821 . . . . 0.0 110.056 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.673 ' HB ' ' CE1' ' A' ' 61' ' ' TYR . 8.6 tp -56.37 -25.64 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 110.098 -3.228 . . . . 0.0 117.351 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -70.44 -11.12 60.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 62' ' ' ARG . 23.0 ttp180 -135.06 163.13 30.59 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -176.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 39' ' ' ILE . 16.1 t -117.08 128.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -102.47 110.11 21.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 114.03 -3.068 . . . . 0.0 114.207 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 39' ' ' ILE . 6.1 mt -107.49 104.79 14.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 111.515 -2.584 . . . . 0.0 106.65 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.677 ' HB3' HG22 ' A' ' 53' ' ' VAL . 8.9 m-85 -69.18 122.24 18.4 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.875 -1.93 . . . . 0.0 107.861 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' A' ' 50' ' ' VAL . 8.3 m -102.46 170.97 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 110.642 -2.981 . . . . 0.0 105.948 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -96.45 -135.88 0.24 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 117.144 -1.823 . . . . 0.0 112.129 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -91.34 3.01 55.97 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 110.405 -3.089 . . . . 0.0 112.306 177.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.433 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 73.5 mt -135.78 34.43 2.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.769 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.29 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -178.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -102.98 139.05 39.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 13.1 mt -64.37 115.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.219 0 CA-C-O 126.491 3.043 . . . . 0.0 112.177 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.579 . . -97.98 -39.3 9.02 Favored 'General case' 0 C--N 1.281 -2.394 1 CA-C-N 105.158 -5.474 . . . . 0.0 101.979 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 33.8 mt-30 -115.95 129.24 56.3 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.638 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 98.8 t -44.6 -61.83 1.93 Allowed Pre-proline 0 N--CA 1.514 2.765 1 N-CA-C 125.148 5.24 . . . . 0.0 125.148 177.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.261 0.0 OUTLIER 4.8 -161.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 2 C-N-CA 131.114 7.876 . . . . 0.0 128.61 -168.582 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.466 ' C ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -145.78 175.19 10.59 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -161.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 66' ' ' VAL . 21.6 t -68.22 137.34 24.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 109.099 -3.682 . . . . 0.0 108.416 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.503 3.139 0 CA-C-O 114.911 -3.16 . . . . 0.0 117.92 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 8.9 mtpm? . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -107.16 7.25 29.43 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.515 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -142.74 150.72 40.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 126.15 2.156 . . . . 0.0 112.096 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.617 ' CE3' HG11 ' A' ' 66' ' ' VAL . 25.4 m-90 -132.45 79.51 65.12 Favored Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 28' ' ' VAL . 15.9 Cg_endo -77.48 -30.85 3.76 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 120.872 1.048 . . . . 0.0 110.021 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 21' ' ' LYS . 3.0 pm0 -51.8 -20.88 2.42 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 122.501 1.143 . . . . 0.0 113.459 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.1 pp -107.93 16.19 23.7 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 79' ' ' VAL . 22.3 t -70.64 155.92 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-O 122.343 1.068 . . . . 0.0 112.104 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.29 18.05 70.95 Favored Glycine 0 N--CA 1.512 3.735 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.927 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -128.69 167.48 17.17 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 116.843 -1.551 . . . . 0.0 110.278 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -91.01 166.18 13.14 Favored 'General case' 0 CA--C 1.472 -2.045 1 CA-C-O 128.573 4.035 . . . . 0.0 115.508 179.81 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' A' ' 50' ' ' VAL . 1.4 p -53.92 -29.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 1 CA-C-N 103.175 -6.375 . . . . 0.0 115.435 -174.458 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.03 -37.54 23.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.718 -1.239 . . . . 0.0 111.992 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 46.5 mt-10 -61.02 -48.09 83.42 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -47.14 -50.78 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.683 -1.607 . . . . 0.0 112.962 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 58.3 mttp -51.2 -51.46 53.63 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.682 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.3 -47.41 69.25 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.04 -2.345 . . . . 0.0 108.868 -178.394 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 96.2 t -59.16 -57.64 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 CA-C-O 123.555 1.645 . . . . 0.0 111.944 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.563 ' CG2' HG21 ' A' ' 66' ' ' VAL . 14.0 mt -54.98 -46.44 76.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.221 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 96.0 mt -57.18 -33.55 67.59 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 26.2 mt-30 -64.42 -19.6 65.62 Favored 'General case' 0 N--CA 1.519 3.023 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.457 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -96.07 -58.59 2.05 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.24 1.416 . . . . 0.0 110.457 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -121.94 67.8 24.24 Favored Pre-proline 0 N--CA 1.499 1.997 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.328 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.96 -45.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 125.107 3.872 . . . . 0.0 120.271 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -81.14 -5.26 57.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.64 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -76.44 77.74 3.17 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.626 HG12 ' H ' ' A' ' 66' ' ' VAL . 44.2 mt -74.89 133.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.7 mp -117.43 162.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 112.463 -2.153 . . . . 0.0 113.119 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 32' ' ' VAL . 7.7 p -106.02 131.47 55.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 112.913 -1.949 . . . . 0.0 114.488 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 5.1 mp -138.94 155.87 72.81 Favored Pre-proline 0 N--CA 1.508 2.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -81.38 130.49 7.11 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 121.737 1.624 . . . . 0.0 109.794 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 69' ' ' PHE . 93.7 t -40.44 132.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.43 1.97 Allowed Glycine 0 N--CA 1.505 3.265 0 CA-C-N 110.353 -3.112 . . . . 0.0 108.168 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.586 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 43.3 m -47.09 131.35 12.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.871 1.32 . . . . 0.0 109.264 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.693 ' H ' HD12 ' A' ' 56' ' ' ILE . 1.9 mp -52.01 113.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.618 HG13 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -104.1 -70.57 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.32 66.54 4.8 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 127.345 3.45 . . . . 0.0 118.757 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -99.66 -119.39 0.15 Allowed 'General case' 0 C--N 1.288 -2.095 1 CA-C-N 104.405 -5.816 . . . . 0.0 106.245 -179.085 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -72.51 -152.22 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 108.998 -3.728 . . . . 0.0 105.461 171.145 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.544 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -128.84 91.59 3.25 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -176.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.663 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -94.77 66.22 3.12 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 127.496 3.522 . . . . 0.0 105.937 175.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.588 HD12 HG11 ' A' ' 82' ' ' VAL . 2.7 tp -59.91 -25.13 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 1 CA-C-N 106.549 -4.841 . . . . 0.0 114.019 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.51 24.93 1.55 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.8 ttm-85 -158.16 131.64 7.66 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.626 ' H ' HG12 ' A' ' 48' ' ' ILE . 12.4 t -104.86 70.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 C-N-CA 116.543 -2.063 . . . . 0.0 105.979 173.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.615 ' HD3' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -45.98 138.11 5.3 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.119 1.914 . . . . 0.0 112.157 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.23 116.65 33.1 Favored 'General case' 0 C--N 1.295 -1.786 1 CA-C-N 108.304 -4.044 . . . . 0.0 112.775 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.618 ' HE2' HG13 ' A' ' 57' ' ' VAL . 42.8 m-85 -93.14 99.56 12.12 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 125.721 2.677 . . . . 0.0 110.162 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.487 HG11 ' CG2' ' A' ' 32' ' ' VAL . 1.1 m -111.01 177.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 1 CA-C-N 107.787 -4.279 . . . . 0.0 113.508 -174.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -106.67 -141.87 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 124.177 1.942 . . . . 0.0 113.906 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -83.99 -5.41 59.22 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 110.338 -3.119 . . . . 0.0 113.091 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.5 mt -136.12 43.18 2.54 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 111.075 -2.784 . . . . 0.0 111.171 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.3 OUTLIER 33.15 30.26 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.1 m-20 -106.83 141.0 38.76 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 123.455 1.598 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.61 93.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 127.756 3.646 . . . . 0.0 116.329 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.44 . . -74.41 -40.72 61.83 Favored 'General case' 0 C--N 1.289 -2.053 2 CA-C-N 100.718 -7.492 . . . . 0.0 110.516 -179.273 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . 9.0 tt0 -119.52 158.71 25.74 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 ' CG2' ' A' ' 28' ' ' VAL . 97.2 t -76.92 138.39 65.7 Favored Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 114.506 -2.877 . . . . 0.0 110.71 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.6 Cg_exo -75.89 165.73 29.43 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.773 2.315 . . . . 0.0 110.193 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.579 HH12 HG21 ' A' ' 57' ' ' VAL . 9.3 ptp85 -162.77 167.94 22.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.588 HG11 HD12 ' A' ' 63' ' ' ILE . 37.5 t -82.61 133.53 28.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 C-N-CA 118.964 -1.095 . . . . 0.0 109.69 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.414 ' OXT' ' HD3' ' A' ' 67' ' ' ARG . . . . . . . . 0 CA--C 1.548 2.138 0 O-C-N 125.32 1.638 . . . . 0.0 112.428 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 81.2 tttt . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 122.273 1.035 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -97.41 26.55 4.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 7.5 pt-20 -138.62 156.4 47.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.822 1.326 . . . . 0.0 112.743 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.673 ' NE1' ' HA ' ' A' ' 39' ' ' ILE . 11.7 m-90 -134.56 78.61 55.9 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 28' ' ' VAL . 66.8 Cg_endo -75.2 -26.21 10.82 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 120.598 0.865 . . . . 0.0 113.993 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 16.1 mp0 -51.33 -29.62 15.76 Favored 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 124.845 2.26 . . . . 0.0 110.11 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.98 -27.9 49.23 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.035 -177.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG2' HG22 ' A' ' 79' ' ' VAL . 58.5 t -49.02 136.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 CA-C-N 119.97 1.259 . . . . 0.0 112.335 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.83 2.01 69.92 Favored Glycine 0 N--CA 1.507 3.407 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.169 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -126.09 169.49 12.73 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.65 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -87.59 177.13 7.15 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 125.331 2.491 . . . . 0.0 113.829 176.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.58 -37.4 77.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 109.863 -3.335 . . . . 0.0 115.716 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.66 -48.32 69.74 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.509 -1.276 . . . . 0.0 111.162 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 58.5 mm-40 -60.07 -42.1 93.83 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB1' HD23 ' A' ' 27' ' ' LEU . . . -53.52 -60.94 2.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.74 -1.225 . . . . 0.0 110.419 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 55.2 mtpt -45.68 -50.22 13.75 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.339 1.066 . . . . 0.0 108.806 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 73.3 tttt -48.99 -47.64 44.04 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.031 -2.804 . . . . 0.0 109.142 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.64 -49.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 124.731 1.269 . . . . 0.0 112.686 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.673 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 11.1 mt -48.11 -47.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.476 0.655 . . . . 0.0 111.448 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 46' ' ' ALA 0.252 96.0 mt -63.88 -12.81 39.97 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.921 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.99 -47.31 18.78 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.96 -52.72 26.05 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 124.831 2.253 . . . . 0.0 110.773 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 57.6 tttm -122.76 70.06 36.96 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.137 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -28.44 -45.19 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.844 3.029 . . . . 0.0 119.603 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.93 8.85 24.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -64.96 113.14 3.66 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 116.953 -1.899 . . . . 0.0 115.483 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -82.44 67.77 8.62 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.735 -1.853 . . . . 0.0 106.273 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.567 HD11 HG21 ' A' ' 39' ' ' ILE . 2.8 mp -80.77 137.7 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 124.19 1.948 . . . . 0.0 115.528 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.3 mp -120.27 177.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 109.908 -3.315 . . . . 0.0 109.628 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 12.1 p -98.33 125.26 51.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.58 1.181 . . . . 0.0 109.48 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 9.7 mt -122.47 89.06 49.46 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.422 ' HG2' ' OG1' ' A' ' 55' ' ' THR . 37.8 Cg_endo -53.39 130.39 38.29 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 O-C-N 119.005 -1.103 . . . . 0.0 113.436 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 69' ' ' PHE . 54.8 t -45.36 115.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 123.133 1.444 . . . . 0.0 111.157 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.36 8.1 Favored Glycine 0 N--CA 1.513 3.78 1 CA-C-N 107.779 -4.282 . . . . 0.0 115.039 -173.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.539 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.284 1.4 m -56.94 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 118.945 1.372 . . . . 0.0 107.908 177.261 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.31 110.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 120.085 3.365 . . . . 0.0 120.085 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.63 HG21 ' HE2' ' A' ' 69' ' ' PHE . 35.3 m -124.12 177.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 108.473 -3.967 . . . . 0.0 110.672 176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -94.89 142.87 26.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 109.759 -3.382 . . . . 0.0 112.574 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.3 tpt -93.28 57.9 2.75 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 123.399 2.818 . . . . 0.0 104.419 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 20.2 pt-20 -80.49 -169.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 111.18 -2.736 . . . . 0.0 113.208 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.642 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 12.8 t80 -140.21 63.33 1.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.634 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.28 74.61 7.0 Favored 'General case' 0 N--CA 1.486 1.331 1 N-CA-C 97.91 -4.848 . . . . 0.0 97.91 174.358 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.642 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.07 -20.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 109.899 -3.319 . . . . 0.0 116.334 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -62.52 4.24 0.16 Allowed 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.904 1.335 . . . . 0.0 109.466 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.5 ttm-85 -149.87 154.71 38.81 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.66 HG21 ' CG2' ' A' ' 39' ' ' ILE . 3.2 t -115.99 135.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 1 N-CA-C 99.454 -4.276 . . . . 0.0 99.454 176.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.563 ' HD3' HG21 ' A' ' 57' ' ' VAL . 8.9 ttm-85 -94.49 126.19 39.61 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.837 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 48' ' ' ILE . 11.1 mp -110.59 76.81 1.0 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.526 2.391 . . . . 0.0 112.048 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.63 ' HE2' HG21 ' A' ' 57' ' ' VAL . 26.1 m-85 -74.98 102.44 4.81 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 126.996 3.284 . . . . 0.0 105.468 168.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 53' ' ' VAL . 18.7 m -100.77 179.75 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.326 1 CA-C-N 106.055 -5.066 . . . . 0.0 109.975 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.591 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -89.43 -145.49 0.16 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 117.438 -3.289 . . . . 0.0 111.425 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.591 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.6 -4.95 59.25 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 111.336 -2.666 . . . . 0.0 115.62 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 73' ' ' LEU 0.266 0.6 OUTLIER -138.02 48.47 1.98 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 126.875 3.226 . . . . 0.0 106.959 176.938 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 34.58 37.02 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.302 -3.135 . . . . 0.0 116.663 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -106.9 147.73 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 124.14 1.924 . . . . 0.0 107.633 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.92 97.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 127.176 3.369 . . . . 0.0 116.623 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.374 . . -73.1 -48.81 32.55 Favored 'General case' 0 C--N 1.29 -2.016 2 CA-C-N 100.257 -7.701 . . . . 0.0 111.767 179.71 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -119.1 155.85 30.8 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.636 HG22 ' CG2' ' A' ' 28' ' ' VAL . 89.2 t -72.47 142.89 84.64 Favored Pre-proline 0 N--CA 1.507 2.392 0 C-N-CA 114.312 -2.955 . . . . 0.0 108.505 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 7.0 Cg_exo -82.11 159.03 17.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 123.549 2.833 . . . . 0.0 108.725 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 7.7 ptp85 -162.57 171.81 16.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 108.257 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 35.9 t -79.5 140.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.15 0 CA-C-O 116.399 -2.334 . . . . 0.0 109.946 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' A' ' 23' ' ' GLU . 81.9 tttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -113.78 21.03 15.36 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.151 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -143.94 132.52 22.31 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 118.381 2.734 . . . . 0.0 118.381 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.605 ' CE2' HG23 ' A' ' 39' ' ' ILE . 21.3 m-90 -119.1 67.73 8.83 Favored Pre-proline 0 N--CA 1.504 2.234 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -61.9 -36.25 73.44 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 120.867 1.045 . . . . 0.0 110.889 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 21' ' ' LYS . 8.1 pm0 -49.8 -25.02 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.677 1.227 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.546 HD13 ' HB1' ' A' ' 35' ' ' ALA . 52.1 mt -77.07 -34.19 57.09 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.657 -177.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 79' ' ' VAL . 60.5 t -45.91 135.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.545 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 -177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.84 -15.5 59.47 Favored Glycine 0 N--CA 1.513 3.803 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.129 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -119.49 176.02 5.56 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -87.97 156.43 19.34 Favored 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.787 3.184 . . . . 0.0 118.314 176.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -54.45 -46.76 70.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 1 CA-C-N 107.426 -4.443 . . . . 0.0 116.545 -175.848 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 63.1 mm-40 -54.46 -49.38 70.19 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 116.883 -1.927 . . . . 0.0 111.203 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -49.88 -53.61 24.75 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 124.333 2.016 . . . . 0.0 106.012 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.546 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -54.02 -54.91 32.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.275 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HG2' ' CG2' ' A' ' 48' ' ' ILE . 9.5 mtpm? -46.27 -52.02 13.38 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 125.416 1.487 . . . . 0.0 107.72 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 21.1 ttpp -56.98 -57.59 11.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 110.78 -2.918 . . . . 0.0 108.98 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 72.2 t -55.0 -46.44 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 122.85 1.31 . . . . 0.0 112.955 -178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.798 HG21 HG21 ' A' ' 66' ' ' VAL . 96.9 mt -66.59 -49.41 75.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.227 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.46 -39.89 73.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 33.4 mt-30 -57.69 -37.37 73.35 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.438 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 5.1 t0 -98.16 21.57 10.68 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 126.978 2.111 . . . . 0.0 115.955 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.645 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 65.7 tttt -98.72 105.91 33.68 Favored Pre-proline 0 N--CA 1.526 3.374 1 N-CA-C 128.299 6.407 . . . . 0.0 128.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 4.0 Cg_exo -90.95 -63.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.594 3.479 0 N-CA-C 104.132 -3.064 . . . . 0.0 104.132 161.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' C ' HG11 ' A' ' 82' ' ' VAL . 19.8 mp0 -88.81 -27.0 21.39 Favored 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.645 ' N ' ' HG3' ' A' ' 43' ' ' LYS . . . -62.35 67.58 0.01 OUTLIER 'General case' 1 N--CA 1.541 4.115 1 N-CA-C 132.85 8.092 . . . . 0.0 132.85 -179.064 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 60.7 tp60 -89.81 113.08 24.59 Favored 'General case' 1 N--CA 1.541 4.078 0 CA-C-N 124.965 3.53 . . . . 0.0 108.21 178.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 48' ' ' ILE . 1.1 mp -78.48 144.65 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 48' ' ' ILE . 42.9 mm -139.3 142.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 110.433 -3.076 . . . . 0.0 105.402 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.8 141.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.64 HD13 ' CE2' ' A' ' 69' ' ' PHE . 5.9 mt -132.0 128.66 21.55 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 116.88 -1.533 . . . . 0.0 107.675 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.27 135.89 23.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 104.058 -3.093 . . . . 0.0 104.058 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.589 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -41.41 124.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.12 -20.21 38.64 Favored Glycine 0 N--CA 1.505 3.256 0 CA-C-N 109.055 -3.702 . . . . 0.0 118.172 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.481 ' OG1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -48.79 143.94 4.91 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.466 2.133 . . . . 0.0 112.587 -175.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.3 121.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.613 HG21 ' HE2' ' A' ' 69' ' ' PHE . 1.8 m -115.89 -87.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -175.181 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.47 107.64 16.09 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 119.487 3.143 . . . . 0.0 119.487 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.6 mtm -96.14 -58.56 2.05 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 127.649 3.595 . . . . 0.0 108.82 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.619 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -84.36 -145.92 0.09 Allowed 'General case' 0 C--N 1.273 -2.743 1 CA-C-N 104.05 -5.977 . . . . 0.0 105.7 175.173 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.576 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -126.07 94.61 4.14 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.438 172.445 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.626 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -77.84 50.97 0.9 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 124.911 2.291 . . . . 0.0 112.466 175.442 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 10.4 tp -76.66 31.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-O 125.234 2.445 . . . . 0.0 117.321 -176.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -98.5 -30.63 12.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 111.212 -2.722 . . . . 0.0 109.386 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.626 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 3.8 ttp85 -127.5 158.62 36.92 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 118.923 2.934 . . . . 0.0 118.923 -171.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.798 HG21 HG21 ' A' ' 39' ' ' ILE . 2.2 t -107.09 127.34 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.555 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.6 ttp180 -87.1 102.03 14.04 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 108.693 -3.867 . . . . 0.0 104.917 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 80' ' ' PRO . 10.9 mp -103.09 90.47 3.75 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 125.398 1.686 . . . . 0.0 111.307 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.64 ' CE2' HD13 ' A' ' 51' ' ' LEU . 13.0 m-85 -73.28 105.75 4.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 124.762 2.22 . . . . 0.0 109.744 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -106.69 173.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 109.062 -3.699 . . . . 0.0 107.829 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.575 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.7 p-10 -98.39 -139.19 0.3 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 124.575 2.131 . . . . 0.0 111.885 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.575 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.6 mtmm -83.79 -13.52 53.62 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 109.477 -3.511 . . . . 0.0 114.83 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 73' ' ' LEU 0.323 0.3 OUTLIER -136.35 51.13 2.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-O 124.447 2.07 . . . . 0.0 107.197 -178.661 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.75 25.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 178.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 38.4 m-20 -102.73 156.98 17.27 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.4 mt -78.86 116.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 126.465 3.031 . . . . 0.0 115.563 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 53' ' ' VAL 0.478 . . -94.53 -47.29 6.61 Favored 'General case' 0 C--N 1.287 -2.135 2 CA-C-N 103.381 -6.282 . . . . 0.0 110.065 -174.18 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -114.7 159.62 20.32 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.486 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 94.6 t -72.29 132.44 84.11 Favored Pre-proline 0 N--CA 1.499 2.018 0 C-N-CA 114.022 -3.071 . . . . 0.0 110.12 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 38.0 Cg_exo -67.05 144.25 68.9 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.811 2.341 . . . . 0.0 107.88 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.86 153.07 31.43 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.246 -1.359 . . . . 0.0 112.134 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 13.1 t -82.32 102.64 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.55 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.286 -2.22 0 C-N-CA 118.767 -1.683 . . . . 0.0 110.056 176.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -114.89 9.27 16.14 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.255 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.38 150.4 45.26 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.528 -179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.433 ' HZ3' HG23 ' A' ' 82' ' ' VAL . 16.3 m-90 -127.86 65.78 69.2 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 123.477 1.608 . . . . 0.0 112.444 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 27' ' ' LEU . 54.2 Cg_endo -67.74 -32.95 28.94 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.596 1.531 . . . . 0.0 109.481 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -65.5 0.49 1.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD11 HG13 ' A' ' 39' ' ' ILE . 40.9 mt -99.17 -17.68 18.04 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.986 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' CG2' HG22 ' A' ' 79' ' ' VAL . 64.0 t -63.11 116.06 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 116.821 -1.952 . . . . 0.0 108.596 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.46 -5.68 24.76 Favored Glycine 0 N--CA 1.508 3.479 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.8 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 27' ' ' LEU . 35.7 mmtm -101.63 171.72 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.47 1.108 . . . . 0.0 108.564 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -87.19 168.75 12.95 Favored 'General case' 0 CA--C 1.445 -3.079 0 CA-C-O 124.942 2.306 . . . . 0.0 111.688 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.726 HG23 HG11 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -70.39 -39.57 76.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 108.566 -3.925 . . . . 0.0 109.066 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 2.1 pp20? -65.32 -49.74 68.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.287 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 tt0 -58.82 -46.08 88.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 27' ' ' LEU . . . -50.44 -58.51 5.58 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 116.721 -1.609 . . . . 0.0 109.809 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -47.69 -55.17 10.06 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 120.994 1.724 . . . . 0.0 107.481 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 14.0 ttpt -48.04 -51.33 24.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 110.394 -3.094 . . . . 0.0 109.894 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.49 -52.92 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.066 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.709 ' CG2' HG21 ' A' ' 66' ' ' VAL . 22.5 mt -51.34 -47.79 34.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 123.021 1.391 . . . . 0.0 109.832 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.6 -28.79 57.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.01 -34.81 79.33 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 123.313 1.53 . . . . 0.0 109.679 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 36.8 m-20 -88.82 -49.53 6.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 119.661 3.208 . . . . 0.0 119.661 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 24.1 tptp -116.06 72.1 4.46 Favored Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 71.6 Cg_exo -10.98 -38.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 2 C-N-CA 127.289 5.326 . . . . 0.0 122.773 -178.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.9 mp0 -91.42 -25.11 19.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -38.17 80.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 1 N-CA-C 123.353 4.575 . . . . 0.0 123.353 -171.61 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -76.64 69.88 3.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 66' ' ' VAL . 4.6 mt -72.46 131.69 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.352 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.57 162.01 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.77 113.19 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.36 1.076 . . . . 0.0 109.803 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.767 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -114.16 100.85 53.42 Favored Pre-proline 0 N--CA 1.501 2.1 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.616 -178.041 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.3 131.83 29.56 Favored 'Trans proline' 0 N--CA 1.509 2.416 0 CA-C-N 122.035 1.763 . . . . 0.0 108.926 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 78.1 t -46.57 121.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 120.371 -1.455 . . . . 0.0 113.223 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.07 -30.19 6.42 Favored Glycine 1 N--CA 1.517 4.098 0 CA-C-N 110.512 -3.04 . . . . 0.0 114.849 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.552 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.289 91.6 m -47.21 92.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 124.742 1.217 . . . . 0.0 109.205 176.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mm -52.06 101.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 124.046 1.879 . . . . 0.0 115.804 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.492 HG21 ' HE2' ' A' ' 69' ' ' PHE . 28.2 m -103.65 -178.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.44 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -91.16 158.76 16.44 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -174.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.459 ' N ' ' SD ' ' A' ' 59' ' ' MET . 3.6 mpp? -92.13 37.26 0.98 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 123.876 1.798 . . . . 0.0 108.237 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 58' ' ' THR . 18.2 pt-20 -81.89 -171.67 3.49 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.757 -2.928 . . . . 0.0 111.773 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.524 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -133.98 82.42 1.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.738 1.256 . . . . 0.0 108.771 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 6.8 mmm180 -88.3 78.21 8.05 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 101.291 -3.596 . . . . 0.0 101.291 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.536 ' HA ' HG12 ' A' ' 82' ' ' VAL . 7.4 tp -69.77 -3.61 3.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 109.412 -3.54 . . . . 0.0 112.659 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.5 -6.7 58.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 110.047 -3.252 . . . . 0.0 106.755 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.292 5.3 ttm-85 -145.33 150.83 37.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 120.265 3.432 . . . . 0.0 120.265 -171.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.709 HG21 ' CG2' ' A' ' 39' ' ' ILE . 4.4 t -111.67 108.64 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -63.15 125.35 23.77 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -177.087 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.1 tp -115.12 74.55 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 O-C-N 124.905 1.378 . . . . 0.0 111.641 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.767 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 24.4 m-85 -72.76 104.94 4.13 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 126.593 3.092 . . . . 0.0 111.344 169.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.726 HG11 HG23 ' A' ' 32' ' ' VAL . 3.6 m -107.36 171.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 CA-C-N 108.724 -3.853 . . . . 0.0 112.156 -175.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.1 p-10 -83.0 -147.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 123.738 2.972 . . . . 0.0 112.889 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.8 ttpp -91.55 8.5 36.29 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.389 -3.096 . . . . 0.0 112.031 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.479 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.7 mt -141.7 36.45 1.63 Allowed 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 111.458 -2.61 . . . . 0.0 110.245 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.531 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.13 26.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 -177.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -103.62 135.47 45.15 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.64 118.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 127.542 3.544 . . . . 0.0 114.039 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.443 . . -94.68 -51.24 4.81 Favored 'General case' 0 C--N 1.288 -2.105 2 CA-C-N 103.159 -6.382 . . . . 0.0 112.064 -173.023 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -116.41 161.78 18.55 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.5 HG22 ' CG2' ' A' ' 28' ' ' VAL . 95.0 t -73.46 137.68 77.84 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 113.819 -3.152 . . . . 0.0 108.757 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 13.1 Cg_exo -78.36 152.71 27.07 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.421 ' NH2' ' O ' ' A' ' 82' ' ' VAL . 2.6 ptm180 -156.43 157.83 36.23 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 117.748 -1.581 . . . . 0.0 112.391 -176.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 63' ' ' ILE . 3.5 t -81.49 131.5 33.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.401 -1.319 . . . . 0.0 108.104 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.593 0 CA-C-O 114.538 -3.368 . . . . 0.0 112.804 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 tttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 125.736 2.684 . . . . 0.0 115.041 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -111.94 33.77 4.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 100.458 -3.904 . . . . 0.0 100.458 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -142.31 156.08 45.24 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 126.671 2.482 . . . . 0.0 113.56 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 27' ' ' LEU . 22.4 m-90 -140.77 62.78 18.47 Favored Pre-proline 0 N--CA 1.509 2.522 0 CA-C-O 123.73 1.729 . . . . 0.0 115.09 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -63.3 -13.02 33.31 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.293 1.995 . . . . 0.0 113.125 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 12.0 mp0 -77.43 -20.43 54.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.686 HD13 ' HB1' ' A' ' 35' ' ' ALA . 69.8 mt -87.46 -19.62 27.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 79' ' ' VAL . 45.4 t -49.51 130.57 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.22 -10.88 60.08 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.637 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -110.11 161.7 15.29 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.7 p -74.5 162.7 28.56 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-O 126.867 3.222 . . . . 0.0 110.961 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HA ' HD23 ' A' ' 68' ' ' LEU 0.279 9.1 p -62.89 -47.39 93.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 1 CA-C-N 107.199 -4.546 . . . . 0.0 112.163 -173.573 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -68.42 -34.2 75.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.343 -1.743 . . . . 0.0 110.954 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -62.94 -51.1 68.21 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -62.41 -44.19 97.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.398 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 85.7 mttt -45.85 -50.49 14.24 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.236 1.017 . . . . 0.0 108.518 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.559 ' HZ3' ' HB3' ' A' ' 37' ' ' LYS . 5.7 ttpm? -48.14 -54.19 14.16 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 111.876 -2.42 . . . . 0.0 110.932 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 71.4 t -65.76 -47.34 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 112.768 -2.015 . . . . 0.0 111.898 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 66' ' ' VAL . 17.1 mt -52.92 -53.57 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.886 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.257 34.7 mt -58.2 -19.62 34.92 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 125.154 1.534 . . . . 0.0 110.999 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -75.54 -25.88 57.55 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.406 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -96.45 -53.86 3.45 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -118.87 55.05 2.46 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.671 -0.643 . . . . 0.0 110.844 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -17.91 -40.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 125.131 3.888 . . . . 0.0 119.507 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.51 -30.37 68.53 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.518 0.675 . . . . 0.0 112.301 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.0 76.32 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 120.86 3.652 . . . . 0.0 120.86 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.43 74.84 4.96 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 39' ' ' ILE . 55.6 mt -73.03 141.84 15.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.645 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 50' ' ' VAL . 11.7 mm -108.36 170.43 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.047 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 49' ' ' ILE . 39.8 t -84.11 122.65 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.67 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 40.9 mt -118.51 77.47 13.98 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -50.79 129.88 28.87 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 106.927 -1.99 . . . . 0.0 106.927 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.628 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 1.3 t -40.86 130.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 123.885 1.802 . . . . 0.0 115.725 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.75 -29.61 12.14 Favored Glycine 0 N--CA 1.508 3.489 0 CA-C-N 110.652 -2.976 . . . . 0.0 113.811 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.618 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.298 3.2 m -45.76 162.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.03 136.63 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.582 HG21 ' CD ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -141.79 -70.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.873 0 N-CA-C 121.249 3.796 . . . . 0.0 121.249 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 93.33 8.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -98.64 -86.97 0.35 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 108.922 -3.763 . . . . 0.0 102.35 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' HG2' ' NE ' ' A' ' 62' ' ' ARG . 20.2 pt-20 -81.73 -167.91 1.69 Allowed 'General case' 0 C--N 1.277 -2.557 1 CA-C-N 107.263 -4.517 . . . . 0.0 106.321 173.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.37 95.99 8.44 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.412 ' NE ' ' HG2' ' A' ' 60' ' ' GLU . 3.0 mpt_? -83.74 66.24 8.95 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 125.088 2.375 . . . . 0.0 104.863 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.664 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.6 tp -74.8 -23.46 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.922 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.56 6.4 5.9 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 109.445 -3.525 . . . . 0.0 108.583 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.303 12.6 ttm-85 -154.87 149.38 26.31 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 39' ' ' ILE . 2.9 t -117.17 126.44 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-N 120.647 1.567 . . . . 0.0 112.393 174.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.582 ' CD ' HG21 ' A' ' 57' ' ' VAL . 2.3 mtp180 -56.25 104.04 0.13 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 117.1 -1.429 . . . . 0.0 113.035 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.601 HD23 ' HA ' ' A' ' 32' ' ' VAL . 10.3 mp -106.48 74.27 1.01 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 123.208 2.731 . . . . 0.0 104.496 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.67 ' CZ ' HD22 ' A' ' 51' ' ' LEU . 16.7 m-85 -72.82 108.64 5.89 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 127.42 3.486 . . . . 0.0 109.262 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 68' ' ' LEU . 32.7 m -106.03 170.33 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 1 CA-C-N 106.647 -4.797 . . . . 0.0 110.088 -173.444 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.3 p-10 -94.83 -138.15 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 124.096 1.903 . . . . 0.0 111.082 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 30.0 mmtp -83.57 -11.83 56.88 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 109.74 -3.391 . . . . 0.0 112.447 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 ' CD1' HD22 ' A' ' 75' ' ' ASN 0.302 0.4 OUTLIER -136.53 52.2 1.97 Allowed 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 124.144 1.926 . . . . 0.0 108.955 -179.202 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' C ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.47 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 110.735 -2.938 . . . . 0.0 118.547 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.513 HD22 ' CD1' ' A' ' 73' ' ' LEU . 56.3 m-20 -99.38 134.56 42.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.641 1.21 . . . . 0.0 110.274 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 mt -52.28 117.9 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 126.326 2.965 . . . . 0.0 111.877 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.435 . . -102.37 -39.19 7.28 Favored 'General case' 0 C--N 1.286 -2.168 1 CA-C-N 104.633 -5.712 . . . . 0.0 112.348 -170.913 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -114.47 160.25 19.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 102.831 -3.025 . . . . 0.0 102.831 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 28' ' ' VAL . 88.3 t -76.88 145.03 73.54 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 114.273 -2.971 . . . . 0.0 109.405 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 14.5 Cg_exo -78.42 151.33 25.86 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.297 -1.463 . . . . 0.0 108.297 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.568 HH22 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -153.63 155.73 36.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 66' ' ' VAL . 45.2 t -75.53 -83.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 124.01 1.862 . . . . 0.0 108.454 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.568 ' C ' HH22 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.285 -2.276 1 N-CA-C 102.304 -4.318 . . . . 0.0 102.304 -175.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.616 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 14.6 pttp . . . . . 0 CA--C 1.488 -1.416 0 CA-C-O 124.397 2.046 . . . . 0.0 107.874 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 36.2 p -106.92 -3.7 19.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 110.596 -3.002 . . . . 0.0 111.034 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.616 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -129.77 142.84 50.63 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.625 ' CZ2' HG23 ' A' ' 39' ' ' ILE . 25.5 m-90 -134.23 76.55 62.86 Favored Pre-proline 0 N--CA 1.52 3.068 1 N-CA-C 123.363 4.579 . . . . 0.0 123.363 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . 7.4 Cg_endo -79.84 -35.69 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.873 1.716 . . . . 0.0 111.985 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.13 -18.19 9.23 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -176.246 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 1.2 pp -104.09 2.05 31.59 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.282 1.433 . . . . 0.0 114.389 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.56 HG21 HG22 ' A' ' 79' ' ' VAL . 49.0 t -70.55 141.67 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.754 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.84 7.6 59.83 Favored Glycine 0 N--CA 1.515 3.941 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -125.96 167.38 15.37 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.525 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 3.2 p -88.17 155.01 19.99 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 126.354 2.978 . . . . 0.0 114.033 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 33' ' ' GLU . 5.3 p -40.97 -49.62 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 1 CA-C-N 106.411 -4.904 . . . . 0.0 120.14 -175.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' N ' HG13 ' A' ' 32' ' ' VAL . 57.6 mm-40 -59.88 -49.02 79.35 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.211 -1.395 . . . . 0.0 109.605 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -51.3 -51.82 50.86 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 76' ' ' ILE . . . -52.6 -58.02 8.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.547 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 49.1 mtpt -45.99 -52.45 11.74 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 123.364 1.554 . . . . 0.0 107.107 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.8 -54.05 43.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.483 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.4 t -54.33 -54.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-O 124.896 2.284 . . . . 0.0 109.778 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.656 HD13 HG11 ' A' ' 66' ' ' VAL . 9.3 mt -54.26 -43.88 63.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 110.526 -3.033 . . . . 0.0 112.216 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 46' ' ' ALA . 57.7 mt -73.22 -32.87 65.02 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 125.655 1.847 . . . . 0.0 110.866 175.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -64.81 -18.54 65.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 10.9 t70 -96.36 -64.15 1.08 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.277 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -104.65 62.62 0.11 Allowed Pre-proline 0 C--N 1.29 -1.979 0 C-N-CA 127.873 2.469 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -18.86 -49.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 123.983 3.122 . . . . 0.0 120.052 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.53 14.91 13.59 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 48' ' ' ILE . . . -59.56 97.87 0.04 OUTLIER 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.762 1.268 . . . . 0.0 113.626 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 30.0 tt0 -73.59 77.33 1.49 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.632 HD11 ' CG2' ' A' ' 39' ' ' ILE . 66.8 mt -74.52 135.06 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 123.153 1.454 . . . . 0.0 113.524 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.51 137.58 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 111.514 -2.585 . . . . 0.0 108.758 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.27 141.37 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 123.117 1.437 . . . . 0.0 110.541 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.604 ' CD2' HG22 ' A' ' 55' ' ' THR . 2.5 mp -137.43 140.19 29.77 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.01 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 55' ' ' THR . 32.3 Cg_endo -74.82 141.79 27.63 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.505 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 8.4 t -42.14 128.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.12 20.63 Favored Glycine 0 N--CA 1.507 3.396 0 CA-C-N 111.213 -2.721 . . . . 0.0 112.543 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.604 HG22 ' CD2' ' A' ' 51' ' ' LEU 0.28 0.9 OUTLIER -69.02 177.05 2.82 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 123.76 1.743 . . . . 0.0 112.428 179.106 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.3 mm -59.18 105.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 124.037 4.829 . . . . 0.0 124.037 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.716 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -105.18 -50.84 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.613 0 CA-C-N 111.207 -2.724 . . . . 0.0 111.682 173.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 62.95 4.53 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 128.284 3.897 . . . . 0.0 119.156 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.66 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 3.5 ttt -98.65 -162.38 0.95 Allowed 'General case' 0 C--N 1.279 -2.475 1 CA-C-N 103.038 -6.437 . . . . 0.0 108.687 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.66 ' H ' ' HG2' ' A' ' 59' ' ' MET . 0.4 OUTLIER -73.87 -141.69 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.226 172.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.566 ' CE2' HD13 ' A' ' 63' ' ' ILE . 12.1 t80 -136.49 83.35 2.0 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 6.6 mmp_? -87.41 76.61 9.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.582 HD12 HG11 ' A' ' 82' ' ' VAL . 5.9 tp -52.2 -19.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 110.952 -2.84 . . . . 0.0 112.808 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.625 ' O ' ' HB3' ' A' ' 47' ' ' GLN 0.263 2.2 p30 -81.43 15.96 1.85 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.975 177.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.482 HH21 ' C ' ' A' ' 83' ' ' GLY . 53.0 ttp180 -153.64 122.65 6.46 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 82' ' ' VAL . 24.0 t -91.12 146.79 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 C-N-CA 114.467 -2.893 . . . . 0.0 105.016 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.653 HH21 ' C ' ' A' ' 83' ' ' GLY . 14.9 tpp85 -99.94 114.08 27.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.076 -2.784 . . . . 0.0 105.527 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 39' ' ' ILE . 84.3 mt -113.74 105.21 13.03 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.46 -1.296 . . . . 0.0 114.094 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.716 ' CE2' HG22 ' A' ' 57' ' ' VAL . 25.7 m-85 -80.14 102.91 9.66 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 125.697 2.665 . . . . 0.0 112.174 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.99 173.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 108.593 -3.912 . . . . 0.0 110.018 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -99.72 -141.75 0.33 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 124.53 2.109 . . . . 0.0 111.935 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.596 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.64 8.54 43.11 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.054 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 75' ' ' ASN . 65.2 mt -135.46 39.95 2.84 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 111.075 -2.784 . . . . 0.0 108.627 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.78 28.0 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 64.0 m-20 -104.8 146.9 28.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.174 1.94 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 35' ' ' ALA . 15.6 mt -77.8 95.33 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-O 127.245 3.403 . . . . 0.0 114.402 -177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.507 . . -72.3 -45.47 59.87 Favored 'General case' 0 C--N 1.289 -2.045 2 CA-C-N 100.608 -7.542 . . . . 0.0 102.437 178.838 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -119.19 135.14 54.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.716 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 87.2 t -42.72 -56.19 6.27 Favored Pre-proline 0 N--CA 1.519 2.98 1 N-CA-C 124.623 5.046 . . . . 0.0 124.623 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.716 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.255 0.0 OUTLIER 7.01 -152.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 2 C-N-CA 130.714 7.609 . . . . 0.0 127.837 -168.309 . . . . . . . . 5 4 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -155.53 -173.23 4.45 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -158.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 66' ' ' VAL . 5.0 t -81.88 148.55 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.289 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.653 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.988 0 O-C-N 126.392 2.307 . . . . 0.0 114.464 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.544 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 1.7 tmtm? . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -123.75 16.51 9.46 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 111.56 -2.564 . . . . 0.0 106.846 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -133.74 150.12 51.48 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.085 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.582 ' HB3' ' CG ' ' A' ' 27' ' ' LEU . 26.8 m-90 -133.22 74.56 72.47 Favored Pre-proline 0 N--CA 1.507 2.388 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.45 ' HA ' HG23 ' A' ' 28' ' ' VAL . 42.0 Cg_endo -74.14 -33.91 5.43 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.704 2.269 . . . . 0.0 110.486 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -48.43 -34.85 11.66 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.739 2.209 . . . . 0.0 109.945 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' CG ' ' HB3' ' A' ' 24' ' ' TRP . 3.7 pp -98.51 23.08 8.96 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.588 ' CG2' HG22 ' A' ' 79' ' ' VAL . 64.5 t -73.32 163.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.85 17.17 60.33 Favored Glycine 0 N--CA 1.512 3.709 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.949 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.23 163.89 25.74 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-O 116.568 -1.682 . . . . 0.0 109.59 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 5.5 p -88.42 158.13 18.47 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 126.575 3.083 . . . . 0.0 113.908 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.49 -27.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 1 CA-C-N 106.41 -4.905 . . . . 0.0 114.76 -176.771 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.605 ' HG3' ' N ' ' A' ' 34' ' ' GLU . 16.8 pt-20 -66.67 -52.16 47.92 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 123.87 1.795 . . . . 0.0 109.429 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.605 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 9.6 tm-20 -62.48 -51.04 69.02 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -50.72 -48.92 58.73 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.06 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.3 mttm -57.95 -53.12 61.81 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD3' ' C ' ' A' ' 37' ' ' LYS . 3.8 tmtm? -48.2 -35.91 12.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 113.382 -1.736 . . . . 0.0 114.775 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.455 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 66.1 t -85.25 -59.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.229 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 66' ' ' VAL . 40.2 mt -49.25 -48.91 17.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.679 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 46' ' ' ALA . 9.8 mt -70.94 -23.18 62.19 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.126 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -96.38 -63.27 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 8.2 tptp -111.13 67.23 0.59 Allowed Pre-proline 0 N--CA 1.499 2.007 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -18.62 -46.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 124.599 3.533 . . . . 0.0 120.096 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.3 mp0 -59.28 -35.07 73.07 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' A' ' 66' ' ' VAL . . . -44.86 79.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.678 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 43.9 tt0 -78.09 65.37 3.46 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.875 1.797 . . . . 0.0 107.269 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 39' ' ' ILE . 32.6 mt -70.46 142.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' VAL . 32.9 mm -125.86 -166.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 110.668 -2.969 . . . . 0.0 106.418 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.8 p -106.02 142.05 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 0.0 112.56 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.39 102.81 7.24 Favored Pre-proline 0 N--CA 1.513 2.723 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.55 129.06 15.17 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 122.799 2.035 . . . . 0.0 109.435 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 4.1 t -41.94 130.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 123.383 1.563 . . . . 0.0 114.476 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.62 -21.49 45.83 Favored Glycine 0 N--CA 1.503 3.144 0 CA-C-N 111.095 -2.775 . . . . 0.0 114.613 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -58.24 156.36 9.98 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 119.261 1.531 . . . . 0.0 113.416 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.04 127.46 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.124 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 69' ' ' PHE . 30.0 m -131.21 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 112.645 -2.071 . . . . 0.0 109.473 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -155.67 0.31 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.556 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 50.2 mtp -58.1 -149.91 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -81.47 -18.68 44.36 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 125.27 2.462 . . . . 0.0 116.318 175.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.639 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -116.54 107.15 14.38 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 109.488 -3.506 . . . . 0.0 106.706 178.392 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.703 ' H ' ' C ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -107.45 43.72 1.16 Allowed 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 125.277 2.465 . . . . 0.0 109.758 179.073 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.639 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.2 tp -42.73 -27.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.444 1 CA-C-N 107.295 -4.502 . . . . 0.0 120.058 -177.671 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.23 -17.62 20.45 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 47' ' ' GLN 0.255 0.1 OUTLIER -142.81 -170.84 3.32 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.863 -2.426 . . . . 0.0 114.017 -176.973 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.696 HG21 HG21 ' A' ' 39' ' ' ILE . 3.0 t -115.64 111.49 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 1 N-CA-C 88.032 -8.507 . . . . 0.0 88.032 169.731 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HD3' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -81.04 101.83 9.82 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 122.515 2.416 . . . . 0.0 111.013 -176.164 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.9 mp -79.9 80.18 6.33 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.556 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 13.6 m-85 -70.12 106.67 3.35 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 125.96 2.79 . . . . 0.0 108.95 166.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 14.9 m -105.9 175.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.766 1 CA-C-N 108.234 -4.075 . . . . 0.0 109.607 -176.336 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.486 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 6.5 p-10 -91.89 -140.21 0.18 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.232 -2.167 . . . . 0.0 113.194 -177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 43.8 mtmt -89.3 0.87 56.47 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 110.673 -2.967 . . . . 0.0 112.072 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.414 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.1 mt -135.77 32.66 2.98 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.874 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.16 28.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -177.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.9 m-80 -103.2 148.83 25.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.0 mt -74.88 106.46 4.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 126.843 3.211 . . . . 0.0 114.18 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 71' ' ' ASP 0.399 . . -81.34 -51.88 7.88 Favored 'General case' 0 C--N 1.287 -2.152 2 CA-C-N 101.692 -7.049 . . . . 0.0 110.042 -177.744 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.49 148.33 39.59 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.588 HG22 ' CG2' ' A' ' 28' ' ' VAL . 88.8 t -70.45 141.73 88.47 Favored Pre-proline 0 N--CA 1.502 2.132 0 C-N-CA 114.193 -3.003 . . . . 0.0 108.113 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 6.2 Cg_exo -89.27 159.16 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.765 2.31 . . . . 0.0 108.26 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -154.29 157.27 38.41 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -177.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' CH2' ' A' ' 24' ' ' TRP . 55.6 t -75.26 109.79 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 176.048 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.703 ' C ' ' H ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.276 -2.768 0 CA-C-N 110.869 -2.878 . . . . 0.0 107.032 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.006 0 CA-C-O 124.31 2.005 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' NZ ' ' CD1' ' A' ' 24' ' ' TRP . 4.0 tmtt? -100.47 56.13 0.9 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.469 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 66.5 p -102.96 34.98 2.66 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-O 122.897 1.332 . . . . 0.0 108.771 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' CD ' HH22 ' A' ' 81' ' ' ARG 0.251 0.0 OUTLIER -154.78 151.62 28.89 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.612 -176.736 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 24.1 m-90 -139.47 81.01 21.01 Favored Pre-proline 0 N--CA 1.517 2.887 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.4 -34.68 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.915 2.41 . . . . 0.0 111.612 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.77 -17.6 9.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.154 -0.966 . . . . 0.0 111.445 -177.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 1.7 pp -107.05 17.63 22.79 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 79' ' ' VAL . 69.8 t -65.99 169.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.109 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.37 18.18 35.18 Favored Glycine 1 N--CA 1.521 4.354 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -121.05 157.4 30.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.2 p -89.03 159.71 17.45 Favored 'General case' 0 CA--C 1.472 -2.053 0 CA-C-O 127.482 3.515 . . . . 0.0 109.083 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -40.01 -54.18 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.263 1 CA-C-N 105.888 -5.142 . . . . 0.0 118.722 -174.009 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 60.3 mm-40 -55.33 -47.87 75.02 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.936 1.698 . . . . 0.0 110.776 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 1.2 tm-20 -50.96 -47.14 61.29 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.77 -47.78 76.9 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.16 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 66.9 mttm -49.32 -50.55 39.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 76.9 tttt -48.64 -55.33 11.55 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 110.803 -2.908 . . . . 0.0 108.757 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 67.5 t -59.87 -54.27 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.764 0 CA-C-O 125.53 2.586 . . . . 0.0 112.72 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.686 ' CG2' HG21 ' A' ' 66' ' ' VAL . 31.6 mt -57.33 -50.03 78.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 112.151 -2.295 . . . . 0.0 110.663 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 67.8 mt -57.3 -36.42 71.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.1 tt0 -58.78 -44.72 90.76 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 118.05 -1.46 . . . . 0.0 110.935 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.74 -48.39 54.75 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.434 -1.712 . . . . 0.0 114.026 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 25.9 ttpp -127.36 68.31 72.96 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -14.72 -43.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 124.678 3.585 . . . . 0.0 119.949 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -86.97 -5.28 59.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -46.6 96.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.641 HE22 HD11 ' A' ' 49' ' ' ILE . 12.1 tm0? -77.76 93.32 4.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.598 HD11 ' CG2' ' A' ' 39' ' ' ILE . 73.0 mt -93.14 114.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 121.377 3.843 . . . . 0.0 121.377 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.641 HD11 HE22 ' A' ' 47' ' ' GLN . 36.5 mm -102.27 149.76 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 112.768 -2.014 . . . . 0.0 107.602 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.92 155.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.116 0.96 . . . . 0.0 112.506 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.769 ' HB3' ' CE1' ' A' ' 69' ' ' PHE 0.254 0.6 OUTLIER -142.42 132.19 12.26 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.579 -179.788 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.452 ' HD2' HD23 ' A' ' 51' ' ' LEU . 52.5 Cg_endo -72.05 113.97 3.84 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.172 1.915 . . . . 0.0 113.994 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 69' ' ' PHE . 36.5 t -41.56 123.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.441 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 119.51 -37.89 2.99 Favored Glycine 0 N--CA 1.507 3.424 2 O-C-N 129.751 4.407 . . . . 0.0 108.651 -175.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.517 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.267 52.0 m -60.04 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.031 1.332 . . . . 0.0 108.183 175.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' GLY . 24.9 mm -55.46 147.98 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.87 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' NE ' ' A' ' 67' ' ' ARG . 12.4 m -123.01 -147.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.42 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -87.49 155.33 20.05 Favored 'General case' 0 C--N 1.306 -1.321 1 N-CA-C 124.796 5.11 . . . . 0.0 124.796 -173.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -93.86 34.7 1.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 123.083 1.421 . . . . 0.0 110.865 176.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.02 -176.11 5.97 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.57 56.36 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 123.145 1.45 . . . . 0.0 107.391 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.48 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mmm180 -88.96 67.28 8.13 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 126.991 3.282 . . . . 0.0 107.782 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.537 HD12 HG11 ' A' ' 82' ' ' VAL . 6.5 tp -53.2 -26.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 1 CA-C-N 107.19 -4.55 . . . . 0.0 109.518 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' GLN . 1.3 p30 -60.91 -7.16 2.2 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.811 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 62' ' ' ARG . 6.1 ttp85 -139.55 151.58 46.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 121.768 3.988 . . . . 0.0 121.768 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.686 HG21 ' CG2' ' A' ' 39' ' ' ILE . 21.2 t -115.08 92.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' NE ' HG21 ' A' ' 57' ' ' VAL . 26.8 ttm180 -48.58 123.24 6.43 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 109.826 -3.352 . . . . 0.0 106.05 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 76' ' ' ILE 0.271 0.6 OUTLIER -115.16 84.03 2.01 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 125.916 2.01 . . . . 0.0 112.303 -176.965 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.769 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 26.0 m-85 -73.33 108.38 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 124.71 2.195 . . . . 0.0 107.057 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 53' ' ' VAL . 14.5 m -113.46 174.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 1 CA-C-N 108.286 -4.052 . . . . 0.0 110.368 -177.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.586 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.2 p-10 -88.69 -146.89 0.16 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 122.941 2.61 . . . . 0.0 111.637 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.586 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 12.0 mptt -90.63 0.34 57.42 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 111.736 -2.484 . . . . 0.0 113.994 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.375 0.2 OUTLIER -139.15 47.8 1.89 Allowed 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 112.558 -2.11 . . . . 0.0 105.772 178.101 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.71 27.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 58.6 m-80 -100.9 151.68 21.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 123.331 1.539 . . . . 0.0 109.576 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.423 HD11 HD11 ' A' ' 68' ' ' LEU . 82.0 mt -78.72 93.71 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 127.466 3.507 . . . . 0.0 116.125 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.351 . . -73.2 -42.09 63.07 Favored 'General case' 0 C--N 1.291 -1.957 2 CA-C-N 100.292 -7.685 . . . . 0.0 112.958 178.702 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 10.1 tt0 -117.57 156.14 28.61 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 28' ' ' VAL . 88.5 t -76.34 136.51 68.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 112.75 -3.58 . . . . 0.0 104.981 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_exo -81.48 169.59 15.35 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.518 2.812 . . . . 0.0 111.695 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.527 HH22 ' CD ' ' A' ' 23' ' ' GLU . 2.3 ptp180 -163.69 172.38 14.3 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 116.624 -1.655 . . . . 0.0 111.731 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.578 HG22 HG22 ' A' ' 66' ' ' VAL . 6.1 t -82.58 -111.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 82' ' ' VAL . . . . . . . . 0 C--N 1.287 -2.167 3 N-CA-C 96.046 -6.821 . . . . 0.0 96.046 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 120.926 0.393 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 13.3 mtpp -102.07 156.83 17.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 124.011 1.862 . . . . 0.0 112.444 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.5 p -111.42 -6.51 14.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.97 135.08 35.65 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.591 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 25.4 m-90 -117.0 72.94 6.24 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 122.983 1.373 . . . . 0.0 114.581 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HA ' HG23 ' A' ' 28' ' ' VAL . 40.5 Cg_endo -69.45 -31.98 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.643 1.562 . . . . 0.0 110.66 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' ' HZ1' ' A' ' 21' ' ' LYS . 33.4 mp0 -52.18 -34.9 47.19 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.167 1.461 . . . . 0.0 109.928 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 24' ' ' TRP 0.25 4.5 pp -102.06 36.48 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 123.704 1.716 . . . . 0.0 113.027 -177.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.58 ' CG2' HG22 ' A' ' 79' ' ' VAL . 9.9 t -81.45 155.92 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.767 171.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.65 29.1 17.55 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.469 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.0 mmmp? -120.58 176.49 5.48 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 117.13 -1.414 . . . . 0.0 109.44 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -85.32 160.28 19.85 Favored 'General case' 0 CA--C 1.459 -2.532 0 CA-C-O 126.053 2.835 . . . . 0.0 112.109 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' CG2' HG11 ' A' ' 70' ' ' VAL 0.251 1.7 p -69.55 -28.31 37.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 1 CA-C-N 107.189 -4.551 . . . . 0.0 111.13 -173.701 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.432 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 18.6 mm-40 -77.23 -38.55 50.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.1 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 32.8 mt-10 -63.08 -50.85 68.94 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 125.889 1.993 . . . . 0.0 105.632 174.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.73 -58.53 3.01 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.79 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.1 mttp -49.48 -54.96 14.95 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-O 122.549 1.166 . . . . 0.0 108.425 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' NZ ' ' OE1' ' A' ' 33' ' ' GLU . 57.5 mttp -52.95 -46.65 68.27 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.233 -2.258 . . . . 0.0 112.029 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' CD2' ' A' ' 27' ' ' LEU . 99.4 t -67.51 -52.51 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 122.559 1.171 . . . . 0.0 110.705 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 66' ' ' VAL . 17.5 mt -51.74 -48.69 37.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.315 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD21 ' O ' ' A' ' 46' ' ' ALA . 88.4 mt -60.77 -34.83 75.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 124.988 1.43 . . . . 0.0 107.378 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -84.79 -57.24 3.2 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 114.095 -1.412 . . . . 0.0 113.551 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 51.9 tttm -115.54 78.69 6.73 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.338 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -22.71 -52.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 N-CA-C 118.683 2.532 . . . . 0.0 118.683 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.67 9.35 14.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -178.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.696 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -65.15 96.17 0.2 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 117.822 -1.551 . . . . 0.0 113.18 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.92 69.86 4.2 Favored 'General case' 0 N--CA 1.513 2.692 0 O-C-N 118.338 -2.726 . . . . 0.0 107.893 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' HD12 ' A' ' 68' ' ' LEU . 32.8 mt -78.04 122.06 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 112.793 -2.003 . . . . 0.0 116.114 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.638 ' H ' ' CZ ' ' A' ' 65' ' ' ARG . 1.3 mp -115.47 170.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.453 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 7.7 p -72.79 126.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 123.096 1.427 . . . . 0.0 110.512 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 55' ' ' THR . 0.2 OUTLIER -131.62 104.8 14.39 Favored Pre-proline 0 N--CA 1.492 1.673 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.505 -177.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -56.54 115.05 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.625 0.545 . . . . 0.0 111.015 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.597 ' HA ' ' CG ' ' A' ' 69' ' ' PHE . 14.9 p -39.81 142.31 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 123.679 1.704 . . . . 0.0 112.655 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' N ' ' CE2' ' A' ' 69' ' ' PHE . . . 95.84 -26.09 22.09 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 112.067 -2.333 . . . . 0.0 110.976 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.582 HG21 HD23 ' A' ' 51' ' ' LEU 0.321 3.0 m -54.39 -179.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.225 1.012 . . . . 0.0 113.644 176.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.32 99.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 118.646 -2.534 . . . . 0.0 114.388 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -99.25 -48.18 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.268 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.97 68.54 0.68 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 127.659 3.6 . . . . 0.0 113.603 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.483 ' SD ' ' HG3' ' A' ' 62' ' ' ARG . 18.2 ttm -99.77 -177.96 3.72 Favored 'General case' 0 C--N 1.276 -2.609 1 CA-C-N 104.315 -5.857 . . . . 0.0 107.292 -178.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 11.8 pt-20 -78.53 -163.23 0.43 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 174.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.924 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 67.3 t80 -94.76 81.56 3.82 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.616 -1.303 . . . . 0.0 111.602 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.483 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 8.6 mmt85 -88.65 56.78 3.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.45 -1.7 . . . . 0.0 109.528 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.924 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.27 -27.6 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 111.348 -2.66 . . . . 0.0 116.642 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.07 -14.81 1.73 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 124.008 1.861 . . . . 0.0 108.328 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.638 ' CZ ' ' H ' ' A' ' 49' ' ' ILE . 6.2 mtp180 -132.21 157.41 44.41 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 119.443 3.127 . . . . 0.0 119.443 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.71 HG21 HG21 ' A' ' 39' ' ' ILE . 2.9 t -115.45 134.44 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 1 N-CA-C 98.5 -4.629 . . . . 0.0 98.5 171.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CD ' HD13 ' A' ' 51' ' ' LEU . 9.2 tpp180 -83.13 134.68 34.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD12 ' CG2' ' A' ' 48' ' ' ILE . 3.2 mt -113.86 82.01 1.62 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.856 1.347 . . . . 0.0 108.475 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.597 ' CG ' ' HA ' ' A' ' 53' ' ' VAL . 2.6 m-30 -73.46 92.45 1.87 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 126.498 3.047 . . . . 0.0 108.592 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 32' ' ' VAL . 4.8 m -105.16 171.04 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 1 CA-C-N 105.327 -5.397 . . . . 0.0 104.017 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.5 p-10 -96.75 -138.39 0.27 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 125.373 2.511 . . . . 0.0 112.261 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.549 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.0 mtmm -85.32 -11.99 53.36 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 109.195 -3.639 . . . . 0.0 114.166 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.609 ' CD1' HD22 ' A' ' 75' ' ' ASN 0.306 0.3 OUTLIER -138.05 52.36 1.85 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 112.087 -2.324 . . . . 0.0 107.675 -178.816 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 36.42 22.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.609 HD22 ' CD1' ' A' ' 73' ' ' LEU . 34.4 m-20 -105.62 138.27 42.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 123.473 1.606 . . . . 0.0 110.608 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.64 122.43 11.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 126.006 2.812 . . . . 0.0 117.211 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.485 . . -104.5 -44.16 4.98 Favored 'General case' 0 C--N 1.289 -2.03 1 CA-C-N 105.362 -5.381 . . . . 0.0 111.016 -171.831 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . 11.0 tp60 -115.42 161.7 18.18 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.58 HG22 ' CG2' ' A' ' 28' ' ' VAL . 95.4 t -75.79 134.25 72.29 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 113.939 -3.105 . . . . 0.0 109.05 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 31.9 Cg_exo -68.72 131.93 23.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 103.803 -3.191 . . . . 0.0 103.803 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' THR . 4.9 ptm180 -138.67 157.2 46.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.479 1.112 . . . . 0.0 108.703 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.8 t -79.03 152.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.358 1.036 . . . . 0.0 112.697 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.455 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.513 3.824 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.029 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.628 0 CA-C-O 120.841 0.353 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 5.8 tmtt? -77.24 59.94 1.86 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 48.2 p -104.55 24.96 10.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 112.608 -2.087 . . . . 0.0 105.401 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.07 151.16 43.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 126.225 2.203 . . . . 0.0 113.202 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.649 ' CG ' HG12 ' A' ' 39' ' ' ILE . 26.9 m-90 -128.67 67.32 76.73 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 123.285 1.517 . . . . 0.0 112.293 174.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -63.42 -37.67 47.62 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 CA-C-N 113.301 -1.357 . . . . 0.0 110.034 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 27' ' ' LEU . 19.6 pm0 -51.01 -31.32 17.73 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.165 0.983 . . . . 0.0 111.934 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.6 pp -105.84 31.9 4.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.556 HG21 HG22 ' A' ' 79' ' ' VAL . 77.4 t -84.71 124.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 170.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.82 3.46 54.94 Favored Glycine 0 N--CA 1.514 3.868 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -109.53 156.13 20.52 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.367 -0.917 . . . . 0.0 110.306 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 p -85.81 155.07 21.15 Favored 'General case' 0 CA--C 1.474 -1.945 0 CA-C-O 127.386 3.47 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -48.93 -56.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 1 CA-C-N 106.022 -5.081 . . . . 0.0 120.739 -170.259 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 50.0 mm-40 -57.67 -40.43 79.36 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 117.417 -1.713 . . . . 0.0 110.559 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.13 -54.39 46.46 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -44.58 -52.4 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.964 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mttt -55.77 -58.15 9.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 3.8 tmtm? -47.46 -40.14 17.49 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.798 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 77.4 t -70.59 -56.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.549 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HG21 ' A' ' 66' ' ' VAL . 47.7 mt -48.19 -39.18 8.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 122.814 1.292 . . . . 0.0 110.836 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 11.7 mt -53.26 -35.9 60.53 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.077 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -62.66 -46.59 87.49 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-O 123.942 1.829 . . . . 0.0 110.455 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.543 ' CG ' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -62.78 -49.94 72.99 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.988 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 1.2 mtpp -125.81 81.14 66.04 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.799 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.49 -54.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 118.204 2.348 . . . . 0.0 118.204 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.36 13.65 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 64' ' ' ASP . . . -60.22 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.032 0.92 . . . . 0.0 113.293 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -82.74 72.32 9.81 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 124.567 2.127 . . . . 0.0 106.071 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.67 HD11 ' CG2' ' A' ' 39' ' ' ILE . 49.2 mt -73.63 148.95 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 110.617 -2.992 . . . . 0.0 117.37 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.87 162.08 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 112.748 -2.023 . . . . 0.0 112.84 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 133.93 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 112.06 -2.336 . . . . 0.0 105.115 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.722 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.6 mt -141.51 113.36 6.62 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.564 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -76.0 130.04 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 CA-C-N 121.818 1.685 . . . . 0.0 108.0 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 69' ' ' PHE . 13.1 t -39.55 130.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.61 -40.69 2.46 Favored Glycine 1 N--CA 1.518 4.144 0 CA-C-N 109.302 -3.59 . . . . 0.0 111.019 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.56 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 40.6 m -46.29 125.49 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.721 1.208 . . . . 0.0 108.778 177.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.39 152.28 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.502 HG21 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -128.62 -51.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.716 1 N-CA-C 125.002 5.186 . . . . 0.0 125.002 -175.653 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.08 99.98 5.54 Favored 'General case' 0 C--N 1.288 -2.081 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.431 ' HB2' ' NH2' ' A' ' 62' ' ' ARG . 87.9 mtp -94.11 -117.55 0.1 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 100.809 -3.775 . . . . 0.0 100.809 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.257 3.1 pp20? -76.54 -167.29 0.78 Allowed 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 111.012 -2.813 . . . . 0.0 106.251 172.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -79.68 98.73 7.08 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.975 0.893 . . . . 0.0 112.074 -173.148 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -85.59 58.7 5.19 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 125.758 2.694 . . . . 0.0 109.468 177.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.515 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 7.6 tp -71.47 -9.22 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 109.524 -3.489 . . . . 0.0 116.476 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 11.5 p-10 -96.87 -1.69 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.788 1.28 . . . . 0.0 108.252 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.03 144.61 50.98 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.721 HG21 HG21 ' A' ' 39' ' ' ILE . 3.1 t -116.94 145.86 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -103.66 130.79 51.18 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.746 175.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 35' ' ' ALA . 20.3 mt -103.2 83.05 2.14 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.662 -2.063 . . . . 0.0 107.398 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.722 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.5 m-85 -73.18 100.15 3.0 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 126.478 3.037 . . . . 0.0 108.485 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 68' ' ' LEU . 32.8 m -101.52 171.15 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 1 CA-C-N 106.541 -4.845 . . . . 0.0 108.211 -176.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.514 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.2 p-10 -97.35 -140.87 0.29 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 124.633 2.158 . . . . 0.0 111.689 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.514 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 37.4 tttp -85.88 -0.97 56.77 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 109.199 -3.637 . . . . 0.0 111.451 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.492 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.3 mt -136.08 38.79 2.75 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.624 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.49 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -100.08 134.38 43.09 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.616 HG21 ' HG3' ' A' ' 80' ' ' PRO . 50.8 mt -58.37 122.96 9.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 125.328 2.49 . . . . 0.0 109.651 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.476 . . -105.4 -38.13 6.59 Favored 'General case' 0 C--N 1.284 -2.267 2 CA-C-N 105.19 -5.459 . . . . 0.0 110.261 -172.601 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -118.71 160.08 22.49 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.069 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG22 HG21 ' A' ' 28' ' ' VAL . 95.4 t -65.55 135.99 95.95 Favored Pre-proline 0 N--CA 1.501 2.089 0 C-N-CA 114.881 -2.728 . . . . 0.0 110.107 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HG3' HG21 ' A' ' 76' ' ' ILE . 4.4 Cg_exo -83.45 142.46 10.54 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 N-CA-C 104.417 -2.955 . . . . 0.0 104.417 -176.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 22' ' ' THR . 6.9 ptm180 -156.56 163.76 39.0 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 116.522 -2.071 . . . . 0.0 113.375 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 83' ' ' GLY . 2.7 t -84.38 155.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 125.924 2.015 . . . . 0.0 111.994 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.542 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.428 0 CA-C-O 114.127 -3.596 . . . . 0.0 112.512 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.758 0 CA-C-O 120.856 0.36 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -102.19 45.63 0.96 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -98.41 31.22 2.9 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.396 -1.322 . . . . 0.0 111.384 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.63 146.29 31.28 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.913 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.637 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 24.1 m-90 -127.4 67.17 71.1 Favored Pre-proline 0 N--CA 1.498 1.966 0 CA-C-O 124.262 1.982 . . . . 0.0 111.396 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' HG22 ' A' ' 79' ' ' VAL . 40.8 Cg_endo -69.29 -41.51 4.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 CA-C-N 111.068 -2.154 . . . . 0.0 110.614 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.7 pm0 -67.42 -9.64 43.67 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.786 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.637 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -107.78 13.73 26.16 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.645 HG21 HG22 ' A' ' 79' ' ' VAL . 48.6 t -68.01 161.46 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.72 57.15 Favored Glycine 1 N--CA 1.518 4.147 0 C-N-CA 118.475 -1.821 . . . . 0.0 113.829 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 2.9 mtpp -106.48 166.62 10.42 Favored 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 124.122 0.969 . . . . 0.0 111.655 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 p -85.7 154.23 21.79 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 126.249 2.928 . . . . 0.0 115.717 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.479 ' CG2' HG11 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -48.94 -57.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 1 CA-C-N 107.875 -4.239 . . . . 0.0 114.202 -172.081 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -53.01 -36.51 60.6 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 121.506 1.957 . . . . 0.0 113.802 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -50.68 38.83 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -46.55 -51.82 14.71 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 123.422 1.582 . . . . 0.0 107.488 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 40' ' ' LEU . 15.5 mtpp -55.16 -54.2 46.23 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -49.1 -42.03 37.66 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.341 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 85.5 t -67.57 -53.49 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.393 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.813 HG21 HG21 ' A' ' 66' ' ' VAL . 45.6 mt -60.3 -51.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.084 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 36' ' ' LYS . 1.3 mp -52.68 -27.75 18.75 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.575 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 39.4 tp60 -68.98 -23.75 64.16 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.1 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.19 -53.37 3.82 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.283 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 18.6 ttpp -116.7 76.69 7.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.24 -45.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 123.387 2.725 . . . . 0.0 117.446 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.25 0.7 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 16.3 mt-30 -77.94 60.74 2.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.651 ' HA ' ' HG3' ' A' ' 65' ' ' ARG . 65.6 mt -73.22 140.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 43.1 mm -115.86 175.7 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.607 1.194 . . . . 0.0 112.645 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.477 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 17.2 t -102.52 116.09 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 110.279 -3.146 . . . . 0.0 108.327 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 13.4 mt -124.04 92.18 48.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.05 127.94 27.76 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 N-CA-C 109.286 -1.082 . . . . 0.0 109.286 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.429 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -43.18 127.89 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.877 0 CA-C-O 123.613 1.673 . . . . 0.0 111.186 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 -21.04 35.42 Favored Glycine 1 N--CA 1.517 4.063 0 CA-C-N 109.587 -3.461 . . . . 0.0 112.778 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.626 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.333 23.7 m -68.25 62.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 173.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 mm -51.11 112.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 124.308 2.004 . . . . 0.0 116.382 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' CG2' ' HE2' ' A' ' 69' ' ' PHE . 30.2 m -103.56 167.82 2.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 110.106 -3.225 . . . . 0.0 104.394 175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 -171.68 2.3 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 108.852 -3.794 . . . . 0.0 111.958 -174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.3 tpp -92.23 23.76 3.69 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.073 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.03 166.21 16.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.631 ' CD2' ' HA2' ' A' ' 83' ' ' GLY . 8.3 t80 -145.59 154.19 41.89 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.601 ' N ' ' CD2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -116.43 62.1 0.72 Allowed 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.619 HD12 HG12 ' A' ' 82' ' ' VAL . 5.3 tp -44.54 -27.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.07 -24.37 24.9 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.154 -2.294 . . . . 0.0 108.261 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HG3' ' HA ' ' A' ' 48' ' ' ILE 0.269 7.1 ttm-85 -129.38 158.77 38.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 110.375 -3.102 . . . . 0.0 114.434 -168.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 39' ' ' ILE . 3.1 t -103.8 140.86 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -81.34 115.55 20.76 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 80' ' ' PRO . 10.3 mp -113.46 84.79 2.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.518 1.136 . . . . 0.0 112.791 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 36.0 m-85 -74.41 104.77 5.27 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 127.238 3.399 . . . . 0.0 106.361 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 32' ' ' VAL . 21.3 m -99.51 172.17 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.042 1 CA-C-N 107.166 -4.561 . . . . 0.0 105.833 -177.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.6 p-10 -95.43 -142.4 0.26 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 123.793 2.997 . . . . 0.0 113.688 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.2 ttpp -92.02 9.4 33.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.732 -3.395 . . . . 0.0 110.34 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.4 mt -142.71 38.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 111.513 -2.585 . . . . 0.0 110.74 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.69 20.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -176.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.5 m-20 -104.61 142.3 34.9 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.943 1.354 . . . . 0.0 108.845 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 44.7 mt -63.28 113.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 126.518 3.056 . . . . 0.0 112.359 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.488 . . -88.51 -51.34 5.76 Favored 'General case' 0 C--N 1.283 -2.294 2 CA-C-N 103.479 -6.237 . . . . 0.0 107.909 -173.258 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -118.02 157.84 26.06 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 28' ' ' VAL . 94.4 t -63.66 138.64 97.43 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 115.75 -2.38 . . . . 0.0 112.482 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 3.5 Cg_exo -86.63 157.13 9.09 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.58 2.186 . . . . 0.0 108.26 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.44 HH21 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -154.5 150.24 27.59 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.142 -176.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG12 HD12 ' A' ' 63' ' ' ILE 0.278 21.9 t -89.13 105.09 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.729 1.268 . . . . 0.0 107.783 175.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.631 ' HA2' ' CD2' ' A' ' 61' ' ' TYR . . . . . . . . 0 C--N 1.27 -3.121 0 C-N-CA 117.7 -2.191 . . . . 0.0 110.853 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 121.625 0.726 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.07 49.59 2.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.848 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -101.29 17.84 21.54 Favored 'General case' 0 N--CA 1.526 3.354 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -140.15 151.89 45.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 125.105 1.503 . . . . 0.0 114.327 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.565 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 29.4 m-90 -134.53 73.16 68.72 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 123.762 1.744 . . . . 0.0 112.944 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' A' ' 28' ' ' VAL . 13.1 Cg_endo -77.45 -34.77 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.702 1.601 . . . . 0.0 111.576 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -62.35 -18.89 62.61 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 123.402 1.572 . . . . 0.0 109.429 -177.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -97.94 15.31 24.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.528 HG21 HG22 ' A' ' 79' ' ' VAL . 99.2 t -73.53 164.45 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.838 -1.164 . . . . 0.0 108.325 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 2.1 89.75 Favored Glycine 1 N--CA 1.518 4.112 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.809 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.582 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 14.5 mtmm -130.05 168.51 16.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.312 1.045 . . . . 0.0 108.536 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 10.7 p -87.82 160.08 18.16 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 127.835 3.683 . . . . 0.0 114.319 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -45.76 -50.88 3.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 1 CA-C-N 105.277 -5.42 . . . . 0.0 116.141 -172.738 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 8.8 mm-40 -54.99 -42.41 72.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.082 -1.011 . . . . 0.0 112.162 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.98 -46.59 74.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.448 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -51.64 -49.37 62.42 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.116 -1.434 . . . . 0.0 111.336 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 57.5 mtpt -53.04 -50.2 64.78 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 52.5 mttp -50.9 -46.65 60.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.99 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 84.2 t -61.1 -56.9 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-O 124.685 2.183 . . . . 0.0 111.309 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.71 ' CG2' HG21 ' A' ' 66' ' ' VAL . 35.3 mt -54.38 -45.84 69.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.011 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 46' ' ' ALA . 91.7 mt -58.13 -36.51 73.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.728 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 55.9 tt0 -63.55 -39.33 94.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.183 -1.407 . . . . 0.0 110.933 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.41 -45.96 29.31 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.101 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 63.7 tttm -125.18 66.86 53.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -9.83 -57.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 1 C-N-CA 125.466 4.111 . . . . 0.0 121.233 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -82.59 1.49 37.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -57.74 84.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.21 111.01 7.05 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.58 HG12 ' H ' ' A' ' 66' ' ' VAL . 20.2 mt -107.77 152.37 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 50' ' ' VAL . 18.6 mm -124.58 163.06 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 123.752 1.739 . . . . 0.0 114.009 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.457 ' CB ' HG21 ' A' ' 32' ' ' VAL . 7.1 p -106.76 118.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 112.316 -2.22 . . . . 0.0 113.805 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 5.7 mp -128.6 136.58 29.33 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.095 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.79 135.97 20.22 Favored 'Trans proline' 0 N--CA 1.512 2.58 0 C-N-CA 123.017 2.478 . . . . 0.0 109.059 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 72.1 t -43.16 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-N 120.437 1.471 . . . . 0.0 114.894 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.32 -39.82 2.47 Favored Glycine 0 N--CA 1.51 3.581 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.902 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.653 ' HB ' ' CZ ' ' A' ' 69' ' ' PHE . 22.4 m -47.61 168.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.787 1.28 . . . . 0.0 113.803 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.79 118.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.638 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -114.91 -77.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.362 174.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 78.6 9.77 Favored 'General case' 0 C--N 1.283 -2.326 1 N-CA-C 124.172 4.879 . . . . 0.0 124.172 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' A' ' 60' ' ' GLU . 1.9 tpt -98.99 -128.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 1 CA-C-N 107.153 -4.567 . . . . 0.0 104.098 176.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.545 ' CD ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.87 -169.49 2.38 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 172.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.652 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 39.3 t80 -118.04 102.56 9.14 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.72 -1.238 . . . . 0.0 112.311 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 65' ' ' ARG . 2.1 mpt_? -90.83 68.46 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 124.188 1.947 . . . . 0.0 108.739 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.749 HD12 HG11 ' A' ' 82' ' ' VAL . 4.6 tp -42.34 -29.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 112.681 -2.054 . . . . 0.0 116.026 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 2.2 p30 -57.04 -17.43 10.1 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 124.16 1.933 . . . . 0.0 111.448 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 62' ' ' ARG . 21.6 ttp85 -132.14 149.7 52.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.71 HG21 ' CG2' ' A' ' 39' ' ' ILE . 3.3 t -106.73 139.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' CZ ' ' HA ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.15 124.69 44.38 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 67' ' ' ARG . 2.7 mp -109.29 90.39 3.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 125.879 1.987 . . . . 0.0 110.761 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.653 ' CZ ' ' HB ' ' A' ' 55' ' ' THR . 12.8 m-85 -70.99 110.96 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 126.155 2.883 . . . . 0.0 110.475 170.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.9 m -103.25 170.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-N 108.912 -3.767 . . . . 0.0 109.221 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.7 p-10 -93.43 -140.62 0.22 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 124.285 1.993 . . . . 0.0 112.033 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -92.14 6.82 45.15 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 110.545 -3.025 . . . . 0.0 111.21 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 72.1 mt -136.74 32.08 2.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.534 -2.121 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 34.96 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.97 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 45.0 m-20 -108.47 137.94 45.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.4 mt -61.51 111.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 126.431 3.015 . . . . 0.0 112.796 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.475 . . -90.22 -47.01 8.06 Favored 'General case' 0 C--N 1.288 -2.108 2 CA-C-N 103.27 -6.332 . . . . 0.0 108.657 -173.842 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -117.14 157.15 26.42 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 111.556 -2.565 . . . . 0.0 107.765 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.528 HG22 HG21 ' A' ' 28' ' ' VAL . 94.5 t -75.4 141.03 72.89 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 115.122 -2.631 . . . . 0.0 108.74 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.573 ' HG2' HD11 ' A' ' 27' ' ' LEU . 6.5 Cg_exo -84.25 158.68 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.56 2.173 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 156.65 32.49 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.032 -1.461 . . . . 0.0 109.195 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG11 HD12 ' A' ' 63' ' ' ILE . 23.9 t -74.93 144.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.258 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.652 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . . . . . . 0 N--CA 1.509 3.53 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.63 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.178 0 CA-C-O 122.7 1.238 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -100.45 76.9 1.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 123.584 1.659 . . . . 0.0 113.241 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -98.34 1.74 47.34 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.554 ' HB2' ' NH2' ' A' ' 81' ' ' ARG . 0.6 OUTLIER -139.68 155.9 47.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.635 0.731 . . . . 0.0 111.736 172.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.498 ' CG ' HG12 ' A' ' 39' ' ' ILE . 30.1 m-90 -118.87 71.93 10.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -70.71 -30.54 17.72 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.054 1.169 . . . . 0.0 109.501 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -66.06 2.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.916 0.865 . . . . 0.0 109.979 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.521 HD13 ' HB1' ' A' ' 35' ' ' ALA . 31.3 mt -103.97 -8.07 19.9 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.653 -0.654 . . . . 0.0 110.902 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 79' ' ' VAL . 53.2 t -66.51 107.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 123.148 1.452 . . . . 0.0 108.846 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.56 5.04 22.94 Favored Glycine 0 N--CA 1.506 3.306 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.639 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' NZ ' ' CD ' ' A' ' 34' ' ' GLU . 1.5 mmmp? -111.69 167.6 10.22 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.736 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -88.28 173.18 8.92 Favored 'General case' 0 CA--C 1.443 -3.14 0 CA-C-O 123.008 1.385 . . . . 0.0 112.791 177.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.709 ' CG2' HG11 ' A' ' 70' ' ' VAL . 1.4 p -80.98 -55.62 7.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 108.903 -3.771 . . . . 0.0 115.641 -171.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 35.1 mm-40 -62.83 -21.13 65.7 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 122.362 2.346 . . . . 0.0 109.867 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 38.0 tt0 -75.9 -49.07 18.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.521 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -46.33 -52.5 12.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 82.0 tttt -48.05 -46.58 33.49 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 112.768 -2.015 . . . . 0.0 106.645 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 40.4 tttm -55.54 -54.3 45.65 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.487 -1.285 . . . . 0.0 109.891 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 69.1 t -59.02 -47.88 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 CA-C-O 124.291 1.996 . . . . 0.0 111.734 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 66' ' ' VAL . 14.7 mt -56.16 -51.8 58.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 112.764 -2.017 . . . . 0.0 109.21 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -61.93 -37.66 85.53 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 29.5 tp60 -58.92 -24.25 62.22 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.205 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' OD2' ' NE1' ' A' ' 24' ' ' TRP . 49.5 t0 -96.2 -51.53 4.37 Favored 'General case' 0 N--CA 1.523 3.194 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.01 75.28 21.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -9.79 -55.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 2 C-N-CA 126.121 4.547 . . . . 0.0 122.717 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -89.67 -0.29 57.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . . . -42.27 97.75 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.437 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 93.4 mm-40 -87.59 65.21 8.44 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 39' ' ' ILE . 46.6 mt -72.26 127.03 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 121.456 3.873 . . . . 0.0 121.456 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.441 HD13 HH12 ' A' ' 65' ' ' ARG . 1.7 mp -123.14 128.23 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.062 -3.245 . . . . 0.0 106.085 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 51' ' ' LEU . 12.4 p -81.07 158.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 126.411 2.319 . . . . 0.0 113.129 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 HG21 ' A' ' 55' ' ' THR . 0.8 OUTLIER -141.1 151.65 62.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -85.48 131.83 4.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.145 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 70' ' ' VAL . 13.3 t -42.33 133.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 106.75 -31.27 8.39 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 110.273 -3.149 . . . . 0.0 113.487 -178.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.624 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.312 40.2 m -48.62 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.8 1.24 . . . . 0.0 108.186 175.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' GLY . 21.1 mm -53.61 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 125.033 2.349 . . . . 0.0 112.274 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.619 HG21 ' HE2' ' A' ' 69' ' ' PHE . 7.0 m -98.75 -173.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 110.046 -3.252 . . . . 0.0 105.776 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -92.43 144.95 24.85 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 111.68 -2.509 . . . . 0.0 116.231 -174.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.11 40.14 1.06 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.291 1.52 . . . . 0.0 108.388 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 19.4 pt-20 -83.14 -171.97 3.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.589 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -137.47 74.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 123.614 1.673 . . . . 0.0 113.914 178.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' ASP . 15.5 mmt180 -89.69 68.22 7.55 Favored 'General case' 0 C--N 1.294 -1.843 1 N-CA-C 97.865 -4.865 . . . . 0.0 97.865 176.351 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 HG11 ' A' ' 82' ' ' VAL . 6.5 tp -43.85 -1.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' ARG . 3.1 p30 -85.67 -9.11 57.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.492 1.917 . . . . 0.0 108.71 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.441 HH12 HD13 ' A' ' 49' ' ' ILE . 38.9 ttm-85 -128.53 148.76 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 -172.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.723 HG21 HG21 ' A' ' 39' ' ' ILE . 4.2 t -117.27 120.63 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 1 N-CA-C 99.214 -4.365 . . . . 0.0 99.214 170.131 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.595 HH21 ' C ' ' A' ' 83' ' ' GLY . 3.1 tpp85 -79.92 117.14 20.5 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD23 HG23 ' A' ' 32' ' ' VAL . 10.0 mp -107.76 93.06 4.34 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 124.533 1.146 . . . . 0.0 110.633 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.624 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 26.5 m-85 -79.43 102.43 8.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 126.124 2.869 . . . . 0.0 109.93 170.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.709 HG11 ' CG2' ' A' ' 32' ' ' VAL . 2.3 m -108.93 177.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 108.475 -3.966 . . . . 0.0 109.47 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.6 p-10 -101.96 -142.77 0.35 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 124.478 2.085 . . . . 0.0 113.533 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -86.67 -2.09 58.24 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 109.021 -3.718 . . . . 0.0 113.09 -178.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 54.3 mt -135.84 37.95 2.82 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 37.13 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 65.6 m-20 -109.73 149.95 29.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -72.8 121.63 23.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 126.911 3.243 . . . . 0.0 116.983 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.462 . . -106.05 -42.58 5.06 Favored 'General case' 0 C--N 1.295 -1.796 2 CA-C-N 103.671 -6.149 . . . . 0.0 112.559 -173.213 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 27.8 mt-30 -111.46 153.97 25.37 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.524 HG22 ' CG2' ' A' ' 28' ' ' VAL . 62.8 t -75.9 139.89 70.09 Favored Pre-proline 0 N--CA 1.508 2.447 0 C-N-CA 112.547 -3.661 . . . . 0.0 106.893 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 9.7 Cg_exo -78.92 152.12 24.67 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 N-CA-C 106.673 -2.087 . . . . 0.0 106.673 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.554 ' NH2' ' HB2' ' A' ' 23' ' ' GLU . 7.7 ptp180 -160.76 159.31 29.91 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.079 -1.048 . . . . 0.0 112.041 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.55 HG11 HD12 ' A' ' 63' ' ' ILE . 5.4 t -78.24 143.66 12.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 124.265 1.983 . . . . 0.0 111.36 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.595 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C--N 1.296 -1.64 0 CA-C-N 110.014 -3.266 . . . . 0.0 110.215 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -124.9 49.57 1.84 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p -100.87 16.44 25.17 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.599 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.79 153.74 51.5 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 125.253 1.596 . . . . 0.0 110.267 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -128.49 60.44 48.41 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 123.075 1.416 . . . . 0.0 114.714 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -53.47 -35.95 77.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.417 2.078 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -48.05 -31.32 5.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.136 1.446 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.56 HD11 HG13 ' A' ' 39' ' ' ILE . 56.0 mt -79.77 -26.85 40.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.886 -1.961 . . . . 0.0 114.847 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG2' HG22 ' A' ' 79' ' ' VAL . 14.3 t -50.92 137.83 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 117.877 -1.529 . . . . 0.0 107.59 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.23 -13.9 66.54 Favored Glycine 0 N--CA 1.505 3.238 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.305 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -111.34 166.84 10.77 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 117.438 0.619 . . . . 0.0 111.617 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.2 p -90.62 164.32 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 128.273 3.892 . . . . 0.0 115.119 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.69 -31.22 6.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 105.511 -5.313 . . . . 0.0 121.921 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -50.25 13.8 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 123.336 1.541 . . . . 0.0 107.195 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.673 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 2.2 tm-20 -50.67 -52.1 43.09 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 102.75 -3.055 . . . . 0.0 102.75 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.71 -60.16 3.14 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.952 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -48.37 -49.07 36.07 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.673 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 8.9 ttpp -53.1 -53.45 50.12 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.626 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.456 HG23 ' HZ1' ' A' ' 37' ' ' LYS . 90.5 t -60.64 -55.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 CA-C-O 123.432 1.587 . . . . 0.0 111.607 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.779 HG21 HG21 ' A' ' 66' ' ' VAL . 23.0 mt -53.54 -43.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.871 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 46' ' ' ALA . 60.3 mt -64.99 -38.06 89.72 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.387 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -57.79 -48.29 80.14 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.441 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.66 -47.18 73.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.78 -1.555 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HE3' HG11 ' A' ' 82' ' ' VAL . 58.8 tttm -124.74 71.83 60.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 C-N-CA 124.513 1.125 . . . . 0.0 111.617 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -21.58 -50.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 124.35 3.366 . . . . 0.0 118.331 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 0.34 43.19 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -59.87 92.31 0.02 OUTLIER 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' ASP . 19.3 tt0 -75.72 70.4 2.51 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.571 HG12 ' H ' ' A' ' 66' ' ' VAL . 47.5 mt -72.68 141.22 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.852 -2.431 . . . . 0.0 117.135 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.451 ' HB ' ' HD3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -125.91 156.52 35.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 123.075 1.417 . . . . 0.0 108.063 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.85 142.78 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 111.964 -2.38 . . . . 0.0 106.854 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 1.4 mt -137.17 125.29 14.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.59 135.12 35.03 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.049 1.41 . . . . 0.0 108.857 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 70' ' ' VAL . 2.6 t -44.02 123.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.957 0.885 . . . . 0.0 112.742 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.22 -35.58 3.85 Favored Glycine 0 N--CA 1.513 3.803 0 O-C-N 128.075 3.359 . . . . 0.0 113.278 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.701 ' HB ' ' CE1' ' A' ' 69' ' ' PHE . 60.1 m -47.61 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.463 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mm -53.4 97.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 124.437 2.065 . . . . 0.0 112.481 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.564 HG21 ' HE2' ' A' ' 69' ' ' PHE . 14.7 m -97.26 -176.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 110.76 -2.927 . . . . 0.0 105.563 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.33 147.1 24.27 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 112.197 -2.274 . . . . 0.0 115.328 -172.04 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtp -91.55 34.23 0.98 Allowed 'General case' 0 N--CA 1.515 2.788 0 CA-C-O 124.929 2.299 . . . . 0.0 112.315 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.444 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 24.1 pt-20 -83.71 -163.25 0.74 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 109.134 -3.666 . . . . 0.0 115.299 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.65 67.16 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.06 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.444 ' HE ' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.39 66.73 7.54 Favored 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 126.608 3.099 . . . . 0.0 105.865 177.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.582 HD12 HG11 ' A' ' 82' ' ' VAL . 4.9 tp -42.8 -8.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 109.717 -3.401 . . . . 0.0 119.446 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 65' ' ' ARG . 45.8 p30 -80.86 -5.7 57.67 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 119.588 1.086 . . . . 0.0 108.166 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.465 HH21 ' CG ' ' A' ' 64' ' ' ASP 0.26 15.9 ttm-85 -137.45 147.58 45.44 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -174.163 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.779 HG21 HG21 ' A' ' 39' ' ' ILE . 5.2 t -101.33 140.06 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 1 N-CA-C 99.205 -4.369 . . . . 0.0 99.205 173.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.408 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 1.5 tpp180 -89.44 120.11 30.48 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.9 mt -111.33 88.15 2.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 126.066 2.104 . . . . 0.0 114.036 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.701 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 38.2 m-85 -81.76 99.62 9.06 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 127.852 3.691 . . . . 0.0 107.734 170.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 5.7 m -100.19 171.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 1 CA-C-N 106.042 -5.072 . . . . 0.0 106.75 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.4 p-10 -87.72 -141.02 0.11 Allowed 'General case' 0 C--N 1.293 -1.874 0 O-C-N 118.818 -2.426 . . . . 0.0 110.72 -175.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 44.3 mmtm -95.88 8.2 44.25 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 110.256 -3.156 . . . . 0.0 112.683 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.1 mt -137.59 32.46 2.51 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.198 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' HA ' ' CG2' ' A' ' 70' ' ' VAL 0.322 3.9 p-10 31.9 41.71 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 m-80 -113.46 151.47 31.4 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 110.93 -2.85 . . . . 0.0 104.968 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -80.69 117.68 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 125.415 2.531 . . . . 0.0 113.695 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 71' ' ' ASP 0.416 . . -105.37 -38.71 6.4 Favored 'General case' 0 C--N 1.298 -1.644 2 CA-C-N 104.062 -5.972 . . . . 0.0 114.344 -174.049 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 155.87 27.23 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.533 HG22 ' CG2' ' A' ' 28' ' ' VAL . 67.2 t -75.46 147.72 82.45 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 113.628 -3.229 . . . . 0.0 109.155 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HG2' HD12 ' A' ' 27' ' ' LEU . 25.4 Cg_exo -73.05 139.35 29.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.24 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.377 -1.329 . . . . 0.0 110.281 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 63' ' ' ILE . 14.9 t -82.09 134.09 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 117.374 -1.731 . . . . 0.0 114.522 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.494 2.505 0 C-N-CA 118.957 -1.592 . . . . 0.0 113.968 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.803 0 CA-C-O 122.413 1.101 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HE3' ' NE1' ' A' ' 24' ' ' TRP . 4.4 tmtm? -116.16 72.93 0.83 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 68.1 p -120.95 20.02 11.62 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 109.066 -3.697 . . . . 0.0 111.028 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.566 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -153.11 159.38 42.76 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 126.327 1.851 . . . . 0.0 113.33 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.62 ' NE1' ' HE3' ' A' ' 21' ' ' LYS . 11.6 m-90 -139.32 64.91 33.45 Favored Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.596 ' HA ' HG21 ' A' ' 79' ' ' VAL . 75.6 Cg_exo -53.85 -40.05 81.92 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.407 2.738 . . . . 0.0 111.184 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 14.6 mp0 -50.5 -27.88 7.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 123.767 1.746 . . . . 0.0 109.671 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CD1' HG13 ' A' ' 39' ' ' ILE . 29.4 mt -79.46 -24.09 42.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 116.542 -1.694 . . . . 0.0 113.514 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.742 HG23 ' CG2' ' A' ' 79' ' ' VAL . 95.7 t -47.97 136.72 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -17.49 55.16 Favored Glycine 0 N--CA 1.51 3.591 0 C-N-CA 119.371 -1.395 . . . . 0.0 112.487 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -113.73 161.76 17.12 Favored 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.759 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.5 p -86.55 153.82 21.54 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 126.548 3.07 . . . . 0.0 115.102 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.298 4.3 p -38.9 -56.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 1 CA-C-N 107.128 -4.578 . . . . 0.0 117.446 -174.131 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.39 -23.8 65.61 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 120.508 1.504 . . . . 0.0 113.833 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -77.46 -48.94 15.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.46 -44.13 62.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' CG ' HD12 ' A' ' 40' ' ' LEU . 36.7 ttmt -54.53 -47.2 73.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.084 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -54.13 -48.81 70.38 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 124.901 1.376 . . . . 0.0 110.758 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.3 t -64.99 -48.0 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 124.133 1.92 . . . . 0.0 112.029 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.78 HG21 HG21 ' A' ' 66' ' ' VAL . 31.4 mt -55.89 -55.39 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.961 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD12 ' CG ' ' A' ' 36' ' ' LYS . 3.8 mt -64.74 -22.86 67.08 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.131 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 17.5 tp60 -66.46 -29.04 69.08 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.742 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -97.02 -53.47 3.49 Favored 'General case' 0 N--CA 1.517 2.914 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 20.0 tptp -118.75 72.15 10.79 Favored Pre-proline 0 N--CA 1.506 2.342 0 O-C-N 120.168 -1.583 . . . . 0.0 112.04 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -20.03 -50.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 124.684 3.589 . . . . 0.0 120.144 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.1 mp0 -63.8 -22.21 66.8 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.49 84.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 120.084 3.364 . . . . 0.0 120.084 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -75.33 74.59 2.43 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.521 HD11 HG21 ' A' ' 39' ' ' ILE . 23.9 mt -76.47 121.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 50' ' ' VAL . 3.9 mp -119.29 163.05 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 173.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.6 p -85.01 130.2 36.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 111.153 -2.748 . . . . 0.0 106.982 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.688 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -129.12 102.02 19.15 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.58 118.39 5.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 120.912 1.075 . . . . 0.0 113.686 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 69' ' ' PHE . 2.4 t -38.81 134.3 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 118.186 2.662 . . . . 0.0 118.186 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 113.61 -37.28 3.66 Favored Glycine 0 N--CA 1.506 3.362 1 CA-C-N 108.232 -4.076 . . . . 0.0 107.13 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' VAL 0.297 80.7 m -56.07 69.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.91 1.684 . . . . 0.0 108.235 174.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' GLY . 11.5 mm -62.63 116.76 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.445 1.593 . . . . 0.0 109.832 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.469 HG21 ' HD3' ' A' ' 67' ' ' ARG . 18.4 m -98.67 -168.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 111.325 -2.671 . . . . 0.0 112.428 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.17 150.37 24.0 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 117.824 2.528 . . . . 0.0 117.824 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.7 mmm -91.71 47.61 1.38 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 123.044 1.402 . . . . 0.0 107.336 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' CD ' ' HB2' ' A' ' 62' ' ' ARG . 13.0 pt-20 -81.16 -179.55 7.4 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.488 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.559 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 1.1 t80 -127.57 41.91 3.42 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 125.479 2.561 . . . . 0.0 107.817 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 64' ' ' ASP . 3.6 mpt_? -88.43 77.42 8.1 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.744 ' HA ' HG12 ' A' ' 82' ' ' VAL . 8.7 tp -67.23 22.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.747 1 CA-C-N 107.835 -4.257 . . . . 0.0 116.931 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 62' ' ' ARG . 2.3 p-10 -95.93 -11.82 26.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 110.195 -3.184 . . . . 0.0 108.971 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 6.3 mtm180 -129.46 88.1 2.64 Favored 'General case' 0 N--CA 1.503 2.194 1 N-CA-C 128.496 6.48 . . . . 0.0 128.496 -173.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.78 HG21 HG21 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.83 83.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 121.898 2.135 . . . . 0.0 107.072 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' HD3' HG21 ' A' ' 57' ' ' VAL . 2.2 ptp180 -59.32 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 111.23 -2.714 . . . . 0.0 111.088 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 80' ' ' PRO . 53.9 mt -73.99 100.17 3.49 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 116.993 -1.883 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.7 m-85 -74.63 98.86 3.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 127.624 3.583 . . . . 0.0 107.268 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.1 m -100.9 165.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 1 CA-C-N 107.267 -4.515 . . . . 0.0 107.21 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.9 p-10 -89.91 -140.61 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 115.935 -2.306 . . . . 0.0 107.973 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 11.3 mptt -95.78 8.98 42.01 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 111.12 -2.763 . . . . 0.0 113.906 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 31.1 mt -137.6 39.32 2.42 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 112.242 -2.254 . . . . 0.0 107.164 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 33.91 28.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 118.86 2.911 . . . . 0.0 118.86 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.0 m-20 -104.76 148.59 26.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.443 HG21 HG23 ' A' ' 79' ' ' VAL . 23.0 mt -74.93 120.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 126.446 3.022 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.48 . . -104.54 -52.81 2.82 Favored 'General case' 0 C--N 1.285 -2.227 2 CA-C-N 102.468 -6.697 . . . . 0.0 107.794 -173.592 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 69' ' ' PHE . 6.3 mp0 -119.98 84.91 2.29 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.761 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.742 ' CG2' HG23 ' A' ' 28' ' ' VAL . 1.2 t -42.2 147.71 0.55 Allowed Pre-proline 0 N--CA 1.503 2.18 0 C-N-CA 117.079 -1.848 . . . . 0.0 115.69 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -89.19 -170.79 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.473 3.449 . . . . 0.0 119.51 -175.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.532 HH11 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -156.46 136.35 12.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.961 -3.291 . . . . 0.0 105.556 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 63' ' ' ILE . 96.7 t -53.65 -63.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 125.888 2.756 . . . . 0.0 109.67 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.532 ' C ' HH11 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.291 -1.919 1 CA-C-N 107.705 -4.316 . . . . 0.0 105.459 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.003 0 CA-C-O 123.049 1.405 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 7.4 tmtm? -102.16 70.56 1.2 Allowed 'General case' 0 C--N 1.305 -1.368 1 N-CA-C 99.302 -4.332 . . . . 0.0 99.302 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -98.78 13.29 32.87 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.214 -2.721 . . . . 0.0 111.839 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.4 146.56 40.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 126.27 2.231 . . . . 0.0 113.625 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.603 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 19.6 m-90 -131.16 64.7 74.51 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -60.08 -33.96 94.89 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.951 2.434 . . . . 0.0 111.234 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.05 -12.1 3.09 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.201 1.477 . . . . 0.0 109.336 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.603 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 17.9 mt -99.31 2.86 45.8 Favored 'General case' 0 CA--C 1.56 1.36 0 O-C-N 121.123 -0.986 . . . . 0.0 112.365 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG2' HG22 ' A' ' 79' ' ' VAL . 88.6 t -73.4 127.07 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-N 120.652 1.569 . . . . 0.0 107.068 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.6 4.04 57.18 Favored Glycine 0 N--CA 1.505 3.298 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -117.63 160.83 20.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -89.6 153.21 20.93 Favored 'General case' 0 CA--C 1.474 -1.967 0 CA-C-O 125.989 2.804 . . . . 0.0 114.696 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.576 ' HB ' HG11 ' A' ' 70' ' ' VAL 0.318 11.6 p -42.37 -62.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.415 1 CA-C-N 107.533 -4.394 . . . . 0.0 118.215 -172.265 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.23 -18.51 63.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.514 -1.674 . . . . 0.0 111.356 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 36.7 tt0 -76.61 -45.75 28.88 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.501 ' CA ' HD13 ' A' ' 27' ' ' LEU . . . -54.38 -55.64 26.58 Favored 'General case' 0 C--O 1.205 -1.251 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -48.5 -49.6 35.17 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.717 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 3.2 ttpp -52.94 -44.29 66.96 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.555 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' N ' ' HZ2' ' A' ' 37' ' ' LYS . 78.4 t -70.66 -47.08 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 CA-C-O 122.156 0.979 . . . . 0.0 112.252 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.712 HG21 HG21 ' A' ' 66' ' ' VAL . 40.5 mt -48.24 -48.27 13.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 122.932 1.348 . . . . 0.0 109.691 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 46' ' ' ALA . 31.1 mt -59.91 -22.27 62.18 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.364 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -16.16 57.31 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.451 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.39 -52.54 3.93 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.749 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mmmp? -119.08 77.99 16.76 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -19.06 -56.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.503 4.135 . . . . 0.0 120.728 -177.49 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.48 8.27 19.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.494 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -52.83 87.05 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.24 70.71 3.67 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.527 HD11 ' CG2' ' A' ' 39' ' ' ILE . 62.1 mt -74.3 148.04 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 112.383 -2.19 . . . . 0.0 116.794 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.11 152.76 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.969 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 32' ' ' VAL . 3.5 p -93.6 122.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 112.84 -1.982 . . . . 0.0 113.404 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.618 HD23 HG21 ' A' ' 55' ' ' THR . 1.4 mp -136.77 141.58 35.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.5 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -80.38 139.54 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.369 1.38 . . . . 0.0 108.769 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 69' ' ' PHE . 41.7 t -43.81 127.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.98 -34.82 4.67 Favored Glycine 1 N--CA 1.523 4.448 0 CA-C-N 111.179 -2.737 . . . . 0.0 115.613 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.618 HG21 HD23 ' A' ' 51' ' ' LEU 0.253 50.2 m -45.03 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.981 1.312 . . . . 0.0 112.695 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.45 106.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 CA-C-O 122.58 1.181 . . . . 0.0 111.545 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.617 HG21 ' HE2' ' A' ' 69' ' ' PHE . 1.7 m -111.38 -106.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 85.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 1 N-CA-C 123.297 4.554 . . . . 0.0 123.297 -173.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 18.5 mmm -95.11 -47.57 6.32 Favored 'General case' 0 N--CA 1.501 2.116 1 CA-C-N 106.874 -4.694 . . . . 0.0 105.426 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' HB2' HH21 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -82.94 -175.9 6.06 Favored 'General case' 0 C--N 1.284 -2.279 3 CA-C-N 103.161 -6.381 . . . . 0.0 112.062 179.385 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.535 ' CE2' HD13 ' A' ' 63' ' ' ILE . 20.8 t80 -157.97 85.66 0.89 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.586 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.542 HH21 ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -100.84 81.76 2.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 175.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.668 HD12 HG11 ' A' ' 82' ' ' VAL 0.262 6.0 tp -42.54 -6.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.136 1 CA-C-N 108.341 -4.027 . . . . 0.0 117.007 177.711 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.1 p30 -93.88 7.27 45.6 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.228 1.011 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.572 ' HD2' ' CZ ' ' A' ' 67' ' ' ARG . 20.0 ttp180 -129.78 140.38 51.06 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 39' ' ' ILE . 9.6 t -111.52 150.68 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 122.918 2.599 . . . . 0.0 106.073 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.77 112.77 24.48 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.326 -177.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.58 85.14 2.4 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.343 1.652 . . . . 0.0 109.458 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.617 ' HE2' HG21 ' A' ' 57' ' ' VAL . 29.6 m-85 -83.54 97.42 9.02 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 127.335 3.445 . . . . 0.0 109.965 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.576 HG11 ' HB ' ' A' ' 32' ' ' VAL . 4.4 m -104.24 174.09 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 1 CA-C-N 105.746 -5.206 . . . . 0.0 109.392 -175.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.6 p-10 -99.74 -148.77 0.35 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 124.163 1.935 . . . . 0.0 109.28 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.33 17.17 14.95 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 111.26 -2.7 . . . . 0.0 113.641 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -133.8 26.16 3.99 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 111.222 -2.717 . . . . 0.0 103.715 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.28 0.0 OUTLIER 33.36 35.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.61 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.7 m-20 -113.42 154.91 26.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.6 mt -78.21 119.85 27.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 126.483 3.039 . . . . 0.0 115.423 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.474 . . -98.51 -45.61 6.04 Favored 'General case' 0 C--N 1.293 -1.874 2 CA-C-N 103.662 -6.154 . . . . 0.0 111.696 -173.668 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -117.72 160.66 20.96 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.549 HG22 ' CG2' ' A' ' 28' ' ' VAL . 89.4 t -71.68 146.56 91.2 Favored Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 114.052 -3.059 . . . . 0.0 110.282 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 8.1 Cg_exo -79.13 159.28 26.79 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.331 2.021 . . . . 0.0 109.6 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 79' ' ' VAL . 8.7 ptp85 -160.38 162.11 33.27 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 117.376 -1.297 . . . . 0.0 113.659 -176.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 63' ' ' ILE . 2.9 t -84.55 150.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.197 0 C-N-CA 126.6 2.048 . . . . 0.0 114.427 176.239 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 122.473 1.13 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -119.36 60.75 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -100.0 19.59 15.97 Favored 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 112.079 -2.328 . . . . 0.0 112.292 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -142.63 151.41 41.43 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.204 176.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.578 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 30.5 m-90 -127.84 75.37 78.19 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.616 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.2 -18.02 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.352 2.035 . . . . 0.0 111.071 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -77.58 -28.68 51.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 2.0 pp -92.27 23.48 3.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.391 1.091 . . . . 0.0 113.918 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 79' ' ' VAL . 55.7 t -72.53 167.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.83 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.01 36.58 20.94 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-O 123.209 1.449 . . . . 0.0 112.799 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 50.2 mttp -138.1 174.58 10.41 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 112.203 -1.999 . . . . 0.0 110.534 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 p -85.51 159.85 19.82 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 125.321 2.486 . . . . 0.0 114.331 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG2' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -64.25 -32.35 57.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 1 CA-C-N 108.324 -4.035 . . . . 0.0 109.719 -175.739 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 44.5 mm-40 -63.81 -46.41 85.24 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.024 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.36 -54.93 41.47 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 126.327 2.267 . . . . 0.0 105.079 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -45.69 -54.85 7.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.354 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.5 mtpt -49.43 -56.44 9.69 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -54.45 -48.43 71.75 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.05 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 94.2 t -57.71 -56.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 CA-C-O 124.787 2.232 . . . . 0.0 110.646 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.772 HG21 HG21 ' A' ' 66' ' ' VAL . 37.9 mt -55.32 -45.68 77.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.57 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 26.1 mt -56.49 -38.72 72.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 8.7 tt0 -59.0 -44.77 91.71 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.816 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.04 -47.74 60.81 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.782 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 63.6 tttm -125.23 74.84 67.98 Favored Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -7.77 -65.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 1 C-N-CA 125.487 4.125 . . . . 0.0 120.139 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.575 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -88.34 7.12 33.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 -177.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.517 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -43.95 103.23 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -85.24 83.47 7.98 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.586 HD11 ' CG2' ' A' ' 39' ' ' ILE . 68.5 mt -80.31 135.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 111.581 -2.554 . . . . 0.0 115.809 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 48' ' ' ILE . 1.8 mp -125.95 137.68 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 111.956 -2.384 . . . . 0.0 111.522 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.481 ' C ' HD12 ' A' ' 51' ' ' LEU . 12.1 p -95.81 145.51 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 5.5 mp -141.12 149.62 56.1 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -81.55 135.38 9.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 N-CA-C 105.474 -2.548 . . . . 0.0 105.474 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 69' ' ' PHE . 87.4 t -42.91 130.48 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.31 -41.1 2.11 Favored Glycine 1 N--CA 1.519 4.214 0 CA-C-N 111.528 -2.578 . . . . 0.0 112.977 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.636 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.258 11.4 m -50.02 165.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 125.279 1.432 . . . . 0.0 111.338 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mm -61.14 136.05 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.68 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -123.69 -77.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.015 176.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 83.73 6.41 Favored 'General case' 0 C--N 1.295 -1.78 1 N-CA-C 122.698 4.333 . . . . 0.0 122.698 -179.115 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 tpt -97.44 -137.11 0.27 Allowed 'General case' 0 C--N 1.29 -2.003 1 CA-C-N 107.769 -4.287 . . . . 0.0 103.273 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 60' ' ' GLU 0.277 0.1 OUTLIER -78.4 -174.07 3.6 Favored 'General case' 0 C--N 1.288 -2.105 1 N-CA-C 98.843 -4.503 . . . . 0.0 98.843 170.168 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 7.9 t80 -120.33 135.85 54.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.015 -2.303 . . . . 0.0 117.059 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -115.56 64.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 124.074 1.892 . . . . 0.0 106.844 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.638 HD12 HG11 ' A' ' 82' ' ' VAL . 5.8 tp -42.83 -7.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.8 p30 -81.66 -9.83 59.56 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 124.207 1.003 . . . . 0.0 110.035 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -129.07 149.3 50.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 120.562 3.541 . . . . 0.0 120.562 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.772 HG21 HG21 ' A' ' 39' ' ' ILE . 5.0 t -110.18 132.21 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 101.962 -3.347 . . . . 0.0 101.962 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.64 ' NH1' ' HA ' ' A' ' 57' ' ' VAL . 16.8 tpp85 -89.83 116.21 27.74 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.779 -2.01 . . . . 0.0 108.098 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 80' ' ' PRO . 7.6 mp -107.92 90.97 3.46 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 124.816 1.323 . . . . 0.0 113.996 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 57' ' ' VAL . 22.5 m-85 -76.34 103.52 6.4 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 125.588 2.613 . . . . 0.0 112.153 169.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 4.5 m -109.77 171.78 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-N 109.077 -3.692 . . . . 0.0 109.074 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -93.62 -140.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.494 -2.004 . . . . 0.0 111.818 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.4 mmtm -88.51 0.91 55.81 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 110.911 -2.859 . . . . 0.0 112.303 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 38.5 mt -136.97 39.52 2.55 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 111.62 -2.537 . . . . 0.0 109.846 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.57 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -178.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 53.7 m-20 -105.27 142.31 35.27 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.532 HD13 ' HG2' ' A' ' 80' ' ' PRO . 79.9 mt -67.18 116.98 7.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 126.69 3.138 . . . . 0.0 114.561 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 53' ' ' VAL 0.468 . . -102.82 -40.61 6.49 Favored 'General case' 0 C--N 1.289 -2.057 1 CA-C-N 104.414 -5.812 . . . . 0.0 111.815 -172.198 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.2 163.72 15.87 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 102.266 -3.235 . . . . 0.0 102.266 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 28' ' ' VAL . 78.1 t -77.3 141.22 66.06 Favored Pre-proline 0 N--CA 1.499 1.998 0 C-N-CA 114.092 -3.043 . . . . 0.0 110.235 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.532 ' HG2' HD13 ' A' ' 76' ' ' ILE . 14.6 Cg_exo -80.84 145.49 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.544 2.829 . . . . 0.0 106.464 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -153.28 168.45 25.98 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.502 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.638 HG11 HD12 ' A' ' 63' ' ' ILE . 25.0 t -82.64 154.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 116.731 -1.987 . . . . 0.0 113.105 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.561 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.511 3.636 0 C-N-CA 125.937 1.732 . . . . 0.0 114.01 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.944 0 CA-C-O 121.453 0.644 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' CG ' ' A' ' 42' ' ' ASP . 37.3 mtpt -118.68 152.3 36.36 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.517 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 45.6 p -128.94 19.26 6.04 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.331 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -156.88 150.58 24.57 Favored 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.731 178.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CE3' ' C ' ' A' ' 23' ' ' GLU . 20.3 m-90 -133.77 59.89 42.39 Favored Pre-proline 0 N--CA 1.516 2.83 0 N-CA-C 121.118 3.747 . . . . 0.0 121.118 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' N ' HG13 ' A' ' 79' ' ' VAL . 52.8 Cg_exo -48.98 -40.3 40.58 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 124.098 3.198 . . . . 0.0 110.983 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 4.8 mp0 -46.38 -30.41 2.11 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.621 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 32.6 mt -79.65 -27.37 40.88 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.775 ' CG2' HG22 ' A' ' 79' ' ' VAL . 30.8 t -48.05 137.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.85 -4.12 71.79 Favored Glycine 0 N--CA 1.508 3.446 0 CA-C-N 114.566 -1.197 . . . . 0.0 113.255 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 32.4 mtmm -114.27 178.42 4.29 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.504 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.7 p -85.71 171.56 11.53 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 127.518 3.533 . . . . 0.0 116.867 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.1 p -72.15 -18.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 1 CA-C-N 104.863 -5.608 . . . . 0.0 112.752 -176.195 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -85.42 -49.09 8.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 24.4 mt-10 -50.06 -52.78 31.73 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' CB ' HD13 ' A' ' 27' ' ' LEU . . . -50.91 -44.21 60.0 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.406 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' ILE . 61.1 mttm -62.05 -49.14 77.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.082 1.765 . . . . 0.0 108.24 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -54.97 -52.76 62.04 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.976 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 84.9 t -61.8 -54.99 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.239 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.662 ' CG2' HG21 ' A' ' 66' ' ' VAL . 32.2 mt -55.34 -51.0 60.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.095 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' PRO . 96.9 mt -57.37 -33.28 67.64 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 24.1 mt-30 -59.81 -43.76 94.35 Favored 'General case' 0 N--CA 1.516 2.871 0 C-N-CA 117.432 -1.707 . . . . 0.0 110.137 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' CG ' ' NZ ' ' A' ' 21' ' ' LYS . 52.0 m-20 -72.63 -53.06 12.86 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 82' ' ' VAL . 26.3 tptp -121.43 57.17 6.79 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 112.347 -2.206 . . . . 0.0 108.389 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 12.5 Cg_exo -12.48 -65.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 125.198 3.932 . . . . 0.0 120.414 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.74 24.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -71.22 124.67 25.01 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-O 122.442 1.115 . . . . 0.0 111.203 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -91.71 67.9 5.46 Favored 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.543 HG12 ' HB ' ' A' ' 66' ' ' VAL . 20.6 mt -72.37 134.4 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 119.359 3.096 . . . . 0.0 119.359 -173.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 50' ' ' VAL . 40.5 mm -103.53 175.22 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 113.385 -1.734 . . . . 0.0 111.569 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.6 p -106.4 118.19 53.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 126.516 1.926 . . . . 0.0 111.516 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.786 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 16.7 mt -136.29 119.41 12.21 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.399 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 27.3 Cg_exo -70.45 138.44 35.62 Favored 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 123.51 2.807 . . . . 0.0 110.465 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.459 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 32.7 t -42.28 131.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.45 99.07 1.92 Allowed Glycine 0 N--CA 1.509 3.555 2 N-CA-C 96.215 -6.754 . . . . 0.0 96.215 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.717 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -68.24 116.2 8.57 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -171.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -83.14 -0.24 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 126.036 2.827 . . . . 0.0 111.036 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' CG2' ' HE2' ' A' ' 69' ' ' PHE . 24.9 m -110.62 -173.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 108.592 -3.913 . . . . 0.0 111.61 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.489 ' OG1' ' NH1' ' A' ' 62' ' ' ARG . 2.8 p -87.09 -178.53 6.28 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.9 tpt -91.03 -38.08 13.03 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 125.961 2.791 . . . . 0.0 115.345 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 9.5 pt-20 -49.82 -160.68 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.34 1 CA-C-N 105.061 -5.518 . . . . 0.0 117.24 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.824 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 57.8 t80 -114.76 70.84 0.74 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.695 1.247 . . . . 0.0 113.376 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.655 ' H ' ' CD ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -88.22 66.13 8.34 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 126.718 3.152 . . . . 0.0 109.602 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.824 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.23 -31.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 2 N-CA-C 125.652 5.427 . . . . 0.0 125.652 -179.079 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' CG ' HH22 ' A' ' 65' ' ' ARG . 6.4 p-10 -55.09 -18.11 5.03 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 123.458 1.599 . . . . 0.0 108.058 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.738 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 14.8 ttp-105 -135.45 104.37 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 82' ' ' VAL . 18.4 t -62.04 136.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 123.495 2.861 . . . . 0.0 104.193 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.771 ' CZ ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -96.57 134.89 39.22 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.038 -1.865 . . . . 0.0 112.577 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.771 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 80.5 mt -114.96 81.3 1.54 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.855 -1.975 . . . . 0.0 111.432 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.786 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 9.4 m-85 -73.7 102.93 4.1 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 126.713 3.149 . . . . 0.0 105.26 167.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -100.75 167.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 1 CA-C-N 107.481 -4.418 . . . . 0.0 106.301 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.5 p-10 -91.39 -141.44 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 123.386 2.812 . . . . 0.0 112.424 -177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.547 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 9.9 mptt -91.66 5.22 50.52 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 111.055 -2.793 . . . . 0.0 114.939 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 73' ' ' LEU 0.264 0.5 OUTLIER -138.6 34.52 2.23 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.6 176.893 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.62 48.03 0.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 124.665 2.174 . . . . 0.0 110.005 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 4.1 m-20 -115.0 142.71 46.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.63 119.55 15.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 124.359 2.028 . . . . 0.0 112.846 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.477 . . -103.21 -35.67 8.37 Favored 'General case' 0 C--N 1.297 -1.707 2 CA-C-N 104.687 -5.688 . . . . 0.0 110.726 -174.875 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.53 126.63 53.6 Favored 'General case' 0 N--CA 1.52 3.049 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.12 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.87 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 94.2 t -78.38 -75.83 0.07 OUTLIER Pre-proline 0 N--CA 1.516 2.831 1 N-CA-C 124.997 5.184 . . . . 0.0 124.997 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.87 ' HD3' ' HB ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -66.6 51.3 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.613 2 N-CA-C 133.547 8.249 . . . . 0.0 133.547 -171.795 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.501 HH21 ' C ' ' A' ' 83' ' ' GLY 0.262 0.0 OUTLIER -170.69 120.65 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 2 N-CA-C 131.144 7.461 . . . . 0.0 131.144 172.956 . . . . . . . . 5 4 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.666 ' HA ' HG22 ' A' ' 66' ' ' VAL . 4.4 t -51.26 -23.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 111.939 -2.391 . . . . 0.0 113.853 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.501 ' C ' HH21 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.28 -2.569 0 O-C-N 128.786 3.804 . . . . 0.0 103.605 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 120.186 0.041 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 42.5 tptt -131.42 58.57 1.72 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.659 0.742 . . . . 0.0 109.341 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -112.37 24.53 12.44 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-O 122.733 1.254 . . . . 0.0 110.601 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -136.77 146.03 45.27 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 112.729 -2.032 . . . . 0.0 108.999 175.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.585 ' CZ3' HG23 ' A' ' 82' ' ' VAL . 15.6 m-90 -129.95 62.78 65.77 Favored Pre-proline 0 N--CA 1.522 3.156 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.624 ' HA ' HG21 ' A' ' 79' ' ' VAL . 77.9 Cg_exo -53.68 -38.92 84.88 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.978 3.118 . . . . 0.0 111.586 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 30.4 mp0 -49.58 -28.65 5.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.919 1.343 . . . . 0.0 110.333 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' A' ' 35' ' ' ALA . 74.4 mt -79.92 -19.99 46.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.671 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.677 HG23 ' CG2' ' A' ' 79' ' ' VAL . 59.9 t -49.73 137.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 121.625 2.011 . . . . 0.0 107.831 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.65 -9.03 66.36 Favored Glycine 0 N--CA 1.515 3.922 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.27 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 35.0 mmtm -106.45 166.92 10.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.404 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -88.46 165.81 14.64 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 126.679 3.133 . . . . 0.0 116.533 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 68' ' ' LEU 0.255 0.3 OUTLIER -60.84 -50.51 80.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 1 CA-C-N 107.174 -4.557 . . . . 0.0 116.569 -174.241 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 41.1 mm-40 -68.17 -37.55 81.11 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.572 -1.651 . . . . 0.0 111.127 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -58.98 -51.09 71.58 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.406 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -49.82 -59.08 4.17 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.293 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 48' ' ' ILE 0.303 21.7 tttm -44.55 -53.78 6.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.311 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 54.5 mttp -53.47 -53.93 44.3 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.6 -2.091 . . . . 0.0 111.072 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.6 t -59.53 -52.3 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 123.941 1.829 . . . . 0.0 113.193 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 66' ' ' VAL . 15.8 mt -54.17 -50.94 51.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.101 -2.318 . . . . 0.0 107.864 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.64 -14.12 56.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 124.294 0.996 . . . . 0.0 112.675 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 2.6 tm0? -80.27 -21.13 43.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -97.0 -52.12 3.98 Favored 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 82' ' ' VAL . 10.7 tptp -118.35 72.94 10.19 Favored Pre-proline 0 N--CA 1.514 2.754 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -9.76 -51.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 1 C-N-CA 125.421 4.081 . . . . 0.0 120.495 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.4 mp0 -71.89 -23.28 61.47 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.27 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.479 1.133 . . . . 0.0 113.713 -177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' GLU . 8.2 tp60 -87.57 71.3 9.77 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -175.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 39' ' ' ILE . 56.0 mt -74.03 142.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.35 160.92 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 1 CA-C-N 107.687 -4.324 . . . . 0.0 110.053 -179.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.04 119.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 112.254 -2.248 . . . . 0.0 106.83 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.538 HD13 ' CZ ' ' A' ' 69' ' ' PHE . 1.5 mt -135.2 121.24 14.3 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 117.249 2.314 . . . . 0.0 117.249 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 32.5 Cg_exo -64.66 127.84 19.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 N-CA-C 108.438 -1.408 . . . . 0.0 108.438 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 69' ' ' PHE . 5.2 p -57.77 139.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 123.876 1.798 . . . . 0.0 113.58 177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.19 -15.55 27.86 Favored Glycine 1 N--CA 1.521 4.309 0 CA-C-N 110.747 -2.933 . . . . 0.0 113.049 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.304 17.6 m -45.56 139.28 3.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.0 mm -80.54 82.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 CA-C-N 123.156 2.707 . . . . 0.0 111.773 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.675 HG21 ' CE2' ' A' ' 69' ' ' PHE . 1.5 m -127.27 156.56 38.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.986 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.57 178.05 5.73 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 109.275 -3.602 . . . . 0.0 115.049 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.584 ' SD ' ' CD ' ' A' ' 81' ' ' ARG . 1.2 tpt -89.41 67.13 7.63 Favored 'General case' 0 N--CA 1.494 1.741 1 N-CA-C 96.432 -5.396 . . . . 0.0 96.432 173.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' CD ' ' NH1' ' A' ' 62' ' ' ARG . 10.3 pt-20 -78.44 154.24 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' HE1' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -111.83 50.81 0.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.956 1.836 . . . . 0.0 111.783 -176.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NH1' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mpt_? -90.88 72.76 6.54 Favored 'General case' 0 N--CA 1.491 1.595 1 N-CA-C 94.973 -5.936 . . . . 0.0 94.973 175.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' HA ' HG12 ' A' ' 82' ' ' VAL . 6.6 tp -40.87 -4.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' NH2' ' A' ' 65' ' ' ARG . 3.9 p-10 -99.3 2.86 45.84 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HG3' ' H ' ' A' ' 67' ' ' ARG . 8.7 tpp180 -123.95 95.51 4.59 Favored 'General case' 0 N--CA 1.498 1.969 1 N-CA-C 124.97 5.174 . . . . 0.0 124.97 -170.304 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -89.2 52.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 115.264 -2.574 . . . . 0.0 105.62 177.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.496 HH11 ' CD ' ' A' ' 60' ' ' GLU . 9.9 ptm180 -48.0 116.46 1.52 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 123.714 1.721 . . . . 0.0 111.703 -174.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' CD2' ' HG2' ' A' ' 80' ' ' PRO . 67.3 mt -82.15 93.08 6.98 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 109.341 -3.572 . . . . 0.0 115.668 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 57' ' ' VAL . 37.0 m-85 -74.39 96.06 2.81 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 126.811 3.196 . . . . 0.0 108.45 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 18.1 m -106.82 174.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.304 1 CA-C-N 106.937 -4.665 . . . . 0.0 110.422 -174.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.5 p-10 -95.95 -141.55 0.27 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 124.919 2.295 . . . . 0.0 112.769 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 58.6 mttp -83.98 -8.11 59.24 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 108.971 -3.741 . . . . 0.0 113.457 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.287 0.5 OUTLIER -137.41 48.13 2.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 124.924 2.297 . . . . 0.0 109.677 178.73 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.82 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 42.0 m-20 -99.71 142.57 31.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.752 1.263 . . . . 0.0 108.222 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.37 117.7 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 126.389 2.995 . . . . 0.0 115.279 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.459 . . -98.48 -44.27 6.56 Favored 'General case' 0 C--N 1.283 -2.306 2 CA-C-N 103.905 -6.043 . . . . 0.0 109.86 -172.273 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -117.43 118.88 33.43 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 101.073 -3.677 . . . . 0.0 101.073 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.677 ' CG2' HG23 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -73.1 137.65 79.03 Favored Pre-proline 0 N--CA 1.501 2.106 1 C-N-CA 110.947 -4.301 . . . . 0.0 109.818 -178.455 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HG2' ' CD2' ' A' ' 68' ' ' LEU . 5.8 Cg_exo -82.16 169.75 14.13 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 123.901 3.067 . . . . 0.0 113.836 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.584 ' CD ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -145.87 154.18 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.294 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.592 ' CG2' HG22 ' A' ' 66' ' ' VAL . 70.8 t -71.97 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.734 2 CA-C-N 107.048 -4.615 . . . . 0.0 102.923 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 122.975 1.369 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 31.3 tttp -106.3 136.49 45.94 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.634 -4.21 . . . . 0.0 99.634 178.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 8.3 p -106.42 -6.29 18.33 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 118.264 -1.374 . . . . 0.0 108.386 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' OE2' ' HG3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -130.69 136.01 48.37 Favored 'General case' 0 N--CA 1.523 3.214 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -176.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.721 ' CZ2' HG23 ' A' ' 39' ' ' ILE . 29.6 m-90 -126.45 71.62 72.14 Favored Pre-proline 0 N--CA 1.513 2.71 1 N-CA-C 126.553 5.76 . . . . 0.0 126.553 -176.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' TRP . 70.5 Cg_endo -68.08 -35.41 19.99 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.143 1.229 . . . . 0.0 113.828 176.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 23.0 mp0 -57.61 -37.88 74.02 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 126.344 2.973 . . . . 0.0 114.097 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.568 ' HA ' ' NZ ' ' A' ' 30' ' ' LYS . 4.2 pp -78.57 -16.06 57.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.239 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 79' ' ' VAL . 93.3 t -49.51 157.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.913 0 O-C-N 123.22 0.325 . . . . 0.0 110.554 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.74 -13.76 46.08 Favored Glycine 1 N--CA 1.518 4.151 0 O-C-N 120.347 -1.47 . . . . 0.0 113.901 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.568 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.08 167.88 10.59 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 117.203 -1.379 . . . . 0.0 112.671 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.5 p -86.52 159.62 19.23 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 127.039 3.304 . . . . 0.0 114.747 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.8 p -45.46 -23.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 1 CA-C-N 106.847 -4.706 . . . . 0.0 119.015 -174.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.565 ' CG ' ' H ' ' A' ' 34' ' ' GLU . 14.3 pt-20 -67.2 -58.67 4.41 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.796 0.808 . . . . 0.0 109.293 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.565 ' H ' ' CG ' ' A' ' 33' ' ' GLU . 2.5 tt0 -56.97 -50.43 72.71 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB1' ' CD1' ' A' ' 68' ' ' LEU . . . -47.77 -51.58 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 117.573 -1.651 . . . . 0.0 112.711 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.679 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 17.5 mtpp -58.36 -52.8 64.07 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 4.3 tmtm? -48.6 -41.1 29.77 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.926 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 62.3 t -69.11 -60.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.925 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.721 HG23 ' CZ2' ' A' ' 24' ' ' TRP . 42.9 mt -56.05 -53.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.186 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mp -56.92 -23.74 47.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.419 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 57.3 tp60 -67.65 -33.5 75.07 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.119 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 51.0 m-20 -92.59 -49.49 6.08 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 80.45 32.39 Favored Pre-proline 0 N--CA 1.515 2.82 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -35.19 -31.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.574 0 N-CA-C 120.408 3.195 . . . . 0.0 120.408 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.72 -0.23 57.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.843 0.714 . . . . 0.0 112.289 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.46 99.32 0.14 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.699 1.238 . . . . 0.0 111.738 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.26 113.7 25.97 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.679 ' HB ' ' HG2' ' A' ' 36' ' ' LYS . 21.8 mt -105.47 155.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.406 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 42.4 mm -125.19 169.74 16.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.581 -3.009 . . . . 0.0 105.899 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' CG2' HG21 ' A' ' 70' ' ' VAL . 8.7 p -107.25 142.43 20.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -139.51 122.27 10.37 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 178.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HD2' HD23 ' A' ' 51' ' ' LEU . 55.1 Cg_endo -72.7 129.14 14.15 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.27 1.98 . . . . 0.0 112.319 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 69' ' ' PHE . 6.7 t -42.2 133.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.52 -27.0 19.73 Favored Glycine 0 N--CA 1.512 3.72 0 CA-C-N 109.552 -3.476 . . . . 0.0 112.683 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.45 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.305 51.8 m -60.66 178.38 0.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 126.28 1.832 . . . . 0.0 112.928 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 57' ' ' VAL . 14.1 mt -86.46 154.18 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -140.45 -59.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.972 1 N-CA-C 122.666 4.321 . . . . 0.0 122.666 177.113 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 78.14 6.89 Favored 'General case' 0 C--N 1.288 -2.093 1 N-CA-C 123.098 4.481 . . . . 0.0 123.098 -177.5 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 88.9 mtp -97.13 -144.14 0.29 Allowed 'General case' 0 C--N 1.291 -1.942 1 CA-C-N 104.459 -5.791 . . . . 0.0 104.352 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.3 pm0 -60.5 -142.31 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 O-C-N 124.854 1.346 . . . . 0.0 112.393 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.673 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -100.25 113.46 26.17 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.339 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.635 ' NH2' ' HB2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -105.54 39.66 1.71 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 123.925 1.821 . . . . 0.0 110.056 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.673 ' HB ' ' CE1' ' A' ' 61' ' ' TYR . 8.6 tp -56.37 -25.64 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 110.098 -3.228 . . . . 0.0 117.351 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -70.44 -11.12 60.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 62' ' ' ARG . 23.0 ttp180 -135.06 163.13 30.59 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -176.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 39' ' ' ILE . 16.1 t -117.08 128.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -102.47 110.11 21.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 114.03 -3.068 . . . . 0.0 114.207 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 39' ' ' ILE . 6.1 mt -107.49 104.79 14.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 111.515 -2.584 . . . . 0.0 106.65 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.677 ' HB3' HG22 ' A' ' 53' ' ' VAL . 8.9 m-85 -69.18 122.24 18.4 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.875 -1.93 . . . . 0.0 107.861 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' A' ' 50' ' ' VAL . 8.3 m -102.46 170.97 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 110.642 -2.981 . . . . 0.0 105.948 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -96.45 -135.88 0.24 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 117.144 -1.823 . . . . 0.0 112.129 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -91.34 3.01 55.97 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 110.405 -3.089 . . . . 0.0 112.306 177.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.433 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 73.5 mt -135.78 34.43 2.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.769 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.29 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -178.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -102.98 139.05 39.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 13.1 mt -64.37 115.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.219 0 CA-C-O 126.491 3.043 . . . . 0.0 112.177 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.579 . . -97.98 -39.3 9.02 Favored 'General case' 0 C--N 1.281 -2.394 1 CA-C-N 105.158 -5.474 . . . . 0.0 101.979 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 33.8 mt-30 -115.95 129.24 56.3 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.638 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 98.8 t -44.6 -61.83 1.93 Allowed Pre-proline 0 N--CA 1.514 2.765 1 N-CA-C 125.148 5.24 . . . . 0.0 125.148 177.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.261 0.0 OUTLIER 4.8 -161.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 2 C-N-CA 131.114 7.876 . . . . 0.0 128.61 -168.582 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.466 ' C ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -145.78 175.19 10.59 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -161.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 66' ' ' VAL . 21.6 t -68.22 137.34 24.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 109.099 -3.682 . . . . 0.0 108.416 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.503 3.139 0 CA-C-O 114.911 -3.16 . . . . 0.0 117.92 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 121.99 0.9 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 8.9 mtpm? -99.08 144.5 28.15 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.377 -1.283 . . . . 0.0 107.907 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -107.16 7.25 29.43 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.515 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -142.74 150.72 40.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 126.15 2.156 . . . . 0.0 112.096 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.617 ' CE3' HG11 ' A' ' 66' ' ' VAL . 25.4 m-90 -132.45 79.51 65.12 Favored Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 28' ' ' VAL . 15.9 Cg_endo -77.48 -30.85 3.76 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 120.872 1.048 . . . . 0.0 110.021 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 21' ' ' LYS . 3.0 pm0 -51.8 -20.88 2.42 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 122.501 1.143 . . . . 0.0 113.459 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.1 pp -107.93 16.19 23.7 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 79' ' ' VAL . 22.3 t -70.64 155.92 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-O 122.343 1.068 . . . . 0.0 112.104 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.29 18.05 70.95 Favored Glycine 0 N--CA 1.512 3.735 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.927 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -128.69 167.48 17.17 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 116.843 -1.551 . . . . 0.0 110.278 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -91.01 166.18 13.14 Favored 'General case' 0 CA--C 1.472 -2.045 1 CA-C-O 128.573 4.035 . . . . 0.0 115.508 179.81 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' A' ' 50' ' ' VAL . 1.4 p -53.92 -29.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 1 CA-C-N 103.175 -6.375 . . . . 0.0 115.435 -174.458 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.03 -37.54 23.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.718 -1.239 . . . . 0.0 111.992 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 46.5 mt-10 -61.02 -48.09 83.42 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -47.14 -50.78 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.683 -1.607 . . . . 0.0 112.962 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 58.3 mttp -51.2 -51.46 53.63 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.682 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.3 -47.41 69.25 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.04 -2.345 . . . . 0.0 108.868 -178.394 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 96.2 t -59.16 -57.64 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 CA-C-O 123.555 1.645 . . . . 0.0 111.944 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.563 ' CG2' HG21 ' A' ' 66' ' ' VAL . 14.0 mt -54.98 -46.44 76.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.221 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 96.0 mt -57.18 -33.55 67.59 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 26.2 mt-30 -64.42 -19.6 65.62 Favored 'General case' 0 N--CA 1.519 3.023 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.457 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -96.07 -58.59 2.05 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.24 1.416 . . . . 0.0 110.457 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -121.94 67.8 24.24 Favored Pre-proline 0 N--CA 1.499 1.997 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.328 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.96 -45.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 125.107 3.872 . . . . 0.0 120.271 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -81.14 -5.26 57.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.64 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -76.44 77.74 3.17 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.626 HG12 ' H ' ' A' ' 66' ' ' VAL . 44.2 mt -74.89 133.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.7 mp -117.43 162.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 112.463 -2.153 . . . . 0.0 113.119 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 32' ' ' VAL . 7.7 p -106.02 131.47 55.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 112.913 -1.949 . . . . 0.0 114.488 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 5.1 mp -138.94 155.87 72.81 Favored Pre-proline 0 N--CA 1.508 2.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -81.38 130.49 7.11 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 121.737 1.624 . . . . 0.0 109.794 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 69' ' ' PHE . 93.7 t -40.44 132.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.43 1.97 Allowed Glycine 0 N--CA 1.505 3.265 0 CA-C-N 110.353 -3.112 . . . . 0.0 108.168 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.586 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 43.3 m -47.09 131.35 12.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.871 1.32 . . . . 0.0 109.264 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.693 ' H ' HD12 ' A' ' 56' ' ' ILE . 1.9 mp -52.01 113.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.618 HG13 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -104.1 -70.57 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.32 66.54 4.8 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 127.345 3.45 . . . . 0.0 118.757 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -99.66 -119.39 0.15 Allowed 'General case' 0 C--N 1.288 -2.095 1 CA-C-N 104.405 -5.816 . . . . 0.0 106.245 -179.085 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -72.51 -152.22 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 108.998 -3.728 . . . . 0.0 105.461 171.145 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.544 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -128.84 91.59 3.25 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -176.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.663 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -94.77 66.22 3.12 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 127.496 3.522 . . . . 0.0 105.937 175.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.588 HD12 HG11 ' A' ' 82' ' ' VAL . 2.7 tp -59.91 -25.13 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 1 CA-C-N 106.549 -4.841 . . . . 0.0 114.019 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.51 24.93 1.55 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.8 ttm-85 -158.16 131.64 7.66 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.626 ' H ' HG12 ' A' ' 48' ' ' ILE . 12.4 t -104.86 70.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 C-N-CA 116.543 -2.063 . . . . 0.0 105.979 173.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.615 ' HD3' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -45.98 138.11 5.3 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.119 1.914 . . . . 0.0 112.157 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.23 116.65 33.1 Favored 'General case' 0 C--N 1.295 -1.786 1 CA-C-N 108.304 -4.044 . . . . 0.0 112.775 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.618 ' HE2' HG13 ' A' ' 57' ' ' VAL . 42.8 m-85 -93.14 99.56 12.12 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 125.721 2.677 . . . . 0.0 110.162 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.487 HG11 ' CG2' ' A' ' 32' ' ' VAL . 1.1 m -111.01 177.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 1 CA-C-N 107.787 -4.279 . . . . 0.0 113.508 -174.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -106.67 -141.87 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 124.177 1.942 . . . . 0.0 113.906 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -83.99 -5.41 59.22 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 110.338 -3.119 . . . . 0.0 113.091 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.5 mt -136.12 43.18 2.54 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 111.075 -2.784 . . . . 0.0 111.171 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.3 OUTLIER 33.15 30.26 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.1 m-20 -106.83 141.0 38.76 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 123.455 1.598 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.61 93.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 127.756 3.646 . . . . 0.0 116.329 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.44 . . -74.41 -40.72 61.83 Favored 'General case' 0 C--N 1.289 -2.053 2 CA-C-N 100.718 -7.492 . . . . 0.0 110.516 -179.273 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . 9.0 tt0 -119.52 158.71 25.74 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 ' CG2' ' A' ' 28' ' ' VAL . 97.2 t -76.92 138.39 65.7 Favored Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 114.506 -2.877 . . . . 0.0 110.71 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.6 Cg_exo -75.89 165.73 29.43 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.773 2.315 . . . . 0.0 110.193 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.579 HH12 HG21 ' A' ' 57' ' ' VAL . 9.3 ptp85 -162.77 167.94 22.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.588 HG11 HD12 ' A' ' 63' ' ' ILE . 37.5 t -82.61 133.53 28.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 C-N-CA 118.964 -1.095 . . . . 0.0 109.69 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' OXT' ' HD3' ' A' ' 67' ' ' ARG . . . . . . . . 0 CA--C 1.548 2.138 0 O-C-N 125.32 1.638 . . . . 0.0 112.428 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.863 0 CA-C-O 122.326 1.06 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 81.2 tttt -114.22 86.45 2.42 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.469 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -97.41 26.55 4.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 7.5 pt-20 -138.62 156.4 47.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.822 1.326 . . . . 0.0 112.743 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.673 ' NE1' ' HA ' ' A' ' 39' ' ' ILE . 11.7 m-90 -134.56 78.61 55.9 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 28' ' ' VAL . 66.8 Cg_endo -75.2 -26.21 10.82 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 120.598 0.865 . . . . 0.0 113.993 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 16.1 mp0 -51.33 -29.62 15.76 Favored 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 124.845 2.26 . . . . 0.0 110.11 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.98 -27.9 49.23 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.035 -177.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG2' HG22 ' A' ' 79' ' ' VAL . 58.5 t -49.02 136.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 CA-C-N 119.97 1.259 . . . . 0.0 112.335 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.83 2.01 69.92 Favored Glycine 0 N--CA 1.507 3.407 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.169 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -126.09 169.49 12.73 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.65 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -87.59 177.13 7.15 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 125.331 2.491 . . . . 0.0 113.829 176.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.58 -37.4 77.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 109.863 -3.335 . . . . 0.0 115.716 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.66 -48.32 69.74 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.509 -1.276 . . . . 0.0 111.162 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 58.5 mm-40 -60.07 -42.1 93.83 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB1' HD23 ' A' ' 27' ' ' LEU . . . -53.52 -60.94 2.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.74 -1.225 . . . . 0.0 110.419 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 55.2 mtpt -45.68 -50.22 13.75 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.339 1.066 . . . . 0.0 108.806 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 73.3 tttt -48.99 -47.64 44.04 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.031 -2.804 . . . . 0.0 109.142 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.64 -49.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 124.731 1.269 . . . . 0.0 112.686 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.673 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 11.1 mt -48.11 -47.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.476 0.655 . . . . 0.0 111.448 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 46' ' ' ALA 0.252 96.0 mt -63.88 -12.81 39.97 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.921 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.99 -47.31 18.78 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.96 -52.72 26.05 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 124.831 2.253 . . . . 0.0 110.773 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 57.6 tttm -122.76 70.06 36.96 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.137 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -28.44 -45.19 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.844 3.029 . . . . 0.0 119.603 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.93 8.85 24.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -64.96 113.14 3.66 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 116.953 -1.899 . . . . 0.0 115.483 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -82.44 67.77 8.62 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.735 -1.853 . . . . 0.0 106.273 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.567 HD11 HG21 ' A' ' 39' ' ' ILE . 2.8 mp -80.77 137.7 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 124.19 1.948 . . . . 0.0 115.528 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.3 mp -120.27 177.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 109.908 -3.315 . . . . 0.0 109.628 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 12.1 p -98.33 125.26 51.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.58 1.181 . . . . 0.0 109.48 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 9.7 mt -122.47 89.06 49.46 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.422 ' HG2' ' OG1' ' A' ' 55' ' ' THR . 37.8 Cg_endo -53.39 130.39 38.29 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 O-C-N 119.005 -1.103 . . . . 0.0 113.436 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 69' ' ' PHE . 54.8 t -45.36 115.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 123.133 1.444 . . . . 0.0 111.157 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.36 8.1 Favored Glycine 0 N--CA 1.513 3.78 1 CA-C-N 107.779 -4.282 . . . . 0.0 115.039 -173.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.539 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.284 1.4 m -56.94 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 118.945 1.372 . . . . 0.0 107.908 177.261 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.31 110.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 120.085 3.365 . . . . 0.0 120.085 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.63 HG21 ' HE2' ' A' ' 69' ' ' PHE . 35.3 m -124.12 177.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 108.473 -3.967 . . . . 0.0 110.672 176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -94.89 142.87 26.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 109.759 -3.382 . . . . 0.0 112.574 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.3 tpt -93.28 57.9 2.75 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 123.399 2.818 . . . . 0.0 104.419 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 20.2 pt-20 -80.49 -169.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 111.18 -2.736 . . . . 0.0 113.208 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.642 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 12.8 t80 -140.21 63.33 1.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.634 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.28 74.61 7.0 Favored 'General case' 0 N--CA 1.486 1.331 1 N-CA-C 97.91 -4.848 . . . . 0.0 97.91 174.358 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.642 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.07 -20.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 109.899 -3.319 . . . . 0.0 116.334 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -62.52 4.24 0.16 Allowed 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.904 1.335 . . . . 0.0 109.466 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.5 ttm-85 -149.87 154.71 38.81 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.66 HG21 ' CG2' ' A' ' 39' ' ' ILE . 3.2 t -115.99 135.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 1 N-CA-C 99.454 -4.276 . . . . 0.0 99.454 176.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.563 ' HD3' HG21 ' A' ' 57' ' ' VAL . 8.9 ttm-85 -94.49 126.19 39.61 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.837 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 48' ' ' ILE . 11.1 mp -110.59 76.81 1.0 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.526 2.391 . . . . 0.0 112.048 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.63 ' HE2' HG21 ' A' ' 57' ' ' VAL . 26.1 m-85 -74.98 102.44 4.81 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 126.996 3.284 . . . . 0.0 105.468 168.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 53' ' ' VAL . 18.7 m -100.77 179.75 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.326 1 CA-C-N 106.055 -5.066 . . . . 0.0 109.975 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.591 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -89.43 -145.49 0.16 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 117.438 -3.289 . . . . 0.0 111.425 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.591 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.6 -4.95 59.25 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 111.336 -2.666 . . . . 0.0 115.62 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 73' ' ' LEU 0.266 0.6 OUTLIER -138.02 48.47 1.98 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 126.875 3.226 . . . . 0.0 106.959 176.938 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 34.58 37.02 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.302 -3.135 . . . . 0.0 116.663 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -106.9 147.73 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 124.14 1.924 . . . . 0.0 107.633 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.92 97.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 127.176 3.369 . . . . 0.0 116.623 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.374 . . -73.1 -48.81 32.55 Favored 'General case' 0 C--N 1.29 -2.016 2 CA-C-N 100.257 -7.701 . . . . 0.0 111.767 179.71 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -119.1 155.85 30.8 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.636 HG22 ' CG2' ' A' ' 28' ' ' VAL . 89.2 t -72.47 142.89 84.64 Favored Pre-proline 0 N--CA 1.507 2.392 0 C-N-CA 114.312 -2.955 . . . . 0.0 108.505 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 7.0 Cg_exo -82.11 159.03 17.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 123.549 2.833 . . . . 0.0 108.725 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 7.7 ptp85 -162.57 171.81 16.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 108.257 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 35.9 t -79.5 140.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.15 0 CA-C-O 116.399 -2.334 . . . . 0.0 109.946 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.138 0 CA-C-O 121.24 0.543 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' A' ' 23' ' ' GLU . 81.9 tttt -139.94 118.27 12.08 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.171 1.388 . . . . 0.0 108.934 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -113.78 21.03 15.36 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.151 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -143.94 132.52 22.31 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 118.381 2.734 . . . . 0.0 118.381 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.605 ' CE2' HG23 ' A' ' 39' ' ' ILE . 21.3 m-90 -119.1 67.73 8.83 Favored Pre-proline 0 N--CA 1.504 2.234 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -61.9 -36.25 73.44 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 120.867 1.045 . . . . 0.0 110.889 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 21' ' ' LYS . 8.1 pm0 -49.8 -25.02 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.677 1.227 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.546 HD13 ' HB1' ' A' ' 35' ' ' ALA . 52.1 mt -77.07 -34.19 57.09 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.657 -177.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 79' ' ' VAL . 60.5 t -45.91 135.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.545 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 -177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.84 -15.5 59.47 Favored Glycine 0 N--CA 1.513 3.803 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.129 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -119.49 176.02 5.56 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -87.97 156.43 19.34 Favored 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.787 3.184 . . . . 0.0 118.314 176.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -54.45 -46.76 70.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 1 CA-C-N 107.426 -4.443 . . . . 0.0 116.545 -175.848 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 63.1 mm-40 -54.46 -49.38 70.19 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 116.883 -1.927 . . . . 0.0 111.203 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -49.88 -53.61 24.75 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 124.333 2.016 . . . . 0.0 106.012 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.546 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -54.02 -54.91 32.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.275 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HG2' ' CG2' ' A' ' 48' ' ' ILE . 9.5 mtpm? -46.27 -52.02 13.38 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 125.416 1.487 . . . . 0.0 107.72 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 21.1 ttpp -56.98 -57.59 11.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 110.78 -2.918 . . . . 0.0 108.98 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 72.2 t -55.0 -46.44 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 122.85 1.31 . . . . 0.0 112.955 -178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.798 HG21 HG21 ' A' ' 66' ' ' VAL . 96.9 mt -66.59 -49.41 75.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.227 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.46 -39.89 73.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 33.4 mt-30 -57.69 -37.37 73.35 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.438 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 5.1 t0 -98.16 21.57 10.68 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 126.978 2.111 . . . . 0.0 115.955 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.645 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 65.7 tttt -98.72 105.91 33.68 Favored Pre-proline 0 N--CA 1.526 3.374 1 N-CA-C 128.299 6.407 . . . . 0.0 128.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 4.0 Cg_exo -90.95 -63.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.594 3.479 0 N-CA-C 104.132 -3.064 . . . . 0.0 104.132 161.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' C ' HG11 ' A' ' 82' ' ' VAL . 19.8 mp0 -88.81 -27.0 21.39 Favored 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.645 ' N ' ' HG3' ' A' ' 43' ' ' LYS . . . -62.35 67.58 0.01 OUTLIER 'General case' 1 N--CA 1.541 4.115 1 N-CA-C 132.85 8.092 . . . . 0.0 132.85 -179.064 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 60.7 tp60 -89.81 113.08 24.59 Favored 'General case' 1 N--CA 1.541 4.078 0 CA-C-N 124.965 3.53 . . . . 0.0 108.21 178.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 48' ' ' ILE . 1.1 mp -78.48 144.65 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 48' ' ' ILE . 42.9 mm -139.3 142.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 110.433 -3.076 . . . . 0.0 105.402 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.8 141.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.64 HD13 ' CE2' ' A' ' 69' ' ' PHE . 5.9 mt -132.0 128.66 21.55 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 116.88 -1.533 . . . . 0.0 107.675 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.27 135.89 23.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 104.058 -3.093 . . . . 0.0 104.058 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.589 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -41.41 124.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.12 -20.21 38.64 Favored Glycine 0 N--CA 1.505 3.256 0 CA-C-N 109.055 -3.702 . . . . 0.0 118.172 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.481 ' OG1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -48.79 143.94 4.91 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.466 2.133 . . . . 0.0 112.587 -175.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.3 121.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.613 HG21 ' HE2' ' A' ' 69' ' ' PHE . 1.8 m -115.89 -87.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -175.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.47 107.64 16.09 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 119.487 3.143 . . . . 0.0 119.487 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.6 mtm -96.14 -58.56 2.05 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 127.649 3.595 . . . . 0.0 108.82 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.619 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -84.36 -145.92 0.09 Allowed 'General case' 0 C--N 1.273 -2.743 1 CA-C-N 104.05 -5.977 . . . . 0.0 105.7 175.173 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.576 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -126.07 94.61 4.14 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.438 172.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.626 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -77.84 50.97 0.9 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 124.911 2.291 . . . . 0.0 112.466 175.442 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 10.4 tp -76.66 31.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-O 125.234 2.445 . . . . 0.0 117.321 -176.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -98.5 -30.63 12.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 111.212 -2.722 . . . . 0.0 109.386 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.626 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 3.8 ttp85 -127.5 158.62 36.92 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 118.923 2.934 . . . . 0.0 118.923 -171.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.798 HG21 HG21 ' A' ' 39' ' ' ILE . 2.2 t -107.09 127.34 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.555 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.6 ttp180 -87.1 102.03 14.04 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 108.693 -3.867 . . . . 0.0 104.917 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 80' ' ' PRO . 10.9 mp -103.09 90.47 3.75 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 125.398 1.686 . . . . 0.0 111.307 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.64 ' CE2' HD13 ' A' ' 51' ' ' LEU . 13.0 m-85 -73.28 105.75 4.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 124.762 2.22 . . . . 0.0 109.744 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -106.69 173.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 109.062 -3.699 . . . . 0.0 107.829 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.575 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.7 p-10 -98.39 -139.19 0.3 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 124.575 2.131 . . . . 0.0 111.885 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.575 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.6 mtmm -83.79 -13.52 53.62 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 109.477 -3.511 . . . . 0.0 114.83 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 73' ' ' LEU 0.323 0.3 OUTLIER -136.35 51.13 2.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-O 124.447 2.07 . . . . 0.0 107.197 -178.661 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.75 25.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 178.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 38.4 m-20 -102.73 156.98 17.27 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.4 mt -78.86 116.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 126.465 3.031 . . . . 0.0 115.563 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 53' ' ' VAL 0.478 . . -94.53 -47.29 6.61 Favored 'General case' 0 C--N 1.287 -2.135 2 CA-C-N 103.381 -6.282 . . . . 0.0 110.065 -174.18 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -114.7 159.62 20.32 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.486 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 94.6 t -72.29 132.44 84.11 Favored Pre-proline 0 N--CA 1.499 2.018 0 C-N-CA 114.022 -3.071 . . . . 0.0 110.12 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 38.0 Cg_exo -67.05 144.25 68.9 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.811 2.341 . . . . 0.0 107.88 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.86 153.07 31.43 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.246 -1.359 . . . . 0.0 112.134 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 13.1 t -82.32 102.64 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.55 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.286 -2.22 0 C-N-CA 118.767 -1.683 . . . . 0.0 110.056 176.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.766 0 CA-C-O 122.716 1.246 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -122.36 65.97 0.94 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 177.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -114.89 9.27 16.14 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.255 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.38 150.4 45.26 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.528 -179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.433 ' HZ3' HG23 ' A' ' 82' ' ' VAL . 16.3 m-90 -127.86 65.78 69.2 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 123.477 1.608 . . . . 0.0 112.444 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 27' ' ' LEU . 54.2 Cg_endo -67.74 -32.95 28.94 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.596 1.531 . . . . 0.0 109.481 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -65.5 0.49 1.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.598 HD11 HG13 ' A' ' 39' ' ' ILE . 40.9 mt -99.17 -17.68 18.04 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.986 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' CG2' HG22 ' A' ' 79' ' ' VAL . 64.0 t -63.11 116.06 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 116.821 -1.952 . . . . 0.0 108.596 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.46 -5.68 24.76 Favored Glycine 0 N--CA 1.508 3.479 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.8 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 27' ' ' LEU . 35.7 mmtm -101.63 171.72 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.47 1.108 . . . . 0.0 108.564 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -87.19 168.75 12.95 Favored 'General case' 0 CA--C 1.445 -3.079 0 CA-C-O 124.942 2.306 . . . . 0.0 111.688 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.726 HG23 HG11 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -70.39 -39.57 76.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 108.566 -3.925 . . . . 0.0 109.066 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 2.1 pp20? -65.32 -49.74 68.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.287 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 tt0 -58.82 -46.08 88.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 27' ' ' LEU . . . -50.44 -58.51 5.58 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 116.721 -1.609 . . . . 0.0 109.809 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -47.69 -55.17 10.06 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 120.994 1.724 . . . . 0.0 107.481 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 14.0 ttpt -48.04 -51.33 24.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 110.394 -3.094 . . . . 0.0 109.894 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.49 -52.92 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.066 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.709 ' CG2' HG21 ' A' ' 66' ' ' VAL . 22.5 mt -51.34 -47.79 34.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 123.021 1.391 . . . . 0.0 109.832 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.6 -28.79 57.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.01 -34.81 79.33 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 123.313 1.53 . . . . 0.0 109.679 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 36.8 m-20 -88.82 -49.53 6.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 119.661 3.208 . . . . 0.0 119.661 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 24.1 tptp -116.06 72.1 4.46 Favored Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 71.6 Cg_exo -10.98 -38.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 2 C-N-CA 127.289 5.326 . . . . 0.0 122.773 -178.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.9 mp0 -91.42 -25.11 19.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -38.17 80.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 1 N-CA-C 123.353 4.575 . . . . 0.0 123.353 -171.61 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -76.64 69.88 3.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 66' ' ' VAL . 4.6 mt -72.46 131.69 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.352 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.57 162.01 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.77 113.19 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.36 1.076 . . . . 0.0 109.803 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.767 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -114.16 100.85 53.42 Favored Pre-proline 0 N--CA 1.501 2.1 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.616 -178.041 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.3 131.83 29.56 Favored 'Trans proline' 0 N--CA 1.509 2.416 0 CA-C-N 122.035 1.763 . . . . 0.0 108.926 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 78.1 t -46.57 121.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 120.371 -1.455 . . . . 0.0 113.223 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.07 -30.19 6.42 Favored Glycine 1 N--CA 1.517 4.098 0 CA-C-N 110.512 -3.04 . . . . 0.0 114.849 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.552 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.289 91.6 m -47.21 92.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 124.742 1.217 . . . . 0.0 109.205 176.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mm -52.06 101.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 124.046 1.879 . . . . 0.0 115.804 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.492 HG21 ' HE2' ' A' ' 69' ' ' PHE . 28.2 m -103.65 -178.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.44 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -91.16 158.76 16.44 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -174.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.459 ' N ' ' SD ' ' A' ' 59' ' ' MET . 3.6 mpp? -92.13 37.26 0.98 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 123.876 1.798 . . . . 0.0 108.237 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 58' ' ' THR . 18.2 pt-20 -81.89 -171.67 3.49 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.757 -2.928 . . . . 0.0 111.773 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.524 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -133.98 82.42 1.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.738 1.256 . . . . 0.0 108.771 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 6.8 mmm180 -88.3 78.21 8.05 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 101.291 -3.596 . . . . 0.0 101.291 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.536 ' HA ' HG12 ' A' ' 82' ' ' VAL . 7.4 tp -69.77 -3.61 3.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 109.412 -3.54 . . . . 0.0 112.659 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.5 -6.7 58.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 110.047 -3.252 . . . . 0.0 106.755 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.292 5.3 ttm-85 -145.33 150.83 37.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 120.265 3.432 . . . . 0.0 120.265 -171.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.709 HG21 ' CG2' ' A' ' 39' ' ' ILE . 4.4 t -111.67 108.64 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -63.15 125.35 23.77 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -177.087 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.1 tp -115.12 74.55 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 O-C-N 124.905 1.378 . . . . 0.0 111.641 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.767 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 24.4 m-85 -72.76 104.94 4.13 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 126.593 3.092 . . . . 0.0 111.344 169.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.726 HG11 HG23 ' A' ' 32' ' ' VAL . 3.6 m -107.36 171.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 CA-C-N 108.724 -3.853 . . . . 0.0 112.156 -175.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.1 p-10 -83.0 -147.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 123.738 2.972 . . . . 0.0 112.889 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.8 ttpp -91.55 8.5 36.29 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.389 -3.096 . . . . 0.0 112.031 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.479 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.7 mt -141.7 36.45 1.63 Allowed 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 111.458 -2.61 . . . . 0.0 110.245 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.531 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.13 26.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 -177.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -103.62 135.47 45.15 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.64 118.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 127.542 3.544 . . . . 0.0 114.039 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.443 . . -94.68 -51.24 4.81 Favored 'General case' 0 C--N 1.288 -2.105 2 CA-C-N 103.159 -6.382 . . . . 0.0 112.064 -173.023 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -116.41 161.78 18.55 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.5 HG22 ' CG2' ' A' ' 28' ' ' VAL . 95.0 t -73.46 137.68 77.84 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 113.819 -3.152 . . . . 0.0 108.757 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 13.1 Cg_exo -78.36 152.71 27.07 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.421 ' NH2' ' O ' ' A' ' 82' ' ' VAL . 2.6 ptm180 -156.43 157.83 36.23 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 117.748 -1.581 . . . . 0.0 112.391 -176.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 63' ' ' ILE . 3.5 t -81.49 131.5 33.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.401 -1.319 . . . . 0.0 108.104 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.593 0 CA-C-O 114.538 -3.368 . . . . 0.0 112.804 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 22' ' ' THR . . . . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 120.923 0.392 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -57.75 73.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 125.736 2.684 . . . . 0.0 115.041 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LEU . 17.1 p -111.94 33.77 4.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 100.458 -3.904 . . . . 0.0 100.458 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -142.31 156.08 45.24 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 126.671 2.482 . . . . 0.0 113.56 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 27' ' ' LEU . 22.4 m-90 -140.77 62.78 18.47 Favored Pre-proline 0 N--CA 1.509 2.522 0 CA-C-O 123.73 1.729 . . . . 0.0 115.09 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -63.3 -13.02 33.31 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.293 1.995 . . . . 0.0 113.125 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 12.0 mp0 -77.43 -20.43 54.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.686 HD13 ' HB1' ' A' ' 35' ' ' ALA . 69.8 mt -87.46 -19.62 27.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 79' ' ' VAL . 45.4 t -49.51 130.57 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.22 -10.88 60.08 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.637 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -110.11 161.7 15.29 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.7 p -74.5 162.7 28.56 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-O 126.867 3.222 . . . . 0.0 110.961 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HA ' HD23 ' A' ' 68' ' ' LEU 0.279 9.1 p -62.89 -47.39 93.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 1 CA-C-N 107.199 -4.546 . . . . 0.0 112.163 -173.573 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -68.42 -34.2 75.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.343 -1.743 . . . . 0.0 110.954 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -62.94 -51.1 68.21 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -62.41 -44.19 97.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.398 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 85.7 mttt -45.85 -50.49 14.24 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.236 1.017 . . . . 0.0 108.518 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.559 ' HZ3' ' HB3' ' A' ' 37' ' ' LYS . 5.7 ttpm? -48.14 -54.19 14.16 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 111.876 -2.42 . . . . 0.0 110.932 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 71.4 t -65.76 -47.34 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 112.768 -2.015 . . . . 0.0 111.898 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 66' ' ' VAL . 17.1 mt -52.92 -53.57 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.886 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.257 34.7 mt -58.2 -19.62 34.92 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 125.154 1.534 . . . . 0.0 110.999 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -75.54 -25.88 57.55 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.406 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -96.45 -53.86 3.45 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -118.87 55.05 2.46 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.671 -0.643 . . . . 0.0 110.844 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -17.91 -40.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 125.131 3.888 . . . . 0.0 119.507 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.51 -30.37 68.53 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.518 0.675 . . . . 0.0 112.301 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.0 76.32 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 120.86 3.652 . . . . 0.0 120.86 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.43 74.84 4.96 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 39' ' ' ILE . 55.6 mt -73.03 141.84 15.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.645 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 50' ' ' VAL . 11.7 mm -108.36 170.43 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.047 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 49' ' ' ILE . 39.8 t -84.11 122.65 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.67 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 40.9 mt -118.51 77.47 13.98 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -50.79 129.88 28.87 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 106.927 -1.99 . . . . 0.0 106.927 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.628 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 1.3 t -40.86 130.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 123.885 1.802 . . . . 0.0 115.725 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.75 -29.61 12.14 Favored Glycine 0 N--CA 1.508 3.489 0 CA-C-N 110.652 -2.976 . . . . 0.0 113.811 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.618 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.298 3.2 m -45.76 162.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.03 136.63 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.582 HG21 ' CD ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -141.79 -70.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.873 0 N-CA-C 121.249 3.796 . . . . 0.0 121.249 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 93.33 8.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -98.64 -86.97 0.35 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 108.922 -3.763 . . . . 0.0 102.35 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' HG2' ' NE ' ' A' ' 62' ' ' ARG . 20.2 pt-20 -81.73 -167.91 1.69 Allowed 'General case' 0 C--N 1.277 -2.557 1 CA-C-N 107.263 -4.517 . . . . 0.0 106.321 173.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.37 95.99 8.44 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.412 ' NE ' ' HG2' ' A' ' 60' ' ' GLU . 3.0 mpt_? -83.74 66.24 8.95 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 125.088 2.375 . . . . 0.0 104.863 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.664 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.6 tp -74.8 -23.46 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.922 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.56 6.4 5.9 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 109.445 -3.525 . . . . 0.0 108.583 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.303 12.6 ttm-85 -154.87 149.38 26.31 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 39' ' ' ILE . 2.9 t -117.17 126.44 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-N 120.647 1.567 . . . . 0.0 112.393 174.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.582 ' CD ' HG21 ' A' ' 57' ' ' VAL . 2.3 mtp180 -56.25 104.04 0.13 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 117.1 -1.429 . . . . 0.0 113.035 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.601 HD23 ' HA ' ' A' ' 32' ' ' VAL . 10.3 mp -106.48 74.27 1.01 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 123.208 2.731 . . . . 0.0 104.496 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.67 ' CZ ' HD22 ' A' ' 51' ' ' LEU . 16.7 m-85 -72.82 108.64 5.89 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 127.42 3.486 . . . . 0.0 109.262 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 68' ' ' LEU . 32.7 m -106.03 170.33 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 1 CA-C-N 106.647 -4.797 . . . . 0.0 110.088 -173.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.3 p-10 -94.83 -138.15 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 124.096 1.903 . . . . 0.0 111.082 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 30.0 mmtp -83.57 -11.83 56.88 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 109.74 -3.391 . . . . 0.0 112.447 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 ' CD1' HD22 ' A' ' 75' ' ' ASN 0.302 0.4 OUTLIER -136.53 52.2 1.97 Allowed 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 124.144 1.926 . . . . 0.0 108.955 -179.202 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' C ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.47 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 110.735 -2.938 . . . . 0.0 118.547 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.513 HD22 ' CD1' ' A' ' 73' ' ' LEU . 56.3 m-20 -99.38 134.56 42.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.641 1.21 . . . . 0.0 110.274 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 mt -52.28 117.9 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 126.326 2.965 . . . . 0.0 111.877 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.435 . . -102.37 -39.19 7.28 Favored 'General case' 0 C--N 1.286 -2.168 1 CA-C-N 104.633 -5.712 . . . . 0.0 112.348 -170.913 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -114.47 160.25 19.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 102.831 -3.025 . . . . 0.0 102.831 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 28' ' ' VAL . 88.3 t -76.88 145.03 73.54 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 114.273 -2.971 . . . . 0.0 109.405 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 14.5 Cg_exo -78.42 151.33 25.86 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.297 -1.463 . . . . 0.0 108.297 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.568 HH22 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -153.63 155.73 36.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 66' ' ' VAL . 45.2 t -75.53 -83.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 124.01 1.862 . . . . 0.0 108.454 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.568 ' C ' HH22 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.285 -2.276 1 N-CA-C 102.304 -4.318 . . . . 0.0 102.304 -175.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.657 0 CA-C-O 121.609 0.719 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.616 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 14.6 pttp -102.23 165.77 10.95 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 124.397 2.046 . . . . 0.0 107.874 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 36.2 p -106.92 -3.7 19.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 110.596 -3.002 . . . . 0.0 111.034 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.616 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -129.77 142.84 50.63 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.625 ' CZ2' HG23 ' A' ' 39' ' ' ILE . 25.5 m-90 -134.23 76.55 62.86 Favored Pre-proline 0 N--CA 1.52 3.068 1 N-CA-C 123.363 4.579 . . . . 0.0 123.363 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . 7.4 Cg_endo -79.84 -35.69 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.873 1.716 . . . . 0.0 111.985 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.13 -18.19 9.23 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -176.246 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 1.2 pp -104.09 2.05 31.59 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.282 1.433 . . . . 0.0 114.389 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.56 HG21 HG22 ' A' ' 79' ' ' VAL . 49.0 t -70.55 141.67 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.754 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.84 7.6 59.83 Favored Glycine 0 N--CA 1.515 3.941 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -125.96 167.38 15.37 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.525 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 3.2 p -88.17 155.01 19.99 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 126.354 2.978 . . . . 0.0 114.033 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 33' ' ' GLU . 5.3 p -40.97 -49.62 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 1 CA-C-N 106.411 -4.904 . . . . 0.0 120.14 -175.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' N ' HG13 ' A' ' 32' ' ' VAL . 57.6 mm-40 -59.88 -49.02 79.35 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.211 -1.395 . . . . 0.0 109.605 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -51.3 -51.82 50.86 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 76' ' ' ILE . . . -52.6 -58.02 8.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.547 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 49.1 mtpt -45.99 -52.45 11.74 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 123.364 1.554 . . . . 0.0 107.107 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.8 -54.05 43.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.483 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.4 t -54.33 -54.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-O 124.896 2.284 . . . . 0.0 109.778 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.656 HD13 HG11 ' A' ' 66' ' ' VAL . 9.3 mt -54.26 -43.88 63.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 110.526 -3.033 . . . . 0.0 112.216 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 46' ' ' ALA . 57.7 mt -73.22 -32.87 65.02 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 125.655 1.847 . . . . 0.0 110.866 175.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -64.81 -18.54 65.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 10.9 t70 -96.36 -64.15 1.08 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.277 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -104.65 62.62 0.11 Allowed Pre-proline 0 C--N 1.29 -1.979 0 C-N-CA 127.873 2.469 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -18.86 -49.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 123.983 3.122 . . . . 0.0 120.052 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.53 14.91 13.59 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 48' ' ' ILE . . . -59.56 97.87 0.04 OUTLIER 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.762 1.268 . . . . 0.0 113.626 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 30.0 tt0 -73.59 77.33 1.49 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.632 HD11 ' CG2' ' A' ' 39' ' ' ILE . 66.8 mt -74.52 135.06 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 123.153 1.454 . . . . 0.0 113.524 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.51 137.58 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 111.514 -2.585 . . . . 0.0 108.758 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.27 141.37 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 123.117 1.437 . . . . 0.0 110.541 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.604 ' CD2' HG22 ' A' ' 55' ' ' THR . 2.5 mp -137.43 140.19 29.77 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.01 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 55' ' ' THR . 32.3 Cg_endo -74.82 141.79 27.63 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.505 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 8.4 t -42.14 128.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.12 20.63 Favored Glycine 0 N--CA 1.507 3.396 0 CA-C-N 111.213 -2.721 . . . . 0.0 112.543 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.604 HG22 ' CD2' ' A' ' 51' ' ' LEU 0.28 0.9 OUTLIER -69.02 177.05 2.82 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 123.76 1.743 . . . . 0.0 112.428 179.106 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.3 mm -59.18 105.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 124.037 4.829 . . . . 0.0 124.037 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.716 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -105.18 -50.84 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.613 0 CA-C-N 111.207 -2.724 . . . . 0.0 111.682 173.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 62.95 4.53 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 128.284 3.897 . . . . 0.0 119.156 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.66 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 3.5 ttt -98.65 -162.38 0.95 Allowed 'General case' 0 C--N 1.279 -2.475 1 CA-C-N 103.038 -6.437 . . . . 0.0 108.687 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.66 ' H ' ' HG2' ' A' ' 59' ' ' MET . 0.4 OUTLIER -73.87 -141.69 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.226 172.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.566 ' CE2' HD13 ' A' ' 63' ' ' ILE . 12.1 t80 -136.49 83.35 2.0 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 6.6 mmp_? -87.41 76.61 9.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.582 HD12 HG11 ' A' ' 82' ' ' VAL . 5.9 tp -52.2 -19.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 110.952 -2.84 . . . . 0.0 112.808 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.625 ' O ' ' HB3' ' A' ' 47' ' ' GLN 0.263 2.2 p30 -81.43 15.96 1.85 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.975 177.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.482 HH21 ' C ' ' A' ' 83' ' ' GLY . 53.0 ttp180 -153.64 122.65 6.46 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 82' ' ' VAL . 24.0 t -91.12 146.79 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 C-N-CA 114.467 -2.893 . . . . 0.0 105.016 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.653 HH21 ' C ' ' A' ' 83' ' ' GLY . 14.9 tpp85 -99.94 114.08 27.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.076 -2.784 . . . . 0.0 105.527 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 39' ' ' ILE . 84.3 mt -113.74 105.21 13.03 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.46 -1.296 . . . . 0.0 114.094 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.716 ' CE2' HG22 ' A' ' 57' ' ' VAL . 25.7 m-85 -80.14 102.91 9.66 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 125.697 2.665 . . . . 0.0 112.174 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.99 173.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 108.593 -3.912 . . . . 0.0 110.018 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -99.72 -141.75 0.33 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 124.53 2.109 . . . . 0.0 111.935 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.596 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.64 8.54 43.11 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.054 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 75' ' ' ASN . 65.2 mt -135.46 39.95 2.84 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 111.075 -2.784 . . . . 0.0 108.627 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.78 28.0 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 64.0 m-20 -104.8 146.9 28.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.174 1.94 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 35' ' ' ALA . 15.6 mt -77.8 95.33 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-O 127.245 3.403 . . . . 0.0 114.402 -177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.507 . . -72.3 -45.47 59.87 Favored 'General case' 0 C--N 1.289 -2.045 2 CA-C-N 100.608 -7.542 . . . . 0.0 102.437 178.838 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -119.19 135.14 54.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.716 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 87.2 t -42.72 -56.19 6.27 Favored Pre-proline 0 N--CA 1.519 2.98 1 N-CA-C 124.623 5.046 . . . . 0.0 124.623 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.716 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.255 0.0 OUTLIER 7.01 -152.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 2 C-N-CA 130.714 7.609 . . . . 0.0 127.837 -168.309 . . . . . . . . 5 4 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -155.53 -173.23 4.45 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -158.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 66' ' ' VAL . 5.0 t -81.88 148.55 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.289 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.653 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.988 0 O-C-N 126.392 2.307 . . . . 0.0 114.464 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.632 0 CA-C-O 120.991 0.424 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.544 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 1.7 tmtm? -14.2 76.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -123.75 16.51 9.46 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 111.56 -2.564 . . . . 0.0 106.846 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -133.74 150.12 51.48 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.085 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.582 ' HB3' ' CG ' ' A' ' 27' ' ' LEU . 26.8 m-90 -133.22 74.56 72.47 Favored Pre-proline 0 N--CA 1.507 2.388 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' HA ' HG23 ' A' ' 28' ' ' VAL . 42.0 Cg_endo -74.14 -33.91 5.43 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.704 2.269 . . . . 0.0 110.486 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -48.43 -34.85 11.66 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.739 2.209 . . . . 0.0 109.945 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' CG ' ' HB3' ' A' ' 24' ' ' TRP . 3.7 pp -98.51 23.08 8.96 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.588 ' CG2' HG22 ' A' ' 79' ' ' VAL . 64.5 t -73.32 163.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.85 17.17 60.33 Favored Glycine 0 N--CA 1.512 3.709 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.949 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.23 163.89 25.74 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-O 116.568 -1.682 . . . . 0.0 109.59 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 5.5 p -88.42 158.13 18.47 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 126.575 3.083 . . . . 0.0 113.908 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.49 -27.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 1 CA-C-N 106.41 -4.905 . . . . 0.0 114.76 -176.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.605 ' HG3' ' N ' ' A' ' 34' ' ' GLU . 16.8 pt-20 -66.67 -52.16 47.92 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 123.87 1.795 . . . . 0.0 109.429 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.605 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 9.6 tm-20 -62.48 -51.04 69.02 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -50.72 -48.92 58.73 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.06 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.3 mttm -57.95 -53.12 61.81 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD3' ' C ' ' A' ' 37' ' ' LYS . 3.8 tmtm? -48.2 -35.91 12.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 113.382 -1.736 . . . . 0.0 114.775 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.455 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 66.1 t -85.25 -59.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.229 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 66' ' ' VAL . 40.2 mt -49.25 -48.91 17.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.679 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 46' ' ' ALA . 9.8 mt -70.94 -23.18 62.19 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.126 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -96.38 -63.27 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 8.2 tptp -111.13 67.23 0.59 Allowed Pre-proline 0 N--CA 1.499 2.007 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -18.62 -46.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 124.599 3.533 . . . . 0.0 120.096 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.3 mp0 -59.28 -35.07 73.07 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' A' ' 66' ' ' VAL . . . -44.86 79.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.678 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 43.9 tt0 -78.09 65.37 3.46 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.875 1.797 . . . . 0.0 107.269 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 39' ' ' ILE . 32.6 mt -70.46 142.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' VAL . 32.9 mm -125.86 -166.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 110.668 -2.969 . . . . 0.0 106.418 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.8 p -106.02 142.05 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 0.0 112.56 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.39 102.81 7.24 Favored Pre-proline 0 N--CA 1.513 2.723 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.55 129.06 15.17 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 122.799 2.035 . . . . 0.0 109.435 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 4.1 t -41.94 130.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 123.383 1.563 . . . . 0.0 114.476 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.62 -21.49 45.83 Favored Glycine 0 N--CA 1.503 3.144 0 CA-C-N 111.095 -2.775 . . . . 0.0 114.613 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -58.24 156.36 9.98 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 119.261 1.531 . . . . 0.0 113.416 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.04 127.46 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.124 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 69' ' ' PHE . 30.0 m -131.21 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 112.645 -2.071 . . . . 0.0 109.473 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -155.67 0.31 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.556 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 50.2 mtp -58.1 -149.91 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -81.47 -18.68 44.36 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 125.27 2.462 . . . . 0.0 116.318 175.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.639 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -116.54 107.15 14.38 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 109.488 -3.506 . . . . 0.0 106.706 178.392 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.703 ' H ' ' C ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -107.45 43.72 1.16 Allowed 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 125.277 2.465 . . . . 0.0 109.758 179.073 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.639 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.2 tp -42.73 -27.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.444 1 CA-C-N 107.295 -4.502 . . . . 0.0 120.058 -177.671 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.23 -17.62 20.45 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 47' ' ' GLN 0.255 0.1 OUTLIER -142.81 -170.84 3.32 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.863 -2.426 . . . . 0.0 114.017 -176.973 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.696 HG21 HG21 ' A' ' 39' ' ' ILE . 3.0 t -115.64 111.49 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 1 N-CA-C 88.032 -8.507 . . . . 0.0 88.032 169.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HD3' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -81.04 101.83 9.82 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 122.515 2.416 . . . . 0.0 111.013 -176.164 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.9 mp -79.9 80.18 6.33 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.556 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 13.6 m-85 -70.12 106.67 3.35 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 125.96 2.79 . . . . 0.0 108.95 166.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 14.9 m -105.9 175.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.766 1 CA-C-N 108.234 -4.075 . . . . 0.0 109.607 -176.336 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.486 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 6.5 p-10 -91.89 -140.21 0.18 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.232 -2.167 . . . . 0.0 113.194 -177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 43.8 mtmt -89.3 0.87 56.47 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 110.673 -2.967 . . . . 0.0 112.072 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.1 mt -135.77 32.66 2.98 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.874 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.16 28.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -177.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.9 m-80 -103.2 148.83 25.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.0 mt -74.88 106.46 4.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 126.843 3.211 . . . . 0.0 114.18 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 71' ' ' ASP 0.399 . . -81.34 -51.88 7.88 Favored 'General case' 0 C--N 1.287 -2.152 2 CA-C-N 101.692 -7.049 . . . . 0.0 110.042 -177.744 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.49 148.33 39.59 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.588 HG22 ' CG2' ' A' ' 28' ' ' VAL . 88.8 t -70.45 141.73 88.47 Favored Pre-proline 0 N--CA 1.502 2.132 0 C-N-CA 114.193 -3.003 . . . . 0.0 108.113 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 6.2 Cg_exo -89.27 159.16 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.765 2.31 . . . . 0.0 108.26 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -154.29 157.27 38.41 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -177.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' CH2' ' A' ' 24' ' ' TRP . 55.6 t -75.26 109.79 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 176.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.703 ' C ' ' H ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.276 -2.768 0 CA-C-N 110.869 -2.878 . . . . 0.0 107.032 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' NZ ' ' CD1' ' A' ' 24' ' ' TRP . 4.0 tmtt? . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.469 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 66.5 p -102.96 34.98 2.66 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-O 122.897 1.332 . . . . 0.0 108.771 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' CD ' HH22 ' A' ' 81' ' ' ARG 0.251 0.0 OUTLIER -154.78 151.62 28.89 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.612 -176.736 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 24.1 m-90 -139.47 81.01 21.01 Favored Pre-proline 0 N--CA 1.517 2.887 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.4 -34.68 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.915 2.41 . . . . 0.0 111.612 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.77 -17.6 9.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.154 -0.966 . . . . 0.0 111.445 -177.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 1.7 pp -107.05 17.63 22.79 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 79' ' ' VAL . 69.8 t -65.99 169.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.109 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.37 18.18 35.18 Favored Glycine 1 N--CA 1.521 4.354 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -121.05 157.4 30.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.2 p -89.03 159.71 17.45 Favored 'General case' 0 CA--C 1.472 -2.053 0 CA-C-O 127.482 3.515 . . . . 0.0 109.083 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -40.01 -54.18 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.263 1 CA-C-N 105.888 -5.142 . . . . 0.0 118.722 -174.009 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 60.3 mm-40 -55.33 -47.87 75.02 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.936 1.698 . . . . 0.0 110.776 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 1.2 tm-20 -50.96 -47.14 61.29 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.77 -47.78 76.9 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.16 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 66.9 mttm -49.32 -50.55 39.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 76.9 tttt -48.64 -55.33 11.55 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 110.803 -2.908 . . . . 0.0 108.757 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 67.5 t -59.87 -54.27 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.764 0 CA-C-O 125.53 2.586 . . . . 0.0 112.72 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.686 ' CG2' HG21 ' A' ' 66' ' ' VAL . 31.6 mt -57.33 -50.03 78.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 112.151 -2.295 . . . . 0.0 110.663 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 67.8 mt -57.3 -36.42 71.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.1 tt0 -58.78 -44.72 90.76 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 118.05 -1.46 . . . . 0.0 110.935 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.74 -48.39 54.75 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.434 -1.712 . . . . 0.0 114.026 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 25.9 ttpp -127.36 68.31 72.96 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -14.72 -43.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 124.678 3.585 . . . . 0.0 119.949 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -86.97 -5.28 59.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -46.6 96.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.52 HE22 HG12 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -77.76 93.32 4.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 178.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.598 HD11 ' CG2' ' A' ' 39' ' ' ILE . 73.0 mt -93.14 114.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 121.377 3.843 . . . . 0.0 121.377 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.52 HG12 HE22 ' A' ' 47' ' ' GLN . 36.5 mm -102.27 149.76 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 112.768 -2.014 . . . . 0.0 107.602 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.92 155.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.116 0.96 . . . . 0.0 112.506 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.769 ' HB3' ' CE1' ' A' ' 69' ' ' PHE 0.254 0.6 OUTLIER -142.42 132.19 12.26 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.579 -179.788 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.452 ' HD2' HD23 ' A' ' 51' ' ' LEU . 52.5 Cg_endo -72.05 113.97 3.84 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.172 1.915 . . . . 0.0 113.994 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 69' ' ' PHE . 36.5 t -41.56 123.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.441 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 119.51 -37.89 2.99 Favored Glycine 0 N--CA 1.507 3.424 2 O-C-N 129.751 4.407 . . . . 0.0 108.651 -175.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.517 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.267 52.0 m -60.04 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.031 1.332 . . . . 0.0 108.183 175.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' GLY . 24.9 mm -55.46 147.98 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.87 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' NE ' ' A' ' 67' ' ' ARG . 12.4 m -123.01 -147.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.42 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -87.49 155.33 20.05 Favored 'General case' 0 C--N 1.306 -1.321 1 N-CA-C 124.796 5.11 . . . . 0.0 124.796 -173.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -93.86 34.7 1.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 123.083 1.421 . . . . 0.0 110.865 176.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.02 -176.11 5.97 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.57 56.36 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 123.145 1.45 . . . . 0.0 107.391 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.48 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mmm180 -88.96 67.28 8.13 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 126.991 3.282 . . . . 0.0 107.782 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.537 HD12 HG11 ' A' ' 82' ' ' VAL . 6.5 tp -53.2 -26.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 1 CA-C-N 107.19 -4.55 . . . . 0.0 109.518 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' GLN . 1.3 p30 -60.91 -7.16 2.2 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.811 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 62' ' ' ARG . 6.1 ttp85 -139.55 151.58 46.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 121.768 3.988 . . . . 0.0 121.768 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.686 HG21 ' CG2' ' A' ' 39' ' ' ILE . 21.2 t -115.08 92.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' NE ' HG21 ' A' ' 57' ' ' VAL . 26.8 ttm180 -48.58 123.24 6.43 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 109.826 -3.352 . . . . 0.0 106.05 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 76' ' ' ILE 0.271 0.6 OUTLIER -115.16 84.03 2.01 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 125.916 2.01 . . . . 0.0 112.303 -176.965 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.769 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 26.0 m-85 -73.33 108.38 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 124.71 2.195 . . . . 0.0 107.057 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 53' ' ' VAL . 14.5 m -113.46 174.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 1 CA-C-N 108.286 -4.052 . . . . 0.0 110.368 -177.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.586 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.2 p-10 -88.69 -146.89 0.16 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 122.941 2.61 . . . . 0.0 111.637 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.586 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 12.0 mptt -90.63 0.34 57.42 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 111.736 -2.484 . . . . 0.0 113.994 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.375 0.2 OUTLIER -139.15 47.8 1.89 Allowed 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 112.558 -2.11 . . . . 0.0 105.772 178.101 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.71 27.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 58.6 m-80 -100.9 151.68 21.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 123.331 1.539 . . . . 0.0 109.576 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.423 HD11 HD11 ' A' ' 68' ' ' LEU . 82.0 mt -78.72 93.71 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 127.466 3.507 . . . . 0.0 116.125 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.351 . . -73.2 -42.09 63.07 Favored 'General case' 0 C--N 1.291 -1.957 2 CA-C-N 100.292 -7.685 . . . . 0.0 112.958 178.702 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 10.1 tt0 -117.57 156.14 28.61 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 28' ' ' VAL . 88.5 t -76.34 136.51 68.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 112.75 -3.58 . . . . 0.0 104.981 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_exo -81.48 169.59 15.35 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.518 2.812 . . . . 0.0 111.695 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.527 HH22 ' CD ' ' A' ' 23' ' ' GLU . 2.3 ptp180 -163.69 172.38 14.3 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 116.624 -1.655 . . . . 0.0 111.731 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.578 HG22 HG22 ' A' ' 66' ' ' VAL . 6.1 t -82.58 -111.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 82' ' ' VAL . . . . . . . . 0 C--N 1.287 -2.167 3 N-CA-C 96.046 -6.821 . . . . 0.0 96.046 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 13.3 mtpp . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 124.011 1.862 . . . . 0.0 112.444 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.5 p -111.42 -6.51 14.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.97 135.08 35.65 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.591 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 25.4 m-90 -117.0 72.94 6.24 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 122.983 1.373 . . . . 0.0 114.581 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HA ' HG23 ' A' ' 28' ' ' VAL . 40.5 Cg_endo -69.45 -31.98 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.643 1.562 . . . . 0.0 110.66 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' ' HZ1' ' A' ' 21' ' ' LYS . 33.4 mp0 -52.18 -34.9 47.19 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.167 1.461 . . . . 0.0 109.928 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 24' ' ' TRP 0.25 4.5 pp -102.06 36.48 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 123.704 1.716 . . . . 0.0 113.027 -177.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.58 ' CG2' HG22 ' A' ' 79' ' ' VAL . 9.9 t -81.45 155.92 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.767 171.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.65 29.1 17.55 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.469 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.0 mmmp? -120.58 176.49 5.48 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 117.13 -1.414 . . . . 0.0 109.44 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -85.32 160.28 19.85 Favored 'General case' 0 CA--C 1.459 -2.532 0 CA-C-O 126.053 2.835 . . . . 0.0 112.109 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.549 ' CG2' HG11 ' A' ' 70' ' ' VAL 0.251 1.7 p -69.55 -28.31 37.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 1 CA-C-N 107.189 -4.551 . . . . 0.0 111.13 -173.701 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.432 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 18.6 mm-40 -77.23 -38.55 50.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.1 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 32.8 mt-10 -63.08 -50.85 68.94 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 125.889 1.993 . . . . 0.0 105.632 174.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.73 -58.53 3.01 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.79 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.1 mttp -49.48 -54.96 14.95 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-O 122.549 1.166 . . . . 0.0 108.425 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' NZ ' ' OE1' ' A' ' 33' ' ' GLU . 57.5 mttp -52.95 -46.65 68.27 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.233 -2.258 . . . . 0.0 112.029 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' CD2' ' A' ' 27' ' ' LEU . 99.4 t -67.51 -52.51 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 122.559 1.171 . . . . 0.0 110.705 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 66' ' ' VAL . 17.5 mt -51.74 -48.69 37.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.315 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD21 ' O ' ' A' ' 46' ' ' ALA . 88.4 mt -60.77 -34.83 75.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 124.988 1.43 . . . . 0.0 107.378 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -84.79 -57.24 3.2 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 114.095 -1.412 . . . . 0.0 113.551 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 51.9 tttm -115.54 78.69 6.73 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.338 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -22.71 -52.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 N-CA-C 118.683 2.532 . . . . 0.0 118.683 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.67 9.35 14.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -178.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.696 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -65.15 96.17 0.2 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 117.822 -1.551 . . . . 0.0 113.18 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -77.92 69.86 4.2 Favored 'General case' 0 N--CA 1.513 2.692 0 O-C-N 118.338 -2.726 . . . . 0.0 107.893 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' HD12 ' A' ' 68' ' ' LEU . 32.8 mt -78.04 122.06 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 112.793 -2.003 . . . . 0.0 116.114 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.638 ' H ' ' CZ ' ' A' ' 65' ' ' ARG . 1.3 mp -115.47 170.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.453 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 7.7 p -72.79 126.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 123.096 1.427 . . . . 0.0 110.512 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 55' ' ' THR . 0.2 OUTLIER -131.62 104.8 14.39 Favored Pre-proline 0 N--CA 1.492 1.673 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.505 -177.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -56.54 115.05 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.625 0.545 . . . . 0.0 111.015 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.597 ' HA ' ' CG ' ' A' ' 69' ' ' PHE . 14.9 p -39.81 142.31 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 123.679 1.704 . . . . 0.0 112.655 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' N ' ' CE2' ' A' ' 69' ' ' PHE . . . 95.84 -26.09 22.09 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 112.067 -2.333 . . . . 0.0 110.976 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.582 HG21 HD23 ' A' ' 51' ' ' LEU 0.321 3.0 m -54.39 -179.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.225 1.012 . . . . 0.0 113.644 176.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.32 99.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 118.646 -2.534 . . . . 0.0 114.388 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -99.25 -48.18 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.268 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.97 68.54 0.68 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 127.659 3.6 . . . . 0.0 113.603 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.483 ' SD ' ' HG3' ' A' ' 62' ' ' ARG . 18.2 ttm -99.77 -177.96 3.72 Favored 'General case' 0 C--N 1.276 -2.609 1 CA-C-N 104.315 -5.857 . . . . 0.0 107.292 -178.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 11.8 pt-20 -78.53 -163.23 0.43 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 174.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.924 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 67.3 t80 -94.76 81.56 3.82 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.616 -1.303 . . . . 0.0 111.602 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.483 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 8.6 mmt85 -88.65 56.78 3.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.45 -1.7 . . . . 0.0 109.528 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.924 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.27 -27.6 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 111.348 -2.66 . . . . 0.0 116.642 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.07 -14.81 1.73 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 124.008 1.861 . . . . 0.0 108.328 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.638 ' CZ ' ' H ' ' A' ' 49' ' ' ILE . 6.2 mtp180 -132.21 157.41 44.41 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 119.443 3.127 . . . . 0.0 119.443 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.71 HG21 HG21 ' A' ' 39' ' ' ILE . 2.9 t -115.45 134.44 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 1 N-CA-C 98.5 -4.629 . . . . 0.0 98.5 171.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CD ' HD13 ' A' ' 51' ' ' LEU . 9.2 tpp180 -83.13 134.68 34.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD12 ' CG2' ' A' ' 48' ' ' ILE . 3.2 mt -113.86 82.01 1.62 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.856 1.347 . . . . 0.0 108.475 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.597 ' CG ' ' HA ' ' A' ' 53' ' ' VAL . 2.6 m-30 -73.46 92.45 1.87 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 126.498 3.047 . . . . 0.0 108.592 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 32' ' ' VAL . 4.8 m -105.16 171.04 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 1 CA-C-N 105.327 -5.397 . . . . 0.0 104.017 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.5 p-10 -96.75 -138.39 0.27 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 125.373 2.511 . . . . 0.0 112.261 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.549 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.0 mtmm -85.32 -11.99 53.36 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 109.195 -3.639 . . . . 0.0 114.166 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.609 ' CD1' HD22 ' A' ' 75' ' ' ASN 0.306 0.3 OUTLIER -138.05 52.36 1.85 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 112.087 -2.324 . . . . 0.0 107.675 -178.816 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 36.42 22.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.609 HD22 ' CD1' ' A' ' 73' ' ' LEU . 34.4 m-20 -105.62 138.27 42.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 123.473 1.606 . . . . 0.0 110.608 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.64 122.43 11.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 126.006 2.812 . . . . 0.0 117.211 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.485 . . -104.5 -44.16 4.98 Favored 'General case' 0 C--N 1.289 -2.03 1 CA-C-N 105.362 -5.381 . . . . 0.0 111.016 -171.831 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . 11.0 tp60 -115.42 161.7 18.18 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.58 HG22 ' CG2' ' A' ' 28' ' ' VAL . 95.4 t -75.79 134.25 72.29 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 113.939 -3.105 . . . . 0.0 109.05 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 31.9 Cg_exo -68.72 131.93 23.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 103.803 -3.191 . . . . 0.0 103.803 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' THR . 4.9 ptm180 -138.67 157.2 46.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.479 1.112 . . . . 0.0 108.703 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.8 t -79.03 152.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.358 1.036 . . . . 0.0 112.697 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.455 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.513 3.824 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.029 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 5.8 tmtt? . . . . . 0 N--CA 1.508 2.467 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 48.2 p -104.55 24.96 10.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 112.608 -2.087 . . . . 0.0 105.401 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.07 151.16 43.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 126.225 2.203 . . . . 0.0 113.202 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.649 ' CG ' HG12 ' A' ' 39' ' ' ILE . 26.9 m-90 -128.67 67.32 76.73 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 123.285 1.517 . . . . 0.0 112.293 174.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -63.42 -37.67 47.62 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 CA-C-N 113.301 -1.357 . . . . 0.0 110.034 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 27' ' ' LEU . 19.6 pm0 -51.01 -31.32 17.73 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.165 0.983 . . . . 0.0 111.934 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.6 pp -105.84 31.9 4.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.556 HG21 HG22 ' A' ' 79' ' ' VAL . 77.4 t -84.71 124.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 170.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.82 3.46 54.94 Favored Glycine 0 N--CA 1.514 3.868 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -109.53 156.13 20.52 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.367 -0.917 . . . . 0.0 110.306 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 p -85.81 155.07 21.15 Favored 'General case' 0 CA--C 1.474 -1.945 0 CA-C-O 127.386 3.47 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -48.93 -56.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 1 CA-C-N 106.022 -5.081 . . . . 0.0 120.739 -170.259 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 50.0 mm-40 -57.67 -40.43 79.36 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 117.417 -1.713 . . . . 0.0 110.559 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.13 -54.39 46.46 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -44.58 -52.4 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.964 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mttt -55.77 -58.15 9.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 3.8 tmtm? -47.46 -40.14 17.49 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.798 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 77.4 t -70.59 -56.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.549 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HG21 ' A' ' 66' ' ' VAL . 47.7 mt -48.19 -39.18 8.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 122.814 1.292 . . . . 0.0 110.836 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 11.7 mt -53.26 -35.9 60.53 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.077 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -62.66 -46.59 87.49 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-O 123.942 1.829 . . . . 0.0 110.455 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.543 ' CG ' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -62.78 -49.94 72.99 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.988 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 1.2 mtpp -125.81 81.14 66.04 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.799 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.49 -54.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 118.204 2.348 . . . . 0.0 118.204 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.36 13.65 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 64' ' ' ASP . . . -60.22 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.032 0.92 . . . . 0.0 113.293 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -82.74 72.32 9.81 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 124.567 2.127 . . . . 0.0 106.071 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.67 HD11 ' CG2' ' A' ' 39' ' ' ILE . 49.2 mt -73.63 148.95 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 110.617 -2.992 . . . . 0.0 117.37 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.87 162.08 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 112.748 -2.023 . . . . 0.0 112.84 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 133.93 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 112.06 -2.336 . . . . 0.0 105.115 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.722 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.6 mt -141.51 113.36 6.62 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.564 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -76.0 130.04 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 CA-C-N 121.818 1.685 . . . . 0.0 108.0 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 69' ' ' PHE . 13.1 t -39.55 130.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.61 -40.69 2.46 Favored Glycine 1 N--CA 1.518 4.144 0 CA-C-N 109.302 -3.59 . . . . 0.0 111.019 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.56 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 40.6 m -46.29 125.49 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.721 1.208 . . . . 0.0 108.778 177.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.39 152.28 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.502 HG21 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -128.62 -51.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.716 1 N-CA-C 125.002 5.186 . . . . 0.0 125.002 -175.653 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.08 99.98 5.54 Favored 'General case' 0 C--N 1.288 -2.081 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.431 ' HB2' ' NH2' ' A' ' 62' ' ' ARG . 87.9 mtp -94.11 -117.55 0.1 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 100.809 -3.775 . . . . 0.0 100.809 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.257 3.1 pp20? -76.54 -167.29 0.78 Allowed 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 111.012 -2.813 . . . . 0.0 106.251 172.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -79.68 98.73 7.08 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.975 0.893 . . . . 0.0 112.074 -173.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -85.59 58.7 5.19 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 125.758 2.694 . . . . 0.0 109.468 177.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.515 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 7.6 tp -71.47 -9.22 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 109.524 -3.489 . . . . 0.0 116.476 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 11.5 p-10 -96.87 -1.69 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.788 1.28 . . . . 0.0 108.252 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.03 144.61 50.98 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.721 HG21 HG21 ' A' ' 39' ' ' ILE . 3.1 t -116.94 145.86 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -103.66 130.79 51.18 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.746 175.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 35' ' ' ALA . 20.3 mt -103.2 83.05 2.14 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.662 -2.063 . . . . 0.0 107.398 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.722 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.5 m-85 -73.18 100.15 3.0 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 126.478 3.037 . . . . 0.0 108.485 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 68' ' ' LEU . 32.8 m -101.52 171.15 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 1 CA-C-N 106.541 -4.845 . . . . 0.0 108.211 -176.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.514 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.2 p-10 -97.35 -140.87 0.29 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 124.633 2.158 . . . . 0.0 111.689 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.514 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 37.4 tttp -85.88 -0.97 56.77 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 109.199 -3.637 . . . . 0.0 111.451 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.492 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.3 mt -136.08 38.79 2.75 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.624 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.49 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -100.08 134.38 43.09 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.616 HG21 ' HG3' ' A' ' 80' ' ' PRO . 50.8 mt -58.37 122.96 9.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 125.328 2.49 . . . . 0.0 109.651 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.476 . . -105.4 -38.13 6.59 Favored 'General case' 0 C--N 1.284 -2.267 2 CA-C-N 105.19 -5.459 . . . . 0.0 110.261 -172.601 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -118.71 160.08 22.49 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.069 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.556 HG22 HG21 ' A' ' 28' ' ' VAL . 95.4 t -65.55 135.99 95.95 Favored Pre-proline 0 N--CA 1.501 2.089 0 C-N-CA 114.881 -2.728 . . . . 0.0 110.107 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HG3' HG21 ' A' ' 76' ' ' ILE . 4.4 Cg_exo -83.45 142.46 10.54 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 N-CA-C 104.417 -2.955 . . . . 0.0 104.417 -176.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 22' ' ' THR . 6.9 ptm180 -156.56 163.76 39.0 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 116.522 -2.071 . . . . 0.0 113.375 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 83' ' ' GLY . 2.7 t -84.38 155.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 125.924 2.015 . . . . 0.0 111.994 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.542 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.428 0 CA-C-O 114.127 -3.596 . . . . 0.0 112.512 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -98.41 31.22 2.9 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.396 -1.322 . . . . 0.0 111.384 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.63 146.29 31.28 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.913 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.637 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 24.1 m-90 -127.4 67.17 71.1 Favored Pre-proline 0 N--CA 1.498 1.966 0 CA-C-O 124.262 1.982 . . . . 0.0 111.396 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' HG22 ' A' ' 79' ' ' VAL . 40.8 Cg_endo -69.29 -41.51 4.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 CA-C-N 111.068 -2.154 . . . . 0.0 110.614 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.7 pm0 -67.42 -9.64 43.67 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.786 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.637 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -107.78 13.73 26.16 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.645 HG21 HG22 ' A' ' 79' ' ' VAL . 48.6 t -68.01 161.46 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.72 57.15 Favored Glycine 1 N--CA 1.518 4.147 0 C-N-CA 118.475 -1.821 . . . . 0.0 113.829 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 2.9 mtpp -106.48 166.62 10.42 Favored 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 124.122 0.969 . . . . 0.0 111.655 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 p -85.7 154.23 21.79 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 126.249 2.928 . . . . 0.0 115.717 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.479 ' CG2' HG11 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -48.94 -57.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 1 CA-C-N 107.875 -4.239 . . . . 0.0 114.202 -172.081 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -53.01 -36.51 60.6 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 121.506 1.957 . . . . 0.0 113.802 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -50.68 38.83 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -46.55 -51.82 14.71 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 123.422 1.582 . . . . 0.0 107.488 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 40' ' ' LEU . 15.5 mtpp -55.16 -54.2 46.23 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -49.1 -42.03 37.66 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.341 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 85.5 t -67.57 -53.49 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.393 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.813 HG21 HG21 ' A' ' 66' ' ' VAL . 45.6 mt -60.3 -51.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.084 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 36' ' ' LYS . 1.3 mp -52.68 -27.75 18.75 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.575 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 39.4 tp60 -68.98 -23.75 64.16 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.1 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.19 -53.37 3.82 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.283 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 18.6 ttpp -116.7 76.69 7.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.24 -45.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 123.387 2.725 . . . . 0.0 117.446 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.25 0.7 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 16.3 mt-30 -77.94 60.74 2.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.651 ' HA ' ' HG3' ' A' ' 65' ' ' ARG . 65.6 mt -73.22 140.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 43.1 mm -115.86 175.7 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.607 1.194 . . . . 0.0 112.645 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.477 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 17.2 t -102.52 116.09 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 110.279 -3.146 . . . . 0.0 108.327 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 13.4 mt -124.04 92.18 48.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.05 127.94 27.76 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 N-CA-C 109.286 -1.082 . . . . 0.0 109.286 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.429 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -43.18 127.89 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.877 0 CA-C-O 123.613 1.673 . . . . 0.0 111.186 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 -21.04 35.42 Favored Glycine 1 N--CA 1.517 4.063 0 CA-C-N 109.587 -3.461 . . . . 0.0 112.778 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.626 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.333 23.7 m -68.25 62.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 173.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 mm -51.11 112.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 124.308 2.004 . . . . 0.0 116.382 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' CG2' ' HE2' ' A' ' 69' ' ' PHE . 30.2 m -103.56 167.82 2.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 110.106 -3.225 . . . . 0.0 104.394 175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 -171.68 2.3 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 108.852 -3.794 . . . . 0.0 111.958 -174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.3 tpp -92.23 23.76 3.69 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.073 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.03 166.21 16.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.631 ' CD2' ' HA2' ' A' ' 83' ' ' GLY . 8.3 t80 -145.59 154.19 41.89 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.601 ' N ' ' CD2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -116.43 62.1 0.72 Allowed 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.619 HD12 HG12 ' A' ' 82' ' ' VAL . 5.3 tp -44.54 -27.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.07 -24.37 24.9 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.154 -2.294 . . . . 0.0 108.261 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HG3' ' HA ' ' A' ' 48' ' ' ILE 0.269 7.1 ttm-85 -129.38 158.77 38.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 110.375 -3.102 . . . . 0.0 114.434 -168.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 39' ' ' ILE . 3.1 t -103.8 140.86 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -81.34 115.55 20.76 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 80' ' ' PRO . 10.3 mp -113.46 84.79 2.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.518 1.136 . . . . 0.0 112.791 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 36.0 m-85 -74.41 104.77 5.27 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 127.238 3.399 . . . . 0.0 106.361 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 32' ' ' VAL . 21.3 m -99.51 172.17 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.042 1 CA-C-N 107.166 -4.561 . . . . 0.0 105.833 -177.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.6 p-10 -95.43 -142.4 0.26 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 123.793 2.997 . . . . 0.0 113.688 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.2 ttpp -92.02 9.4 33.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.732 -3.395 . . . . 0.0 110.34 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.4 mt -142.71 38.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 111.513 -2.585 . . . . 0.0 110.74 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.69 20.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -176.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.5 m-20 -104.61 142.3 34.9 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.943 1.354 . . . . 0.0 108.845 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 44.7 mt -63.28 113.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 126.518 3.056 . . . . 0.0 112.359 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.488 . . -88.51 -51.34 5.76 Favored 'General case' 0 C--N 1.283 -2.294 2 CA-C-N 103.479 -6.237 . . . . 0.0 107.909 -173.258 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -118.02 157.84 26.06 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 28' ' ' VAL . 94.4 t -63.66 138.64 97.43 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 115.75 -2.38 . . . . 0.0 112.482 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 3.5 Cg_exo -86.63 157.13 9.09 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.58 2.186 . . . . 0.0 108.26 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.44 HH21 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -154.5 150.24 27.59 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.142 -176.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG12 HD12 ' A' ' 63' ' ' ILE 0.278 21.9 t -89.13 105.09 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.729 1.268 . . . . 0.0 107.783 175.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.631 ' HA2' ' CD2' ' A' ' 61' ' ' TYR . . . . . . . . 0 C--N 1.27 -3.121 0 C-N-CA 117.7 -2.191 . . . . 0.0 110.853 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -101.29 17.84 21.54 Favored 'General case' 0 N--CA 1.526 3.354 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -140.15 151.89 45.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 125.105 1.503 . . . . 0.0 114.327 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.565 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 29.4 m-90 -134.53 73.16 68.72 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 123.762 1.744 . . . . 0.0 112.944 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' A' ' 28' ' ' VAL . 13.1 Cg_endo -77.45 -34.77 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.702 1.601 . . . . 0.0 111.576 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -62.35 -18.89 62.61 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 123.402 1.572 . . . . 0.0 109.429 -177.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -97.94 15.31 24.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.528 HG21 HG22 ' A' ' 79' ' ' VAL . 99.2 t -73.53 164.45 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.838 -1.164 . . . . 0.0 108.325 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 2.1 89.75 Favored Glycine 1 N--CA 1.518 4.112 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.809 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.582 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 14.5 mtmm -130.05 168.51 16.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.312 1.045 . . . . 0.0 108.536 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 10.7 p -87.82 160.08 18.16 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 127.835 3.683 . . . . 0.0 114.319 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -45.76 -50.88 3.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 1 CA-C-N 105.277 -5.42 . . . . 0.0 116.141 -172.738 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 8.8 mm-40 -54.99 -42.41 72.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.082 -1.011 . . . . 0.0 112.162 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.98 -46.59 74.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.448 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -51.64 -49.37 62.42 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.116 -1.434 . . . . 0.0 111.336 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 57.5 mtpt -53.04 -50.2 64.78 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 52.5 mttp -50.9 -46.65 60.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.99 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 84.2 t -61.1 -56.9 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-O 124.685 2.183 . . . . 0.0 111.309 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.71 ' CG2' HG21 ' A' ' 66' ' ' VAL . 35.3 mt -54.38 -45.84 69.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.011 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 46' ' ' ALA . 91.7 mt -58.13 -36.51 73.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.728 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 55.9 tt0 -63.55 -39.33 94.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.183 -1.407 . . . . 0.0 110.933 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.41 -45.96 29.31 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.101 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 63.7 tttm -125.18 66.86 53.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -9.83 -57.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 1 C-N-CA 125.466 4.111 . . . . 0.0 121.233 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -82.59 1.49 37.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -57.74 84.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.21 111.01 7.05 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.58 HG12 ' H ' ' A' ' 66' ' ' VAL . 20.2 mt -107.77 152.37 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 50' ' ' VAL . 18.6 mm -124.58 163.06 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 123.752 1.739 . . . . 0.0 114.009 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.457 ' CB ' HG21 ' A' ' 32' ' ' VAL . 7.1 p -106.76 118.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 112.316 -2.22 . . . . 0.0 113.805 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 5.7 mp -128.6 136.58 29.33 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.095 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.79 135.97 20.22 Favored 'Trans proline' 0 N--CA 1.512 2.58 0 C-N-CA 123.017 2.478 . . . . 0.0 109.059 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 72.1 t -43.16 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-N 120.437 1.471 . . . . 0.0 114.894 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.32 -39.82 2.47 Favored Glycine 0 N--CA 1.51 3.581 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.902 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.653 ' HB ' ' CZ ' ' A' ' 69' ' ' PHE . 22.4 m -47.61 168.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.787 1.28 . . . . 0.0 113.803 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.79 118.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.638 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -114.91 -77.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.362 174.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 78.6 9.77 Favored 'General case' 0 C--N 1.283 -2.326 1 N-CA-C 124.172 4.879 . . . . 0.0 124.172 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' A' ' 60' ' ' GLU . 1.9 tpt -98.99 -128.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 1 CA-C-N 107.153 -4.567 . . . . 0.0 104.098 176.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.545 ' CD ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.87 -169.49 2.38 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 172.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.652 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 39.3 t80 -118.04 102.56 9.14 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.72 -1.238 . . . . 0.0 112.311 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 65' ' ' ARG . 2.1 mpt_? -90.83 68.46 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 124.188 1.947 . . . . 0.0 108.739 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.749 HD12 HG11 ' A' ' 82' ' ' VAL . 4.6 tp -42.34 -29.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 112.681 -2.054 . . . . 0.0 116.026 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 2.2 p30 -57.04 -17.43 10.1 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 124.16 1.933 . . . . 0.0 111.448 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 62' ' ' ARG . 21.6 ttp85 -132.14 149.7 52.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.71 HG21 ' CG2' ' A' ' 39' ' ' ILE . 3.3 t -106.73 139.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' CZ ' ' HA ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.15 124.69 44.38 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 67' ' ' ARG . 2.7 mp -109.29 90.39 3.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 125.879 1.987 . . . . 0.0 110.761 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.653 ' CZ ' ' HB ' ' A' ' 55' ' ' THR . 12.8 m-85 -70.99 110.96 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 126.155 2.883 . . . . 0.0 110.475 170.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.9 m -103.25 170.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-N 108.912 -3.767 . . . . 0.0 109.221 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.7 p-10 -93.43 -140.62 0.22 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 124.285 1.993 . . . . 0.0 112.033 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -92.14 6.82 45.15 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 110.545 -3.025 . . . . 0.0 111.21 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 72.1 mt -136.74 32.08 2.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.534 -2.121 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 34.96 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.97 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 45.0 m-20 -108.47 137.94 45.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.4 mt -61.51 111.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 126.431 3.015 . . . . 0.0 112.796 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.475 . . -90.22 -47.01 8.06 Favored 'General case' 0 C--N 1.288 -2.108 2 CA-C-N 103.27 -6.332 . . . . 0.0 108.657 -173.842 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -117.14 157.15 26.42 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 111.556 -2.565 . . . . 0.0 107.765 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.528 HG22 HG21 ' A' ' 28' ' ' VAL . 94.5 t -75.4 141.03 72.89 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 115.122 -2.631 . . . . 0.0 108.74 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.573 ' HG2' HD11 ' A' ' 27' ' ' LEU . 6.5 Cg_exo -84.25 158.68 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.56 2.173 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 156.65 32.49 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.032 -1.461 . . . . 0.0 109.195 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG11 HD12 ' A' ' 63' ' ' ILE . 23.9 t -74.93 144.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.258 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.652 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . . . . . . 0 N--CA 1.509 3.53 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.63 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 123.584 1.659 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -98.34 1.74 47.34 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.554 ' HB2' ' NH2' ' A' ' 81' ' ' ARG . 0.6 OUTLIER -139.68 155.9 47.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.635 0.731 . . . . 0.0 111.736 172.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.498 ' CG ' HG12 ' A' ' 39' ' ' ILE . 30.1 m-90 -118.87 71.93 10.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -70.71 -30.54 17.72 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.054 1.169 . . . . 0.0 109.501 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -66.06 2.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.916 0.865 . . . . 0.0 109.979 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.521 HD13 ' HB1' ' A' ' 35' ' ' ALA . 31.3 mt -103.97 -8.07 19.9 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.653 -0.654 . . . . 0.0 110.902 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 79' ' ' VAL . 53.2 t -66.51 107.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 123.148 1.452 . . . . 0.0 108.846 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.56 5.04 22.94 Favored Glycine 0 N--CA 1.506 3.306 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.639 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' NZ ' ' CD ' ' A' ' 34' ' ' GLU . 1.5 mmmp? -111.69 167.6 10.22 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.736 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -88.28 173.18 8.92 Favored 'General case' 0 CA--C 1.443 -3.14 0 CA-C-O 123.008 1.385 . . . . 0.0 112.791 177.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.709 ' CG2' HG11 ' A' ' 70' ' ' VAL . 1.4 p -80.98 -55.62 7.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 108.903 -3.771 . . . . 0.0 115.641 -171.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 35.1 mm-40 -62.83 -21.13 65.7 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 122.362 2.346 . . . . 0.0 109.867 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 38.0 tt0 -75.9 -49.07 18.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.521 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -46.33 -52.5 12.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 82.0 tttt -48.05 -46.58 33.49 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 112.768 -2.015 . . . . 0.0 106.645 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 40.4 tttm -55.54 -54.3 45.65 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.487 -1.285 . . . . 0.0 109.891 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 69.1 t -59.02 -47.88 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 CA-C-O 124.291 1.996 . . . . 0.0 111.734 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 66' ' ' VAL . 14.7 mt -56.16 -51.8 58.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 112.764 -2.017 . . . . 0.0 109.21 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -61.93 -37.66 85.53 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 29.5 tp60 -58.92 -24.25 62.22 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.205 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' OD2' ' NE1' ' A' ' 24' ' ' TRP . 49.5 t0 -96.2 -51.53 4.37 Favored 'General case' 0 N--CA 1.523 3.194 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.01 75.28 21.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -9.79 -55.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 2 C-N-CA 126.121 4.547 . . . . 0.0 122.717 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -89.67 -0.29 57.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . . . -42.27 97.75 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.437 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 93.4 mm-40 -87.59 65.21 8.44 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 39' ' ' ILE . 46.6 mt -72.26 127.03 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 121.456 3.873 . . . . 0.0 121.456 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.441 HD13 HH12 ' A' ' 65' ' ' ARG . 1.7 mp -123.14 128.23 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.062 -3.245 . . . . 0.0 106.085 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 51' ' ' LEU . 12.4 p -81.07 158.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 126.411 2.319 . . . . 0.0 113.129 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 HG21 ' A' ' 55' ' ' THR . 0.8 OUTLIER -141.1 151.65 62.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -85.48 131.83 4.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.145 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 70' ' ' VAL . 13.3 t -42.33 133.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 106.75 -31.27 8.39 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 110.273 -3.149 . . . . 0.0 113.487 -178.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.624 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.312 40.2 m -48.62 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.8 1.24 . . . . 0.0 108.186 175.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' GLY . 21.1 mm -53.61 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 125.033 2.349 . . . . 0.0 112.274 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.619 HG21 ' HE2' ' A' ' 69' ' ' PHE . 7.0 m -98.75 -173.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 110.046 -3.252 . . . . 0.0 105.776 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -92.43 144.95 24.85 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 111.68 -2.509 . . . . 0.0 116.231 -174.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.11 40.14 1.06 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.291 1.52 . . . . 0.0 108.388 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 19.4 pt-20 -83.14 -171.97 3.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.589 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -137.47 74.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 123.614 1.673 . . . . 0.0 113.914 178.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' ASP . 15.5 mmt180 -89.69 68.22 7.55 Favored 'General case' 0 C--N 1.294 -1.843 1 N-CA-C 97.865 -4.865 . . . . 0.0 97.865 176.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 HG11 ' A' ' 82' ' ' VAL . 6.5 tp -43.85 -1.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' ARG . 3.1 p30 -85.67 -9.11 57.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.492 1.917 . . . . 0.0 108.71 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.441 HH12 HD13 ' A' ' 49' ' ' ILE . 38.9 ttm-85 -128.53 148.76 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 -172.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.723 HG21 HG21 ' A' ' 39' ' ' ILE . 4.2 t -117.27 120.63 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 1 N-CA-C 99.214 -4.365 . . . . 0.0 99.214 170.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.595 HH21 ' C ' ' A' ' 83' ' ' GLY . 3.1 tpp85 -79.92 117.14 20.5 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD23 HG23 ' A' ' 32' ' ' VAL . 10.0 mp -107.76 93.06 4.34 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 124.533 1.146 . . . . 0.0 110.633 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.624 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 26.5 m-85 -79.43 102.43 8.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 126.124 2.869 . . . . 0.0 109.93 170.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.709 HG11 ' CG2' ' A' ' 32' ' ' VAL . 2.3 m -108.93 177.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 108.475 -3.966 . . . . 0.0 109.47 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.6 p-10 -101.96 -142.77 0.35 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 124.478 2.085 . . . . 0.0 113.533 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -86.67 -2.09 58.24 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 109.021 -3.718 . . . . 0.0 113.09 -178.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 54.3 mt -135.84 37.95 2.82 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 37.13 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 65.6 m-20 -109.73 149.95 29.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -72.8 121.63 23.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 126.911 3.243 . . . . 0.0 116.983 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.462 . . -106.05 -42.58 5.06 Favored 'General case' 0 C--N 1.295 -1.796 2 CA-C-N 103.671 -6.149 . . . . 0.0 112.559 -173.213 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 27.8 mt-30 -111.46 153.97 25.37 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.524 HG22 ' CG2' ' A' ' 28' ' ' VAL . 62.8 t -75.9 139.89 70.09 Favored Pre-proline 0 N--CA 1.508 2.447 0 C-N-CA 112.547 -3.661 . . . . 0.0 106.893 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 9.7 Cg_exo -78.92 152.12 24.67 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 N-CA-C 106.673 -2.087 . . . . 0.0 106.673 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.554 ' NH2' ' HB2' ' A' ' 23' ' ' GLU . 7.7 ptp180 -160.76 159.31 29.91 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.079 -1.048 . . . . 0.0 112.041 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.55 HG11 HD12 ' A' ' 63' ' ' ILE . 5.4 t -78.24 143.66 12.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 124.265 1.983 . . . . 0.0 111.36 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.595 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C--N 1.296 -1.64 0 CA-C-N 110.014 -3.266 . . . . 0.0 110.215 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p -100.87 16.44 25.17 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.599 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.79 153.74 51.5 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 125.253 1.596 . . . . 0.0 110.267 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -128.49 60.44 48.41 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 123.075 1.416 . . . . 0.0 114.714 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -53.47 -35.95 77.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.417 2.078 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -48.05 -31.32 5.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.136 1.446 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.56 HD11 HG13 ' A' ' 39' ' ' ILE . 56.0 mt -79.77 -26.85 40.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.886 -1.961 . . . . 0.0 114.847 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG2' HG22 ' A' ' 79' ' ' VAL . 14.3 t -50.92 137.83 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 117.877 -1.529 . . . . 0.0 107.59 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.23 -13.9 66.54 Favored Glycine 0 N--CA 1.505 3.238 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.305 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -111.34 166.84 10.77 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 117.438 0.619 . . . . 0.0 111.617 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.2 p -90.62 164.32 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 128.273 3.892 . . . . 0.0 115.119 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.69 -31.22 6.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 105.511 -5.313 . . . . 0.0 121.921 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -50.25 13.8 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 123.336 1.541 . . . . 0.0 107.195 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.673 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 2.2 tm-20 -50.67 -52.1 43.09 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 102.75 -3.055 . . . . 0.0 102.75 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.71 -60.16 3.14 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.952 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -48.37 -49.07 36.07 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.673 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 8.9 ttpp -53.1 -53.45 50.12 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.626 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.456 HG23 ' HZ1' ' A' ' 37' ' ' LYS . 90.5 t -60.64 -55.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 CA-C-O 123.432 1.587 . . . . 0.0 111.607 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.779 HG21 HG21 ' A' ' 66' ' ' VAL . 23.0 mt -53.54 -43.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.871 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 46' ' ' ALA . 60.3 mt -64.99 -38.06 89.72 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.387 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -57.79 -48.29 80.14 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.441 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.66 -47.18 73.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.78 -1.555 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HE3' HG11 ' A' ' 82' ' ' VAL . 58.8 tttm -124.74 71.83 60.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 C-N-CA 124.513 1.125 . . . . 0.0 111.617 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -21.58 -50.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 124.35 3.366 . . . . 0.0 118.331 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 0.34 43.19 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -59.87 92.31 0.02 OUTLIER 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' ASP . 19.3 tt0 -75.72 70.4 2.51 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.571 HG12 ' H ' ' A' ' 66' ' ' VAL . 47.5 mt -72.68 141.22 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.852 -2.431 . . . . 0.0 117.135 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.451 ' HB ' ' HD3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -125.91 156.52 35.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 123.075 1.417 . . . . 0.0 108.063 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.85 142.78 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 111.964 -2.38 . . . . 0.0 106.854 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 1.4 mt -137.17 125.29 14.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.59 135.12 35.03 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.049 1.41 . . . . 0.0 108.857 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 70' ' ' VAL . 2.6 t -44.02 123.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.957 0.885 . . . . 0.0 112.742 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.22 -35.58 3.85 Favored Glycine 0 N--CA 1.513 3.803 0 O-C-N 128.075 3.359 . . . . 0.0 113.278 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.701 ' HB ' ' CE1' ' A' ' 69' ' ' PHE . 60.1 m -47.61 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.463 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mm -53.4 97.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 124.437 2.065 . . . . 0.0 112.481 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.564 HG21 ' HE2' ' A' ' 69' ' ' PHE . 14.7 m -97.26 -176.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 110.76 -2.927 . . . . 0.0 105.563 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.33 147.1 24.27 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 112.197 -2.274 . . . . 0.0 115.328 -172.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtp -91.55 34.23 0.98 Allowed 'General case' 0 N--CA 1.515 2.788 0 CA-C-O 124.929 2.299 . . . . 0.0 112.315 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.444 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 24.1 pt-20 -83.71 -163.25 0.74 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 109.134 -3.666 . . . . 0.0 115.299 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.65 67.16 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.06 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.444 ' HE ' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.39 66.73 7.54 Favored 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 126.608 3.099 . . . . 0.0 105.865 177.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.582 HD12 HG11 ' A' ' 82' ' ' VAL . 4.9 tp -42.8 -8.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 109.717 -3.401 . . . . 0.0 119.446 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 65' ' ' ARG . 45.8 p30 -80.86 -5.7 57.67 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 119.588 1.086 . . . . 0.0 108.166 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.465 HH21 ' CG ' ' A' ' 64' ' ' ASP 0.26 15.9 ttm-85 -137.45 147.58 45.44 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -174.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.779 HG21 HG21 ' A' ' 39' ' ' ILE . 5.2 t -101.33 140.06 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 1 N-CA-C 99.205 -4.369 . . . . 0.0 99.205 173.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.408 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 1.5 tpp180 -89.44 120.11 30.48 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.9 mt -111.33 88.15 2.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 126.066 2.104 . . . . 0.0 114.036 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.701 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 38.2 m-85 -81.76 99.62 9.06 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 127.852 3.691 . . . . 0.0 107.734 170.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 5.7 m -100.19 171.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 1 CA-C-N 106.042 -5.072 . . . . 0.0 106.75 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.4 p-10 -87.72 -141.02 0.11 Allowed 'General case' 0 C--N 1.293 -1.874 0 O-C-N 118.818 -2.426 . . . . 0.0 110.72 -175.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 44.3 mmtm -95.88 8.2 44.25 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 110.256 -3.156 . . . . 0.0 112.683 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.1 mt -137.59 32.46 2.51 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.198 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' HA ' ' CG2' ' A' ' 70' ' ' VAL 0.322 3.9 p-10 31.9 41.71 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 m-80 -113.46 151.47 31.4 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 110.93 -2.85 . . . . 0.0 104.968 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -80.69 117.68 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 125.415 2.531 . . . . 0.0 113.695 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 71' ' ' ASP 0.416 . . -105.37 -38.71 6.4 Favored 'General case' 0 C--N 1.298 -1.644 2 CA-C-N 104.062 -5.972 . . . . 0.0 114.344 -174.049 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 155.87 27.23 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.533 HG22 ' CG2' ' A' ' 28' ' ' VAL . 67.2 t -75.46 147.72 82.45 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 113.628 -3.229 . . . . 0.0 109.155 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HG2' HD12 ' A' ' 27' ' ' LEU . 25.4 Cg_exo -73.05 139.35 29.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.24 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.377 -1.329 . . . . 0.0 110.281 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 63' ' ' ILE . 14.9 t -82.09 134.09 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 117.374 -1.731 . . . . 0.0 114.522 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.494 2.505 0 C-N-CA 118.957 -1.592 . . . . 0.0 113.968 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HE3' ' NE1' ' A' ' 24' ' ' TRP . 4.4 tmtm? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 68.1 p -120.95 20.02 11.62 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 109.066 -3.697 . . . . 0.0 111.028 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.566 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -153.11 159.38 42.76 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 126.327 1.851 . . . . 0.0 113.33 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.62 ' NE1' ' HE3' ' A' ' 21' ' ' LYS . 11.6 m-90 -139.32 64.91 33.45 Favored Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.596 ' HA ' HG21 ' A' ' 79' ' ' VAL . 75.6 Cg_exo -53.85 -40.05 81.92 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.407 2.738 . . . . 0.0 111.184 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 14.6 mp0 -50.5 -27.88 7.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 123.767 1.746 . . . . 0.0 109.671 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CD1' HG13 ' A' ' 39' ' ' ILE . 29.4 mt -79.46 -24.09 42.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 116.542 -1.694 . . . . 0.0 113.514 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.742 HG23 ' CG2' ' A' ' 79' ' ' VAL . 95.7 t -47.97 136.72 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -17.49 55.16 Favored Glycine 0 N--CA 1.51 3.591 0 C-N-CA 119.371 -1.395 . . . . 0.0 112.487 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -113.73 161.76 17.12 Favored 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.759 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.5 p -86.55 153.82 21.54 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 126.548 3.07 . . . . 0.0 115.102 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.298 4.3 p -38.9 -56.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 1 CA-C-N 107.128 -4.578 . . . . 0.0 117.446 -174.131 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.39 -23.8 65.61 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 120.508 1.504 . . . . 0.0 113.833 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -77.46 -48.94 15.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.46 -44.13 62.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' CG ' HD12 ' A' ' 40' ' ' LEU . 36.7 ttmt -54.53 -47.2 73.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.084 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -54.13 -48.81 70.38 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 124.901 1.376 . . . . 0.0 110.758 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.3 t -64.99 -48.0 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 124.133 1.92 . . . . 0.0 112.029 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.78 HG21 HG21 ' A' ' 66' ' ' VAL . 31.4 mt -55.89 -55.39 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.961 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD12 ' CG ' ' A' ' 36' ' ' LYS . 3.8 mt -64.74 -22.86 67.08 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.131 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 17.5 tp60 -66.46 -29.04 69.08 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.742 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -97.02 -53.47 3.49 Favored 'General case' 0 N--CA 1.517 2.914 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 20.0 tptp -118.75 72.15 10.79 Favored Pre-proline 0 N--CA 1.506 2.342 0 O-C-N 120.168 -1.583 . . . . 0.0 112.04 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -20.03 -50.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 124.684 3.589 . . . . 0.0 120.144 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.1 mp0 -63.8 -22.21 66.8 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.49 84.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 120.084 3.364 . . . . 0.0 120.084 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -75.33 74.59 2.43 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.521 HD11 HG21 ' A' ' 39' ' ' ILE . 23.9 mt -76.47 121.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 50' ' ' VAL . 3.9 mp -119.29 163.05 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 173.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.6 p -85.01 130.2 36.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 111.153 -2.748 . . . . 0.0 106.982 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.688 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -129.12 102.02 19.15 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.58 118.39 5.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 120.912 1.075 . . . . 0.0 113.686 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 69' ' ' PHE . 2.4 t -38.81 134.3 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 118.186 2.662 . . . . 0.0 118.186 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 113.61 -37.28 3.66 Favored Glycine 0 N--CA 1.506 3.362 1 CA-C-N 108.232 -4.076 . . . . 0.0 107.13 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' VAL 0.297 80.7 m -56.07 69.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.91 1.684 . . . . 0.0 108.235 174.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' GLY . 11.5 mm -62.63 116.76 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.445 1.593 . . . . 0.0 109.832 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.469 HG21 ' HD3' ' A' ' 67' ' ' ARG . 18.4 m -98.67 -168.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 111.325 -2.671 . . . . 0.0 112.428 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.17 150.37 24.0 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 117.824 2.528 . . . . 0.0 117.824 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.7 mmm -91.71 47.61 1.38 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 123.044 1.402 . . . . 0.0 107.336 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' CD ' ' HB2' ' A' ' 62' ' ' ARG . 13.0 pt-20 -81.16 -179.55 7.4 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.488 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.559 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 1.1 t80 -127.57 41.91 3.42 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 125.479 2.561 . . . . 0.0 107.817 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 64' ' ' ASP . 3.6 mpt_? -88.43 77.42 8.1 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.744 ' HA ' HG12 ' A' ' 82' ' ' VAL . 8.7 tp -67.23 22.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.747 1 CA-C-N 107.835 -4.257 . . . . 0.0 116.931 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 62' ' ' ARG . 2.3 p-10 -95.93 -11.82 26.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 110.195 -3.184 . . . . 0.0 108.971 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 6.3 mtm180 -129.46 88.1 2.64 Favored 'General case' 0 N--CA 1.503 2.194 1 N-CA-C 128.496 6.48 . . . . 0.0 128.496 -173.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.78 HG21 HG21 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.83 83.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 121.898 2.135 . . . . 0.0 107.072 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.469 ' HD3' HG21 ' A' ' 57' ' ' VAL . 2.2 ptp180 -59.32 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 111.23 -2.714 . . . . 0.0 111.088 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 80' ' ' PRO . 53.9 mt -73.99 100.17 3.49 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 116.993 -1.883 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.7 m-85 -74.63 98.86 3.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 127.624 3.583 . . . . 0.0 107.268 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.1 m -100.9 165.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 1 CA-C-N 107.267 -4.515 . . . . 0.0 107.21 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.9 p-10 -89.91 -140.61 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 115.935 -2.306 . . . . 0.0 107.973 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 11.3 mptt -95.78 8.98 42.01 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 111.12 -2.763 . . . . 0.0 113.906 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.431 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 31.1 mt -137.6 39.32 2.42 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 112.242 -2.254 . . . . 0.0 107.164 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 33.91 28.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 118.86 2.911 . . . . 0.0 118.86 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.0 m-20 -104.76 148.59 26.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.443 HG21 HG23 ' A' ' 79' ' ' VAL . 23.0 mt -74.93 120.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 126.446 3.022 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.48 . . -104.54 -52.81 2.82 Favored 'General case' 0 C--N 1.285 -2.227 2 CA-C-N 102.468 -6.697 . . . . 0.0 107.794 -173.592 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 69' ' ' PHE . 6.3 mp0 -119.98 84.91 2.29 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.761 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.742 ' CG2' HG23 ' A' ' 28' ' ' VAL . 1.2 t -42.2 147.71 0.55 Allowed Pre-proline 0 N--CA 1.503 2.18 0 C-N-CA 117.079 -1.848 . . . . 0.0 115.69 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -89.19 -170.79 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.473 3.449 . . . . 0.0 119.51 -175.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.532 HH11 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -156.46 136.35 12.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.961 -3.291 . . . . 0.0 105.556 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 63' ' ' ILE . 96.7 t -53.65 -63.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 125.888 2.756 . . . . 0.0 109.67 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.532 ' C ' HH11 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.291 -1.919 1 CA-C-N 107.705 -4.316 . . . . 0.0 105.459 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 7.4 tmtm? . . . . . 0 N--CA 1.483 1.185 1 N-CA-C 99.302 -4.332 . . . . 0.0 99.302 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -98.78 13.29 32.87 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.214 -2.721 . . . . 0.0 111.839 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.4 146.56 40.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 126.27 2.231 . . . . 0.0 113.625 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.603 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 19.6 m-90 -131.16 64.7 74.51 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -60.08 -33.96 94.89 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.951 2.434 . . . . 0.0 111.234 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.05 -12.1 3.09 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.201 1.477 . . . . 0.0 109.336 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.603 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 17.9 mt -99.31 2.86 45.8 Favored 'General case' 0 CA--C 1.56 1.36 0 O-C-N 121.123 -0.986 . . . . 0.0 112.365 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG2' HG22 ' A' ' 79' ' ' VAL . 88.6 t -73.4 127.07 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-N 120.652 1.569 . . . . 0.0 107.068 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.6 4.04 57.18 Favored Glycine 0 N--CA 1.505 3.298 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -117.63 160.83 20.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -89.6 153.21 20.93 Favored 'General case' 0 CA--C 1.474 -1.967 0 CA-C-O 125.989 2.804 . . . . 0.0 114.696 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.576 ' HB ' HG11 ' A' ' 70' ' ' VAL 0.318 11.6 p -42.37 -62.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.415 1 CA-C-N 107.533 -4.394 . . . . 0.0 118.215 -172.265 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.23 -18.51 63.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.514 -1.674 . . . . 0.0 111.356 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 36.7 tt0 -76.61 -45.75 28.88 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.501 ' CA ' HD13 ' A' ' 27' ' ' LEU . . . -54.38 -55.64 26.58 Favored 'General case' 0 C--O 1.205 -1.251 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -48.5 -49.6 35.17 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.717 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 3.2 ttpp -52.94 -44.29 66.96 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.555 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' N ' ' HZ2' ' A' ' 37' ' ' LYS . 78.4 t -70.66 -47.08 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 CA-C-O 122.156 0.979 . . . . 0.0 112.252 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.712 HG21 HG21 ' A' ' 66' ' ' VAL . 40.5 mt -48.24 -48.27 13.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 122.932 1.348 . . . . 0.0 109.691 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 46' ' ' ALA . 31.1 mt -59.91 -22.27 62.18 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.364 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -16.16 57.31 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.451 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.39 -52.54 3.93 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.749 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mmmp? -119.08 77.99 16.76 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -19.06 -56.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.503 4.135 . . . . 0.0 120.728 -177.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.48 8.27 19.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.494 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -52.83 87.05 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -77.24 70.71 3.67 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 176.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.527 HD11 ' CG2' ' A' ' 39' ' ' ILE . 62.1 mt -74.3 148.04 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 112.383 -2.19 . . . . 0.0 116.794 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.11 152.76 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.969 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 32' ' ' VAL . 3.5 p -93.6 122.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 112.84 -1.982 . . . . 0.0 113.404 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.618 HD23 HG21 ' A' ' 55' ' ' THR . 1.4 mp -136.77 141.58 35.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.5 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -80.38 139.54 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.369 1.38 . . . . 0.0 108.769 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 69' ' ' PHE . 41.7 t -43.81 127.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.98 -34.82 4.67 Favored Glycine 1 N--CA 1.523 4.448 0 CA-C-N 111.179 -2.737 . . . . 0.0 115.613 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.618 HG21 HD23 ' A' ' 51' ' ' LEU 0.253 50.2 m -45.03 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.981 1.312 . . . . 0.0 112.695 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.45 106.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 CA-C-O 122.58 1.181 . . . . 0.0 111.545 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.617 HG21 ' HE2' ' A' ' 69' ' ' PHE . 1.7 m -111.38 -106.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 85.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 1 N-CA-C 123.297 4.554 . . . . 0.0 123.297 -173.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 18.5 mmm -95.11 -47.57 6.32 Favored 'General case' 0 N--CA 1.501 2.116 1 CA-C-N 106.874 -4.694 . . . . 0.0 105.426 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' HB2' HH21 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -82.94 -175.9 6.06 Favored 'General case' 0 C--N 1.284 -2.279 3 CA-C-N 103.161 -6.381 . . . . 0.0 112.062 179.385 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.535 ' CE2' HD13 ' A' ' 63' ' ' ILE . 20.8 t80 -157.97 85.66 0.89 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.586 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.542 HH21 ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -100.84 81.76 2.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 175.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.668 HD12 HG11 ' A' ' 82' ' ' VAL 0.262 6.0 tp -42.54 -6.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.136 1 CA-C-N 108.341 -4.027 . . . . 0.0 117.007 177.711 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.1 p30 -93.88 7.27 45.6 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.228 1.011 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.572 ' HD2' ' CZ ' ' A' ' 67' ' ' ARG . 20.0 ttp180 -129.78 140.38 51.06 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 39' ' ' ILE . 9.6 t -111.52 150.68 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 122.918 2.599 . . . . 0.0 106.073 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.77 112.77 24.48 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.326 -177.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.58 85.14 2.4 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.343 1.652 . . . . 0.0 109.458 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.617 ' HE2' HG21 ' A' ' 57' ' ' VAL . 29.6 m-85 -83.54 97.42 9.02 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 127.335 3.445 . . . . 0.0 109.965 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.576 HG11 ' HB ' ' A' ' 32' ' ' VAL . 4.4 m -104.24 174.09 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 1 CA-C-N 105.746 -5.206 . . . . 0.0 109.392 -175.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.6 p-10 -99.74 -148.77 0.35 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 124.163 1.935 . . . . 0.0 109.28 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.33 17.17 14.95 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 111.26 -2.7 . . . . 0.0 113.641 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -133.8 26.16 3.99 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 111.222 -2.717 . . . . 0.0 103.715 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.28 0.0 OUTLIER 33.36 35.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.61 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.7 m-20 -113.42 154.91 26.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.6 mt -78.21 119.85 27.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 126.483 3.039 . . . . 0.0 115.423 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.474 . . -98.51 -45.61 6.04 Favored 'General case' 0 C--N 1.293 -1.874 2 CA-C-N 103.662 -6.154 . . . . 0.0 111.696 -173.668 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -117.72 160.66 20.96 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.549 HG22 ' CG2' ' A' ' 28' ' ' VAL . 89.4 t -71.68 146.56 91.2 Favored Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 114.052 -3.059 . . . . 0.0 110.282 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 8.1 Cg_exo -79.13 159.28 26.79 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.331 2.021 . . . . 0.0 109.6 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 79' ' ' VAL . 8.7 ptp85 -160.38 162.11 33.27 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 117.376 -1.297 . . . . 0.0 113.659 -176.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 63' ' ' ILE . 2.9 t -84.55 150.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.197 0 C-N-CA 126.6 2.048 . . . . 0.0 114.427 176.239 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -100.0 19.59 15.97 Favored 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 112.079 -2.328 . . . . 0.0 112.292 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -142.63 151.41 41.43 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.204 176.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.578 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 30.5 m-90 -127.84 75.37 78.19 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.616 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.2 -18.02 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.352 2.035 . . . . 0.0 111.071 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -77.58 -28.68 51.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 2.0 pp -92.27 23.48 3.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.391 1.091 . . . . 0.0 113.918 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 79' ' ' VAL . 55.7 t -72.53 167.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.83 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.01 36.58 20.94 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-O 123.209 1.449 . . . . 0.0 112.799 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 50.2 mttp -138.1 174.58 10.41 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 112.203 -1.999 . . . . 0.0 110.534 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 p -85.51 159.85 19.82 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 125.321 2.486 . . . . 0.0 114.331 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG2' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -64.25 -32.35 57.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 1 CA-C-N 108.324 -4.035 . . . . 0.0 109.719 -175.739 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 44.5 mm-40 -63.81 -46.41 85.24 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.024 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.36 -54.93 41.47 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 126.327 2.267 . . . . 0.0 105.079 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -45.69 -54.85 7.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.354 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.5 mtpt -49.43 -56.44 9.69 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -54.45 -48.43 71.75 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.05 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 94.2 t -57.71 -56.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 CA-C-O 124.787 2.232 . . . . 0.0 110.646 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.772 HG21 HG21 ' A' ' 66' ' ' VAL . 37.9 mt -55.32 -45.68 77.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.57 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 26.1 mt -56.49 -38.72 72.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 8.7 tt0 -59.0 -44.77 91.71 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.816 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.04 -47.74 60.81 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.782 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 63.6 tttm -125.23 74.84 67.98 Favored Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -7.77 -65.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 1 C-N-CA 125.487 4.125 . . . . 0.0 120.139 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.575 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -88.34 7.12 33.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 -177.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.517 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -43.95 103.23 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -85.24 83.47 7.98 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.586 HD11 ' CG2' ' A' ' 39' ' ' ILE . 68.5 mt -80.31 135.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 111.581 -2.554 . . . . 0.0 115.809 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 48' ' ' ILE . 1.8 mp -125.95 137.68 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 111.956 -2.384 . . . . 0.0 111.522 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.481 ' C ' HD12 ' A' ' 51' ' ' LEU . 12.1 p -95.81 145.51 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 5.5 mp -141.12 149.62 56.1 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -81.55 135.38 9.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 N-CA-C 105.474 -2.548 . . . . 0.0 105.474 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 69' ' ' PHE . 87.4 t -42.91 130.48 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.31 -41.1 2.11 Favored Glycine 1 N--CA 1.519 4.214 0 CA-C-N 111.528 -2.578 . . . . 0.0 112.977 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.636 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.258 11.4 m -50.02 165.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 125.279 1.432 . . . . 0.0 111.338 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mm -61.14 136.05 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.68 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -123.69 -77.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.015 176.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 83.73 6.41 Favored 'General case' 0 C--N 1.295 -1.78 1 N-CA-C 122.698 4.333 . . . . 0.0 122.698 -179.115 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 tpt -97.44 -137.11 0.27 Allowed 'General case' 0 C--N 1.29 -2.003 1 CA-C-N 107.769 -4.287 . . . . 0.0 103.273 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 60' ' ' GLU 0.277 0.1 OUTLIER -78.4 -174.07 3.6 Favored 'General case' 0 C--N 1.288 -2.105 1 N-CA-C 98.843 -4.503 . . . . 0.0 98.843 170.168 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 7.9 t80 -120.33 135.85 54.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.015 -2.303 . . . . 0.0 117.059 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -115.56 64.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 124.074 1.892 . . . . 0.0 106.844 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.638 HD12 HG11 ' A' ' 82' ' ' VAL . 5.8 tp -42.83 -7.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.8 p30 -81.66 -9.83 59.56 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 124.207 1.003 . . . . 0.0 110.035 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -129.07 149.3 50.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 120.562 3.541 . . . . 0.0 120.562 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.772 HG21 HG21 ' A' ' 39' ' ' ILE . 5.0 t -110.18 132.21 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 101.962 -3.347 . . . . 0.0 101.962 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.64 ' NH1' ' HA ' ' A' ' 57' ' ' VAL . 16.8 tpp85 -89.83 116.21 27.74 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.779 -2.01 . . . . 0.0 108.098 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 80' ' ' PRO . 7.6 mp -107.92 90.97 3.46 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 124.816 1.323 . . . . 0.0 113.996 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 57' ' ' VAL . 22.5 m-85 -76.34 103.52 6.4 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 125.588 2.613 . . . . 0.0 112.153 169.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 4.5 m -109.77 171.78 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-N 109.077 -3.692 . . . . 0.0 109.074 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -93.62 -140.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.494 -2.004 . . . . 0.0 111.818 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.4 mmtm -88.51 0.91 55.81 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 110.911 -2.859 . . . . 0.0 112.303 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 38.5 mt -136.97 39.52 2.55 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 111.62 -2.537 . . . . 0.0 109.846 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.57 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -178.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 53.7 m-20 -105.27 142.31 35.27 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.532 HD13 ' HG2' ' A' ' 80' ' ' PRO . 79.9 mt -67.18 116.98 7.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 126.69 3.138 . . . . 0.0 114.561 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 53' ' ' VAL 0.468 . . -102.82 -40.61 6.49 Favored 'General case' 0 C--N 1.289 -2.057 1 CA-C-N 104.414 -5.812 . . . . 0.0 111.815 -172.198 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.2 163.72 15.87 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 102.266 -3.235 . . . . 0.0 102.266 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 28' ' ' VAL . 78.1 t -77.3 141.22 66.06 Favored Pre-proline 0 N--CA 1.499 1.998 0 C-N-CA 114.092 -3.043 . . . . 0.0 110.235 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.532 ' HG2' HD13 ' A' ' 76' ' ' ILE . 14.6 Cg_exo -80.84 145.49 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.544 2.829 . . . . 0.0 106.464 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -153.28 168.45 25.98 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.502 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.638 HG11 HD12 ' A' ' 63' ' ' ILE . 25.0 t -82.64 154.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 116.731 -1.987 . . . . 0.0 113.105 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.561 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.511 3.636 0 C-N-CA 125.937 1.732 . . . . 0.0 114.01 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' CG ' ' A' ' 42' ' ' ASP . 37.3 mtpt . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 122.968 1.366 . . . . 0.0 112.517 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 45.6 p -128.94 19.26 6.04 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.331 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -156.88 150.58 24.57 Favored 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.731 178.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CE3' ' C ' ' A' ' 23' ' ' GLU . 20.3 m-90 -133.77 59.89 42.39 Favored Pre-proline 0 N--CA 1.516 2.83 0 N-CA-C 121.118 3.747 . . . . 0.0 121.118 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' N ' HG13 ' A' ' 79' ' ' VAL . 52.8 Cg_exo -48.98 -40.3 40.58 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 124.098 3.198 . . . . 0.0 110.983 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 4.8 mp0 -46.38 -30.41 2.11 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.621 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 32.6 mt -79.65 -27.37 40.88 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.775 ' CG2' HG22 ' A' ' 79' ' ' VAL . 30.8 t -48.05 137.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.85 -4.12 71.79 Favored Glycine 0 N--CA 1.508 3.446 0 CA-C-N 114.566 -1.197 . . . . 0.0 113.255 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 32.4 mtmm -114.27 178.42 4.29 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.504 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.7 p -85.71 171.56 11.53 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 127.518 3.533 . . . . 0.0 116.867 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.1 p -72.15 -18.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 1 CA-C-N 104.863 -5.608 . . . . 0.0 112.752 -176.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -85.42 -49.09 8.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 24.4 mt-10 -50.06 -52.78 31.73 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' CB ' HD13 ' A' ' 27' ' ' LEU . . . -50.91 -44.21 60.0 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.406 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' ILE . 61.1 mttm -62.05 -49.14 77.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.082 1.765 . . . . 0.0 108.24 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -54.97 -52.76 62.04 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.976 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 84.9 t -61.8 -54.99 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.239 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.662 ' CG2' HG21 ' A' ' 66' ' ' VAL . 32.2 mt -55.34 -51.0 60.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.095 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' PRO . 96.9 mt -57.37 -33.28 67.64 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 24.1 mt-30 -59.81 -43.76 94.35 Favored 'General case' 0 N--CA 1.516 2.871 0 C-N-CA 117.432 -1.707 . . . . 0.0 110.137 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' CG ' ' NZ ' ' A' ' 21' ' ' LYS . 52.0 m-20 -72.63 -53.06 12.86 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 82' ' ' VAL . 26.3 tptp -121.43 57.17 6.79 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 112.347 -2.206 . . . . 0.0 108.389 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 12.5 Cg_exo -12.48 -65.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 125.198 3.932 . . . . 0.0 120.414 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.74 24.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -71.22 124.67 25.01 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-O 122.442 1.115 . . . . 0.0 111.203 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -91.71 67.9 5.46 Favored 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.543 HG12 ' HB ' ' A' ' 66' ' ' VAL . 20.6 mt -72.37 134.4 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 119.359 3.096 . . . . 0.0 119.359 -173.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 50' ' ' VAL . 40.5 mm -103.53 175.22 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 113.385 -1.734 . . . . 0.0 111.569 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.6 p -106.4 118.19 53.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 126.516 1.926 . . . . 0.0 111.516 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.786 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 16.7 mt -136.29 119.41 12.21 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.399 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 27.3 Cg_exo -70.45 138.44 35.62 Favored 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 123.51 2.807 . . . . 0.0 110.465 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.459 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 32.7 t -42.28 131.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.45 99.07 1.92 Allowed Glycine 0 N--CA 1.509 3.555 2 N-CA-C 96.215 -6.754 . . . . 0.0 96.215 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.717 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -68.24 116.2 8.57 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -171.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -83.14 -0.24 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 126.036 2.827 . . . . 0.0 111.036 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' CG2' ' HE2' ' A' ' 69' ' ' PHE . 24.9 m -110.62 -173.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 108.592 -3.913 . . . . 0.0 111.61 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.489 ' OG1' ' NH1' ' A' ' 62' ' ' ARG . 2.8 p -87.09 -178.53 6.28 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.9 tpt -91.03 -38.08 13.03 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 125.961 2.791 . . . . 0.0 115.345 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 9.5 pt-20 -49.82 -160.68 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.34 1 CA-C-N 105.061 -5.518 . . . . 0.0 117.24 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.824 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 57.8 t80 -114.76 70.84 0.74 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.695 1.247 . . . . 0.0 113.376 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.655 ' H ' ' CD ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -88.22 66.13 8.34 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 126.718 3.152 . . . . 0.0 109.602 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.824 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.23 -31.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 2 N-CA-C 125.652 5.427 . . . . 0.0 125.652 -179.079 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.543 ' CG ' HH22 ' A' ' 65' ' ' ARG . 6.4 p-10 -55.09 -18.11 5.03 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 123.458 1.599 . . . . 0.0 108.058 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.738 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 14.8 ttp-105 -135.45 104.37 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 82' ' ' VAL . 18.4 t -62.04 136.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 123.495 2.861 . . . . 0.0 104.193 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.771 ' CZ ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -96.57 134.89 39.22 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.038 -1.865 . . . . 0.0 112.577 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.771 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 80.5 mt -114.96 81.3 1.54 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.855 -1.975 . . . . 0.0 111.432 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.786 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 9.4 m-85 -73.7 102.93 4.1 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 126.713 3.149 . . . . 0.0 105.26 167.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -100.75 167.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 1 CA-C-N 107.481 -4.418 . . . . 0.0 106.301 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.5 p-10 -91.39 -141.44 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 123.386 2.812 . . . . 0.0 112.424 -177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.547 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 9.9 mptt -91.66 5.22 50.52 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 111.055 -2.793 . . . . 0.0 114.939 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 73' ' ' LEU 0.264 0.5 OUTLIER -138.6 34.52 2.23 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.6 176.893 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.62 48.03 0.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 124.665 2.174 . . . . 0.0 110.005 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -115.0 142.71 46.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 172.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.63 119.55 15.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 124.359 2.028 . . . . 0.0 112.846 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.477 . . -103.21 -35.67 8.37 Favored 'General case' 0 C--N 1.297 -1.707 2 CA-C-N 104.687 -5.688 . . . . 0.0 110.726 -174.875 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.53 126.63 53.6 Favored 'General case' 0 N--CA 1.52 3.049 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.12 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.87 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 94.2 t -78.38 -75.83 0.07 OUTLIER Pre-proline 0 N--CA 1.516 2.831 1 N-CA-C 124.997 5.184 . . . . 0.0 124.997 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.87 ' HD3' ' HB ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -66.6 51.3 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.613 2 N-CA-C 133.547 8.249 . . . . 0.0 133.547 -171.795 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.501 HH21 ' C ' ' A' ' 83' ' ' GLY 0.262 0.0 OUTLIER -170.69 120.65 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 2 N-CA-C 131.144 7.461 . . . . 0.0 131.144 172.956 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.666 ' HA ' HG22 ' A' ' 66' ' ' VAL . 4.4 t -51.26 -23.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 111.939 -2.391 . . . . 0.0 113.853 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.501 ' C ' HH21 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.28 -2.569 0 O-C-N 128.786 3.804 . . . . 0.0 103.605 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 42.5 tptt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.659 0.742 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -112.37 24.53 12.44 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-O 122.733 1.254 . . . . 0.0 110.601 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -136.77 146.03 45.27 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 112.729 -2.032 . . . . 0.0 108.999 175.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.585 ' CZ3' HG23 ' A' ' 82' ' ' VAL . 15.6 m-90 -129.95 62.78 65.77 Favored Pre-proline 0 N--CA 1.522 3.156 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.624 ' HA ' HG21 ' A' ' 79' ' ' VAL . 77.9 Cg_exo -53.68 -38.92 84.88 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.978 3.118 . . . . 0.0 111.586 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 30.4 mp0 -49.58 -28.65 5.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.919 1.343 . . . . 0.0 110.333 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' A' ' 35' ' ' ALA . 74.4 mt -79.92 -19.99 46.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.671 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.677 HG23 ' CG2' ' A' ' 79' ' ' VAL . 59.9 t -49.73 137.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 121.625 2.011 . . . . 0.0 107.831 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.65 -9.03 66.36 Favored Glycine 0 N--CA 1.515 3.922 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.27 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 35.0 mmtm -106.45 166.92 10.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.404 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.418 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 1.9 p -88.46 165.81 14.64 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 126.679 3.133 . . . . 0.0 116.533 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 68' ' ' LEU 0.255 0.3 OUTLIER -60.84 -50.51 80.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 1 CA-C-N 107.174 -4.557 . . . . 0.0 116.569 -174.241 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 41.1 mm-40 -68.17 -37.55 81.11 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.572 -1.651 . . . . 0.0 111.127 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -58.98 -51.09 71.58 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.406 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -49.82 -59.08 4.17 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.293 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 48' ' ' ILE 0.303 21.7 tttm -44.55 -53.78 6.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 54.5 mttp -53.47 -53.93 44.3 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.6 -2.091 . . . . 0.0 111.072 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.6 t -59.53 -52.3 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 123.941 1.829 . . . . 0.0 113.193 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 66' ' ' VAL . 15.8 mt -54.17 -50.94 51.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.101 -2.318 . . . . 0.0 107.864 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.64 -14.12 56.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 124.294 0.996 . . . . 0.0 112.675 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -80.27 -21.13 43.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -97.0 -52.12 3.98 Favored 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 82' ' ' VAL . 10.7 tptp -118.35 72.94 10.19 Favored Pre-proline 0 N--CA 1.514 2.754 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -9.76 -51.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 1 C-N-CA 125.421 4.081 . . . . 0.0 120.495 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.4 mp0 -71.89 -23.28 61.47 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.27 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.479 1.133 . . . . 0.0 113.713 -177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -87.57 71.3 9.77 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 39' ' ' ILE . 56.0 mt -74.03 142.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.35 160.92 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 1 CA-C-N 107.687 -4.324 . . . . 0.0 110.053 -179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.04 119.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 112.254 -2.248 . . . . 0.0 106.83 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.538 HD13 ' CZ ' ' A' ' 69' ' ' PHE . 1.5 mt -135.2 121.24 14.3 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 117.249 2.314 . . . . 0.0 117.249 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 32.5 Cg_exo -64.66 127.84 19.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 N-CA-C 108.438 -1.408 . . . . 0.0 108.438 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 69' ' ' PHE . 5.2 p -57.77 139.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 123.876 1.798 . . . . 0.0 113.58 177.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.19 -15.55 27.86 Favored Glycine 1 N--CA 1.521 4.309 0 CA-C-N 110.747 -2.933 . . . . 0.0 113.049 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.304 17.6 m -45.56 139.28 3.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.0 mm -80.54 82.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 CA-C-N 123.156 2.707 . . . . 0.0 111.773 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.675 HG21 ' CE2' ' A' ' 69' ' ' PHE . 1.5 m -127.27 156.56 38.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.986 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.57 178.05 5.73 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 109.275 -3.602 . . . . 0.0 115.049 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.584 ' SD ' ' CD ' ' A' ' 81' ' ' ARG . 1.2 tpt -89.41 67.13 7.63 Favored 'General case' 0 N--CA 1.494 1.741 1 N-CA-C 96.432 -5.396 . . . . 0.0 96.432 173.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' CD ' ' NH1' ' A' ' 62' ' ' ARG . 10.3 pt-20 -78.44 154.24 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.417 ' HE1' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -111.83 50.81 0.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.956 1.836 . . . . 0.0 111.783 -176.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NH1' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mpt_? -90.88 72.76 6.54 Favored 'General case' 0 N--CA 1.491 1.595 1 N-CA-C 94.973 -5.936 . . . . 0.0 94.973 175.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' HA ' HG12 ' A' ' 82' ' ' VAL . 6.6 tp -40.87 -4.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' NH2' ' A' ' 65' ' ' ARG . 3.9 p-10 -99.3 2.86 45.84 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HG3' ' H ' ' A' ' 67' ' ' ARG . 8.7 tpp180 -123.95 95.51 4.59 Favored 'General case' 0 N--CA 1.498 1.969 1 N-CA-C 124.97 5.174 . . . . 0.0 124.97 -170.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -89.2 52.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 115.264 -2.574 . . . . 0.0 105.62 177.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.496 HH11 ' CD ' ' A' ' 60' ' ' GLU . 9.9 ptm180 -48.0 116.46 1.52 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 123.714 1.721 . . . . 0.0 111.703 -174.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' CD2' ' HG2' ' A' ' 80' ' ' PRO . 67.3 mt -82.15 93.08 6.98 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 109.341 -3.572 . . . . 0.0 115.668 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 57' ' ' VAL . 37.0 m-85 -74.39 96.06 2.81 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 126.811 3.196 . . . . 0.0 108.45 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 18.1 m -106.82 174.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.304 1 CA-C-N 106.937 -4.665 . . . . 0.0 110.422 -174.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.5 p-10 -95.95 -141.55 0.27 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 124.919 2.295 . . . . 0.0 112.769 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 58.6 mttp -83.98 -8.11 59.24 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 108.971 -3.741 . . . . 0.0 113.457 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.287 0.5 OUTLIER -137.41 48.13 2.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 124.924 2.297 . . . . 0.0 109.677 178.73 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.82 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 2.5 m120 -99.71 142.57 31.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.752 1.263 . . . . 0.0 108.222 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.37 117.7 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 126.389 2.995 . . . . 0.0 115.279 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.459 . . -98.48 -44.27 6.56 Favored 'General case' 0 C--N 1.283 -2.306 2 CA-C-N 103.905 -6.043 . . . . 0.0 109.86 -172.273 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -117.43 118.88 33.43 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 101.073 -3.677 . . . . 0.0 101.073 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.677 ' CG2' HG23 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -73.1 137.65 79.03 Favored Pre-proline 0 N--CA 1.501 2.106 1 C-N-CA 110.947 -4.301 . . . . 0.0 109.818 -178.455 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HG2' ' CD2' ' A' ' 68' ' ' LEU . 5.8 Cg_exo -82.16 169.75 14.13 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 123.901 3.067 . . . . 0.0 113.836 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.584 ' CD ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -145.87 154.18 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.592 ' CG2' HG22 ' A' ' 66' ' ' VAL . 70.8 t -71.97 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.734 2 CA-C-N 107.048 -4.615 . . . . 0.0 102.923 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 31.3 tttp . . . . . 0 N--CA 1.485 1.3 1 N-CA-C 99.634 -4.21 . . . . 0.0 99.634 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 8.3 p -106.42 -6.29 18.33 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 118.264 -1.374 . . . . 0.0 108.386 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' OE2' ' HG3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -130.69 136.01 48.37 Favored 'General case' 0 N--CA 1.523 3.214 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -176.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.721 ' CZ2' HG23 ' A' ' 39' ' ' ILE . 29.6 m-90 -126.45 71.62 72.14 Favored Pre-proline 0 N--CA 1.513 2.71 1 N-CA-C 126.553 5.76 . . . . 0.0 126.553 -176.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' TRP . 70.5 Cg_endo -68.08 -35.41 19.99 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.143 1.229 . . . . 0.0 113.828 176.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 23.0 mp0 -57.61 -37.88 74.02 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 126.344 2.973 . . . . 0.0 114.097 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.568 ' HA ' ' NZ ' ' A' ' 30' ' ' LYS . 4.2 pp -78.57 -16.06 57.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.239 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 79' ' ' VAL . 93.3 t -49.51 157.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.913 0 O-C-N 123.22 0.325 . . . . 0.0 110.554 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.74 -13.76 46.08 Favored Glycine 1 N--CA 1.518 4.151 0 O-C-N 120.347 -1.47 . . . . 0.0 113.901 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.568 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.08 167.88 10.59 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 117.203 -1.379 . . . . 0.0 112.671 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.5 p -86.52 159.62 19.23 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 127.039 3.304 . . . . 0.0 114.747 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.8 p -45.46 -23.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 1 CA-C-N 106.847 -4.706 . . . . 0.0 119.015 -174.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.565 ' CG ' ' H ' ' A' ' 34' ' ' GLU . 14.3 pt-20 -67.2 -58.67 4.41 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.796 0.808 . . . . 0.0 109.293 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.565 ' H ' ' CG ' ' A' ' 33' ' ' GLU . 2.5 tt0 -56.97 -50.43 72.71 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB1' ' CD1' ' A' ' 68' ' ' LEU . . . -47.77 -51.58 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 117.573 -1.651 . . . . 0.0 112.711 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.679 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 17.5 mtpp -58.36 -52.8 64.07 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 4.3 tmtm? -48.6 -41.1 29.77 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.926 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 62.3 t -69.11 -60.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.925 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.721 HG23 ' CZ2' ' A' ' 24' ' ' TRP . 42.9 mt -56.05 -53.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.186 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mp -56.92 -23.74 47.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.419 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 57.3 tp60 -67.65 -33.5 75.07 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.119 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 51.0 m-20 -92.59 -49.49 6.08 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 80.45 32.39 Favored Pre-proline 0 N--CA 1.515 2.82 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -35.19 -31.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.574 0 N-CA-C 120.408 3.195 . . . . 0.0 120.408 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.72 -0.23 57.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.843 0.714 . . . . 0.0 112.289 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.46 99.32 0.14 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.699 1.238 . . . . 0.0 111.738 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.26 113.7 25.97 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.679 ' HB ' ' HG2' ' A' ' 36' ' ' LYS . 21.8 mt -105.47 155.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.406 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 42.4 mm -125.19 169.74 16.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.581 -3.009 . . . . 0.0 105.899 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' CG2' HG21 ' A' ' 70' ' ' VAL . 8.7 p -107.25 142.43 20.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -139.51 122.27 10.37 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 178.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HD2' HD23 ' A' ' 51' ' ' LEU . 55.1 Cg_endo -72.7 129.14 14.15 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.27 1.98 . . . . 0.0 112.319 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 69' ' ' PHE . 6.7 t -42.2 133.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.52 -27.0 19.73 Favored Glycine 0 N--CA 1.512 3.72 0 CA-C-N 109.552 -3.476 . . . . 0.0 112.683 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.45 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.305 51.8 m -60.66 178.38 0.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 126.28 1.832 . . . . 0.0 112.928 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 57' ' ' VAL . 14.1 mt -86.46 154.18 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -140.45 -59.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.972 1 N-CA-C 122.666 4.321 . . . . 0.0 122.666 177.113 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 78.14 6.89 Favored 'General case' 0 C--N 1.288 -2.093 1 N-CA-C 123.098 4.481 . . . . 0.0 123.098 -177.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 88.9 mtp -97.13 -144.14 0.29 Allowed 'General case' 0 C--N 1.291 -1.942 1 CA-C-N 104.459 -5.791 . . . . 0.0 104.352 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.3 pm0 -60.5 -142.31 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 O-C-N 124.854 1.346 . . . . 0.0 112.393 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.673 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -100.25 113.46 26.17 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.339 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.635 ' NH2' ' HB2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -105.54 39.66 1.71 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 123.925 1.821 . . . . 0.0 110.056 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.673 ' HB ' ' CE1' ' A' ' 61' ' ' TYR . 8.6 tp -56.37 -25.64 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 110.098 -3.228 . . . . 0.0 117.351 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -70.44 -11.12 60.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 62' ' ' ARG . 23.0 ttp180 -135.06 163.13 30.59 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -176.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 39' ' ' ILE . 16.1 t -117.08 128.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -102.47 110.11 21.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 114.03 -3.068 . . . . 0.0 114.207 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 39' ' ' ILE . 6.1 mt -107.49 104.79 14.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 111.515 -2.584 . . . . 0.0 106.65 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.677 ' HB3' HG22 ' A' ' 53' ' ' VAL . 8.9 m-85 -69.18 122.24 18.4 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.875 -1.93 . . . . 0.0 107.861 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' A' ' 50' ' ' VAL . 8.3 m -102.46 170.97 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 110.642 -2.981 . . . . 0.0 105.948 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -96.45 -135.88 0.24 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 117.144 -1.823 . . . . 0.0 112.129 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -91.34 3.01 55.97 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 110.405 -3.089 . . . . 0.0 112.306 177.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.433 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 73.5 mt -135.78 34.43 2.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.769 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.29 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -178.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -102.98 139.05 39.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 13.1 mt -64.37 115.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.219 0 CA-C-O 126.491 3.043 . . . . 0.0 112.177 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.579 . . -97.98 -39.3 9.02 Favored 'General case' 0 C--N 1.281 -2.394 1 CA-C-N 105.158 -5.474 . . . . 0.0 101.979 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 33.8 mt-30 -115.95 129.24 56.3 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.638 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 98.8 t -44.6 -61.83 1.93 Allowed Pre-proline 0 N--CA 1.514 2.765 1 N-CA-C 125.148 5.24 . . . . 0.0 125.148 177.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.261 0.0 OUTLIER 4.8 -161.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 2 C-N-CA 131.114 7.876 . . . . 0.0 128.61 -168.582 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.466 ' C ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -145.78 175.19 10.59 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -161.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 66' ' ' VAL . 21.6 t -68.22 137.34 24.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 109.099 -3.682 . . . . 0.0 108.416 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.503 3.139 0 CA-C-O 114.911 -3.16 . . . . 0.0 117.92 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 8.9 mtpm? . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -107.16 7.25 29.43 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.515 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -142.74 150.72 40.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 126.15 2.156 . . . . 0.0 112.096 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.617 ' CE3' HG11 ' A' ' 66' ' ' VAL . 25.4 m-90 -132.45 79.51 65.12 Favored Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 28' ' ' VAL . 15.9 Cg_endo -77.48 -30.85 3.76 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 120.872 1.048 . . . . 0.0 110.021 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 21' ' ' LYS . 3.0 pm0 -51.8 -20.88 2.42 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 122.501 1.143 . . . . 0.0 113.459 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.1 pp -107.93 16.19 23.7 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 79' ' ' VAL . 22.3 t -70.64 155.92 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-O 122.343 1.068 . . . . 0.0 112.104 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.29 18.05 70.95 Favored Glycine 0 N--CA 1.512 3.735 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.927 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -128.69 167.48 17.17 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 116.843 -1.551 . . . . 0.0 110.278 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -91.01 166.18 13.14 Favored 'General case' 0 CA--C 1.472 -2.045 1 CA-C-O 128.573 4.035 . . . . 0.0 115.508 179.81 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' A' ' 50' ' ' VAL . 1.4 p -53.92 -29.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 1 CA-C-N 103.175 -6.375 . . . . 0.0 115.435 -174.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.03 -37.54 23.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.718 -1.239 . . . . 0.0 111.992 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 46.5 mt-10 -61.02 -48.09 83.42 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -47.14 -50.78 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.683 -1.607 . . . . 0.0 112.962 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 58.3 mttp -51.2 -51.46 53.63 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.682 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.3 -47.41 69.25 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.04 -2.345 . . . . 0.0 108.868 -178.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.424 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 96.2 t -59.16 -57.64 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 CA-C-O 123.555 1.645 . . . . 0.0 111.944 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.563 ' CG2' HG21 ' A' ' 66' ' ' VAL . 14.0 mt -54.98 -46.44 76.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.221 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 96.0 mt -57.18 -33.55 67.59 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 38' ' ' VAL . 48.2 mt-30 -64.42 -19.6 65.62 Favored 'General case' 0 N--CA 1.519 3.023 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.457 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -96.07 -58.59 2.05 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.24 1.416 . . . . 0.0 110.457 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -121.94 67.8 24.24 Favored Pre-proline 0 N--CA 1.499 1.997 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.328 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.96 -45.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 125.107 3.872 . . . . 0.0 120.271 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -81.14 -5.26 57.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.64 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -76.44 77.74 3.17 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.626 HG12 ' H ' ' A' ' 66' ' ' VAL . 44.2 mt -74.89 133.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.7 mp -117.43 162.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 112.463 -2.153 . . . . 0.0 113.119 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 32' ' ' VAL . 7.7 p -106.02 131.47 55.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 112.913 -1.949 . . . . 0.0 114.488 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 5.1 mp -138.94 155.87 72.81 Favored Pre-proline 0 N--CA 1.508 2.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -81.38 130.49 7.11 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 121.737 1.624 . . . . 0.0 109.794 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 69' ' ' PHE . 93.7 t -40.44 132.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.43 1.97 Allowed Glycine 0 N--CA 1.505 3.265 0 CA-C-N 110.353 -3.112 . . . . 0.0 108.168 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.586 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 43.3 m -47.09 131.35 12.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.871 1.32 . . . . 0.0 109.264 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.693 ' H ' HD12 ' A' ' 56' ' ' ILE . 1.9 mp -52.01 113.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.618 HG13 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -104.1 -70.57 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.32 66.54 4.8 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 127.345 3.45 . . . . 0.0 118.757 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -99.66 -119.39 0.15 Allowed 'General case' 0 C--N 1.288 -2.095 1 CA-C-N 104.405 -5.816 . . . . 0.0 106.245 -179.085 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -72.51 -152.22 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 108.998 -3.728 . . . . 0.0 105.461 171.145 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.544 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -128.84 91.59 3.25 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -176.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.663 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -94.77 66.22 3.12 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 127.496 3.522 . . . . 0.0 105.937 175.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.588 HD12 HG11 ' A' ' 82' ' ' VAL . 2.7 tp -59.91 -25.13 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 1 CA-C-N 106.549 -4.841 . . . . 0.0 114.019 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.51 24.93 1.55 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.8 ttm-85 -158.16 131.64 7.66 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.626 ' H ' HG12 ' A' ' 48' ' ' ILE . 12.4 t -104.86 70.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 C-N-CA 116.543 -2.063 . . . . 0.0 105.979 173.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.615 ' HD3' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -45.98 138.11 5.3 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.119 1.914 . . . . 0.0 112.157 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.23 116.65 33.1 Favored 'General case' 0 C--N 1.295 -1.786 1 CA-C-N 108.304 -4.044 . . . . 0.0 112.775 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.618 ' HE2' HG13 ' A' ' 57' ' ' VAL . 42.8 m-85 -93.14 99.56 12.12 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 125.721 2.677 . . . . 0.0 110.162 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.487 HG11 ' CG2' ' A' ' 32' ' ' VAL . 1.1 m -111.01 177.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 1 CA-C-N 107.787 -4.279 . . . . 0.0 113.508 -174.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -106.67 -141.87 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 124.177 1.942 . . . . 0.0 113.906 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -83.99 -5.41 59.22 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 110.338 -3.119 . . . . 0.0 113.091 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.5 mt -136.12 43.18 2.54 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 111.075 -2.784 . . . . 0.0 111.171 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.3 OUTLIER 33.15 30.26 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.1 m-20 -106.83 141.0 38.76 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 123.455 1.598 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.61 93.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 127.756 3.646 . . . . 0.0 116.329 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.44 . . -74.41 -40.72 61.83 Favored 'General case' 0 C--N 1.289 -2.053 2 CA-C-N 100.718 -7.492 . . . . 0.0 110.516 -179.273 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . 9.0 tt0 -119.52 158.71 25.74 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 ' CG2' ' A' ' 28' ' ' VAL . 97.2 t -76.92 138.39 65.7 Favored Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 114.506 -2.877 . . . . 0.0 110.71 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.6 Cg_exo -75.89 165.73 29.43 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.773 2.315 . . . . 0.0 110.193 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.579 HH12 HG21 ' A' ' 57' ' ' VAL . 9.3 ptp85 -162.77 167.94 22.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.588 HG11 HD12 ' A' ' 63' ' ' ILE . 37.5 t -82.61 133.53 28.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 C-N-CA 118.964 -1.095 . . . . 0.0 109.69 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.414 ' OXT' ' HD3' ' A' ' 67' ' ' ARG . . . . . . . . 0 CA--C 1.548 2.138 0 O-C-N 125.32 1.638 . . . . 0.0 112.428 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 81.2 tttt . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 122.273 1.035 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -97.41 26.55 4.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 7.5 pt-20 -138.62 156.4 47.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.822 1.326 . . . . 0.0 112.743 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.673 ' NE1' ' HA ' ' A' ' 39' ' ' ILE . 11.7 m-90 -134.56 78.61 55.9 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 28' ' ' VAL . 66.8 Cg_endo -75.2 -26.21 10.82 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 120.598 0.865 . . . . 0.0 113.993 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 16.1 mp0 -51.33 -29.62 15.76 Favored 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 124.845 2.26 . . . . 0.0 110.11 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.98 -27.9 49.23 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.035 -177.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG2' HG22 ' A' ' 79' ' ' VAL . 58.5 t -49.02 136.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 CA-C-N 119.97 1.259 . . . . 0.0 112.335 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.83 2.01 69.92 Favored Glycine 0 N--CA 1.507 3.407 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.169 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -126.09 169.49 12.73 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.65 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -87.59 177.13 7.15 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 125.331 2.491 . . . . 0.0 113.829 176.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.58 -37.4 77.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 109.863 -3.335 . . . . 0.0 115.716 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.66 -48.32 69.74 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.509 -1.276 . . . . 0.0 111.162 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 58.5 mm-40 -60.07 -42.1 93.83 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB1' HD23 ' A' ' 27' ' ' LEU . . . -53.52 -60.94 2.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.74 -1.225 . . . . 0.0 110.419 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 55.2 mtpt -45.68 -50.22 13.75 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.339 1.066 . . . . 0.0 108.806 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 73.3 tttt -48.99 -47.64 44.04 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.031 -2.804 . . . . 0.0 109.142 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.64 -49.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 124.731 1.269 . . . . 0.0 112.686 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.673 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 11.1 mt -48.11 -47.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.476 0.655 . . . . 0.0 111.448 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 46' ' ' ALA 0.252 96.0 mt -63.88 -12.81 39.97 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.921 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.99 -47.31 18.78 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.96 -52.72 26.05 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 124.831 2.253 . . . . 0.0 110.773 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 57.6 tttm -122.76 70.06 36.96 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.137 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -28.44 -45.19 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.844 3.029 . . . . 0.0 119.603 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.93 8.85 24.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -64.96 113.14 3.66 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 116.953 -1.899 . . . . 0.0 115.483 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -82.44 67.77 8.62 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.735 -1.853 . . . . 0.0 106.273 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.567 HD11 HG21 ' A' ' 39' ' ' ILE . 2.8 mp -80.77 137.7 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 124.19 1.948 . . . . 0.0 115.528 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.3 mp -120.27 177.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 109.908 -3.315 . . . . 0.0 109.628 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 12.1 p -98.33 125.26 51.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.58 1.181 . . . . 0.0 109.48 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 9.7 mt -122.47 89.06 49.46 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.422 ' HG2' ' OG1' ' A' ' 55' ' ' THR . 37.8 Cg_endo -53.39 130.39 38.29 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 O-C-N 119.005 -1.103 . . . . 0.0 113.436 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 69' ' ' PHE . 54.8 t -45.36 115.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 123.133 1.444 . . . . 0.0 111.157 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.36 8.1 Favored Glycine 0 N--CA 1.513 3.78 1 CA-C-N 107.779 -4.282 . . . . 0.0 115.039 -173.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.539 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.284 1.4 m -56.94 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 118.945 1.372 . . . . 0.0 107.908 177.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.31 110.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 120.085 3.365 . . . . 0.0 120.085 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.63 HG21 ' HE2' ' A' ' 69' ' ' PHE . 35.3 m -124.12 177.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 108.473 -3.967 . . . . 0.0 110.672 176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -94.89 142.87 26.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 109.759 -3.382 . . . . 0.0 112.574 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.3 tpt -93.28 57.9 2.75 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 123.399 2.818 . . . . 0.0 104.419 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 20.2 pt-20 -80.49 -169.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 111.18 -2.736 . . . . 0.0 113.208 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.642 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 12.8 t80 -140.21 63.33 1.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.634 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.28 74.61 7.0 Favored 'General case' 0 N--CA 1.486 1.331 1 N-CA-C 97.91 -4.848 . . . . 0.0 97.91 174.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.642 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.07 -20.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 109.899 -3.319 . . . . 0.0 116.334 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -62.52 4.24 0.16 Allowed 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.904 1.335 . . . . 0.0 109.466 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.5 ttm-85 -149.87 154.71 38.81 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.66 HG21 ' CG2' ' A' ' 39' ' ' ILE . 3.2 t -115.99 135.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 1 N-CA-C 99.454 -4.276 . . . . 0.0 99.454 176.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.563 ' HD3' HG21 ' A' ' 57' ' ' VAL . 8.9 ttm-85 -94.49 126.19 39.61 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.837 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 48' ' ' ILE . 11.1 mp -110.59 76.81 1.0 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.526 2.391 . . . . 0.0 112.048 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.63 ' HE2' HG21 ' A' ' 57' ' ' VAL . 26.1 m-85 -74.98 102.44 4.81 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 126.996 3.284 . . . . 0.0 105.468 168.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 53' ' ' VAL . 18.7 m -100.77 179.75 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.326 1 CA-C-N 106.055 -5.066 . . . . 0.0 109.975 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.591 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -89.43 -145.49 0.16 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 117.438 -3.289 . . . . 0.0 111.425 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.591 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.6 -4.95 59.25 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 111.336 -2.666 . . . . 0.0 115.62 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 73' ' ' LEU 0.266 0.6 OUTLIER -138.02 48.47 1.98 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 126.875 3.226 . . . . 0.0 106.959 176.938 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 34.58 37.02 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.302 -3.135 . . . . 0.0 116.663 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -106.9 147.73 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 124.14 1.924 . . . . 0.0 107.633 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.92 97.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 127.176 3.369 . . . . 0.0 116.623 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.374 . . -73.1 -48.81 32.55 Favored 'General case' 0 C--N 1.29 -2.016 2 CA-C-N 100.257 -7.701 . . . . 0.0 111.767 179.71 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -119.1 155.85 30.8 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.636 HG22 ' CG2' ' A' ' 28' ' ' VAL . 89.2 t -72.47 142.89 84.64 Favored Pre-proline 0 N--CA 1.507 2.392 0 C-N-CA 114.312 -2.955 . . . . 0.0 108.505 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 7.0 Cg_exo -82.11 159.03 17.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 123.549 2.833 . . . . 0.0 108.725 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 7.7 ptp85 -162.57 171.81 16.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 108.257 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 35.9 t -79.5 140.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.15 0 CA-C-O 116.399 -2.334 . . . . 0.0 109.946 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' A' ' 23' ' ' GLU . 81.9 tttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -113.78 21.03 15.36 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.151 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -143.94 132.52 22.31 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 118.381 2.734 . . . . 0.0 118.381 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.605 ' CE2' HG23 ' A' ' 39' ' ' ILE . 21.3 m-90 -119.1 67.73 8.83 Favored Pre-proline 0 N--CA 1.504 2.234 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -61.9 -36.25 73.44 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 120.867 1.045 . . . . 0.0 110.889 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 21' ' ' LYS . 8.1 pm0 -49.8 -25.02 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.677 1.227 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.546 HD13 ' HB1' ' A' ' 35' ' ' ALA . 52.1 mt -77.07 -34.19 57.09 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.657 -177.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 79' ' ' VAL . 60.5 t -45.91 135.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.545 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 -177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.84 -15.5 59.47 Favored Glycine 0 N--CA 1.513 3.803 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.129 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -119.49 176.02 5.56 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -87.97 156.43 19.34 Favored 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.787 3.184 . . . . 0.0 118.314 176.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -54.45 -46.76 70.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 1 CA-C-N 107.426 -4.443 . . . . 0.0 116.545 -175.848 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 63.1 mm-40 -54.46 -49.38 70.19 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 116.883 -1.927 . . . . 0.0 111.203 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -49.88 -53.61 24.75 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 124.333 2.016 . . . . 0.0 106.012 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.546 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -54.02 -54.91 32.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.275 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HG2' ' CG2' ' A' ' 48' ' ' ILE . 9.5 mtpm? -46.27 -52.02 13.38 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 125.416 1.487 . . . . 0.0 107.72 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 21.1 ttpp -56.98 -57.59 11.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 110.78 -2.918 . . . . 0.0 108.98 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 72.2 t -55.0 -46.44 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 122.85 1.31 . . . . 0.0 112.955 -178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.798 HG21 HG21 ' A' ' 66' ' ' VAL . 96.9 mt -66.59 -49.41 75.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.227 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.46 -39.89 73.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 33.4 mt-30 -57.69 -37.37 73.35 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.438 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 5.1 t0 -98.16 21.57 10.68 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 126.978 2.111 . . . . 0.0 115.955 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.645 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 65.7 tttt -98.72 105.91 33.68 Favored Pre-proline 0 N--CA 1.526 3.374 1 N-CA-C 128.299 6.407 . . . . 0.0 128.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 4.0 Cg_exo -90.95 -63.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.594 3.479 0 N-CA-C 104.132 -3.064 . . . . 0.0 104.132 161.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' C ' HG11 ' A' ' 82' ' ' VAL . 19.8 mp0 -88.81 -27.0 21.39 Favored 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.645 ' N ' ' HG3' ' A' ' 43' ' ' LYS . . . -62.35 67.58 0.01 OUTLIER 'General case' 1 N--CA 1.541 4.115 1 N-CA-C 132.85 8.092 . . . . 0.0 132.85 -179.064 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 60.7 tp60 -89.81 113.08 24.59 Favored 'General case' 1 N--CA 1.541 4.078 0 CA-C-N 124.965 3.53 . . . . 0.0 108.21 178.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 48' ' ' ILE . 1.1 mp -78.48 144.65 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 48' ' ' ILE . 42.9 mm -139.3 142.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 110.433 -3.076 . . . . 0.0 105.402 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.8 141.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.64 HD13 ' CE2' ' A' ' 69' ' ' PHE . 5.9 mt -132.0 128.66 21.55 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 116.88 -1.533 . . . . 0.0 107.675 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.27 135.89 23.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 104.058 -3.093 . . . . 0.0 104.058 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.589 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -41.41 124.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.12 -20.21 38.64 Favored Glycine 0 N--CA 1.505 3.256 0 CA-C-N 109.055 -3.702 . . . . 0.0 118.172 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.481 ' OG1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -48.79 143.94 4.91 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.466 2.133 . . . . 0.0 112.587 -175.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.3 121.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.613 HG21 ' HE2' ' A' ' 69' ' ' PHE . 1.8 m -115.89 -87.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -175.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.47 107.64 16.09 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 119.487 3.143 . . . . 0.0 119.487 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.6 mtm -96.14 -58.56 2.05 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 127.649 3.595 . . . . 0.0 108.82 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.619 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -84.36 -145.92 0.09 Allowed 'General case' 0 C--N 1.273 -2.743 1 CA-C-N 104.05 -5.977 . . . . 0.0 105.7 175.173 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.576 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -126.07 94.61 4.14 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.438 172.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.626 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -77.84 50.97 0.9 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 124.911 2.291 . . . . 0.0 112.466 175.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 10.4 tp -76.66 31.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-O 125.234 2.445 . . . . 0.0 117.321 -176.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -98.5 -30.63 12.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 111.212 -2.722 . . . . 0.0 109.386 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.626 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 3.8 ttp85 -127.5 158.62 36.92 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 118.923 2.934 . . . . 0.0 118.923 -171.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.798 HG21 HG21 ' A' ' 39' ' ' ILE . 2.2 t -107.09 127.34 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.555 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.6 ttp180 -87.1 102.03 14.04 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 108.693 -3.867 . . . . 0.0 104.917 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 80' ' ' PRO . 10.9 mp -103.09 90.47 3.75 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 125.398 1.686 . . . . 0.0 111.307 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.64 ' CE2' HD13 ' A' ' 51' ' ' LEU . 13.0 m-85 -73.28 105.75 4.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 124.762 2.22 . . . . 0.0 109.744 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -106.69 173.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 109.062 -3.699 . . . . 0.0 107.829 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.575 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.7 p-10 -98.39 -139.19 0.3 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 124.575 2.131 . . . . 0.0 111.885 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.575 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.6 mtmm -83.79 -13.52 53.62 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 109.477 -3.511 . . . . 0.0 114.83 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 73' ' ' LEU 0.323 0.3 OUTLIER -136.35 51.13 2.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-O 124.447 2.07 . . . . 0.0 107.197 -178.661 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.75 25.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 178.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 2.4 m120 -102.73 156.98 17.27 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.4 mt -78.86 116.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 126.465 3.031 . . . . 0.0 115.563 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 53' ' ' VAL 0.478 . . -94.53 -47.29 6.61 Favored 'General case' 0 C--N 1.287 -2.135 2 CA-C-N 103.381 -6.282 . . . . 0.0 110.065 -174.18 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -114.7 159.62 20.32 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.486 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 94.6 t -72.29 132.44 84.11 Favored Pre-proline 0 N--CA 1.499 2.018 0 C-N-CA 114.022 -3.071 . . . . 0.0 110.12 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 38.0 Cg_exo -67.05 144.25 68.9 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.811 2.341 . . . . 0.0 107.88 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.86 153.07 31.43 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.246 -1.359 . . . . 0.0 112.134 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 13.1 t -82.32 102.64 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.55 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.286 -2.22 0 C-N-CA 118.767 -1.683 . . . . 0.0 110.056 176.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -114.89 9.27 16.14 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.255 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.38 150.4 45.26 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.528 -179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.433 ' HZ3' HG23 ' A' ' 82' ' ' VAL . 16.3 m-90 -127.86 65.78 69.2 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 123.477 1.608 . . . . 0.0 112.444 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 27' ' ' LEU . 54.2 Cg_endo -67.74 -32.95 28.94 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.596 1.531 . . . . 0.0 109.481 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -65.5 0.49 1.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD11 HG13 ' A' ' 39' ' ' ILE . 40.9 mt -99.17 -17.68 18.04 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.986 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' CG2' HG22 ' A' ' 79' ' ' VAL . 64.0 t -63.11 116.06 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 116.821 -1.952 . . . . 0.0 108.596 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.46 -5.68 24.76 Favored Glycine 0 N--CA 1.508 3.479 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.8 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 27' ' ' LEU . 35.7 mmtm -101.63 171.72 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.47 1.108 . . . . 0.0 108.564 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -87.19 168.75 12.95 Favored 'General case' 0 CA--C 1.445 -3.079 0 CA-C-O 124.942 2.306 . . . . 0.0 111.688 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.726 HG23 HG11 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -70.39 -39.57 76.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 108.566 -3.925 . . . . 0.0 109.066 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 2.1 pp20? -65.32 -49.74 68.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.287 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 tt0 -58.82 -46.08 88.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 27' ' ' LEU . . . -50.44 -58.51 5.58 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 116.721 -1.609 . . . . 0.0 109.809 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -47.69 -55.17 10.06 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 120.994 1.724 . . . . 0.0 107.481 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 14.0 ttpt -48.04 -51.33 24.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 110.394 -3.094 . . . . 0.0 109.894 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.49 -52.92 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.066 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.709 ' CG2' HG21 ' A' ' 66' ' ' VAL . 22.5 mt -51.34 -47.79 34.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 123.021 1.391 . . . . 0.0 109.832 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.6 -28.79 57.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.01 -34.81 79.33 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 123.313 1.53 . . . . 0.0 109.679 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 36.8 m-20 -88.82 -49.53 6.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 119.661 3.208 . . . . 0.0 119.661 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 24.1 tptp -116.06 72.1 4.46 Favored Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 71.6 Cg_exo -10.98 -38.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 2 C-N-CA 127.289 5.326 . . . . 0.0 122.773 -178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.9 mp0 -91.42 -25.11 19.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -38.17 80.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 1 N-CA-C 123.353 4.575 . . . . 0.0 123.353 -171.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -76.64 69.88 3.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 66' ' ' VAL . 4.6 mt -72.46 131.69 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.352 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.57 162.01 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.77 113.19 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.36 1.076 . . . . 0.0 109.803 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.767 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -114.16 100.85 53.42 Favored Pre-proline 0 N--CA 1.501 2.1 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.616 -178.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.3 131.83 29.56 Favored 'Trans proline' 0 N--CA 1.509 2.416 0 CA-C-N 122.035 1.763 . . . . 0.0 108.926 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 78.1 t -46.57 121.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 120.371 -1.455 . . . . 0.0 113.223 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.07 -30.19 6.42 Favored Glycine 1 N--CA 1.517 4.098 0 CA-C-N 110.512 -3.04 . . . . 0.0 114.849 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.552 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.289 91.6 m -47.21 92.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 124.742 1.217 . . . . 0.0 109.205 176.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mm -52.06 101.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 124.046 1.879 . . . . 0.0 115.804 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.492 HG21 ' HE2' ' A' ' 69' ' ' PHE . 28.2 m -103.65 -178.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.44 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -91.16 158.76 16.44 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -174.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.459 ' N ' ' SD ' ' A' ' 59' ' ' MET . 3.6 mpp? -92.13 37.26 0.98 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 123.876 1.798 . . . . 0.0 108.237 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 58' ' ' THR . 18.2 pt-20 -81.89 -171.67 3.49 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.757 -2.928 . . . . 0.0 111.773 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.524 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -133.98 82.42 1.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.738 1.256 . . . . 0.0 108.771 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 6.8 mmm180 -88.3 78.21 8.05 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 101.291 -3.596 . . . . 0.0 101.291 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.536 ' HA ' HG12 ' A' ' 82' ' ' VAL . 7.4 tp -69.77 -3.61 3.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 109.412 -3.54 . . . . 0.0 112.659 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.5 -6.7 58.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 110.047 -3.252 . . . . 0.0 106.755 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.292 5.3 ttm-85 -145.33 150.83 37.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 120.265 3.432 . . . . 0.0 120.265 -171.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.709 HG21 ' CG2' ' A' ' 39' ' ' ILE . 4.4 t -111.67 108.64 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -63.15 125.35 23.77 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -177.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.1 tp -115.12 74.55 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 O-C-N 124.905 1.378 . . . . 0.0 111.641 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.767 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 24.4 m-85 -72.76 104.94 4.13 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 126.593 3.092 . . . . 0.0 111.344 169.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.726 HG11 HG23 ' A' ' 32' ' ' VAL . 3.6 m -107.36 171.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 CA-C-N 108.724 -3.853 . . . . 0.0 112.156 -175.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.1 p-10 -83.0 -147.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 123.738 2.972 . . . . 0.0 112.889 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.8 ttpp -91.55 8.5 36.29 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.389 -3.096 . . . . 0.0 112.031 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.479 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.7 mt -141.7 36.45 1.63 Allowed 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 111.458 -2.61 . . . . 0.0 110.245 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.531 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.13 26.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 -177.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -103.62 135.47 45.15 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.64 118.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 127.542 3.544 . . . . 0.0 114.039 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.443 . . -94.68 -51.24 4.81 Favored 'General case' 0 C--N 1.288 -2.105 2 CA-C-N 103.159 -6.382 . . . . 0.0 112.064 -173.023 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.41 161.78 18.55 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.5 HG22 ' CG2' ' A' ' 28' ' ' VAL . 95.0 t -73.46 137.68 77.84 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 113.819 -3.152 . . . . 0.0 108.757 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 13.1 Cg_exo -78.36 152.71 27.07 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.421 ' NH2' ' O ' ' A' ' 82' ' ' VAL . 2.6 ptm180 -156.43 157.83 36.23 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 117.748 -1.581 . . . . 0.0 112.391 -176.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 63' ' ' ILE . 3.5 t -81.49 131.5 33.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.401 -1.319 . . . . 0.0 108.104 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.593 0 CA-C-O 114.538 -3.368 . . . . 0.0 112.804 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 tttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 125.736 2.684 . . . . 0.0 115.041 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -111.94 33.77 4.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 100.458 -3.904 . . . . 0.0 100.458 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -142.31 156.08 45.24 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 126.671 2.482 . . . . 0.0 113.56 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 27' ' ' LEU . 22.4 m-90 -140.77 62.78 18.47 Favored Pre-proline 0 N--CA 1.509 2.522 0 CA-C-O 123.73 1.729 . . . . 0.0 115.09 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -63.3 -13.02 33.31 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.293 1.995 . . . . 0.0 113.125 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 12.0 mp0 -77.43 -20.43 54.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.686 HD13 ' HB1' ' A' ' 35' ' ' ALA . 69.8 mt -87.46 -19.62 27.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 79' ' ' VAL . 45.4 t -49.51 130.57 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.22 -10.88 60.08 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.637 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -110.11 161.7 15.29 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.7 p -74.5 162.7 28.56 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-O 126.867 3.222 . . . . 0.0 110.961 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HA ' HD23 ' A' ' 68' ' ' LEU 0.279 9.1 p -62.89 -47.39 93.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 1 CA-C-N 107.199 -4.546 . . . . 0.0 112.163 -173.573 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -68.42 -34.2 75.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.343 -1.743 . . . . 0.0 110.954 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -62.94 -51.1 68.21 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -62.41 -44.19 97.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.398 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 85.7 mttt -45.85 -50.49 14.24 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.236 1.017 . . . . 0.0 108.518 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.559 ' HZ3' ' HB3' ' A' ' 37' ' ' LYS . 5.7 ttpm? -48.14 -54.19 14.16 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 111.876 -2.42 . . . . 0.0 110.932 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 71.4 t -65.76 -47.34 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 112.768 -2.015 . . . . 0.0 111.898 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 66' ' ' VAL . 17.1 mt -52.92 -53.57 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.886 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.257 34.7 mt -58.2 -19.62 34.92 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 125.154 1.534 . . . . 0.0 110.999 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -75.54 -25.88 57.55 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -96.45 -53.86 3.45 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -118.87 55.05 2.46 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.671 -0.643 . . . . 0.0 110.844 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -17.91 -40.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 125.131 3.888 . . . . 0.0 119.507 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.51 -30.37 68.53 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.518 0.675 . . . . 0.0 112.301 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.0 76.32 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 120.86 3.652 . . . . 0.0 120.86 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.43 74.84 4.96 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 39' ' ' ILE . 55.6 mt -73.03 141.84 15.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.645 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 50' ' ' VAL . 11.7 mm -108.36 170.43 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.047 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 49' ' ' ILE . 39.8 t -84.11 122.65 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.67 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 40.9 mt -118.51 77.47 13.98 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -50.79 129.88 28.87 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 106.927 -1.99 . . . . 0.0 106.927 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.628 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 1.3 t -40.86 130.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 123.885 1.802 . . . . 0.0 115.725 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.75 -29.61 12.14 Favored Glycine 0 N--CA 1.508 3.489 0 CA-C-N 110.652 -2.976 . . . . 0.0 113.811 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.618 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.298 3.2 m -45.76 162.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.03 136.63 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.582 HG21 ' CD ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -141.79 -70.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.873 0 N-CA-C 121.249 3.796 . . . . 0.0 121.249 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 93.33 8.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -98.64 -86.97 0.35 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 108.922 -3.763 . . . . 0.0 102.35 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' HG2' ' NE ' ' A' ' 62' ' ' ARG . 20.2 pt-20 -81.73 -167.91 1.69 Allowed 'General case' 0 C--N 1.277 -2.557 1 CA-C-N 107.263 -4.517 . . . . 0.0 106.321 173.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.37 95.99 8.44 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.412 ' NE ' ' HG2' ' A' ' 60' ' ' GLU . 3.0 mpt_? -83.74 66.24 8.95 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 125.088 2.375 . . . . 0.0 104.863 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.664 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.6 tp -74.8 -23.46 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.922 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.56 6.4 5.9 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 109.445 -3.525 . . . . 0.0 108.583 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.303 12.6 ttm-85 -154.87 149.38 26.31 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 39' ' ' ILE . 2.9 t -117.17 126.44 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-N 120.647 1.567 . . . . 0.0 112.393 174.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.582 ' CD ' HG21 ' A' ' 57' ' ' VAL . 2.3 mtp180 -56.25 104.04 0.13 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 117.1 -1.429 . . . . 0.0 113.035 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.601 HD23 ' HA ' ' A' ' 32' ' ' VAL . 10.3 mp -106.48 74.27 1.01 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 123.208 2.731 . . . . 0.0 104.496 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.67 ' CZ ' HD22 ' A' ' 51' ' ' LEU . 16.7 m-85 -72.82 108.64 5.89 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 127.42 3.486 . . . . 0.0 109.262 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 68' ' ' LEU . 32.7 m -106.03 170.33 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 1 CA-C-N 106.647 -4.797 . . . . 0.0 110.088 -173.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.3 p-10 -94.83 -138.15 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 124.096 1.903 . . . . 0.0 111.082 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 30.0 mmtp -83.57 -11.83 56.88 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 109.74 -3.391 . . . . 0.0 112.447 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 ' CD1' HD22 ' A' ' 75' ' ' ASN 0.302 0.4 OUTLIER -136.53 52.2 1.97 Allowed 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 124.144 1.926 . . . . 0.0 108.955 -179.202 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' C ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.47 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 110.735 -2.938 . . . . 0.0 118.547 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.513 HD22 ' CD1' ' A' ' 73' ' ' LEU . 56.3 m-20 -99.38 134.56 42.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.641 1.21 . . . . 0.0 110.274 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 mt -52.28 117.9 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 126.326 2.965 . . . . 0.0 111.877 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.435 . . -102.37 -39.19 7.28 Favored 'General case' 0 C--N 1.286 -2.168 1 CA-C-N 104.633 -5.712 . . . . 0.0 112.348 -170.913 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -114.47 160.25 19.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 102.831 -3.025 . . . . 0.0 102.831 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 28' ' ' VAL . 88.3 t -76.88 145.03 73.54 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 114.273 -2.971 . . . . 0.0 109.405 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 14.5 Cg_exo -78.42 151.33 25.86 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.297 -1.463 . . . . 0.0 108.297 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.568 HH22 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -153.63 155.73 36.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 66' ' ' VAL . 45.2 t -75.53 -83.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 124.01 1.862 . . . . 0.0 108.454 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.568 ' C ' HH22 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.285 -2.276 1 N-CA-C 102.304 -4.318 . . . . 0.0 102.304 -175.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.616 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 14.6 pttp . . . . . 0 CA--C 1.488 -1.416 0 CA-C-O 124.397 2.046 . . . . 0.0 107.874 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 36.2 p -106.92 -3.7 19.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 110.596 -3.002 . . . . 0.0 111.034 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.616 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -129.77 142.84 50.63 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.625 ' CZ2' HG23 ' A' ' 39' ' ' ILE . 25.5 m-90 -134.23 76.55 62.86 Favored Pre-proline 0 N--CA 1.52 3.068 1 N-CA-C 123.363 4.579 . . . . 0.0 123.363 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . 7.4 Cg_endo -79.84 -35.69 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.873 1.716 . . . . 0.0 111.985 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.13 -18.19 9.23 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -176.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 1.2 pp -104.09 2.05 31.59 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.282 1.433 . . . . 0.0 114.389 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.56 HG21 HG22 ' A' ' 79' ' ' VAL . 49.0 t -70.55 141.67 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.754 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.84 7.6 59.83 Favored Glycine 0 N--CA 1.515 3.941 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -125.96 167.38 15.37 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.525 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 3.2 p -88.17 155.01 19.99 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 126.354 2.978 . . . . 0.0 114.033 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 33' ' ' GLU . 5.3 p -40.97 -49.62 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 1 CA-C-N 106.411 -4.904 . . . . 0.0 120.14 -175.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' N ' HG13 ' A' ' 32' ' ' VAL . 57.6 mm-40 -59.88 -49.02 79.35 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.211 -1.395 . . . . 0.0 109.605 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -51.3 -51.82 50.86 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 76' ' ' ILE . . . -52.6 -58.02 8.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.547 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 49.1 mtpt -45.99 -52.45 11.74 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 123.364 1.554 . . . . 0.0 107.107 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.8 -54.05 43.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.483 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.4 t -54.33 -54.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-O 124.896 2.284 . . . . 0.0 109.778 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.656 HD13 HG11 ' A' ' 66' ' ' VAL . 9.3 mt -54.26 -43.88 63.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 110.526 -3.033 . . . . 0.0 112.216 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 46' ' ' ALA . 57.7 mt -73.22 -32.87 65.02 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 125.655 1.847 . . . . 0.0 110.866 175.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -64.81 -18.54 65.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 10.9 t70 -96.36 -64.15 1.08 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.277 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -104.65 62.62 0.11 Allowed Pre-proline 0 C--N 1.29 -1.979 0 C-N-CA 127.873 2.469 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -18.86 -49.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 123.983 3.122 . . . . 0.0 120.052 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.53 14.91 13.59 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 48' ' ' ILE . . . -59.56 97.87 0.04 OUTLIER 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.762 1.268 . . . . 0.0 113.626 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 3.3 tt0 -73.59 77.33 1.49 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.632 HD11 ' CG2' ' A' ' 39' ' ' ILE . 66.8 mt -74.52 135.06 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 123.153 1.454 . . . . 0.0 113.524 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.51 137.58 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 111.514 -2.585 . . . . 0.0 108.758 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.27 141.37 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 123.117 1.437 . . . . 0.0 110.541 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.604 ' CD2' HG22 ' A' ' 55' ' ' THR . 2.5 mp -137.43 140.19 29.77 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.01 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 55' ' ' THR . 32.3 Cg_endo -74.82 141.79 27.63 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.505 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 8.4 t -42.14 128.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.12 20.63 Favored Glycine 0 N--CA 1.507 3.396 0 CA-C-N 111.213 -2.721 . . . . 0.0 112.543 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.604 HG22 ' CD2' ' A' ' 51' ' ' LEU 0.28 0.9 OUTLIER -69.02 177.05 2.82 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 123.76 1.743 . . . . 0.0 112.428 179.106 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.3 mm -59.18 105.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 124.037 4.829 . . . . 0.0 124.037 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.716 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -105.18 -50.84 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.613 0 CA-C-N 111.207 -2.724 . . . . 0.0 111.682 173.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 62.95 4.53 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 128.284 3.897 . . . . 0.0 119.156 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.66 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 3.5 ttt -98.65 -162.38 0.95 Allowed 'General case' 0 C--N 1.279 -2.475 1 CA-C-N 103.038 -6.437 . . . . 0.0 108.687 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.66 ' H ' ' HG2' ' A' ' 59' ' ' MET . 0.4 OUTLIER -73.87 -141.69 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.226 172.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.566 ' CE2' HD13 ' A' ' 63' ' ' ILE . 12.1 t80 -136.49 83.35 2.0 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 6.6 mmp_? -87.41 76.61 9.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.582 HD12 HG11 ' A' ' 82' ' ' VAL . 5.9 tp -52.2 -19.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 110.952 -2.84 . . . . 0.0 112.808 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.625 ' O ' ' HB3' ' A' ' 47' ' ' GLN 0.263 2.2 p30 -81.43 15.96 1.85 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.975 177.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.482 HH21 ' C ' ' A' ' 83' ' ' GLY . 53.0 ttp180 -153.64 122.65 6.46 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 82' ' ' VAL . 24.0 t -91.12 146.79 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 C-N-CA 114.467 -2.893 . . . . 0.0 105.016 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.653 HH21 ' C ' ' A' ' 83' ' ' GLY . 14.9 tpp85 -99.94 114.08 27.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.076 -2.784 . . . . 0.0 105.527 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 39' ' ' ILE . 84.3 mt -113.74 105.21 13.03 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.46 -1.296 . . . . 0.0 114.094 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.716 ' CE2' HG22 ' A' ' 57' ' ' VAL . 25.7 m-85 -80.14 102.91 9.66 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 125.697 2.665 . . . . 0.0 112.174 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.99 173.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 108.593 -3.912 . . . . 0.0 110.018 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -99.72 -141.75 0.33 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 124.53 2.109 . . . . 0.0 111.935 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.596 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.64 8.54 43.11 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.054 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 75' ' ' ASN . 65.2 mt -135.46 39.95 2.84 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 111.075 -2.784 . . . . 0.0 108.627 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.78 28.0 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 64.0 m-20 -104.8 146.9 28.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.174 1.94 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 35' ' ' ALA . 15.6 mt -77.8 95.33 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-O 127.245 3.403 . . . . 0.0 114.402 -177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.507 . . -72.3 -45.47 59.87 Favored 'General case' 0 C--N 1.289 -2.045 2 CA-C-N 100.608 -7.542 . . . . 0.0 102.437 178.838 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -119.19 135.14 54.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.716 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 87.2 t -42.72 -56.19 6.27 Favored Pre-proline 0 N--CA 1.519 2.98 1 N-CA-C 124.623 5.046 . . . . 0.0 124.623 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.716 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.255 0.0 OUTLIER 7.01 -152.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 2 C-N-CA 130.714 7.609 . . . . 0.0 127.837 -168.309 . . . . . . . . 5 4 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -155.53 -173.23 4.45 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -158.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 66' ' ' VAL . 5.0 t -81.88 148.55 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.289 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.653 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.988 0 O-C-N 126.392 2.307 . . . . 0.0 114.464 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.544 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 1.7 tmtm? . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -123.75 16.51 9.46 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 111.56 -2.564 . . . . 0.0 106.846 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -133.74 150.12 51.48 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.085 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.582 ' HB3' ' CG ' ' A' ' 27' ' ' LEU . 26.8 m-90 -133.22 74.56 72.47 Favored Pre-proline 0 N--CA 1.507 2.388 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.45 ' HA ' HG23 ' A' ' 28' ' ' VAL . 42.0 Cg_endo -74.14 -33.91 5.43 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.704 2.269 . . . . 0.0 110.486 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -48.43 -34.85 11.66 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.739 2.209 . . . . 0.0 109.945 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' CG ' ' HB3' ' A' ' 24' ' ' TRP . 3.7 pp -98.51 23.08 8.96 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.588 ' CG2' HG22 ' A' ' 79' ' ' VAL . 64.5 t -73.32 163.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.85 17.17 60.33 Favored Glycine 0 N--CA 1.512 3.709 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.949 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.23 163.89 25.74 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-O 116.568 -1.682 . . . . 0.0 109.59 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 5.5 p -88.42 158.13 18.47 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 126.575 3.083 . . . . 0.0 113.908 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.49 -27.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 1 CA-C-N 106.41 -4.905 . . . . 0.0 114.76 -176.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.605 ' HG3' ' N ' ' A' ' 34' ' ' GLU . 16.8 pt-20 -66.67 -52.16 47.92 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 123.87 1.795 . . . . 0.0 109.429 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.605 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 9.6 tm-20 -62.48 -51.04 69.02 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -50.72 -48.92 58.73 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.06 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.3 mttm -57.95 -53.12 61.81 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD3' ' C ' ' A' ' 37' ' ' LYS . 3.8 tmtm? -48.2 -35.91 12.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 113.382 -1.736 . . . . 0.0 114.775 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.455 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 66.1 t -85.25 -59.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.229 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 66' ' ' VAL . 40.2 mt -49.25 -48.91 17.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.679 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 46' ' ' ALA . 9.8 mt -70.94 -23.18 62.19 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.126 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -96.38 -63.27 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 8.2 tptp -111.13 67.23 0.59 Allowed Pre-proline 0 N--CA 1.499 2.007 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -18.62 -46.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 124.599 3.533 . . . . 0.0 120.096 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.3 mp0 -59.28 -35.07 73.07 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' A' ' 66' ' ' VAL . . . -44.86 79.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.678 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 43.9 tt0 -78.09 65.37 3.46 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.875 1.797 . . . . 0.0 107.269 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 39' ' ' ILE . 32.6 mt -70.46 142.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' VAL . 32.9 mm -125.86 -166.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 110.668 -2.969 . . . . 0.0 106.418 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.8 p -106.02 142.05 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 0.0 112.56 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.39 102.81 7.24 Favored Pre-proline 0 N--CA 1.513 2.723 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.55 129.06 15.17 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 122.799 2.035 . . . . 0.0 109.435 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 4.1 t -41.94 130.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 123.383 1.563 . . . . 0.0 114.476 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.62 -21.49 45.83 Favored Glycine 0 N--CA 1.503 3.144 0 CA-C-N 111.095 -2.775 . . . . 0.0 114.613 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -58.24 156.36 9.98 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 119.261 1.531 . . . . 0.0 113.416 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.04 127.46 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.124 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 69' ' ' PHE . 30.0 m -131.21 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 112.645 -2.071 . . . . 0.0 109.473 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -155.67 0.31 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.556 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 50.2 mtp -58.1 -149.91 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -81.47 -18.68 44.36 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 125.27 2.462 . . . . 0.0 116.318 175.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.639 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -116.54 107.15 14.38 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 109.488 -3.506 . . . . 0.0 106.706 178.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.703 ' H ' ' C ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -107.45 43.72 1.16 Allowed 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 125.277 2.465 . . . . 0.0 109.758 179.073 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.639 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.2 tp -42.73 -27.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.444 1 CA-C-N 107.295 -4.502 . . . . 0.0 120.058 -177.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.23 -17.62 20.45 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 47' ' ' GLN 0.255 0.1 OUTLIER -142.81 -170.84 3.32 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.863 -2.426 . . . . 0.0 114.017 -176.973 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.696 HG21 HG21 ' A' ' 39' ' ' ILE . 3.0 t -115.64 111.49 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 1 N-CA-C 88.032 -8.507 . . . . 0.0 88.032 169.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HD3' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -81.04 101.83 9.82 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 122.515 2.416 . . . . 0.0 111.013 -176.164 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.9 mp -79.9 80.18 6.33 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.556 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 13.6 m-85 -70.12 106.67 3.35 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 125.96 2.79 . . . . 0.0 108.95 166.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 14.9 m -105.9 175.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.766 1 CA-C-N 108.234 -4.075 . . . . 0.0 109.607 -176.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.486 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 6.5 p-10 -91.89 -140.21 0.18 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.232 -2.167 . . . . 0.0 113.194 -177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 43.8 mtmt -89.3 0.87 56.47 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 110.673 -2.967 . . . . 0.0 112.072 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.414 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.1 mt -135.77 32.66 2.98 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.874 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.16 28.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -177.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.9 m-80 -103.2 148.83 25.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.0 mt -74.88 106.46 4.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 126.843 3.211 . . . . 0.0 114.18 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 71' ' ' ASP 0.399 . . -81.34 -51.88 7.88 Favored 'General case' 0 C--N 1.287 -2.152 2 CA-C-N 101.692 -7.049 . . . . 0.0 110.042 -177.744 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.49 148.33 39.59 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.588 HG22 ' CG2' ' A' ' 28' ' ' VAL . 88.8 t -70.45 141.73 88.47 Favored Pre-proline 0 N--CA 1.502 2.132 0 C-N-CA 114.193 -3.003 . . . . 0.0 108.113 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 6.2 Cg_exo -89.27 159.16 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.765 2.31 . . . . 0.0 108.26 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -154.29 157.27 38.41 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -177.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' CH2' ' A' ' 24' ' ' TRP . 55.6 t -75.26 109.79 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 176.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.703 ' C ' ' H ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.276 -2.768 0 CA-C-N 110.869 -2.878 . . . . 0.0 107.032 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.006 0 CA-C-O 124.31 2.005 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' NZ ' ' CD1' ' A' ' 24' ' ' TRP . 4.0 tmtt? -100.47 56.13 0.9 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.469 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 66.5 p -102.96 34.98 2.66 Favored 'General case' 0 N--CA 1.516 2.846 0 CA-C-O 122.897 1.332 . . . . 0.0 108.771 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' CD ' HH22 ' A' ' 81' ' ' ARG 0.251 0.0 OUTLIER -154.78 151.62 28.89 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.612 -176.736 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 24.1 m-90 -139.47 81.01 21.01 Favored Pre-proline 0 N--CA 1.517 2.887 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -81.4 -34.68 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.915 2.41 . . . . 0.0 111.612 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.77 -17.6 9.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.154 -0.966 . . . . 0.0 111.445 -177.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 1.7 pp -107.05 17.63 22.79 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 79' ' ' VAL . 69.8 t -65.99 169.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.109 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.37 18.18 35.18 Favored Glycine 1 N--CA 1.521 4.354 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -121.05 157.4 30.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.2 p -89.03 159.71 17.45 Favored 'General case' 0 CA--C 1.472 -2.053 0 CA-C-O 127.482 3.515 . . . . 0.0 109.083 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -40.01 -54.18 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.263 1 CA-C-N 105.888 -5.142 . . . . 0.0 118.722 -174.009 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 60.3 mm-40 -55.33 -47.87 75.02 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.936 1.698 . . . . 0.0 110.776 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 1.2 tm-20 -50.96 -47.14 61.29 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.77 -47.78 76.9 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.16 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 66.9 mttm -49.32 -50.55 39.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 76.9 tttt -48.64 -55.33 11.55 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 110.803 -2.908 . . . . 0.0 108.757 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 67.5 t -59.87 -54.27 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.764 0 CA-C-O 125.53 2.586 . . . . 0.0 112.72 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.686 ' CG2' HG21 ' A' ' 66' ' ' VAL . 31.6 mt -57.33 -50.03 78.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 112.151 -2.295 . . . . 0.0 110.663 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 67.8 mt -57.3 -36.42 71.04 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.1 tt0 -58.78 -44.72 90.76 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 118.05 -1.46 . . . . 0.0 110.935 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.74 -48.39 54.75 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.434 -1.712 . . . . 0.0 114.026 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 25.9 ttpp -127.36 68.31 72.96 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -14.72 -43.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 124.678 3.585 . . . . 0.0 119.949 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -86.97 -5.28 59.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -46.6 96.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.52 HE22 HG12 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -77.76 93.32 4.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 178.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.598 HD11 ' CG2' ' A' ' 39' ' ' ILE . 73.0 mt -93.14 114.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 121.377 3.843 . . . . 0.0 121.377 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.52 HG12 HE22 ' A' ' 47' ' ' GLN . 36.5 mm -102.27 149.76 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 112.768 -2.014 . . . . 0.0 107.602 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.92 155.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.116 0.96 . . . . 0.0 112.506 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.769 ' HB3' ' CE1' ' A' ' 69' ' ' PHE 0.254 0.6 OUTLIER -142.42 132.19 12.26 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.579 -179.788 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.452 ' HD2' HD23 ' A' ' 51' ' ' LEU . 52.5 Cg_endo -72.05 113.97 3.84 Favored 'Trans proline' 0 N--CA 1.503 2.062 0 C-N-CA 122.172 1.915 . . . . 0.0 113.994 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 69' ' ' PHE . 36.5 t -41.56 123.22 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.441 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 119.51 -37.89 2.99 Favored Glycine 0 N--CA 1.507 3.424 2 O-C-N 129.751 4.407 . . . . 0.0 108.651 -175.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.517 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.267 52.0 m -60.04 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.031 1.332 . . . . 0.0 108.183 175.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' GLY . 24.9 mm -55.46 147.98 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.87 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' NE ' ' A' ' 67' ' ' ARG . 12.4 m -123.01 -147.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.42 ' H ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -87.49 155.33 20.05 Favored 'General case' 0 C--N 1.306 -1.321 1 N-CA-C 124.796 5.11 . . . . 0.0 124.796 -173.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -93.86 34.7 1.19 Allowed 'General case' 0 N--CA 1.508 2.427 0 CA-C-O 123.083 1.421 . . . . 0.0 110.865 176.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.02 -176.11 5.97 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.57 56.36 1.81 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 123.145 1.45 . . . . 0.0 107.391 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.48 ' HB2' ' NH1' ' A' ' 65' ' ' ARG . 5.6 mmm180 -88.96 67.28 8.13 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 126.991 3.282 . . . . 0.0 107.782 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.537 HD12 HG11 ' A' ' 82' ' ' VAL . 6.5 tp -53.2 -26.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 1 CA-C-N 107.19 -4.55 . . . . 0.0 109.518 178.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' GLN . 1.3 p30 -60.91 -7.16 2.2 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.811 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 62' ' ' ARG . 6.1 ttp85 -139.55 151.58 46.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 121.768 3.988 . . . . 0.0 121.768 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.686 HG21 ' CG2' ' A' ' 39' ' ' ILE . 21.2 t -115.08 92.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 171.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' NE ' HG21 ' A' ' 57' ' ' VAL . 26.8 ttm180 -48.58 123.24 6.43 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 109.826 -3.352 . . . . 0.0 106.05 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 76' ' ' ILE 0.271 0.6 OUTLIER -115.16 84.03 2.01 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 125.916 2.01 . . . . 0.0 112.303 -176.965 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.769 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 26.0 m-85 -73.33 108.38 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 124.71 2.195 . . . . 0.0 107.057 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 53' ' ' VAL . 14.5 m -113.46 174.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.768 1 CA-C-N 108.286 -4.052 . . . . 0.0 110.368 -177.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.586 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.2 p-10 -88.69 -146.89 0.16 Allowed 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 122.941 2.61 . . . . 0.0 111.637 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.586 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 12.0 mptt -90.63 0.34 57.42 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 111.736 -2.484 . . . . 0.0 113.994 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.375 0.2 OUTLIER -139.15 47.8 1.89 Allowed 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 112.558 -2.11 . . . . 0.0 105.772 178.101 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.71 27.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 119.956 3.317 . . . . 0.0 119.956 178.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 58.6 m-80 -100.9 151.68 21.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 123.331 1.539 . . . . 0.0 109.576 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.423 HD11 HD11 ' A' ' 68' ' ' LEU . 82.0 mt -78.72 93.71 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 127.466 3.507 . . . . 0.0 116.125 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.351 . . -73.2 -42.09 63.07 Favored 'General case' 0 C--N 1.291 -1.957 2 CA-C-N 100.292 -7.685 . . . . 0.0 112.958 178.702 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 79' ' ' VAL . 10.1 tt0 -117.57 156.14 28.61 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 28' ' ' VAL . 88.5 t -76.34 136.51 68.48 Favored Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 112.75 -3.58 . . . . 0.0 104.981 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 11.8 Cg_exo -81.48 169.59 15.35 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.518 2.812 . . . . 0.0 111.695 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.527 HH22 ' CD ' ' A' ' 23' ' ' GLU . 2.3 ptp180 -163.69 172.38 14.3 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 116.624 -1.655 . . . . 0.0 111.731 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.578 HG22 HG22 ' A' ' 66' ' ' VAL . 6.1 t -82.58 -111.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 82' ' ' VAL . . . . . . . . 0 C--N 1.287 -2.167 3 N-CA-C 96.046 -6.821 . . . . 0.0 96.046 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 120.926 0.393 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 13.3 mtpp -102.07 156.83 17.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 124.011 1.862 . . . . 0.0 112.444 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.5 p -111.42 -6.51 14.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.97 135.08 35.65 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.591 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 25.4 m-90 -117.0 72.94 6.24 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 122.983 1.373 . . . . 0.0 114.581 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HA ' HG23 ' A' ' 28' ' ' VAL . 40.5 Cg_endo -69.45 -31.98 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.643 1.562 . . . . 0.0 110.66 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' CD ' ' HZ1' ' A' ' 21' ' ' LYS . 33.4 mp0 -52.18 -34.9 47.19 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 123.167 1.461 . . . . 0.0 109.928 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 24' ' ' TRP 0.25 4.5 pp -102.06 36.48 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 123.704 1.716 . . . . 0.0 113.027 -177.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.58 ' CG2' HG22 ' A' ' 79' ' ' VAL . 9.9 t -81.45 155.92 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.767 171.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.65 29.1 17.55 Favored Glycine 0 N--CA 1.511 3.642 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.469 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.0 mmmp? -120.58 176.49 5.48 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 117.13 -1.414 . . . . 0.0 109.44 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -85.32 160.28 19.85 Favored 'General case' 0 CA--C 1.459 -2.532 0 CA-C-O 126.053 2.835 . . . . 0.0 112.109 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' CG2' HG11 ' A' ' 70' ' ' VAL 0.251 1.7 p -69.55 -28.31 37.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 1 CA-C-N 107.189 -4.551 . . . . 0.0 111.13 -173.701 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.432 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 18.6 mm-40 -77.23 -38.55 50.95 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.1 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 30' ' ' LYS . 32.8 mt-10 -63.08 -50.85 68.94 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 125.889 1.993 . . . . 0.0 105.632 174.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.73 -58.53 3.01 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.79 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.1 mttp -49.48 -54.96 14.95 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-O 122.549 1.166 . . . . 0.0 108.425 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' NZ ' ' OE1' ' A' ' 33' ' ' GLU . 57.5 mttp -52.95 -46.65 68.27 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 112.233 -2.258 . . . . 0.0 112.029 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' CD2' ' A' ' 27' ' ' LEU . 99.4 t -67.51 -52.51 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 122.559 1.171 . . . . 0.0 110.705 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 66' ' ' VAL . 17.5 mt -51.74 -48.69 37.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.315 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD21 ' O ' ' A' ' 46' ' ' ALA . 88.4 mt -60.77 -34.83 75.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 124.988 1.43 . . . . 0.0 107.378 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -84.79 -57.24 3.2 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 114.095 -1.412 . . . . 0.0 113.551 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 51.9 tttm -115.54 78.69 6.73 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.338 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -22.71 -52.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 N-CA-C 118.683 2.532 . . . . 0.0 118.683 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -84.67 9.35 14.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -178.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.696 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -65.15 96.17 0.2 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 117.822 -1.551 . . . . 0.0 113.18 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -77.92 69.86 4.2 Favored 'General case' 0 N--CA 1.513 2.692 0 O-C-N 118.338 -2.726 . . . . 0.0 107.893 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.581 ' CG2' HD12 ' A' ' 68' ' ' LEU . 32.8 mt -78.04 122.06 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 112.793 -2.003 . . . . 0.0 116.114 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.638 ' H ' ' CZ ' ' A' ' 65' ' ' ARG . 1.3 mp -115.47 170.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.453 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 7.7 p -72.79 126.52 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-O 123.096 1.427 . . . . 0.0 110.512 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 55' ' ' THR . 0.2 OUTLIER -131.62 104.8 14.39 Favored Pre-proline 0 N--CA 1.492 1.673 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.505 -177.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -56.54 115.05 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.625 0.545 . . . . 0.0 111.015 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.597 ' HA ' ' CG ' ' A' ' 69' ' ' PHE . 14.9 p -39.81 142.31 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 123.679 1.704 . . . . 0.0 112.655 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' N ' ' CE2' ' A' ' 69' ' ' PHE . . . 95.84 -26.09 22.09 Favored Glycine 0 N--CA 1.512 3.729 0 CA-C-N 112.067 -2.333 . . . . 0.0 110.976 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.582 HG21 HD23 ' A' ' 51' ' ' LEU 0.321 3.0 m -54.39 -179.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.225 1.012 . . . . 0.0 113.644 176.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.32 99.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 118.646 -2.534 . . . . 0.0 114.388 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -99.25 -48.18 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.268 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.97 68.54 0.68 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 127.659 3.6 . . . . 0.0 113.603 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.483 ' SD ' ' HG3' ' A' ' 62' ' ' ARG . 18.2 ttm -99.77 -177.96 3.72 Favored 'General case' 0 C--N 1.276 -2.609 1 CA-C-N 104.315 -5.857 . . . . 0.0 107.292 -178.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 11.8 pt-20 -78.53 -163.23 0.43 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 174.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.924 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 67.3 t80 -94.76 81.56 3.82 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.616 -1.303 . . . . 0.0 111.602 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.483 ' HG3' ' SD ' ' A' ' 59' ' ' MET . 8.6 mmt85 -88.65 56.78 3.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.45 -1.7 . . . . 0.0 109.528 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.924 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.27 -27.6 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 111.348 -2.66 . . . . 0.0 116.642 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.07 -14.81 1.73 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 124.008 1.861 . . . . 0.0 108.328 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.638 ' CZ ' ' H ' ' A' ' 49' ' ' ILE . 6.2 mtp180 -132.21 157.41 44.41 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 119.443 3.127 . . . . 0.0 119.443 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.71 HG21 HG21 ' A' ' 39' ' ' ILE . 2.9 t -115.45 134.44 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 1 N-CA-C 98.5 -4.629 . . . . 0.0 98.5 171.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CD ' HD13 ' A' ' 51' ' ' LEU . 9.2 tpp180 -83.13 134.68 34.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD12 ' CG2' ' A' ' 48' ' ' ILE . 3.2 mt -113.86 82.01 1.62 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.856 1.347 . . . . 0.0 108.475 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.597 ' CG ' ' HA ' ' A' ' 53' ' ' VAL . 2.6 m-30 -73.46 92.45 1.87 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 126.498 3.047 . . . . 0.0 108.592 169.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 32' ' ' VAL . 4.8 m -105.16 171.04 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 1 CA-C-N 105.327 -5.397 . . . . 0.0 104.017 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.5 p-10 -96.75 -138.39 0.27 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 125.373 2.511 . . . . 0.0 112.261 -174.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.549 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.0 mtmm -85.32 -11.99 53.36 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 109.195 -3.639 . . . . 0.0 114.166 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.609 ' CD1' HD22 ' A' ' 75' ' ' ASN 0.306 0.3 OUTLIER -138.05 52.36 1.85 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 112.087 -2.324 . . . . 0.0 107.675 -178.816 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 36.42 22.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.609 HD22 ' CD1' ' A' ' 73' ' ' LEU . 34.4 m-20 -105.62 138.27 42.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 123.473 1.606 . . . . 0.0 110.608 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.64 122.43 11.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 126.006 2.812 . . . . 0.0 117.211 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.485 . . -104.5 -44.16 4.98 Favored 'General case' 0 C--N 1.289 -2.03 1 CA-C-N 105.362 -5.381 . . . . 0.0 111.016 -171.831 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . 11.0 tp60 -115.42 161.7 18.18 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.58 HG22 ' CG2' ' A' ' 28' ' ' VAL . 95.4 t -75.79 134.25 72.29 Favored Pre-proline 0 N--CA 1.488 1.43 0 C-N-CA 113.939 -3.105 . . . . 0.0 109.05 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 31.9 Cg_exo -68.72 131.93 23.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 103.803 -3.191 . . . . 0.0 103.803 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' THR . 4.9 ptm180 -138.67 157.2 46.57 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.479 1.112 . . . . 0.0 108.703 -175.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 11.8 t -79.03 152.09 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.358 1.036 . . . . 0.0 112.697 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.455 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.513 3.824 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.029 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.628 0 CA-C-O 120.841 0.353 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 5.8 tmtt? -77.24 59.94 1.86 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 48.2 p -104.55 24.96 10.86 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 112.608 -2.087 . . . . 0.0 105.401 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.07 151.16 43.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 126.225 2.203 . . . . 0.0 113.202 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.649 ' CG ' HG12 ' A' ' 39' ' ' ILE . 26.9 m-90 -128.67 67.32 76.73 Favored Pre-proline 0 N--CA 1.491 1.61 0 CA-C-O 123.285 1.517 . . . . 0.0 112.293 174.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -63.42 -37.67 47.62 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 CA-C-N 113.301 -1.357 . . . . 0.0 110.034 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 27' ' ' LEU . 19.6 pm0 -51.01 -31.32 17.73 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.165 0.983 . . . . 0.0 111.934 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.629 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.6 pp -105.84 31.9 4.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.556 HG21 HG22 ' A' ' 79' ' ' VAL . 77.4 t -84.71 124.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 170.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.82 3.46 54.94 Favored Glycine 0 N--CA 1.514 3.868 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -109.53 156.13 20.52 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.367 -0.917 . . . . 0.0 110.306 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 p -85.81 155.07 21.15 Favored 'General case' 0 CA--C 1.474 -1.945 0 CA-C-O 127.386 3.47 . . . . 0.0 109.839 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -48.93 -56.26 2.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 1 CA-C-N 106.022 -5.081 . . . . 0.0 120.739 -170.259 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 50.0 mm-40 -57.67 -40.43 79.36 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 117.417 -1.713 . . . . 0.0 110.559 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.13 -54.39 46.46 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -44.58 -52.4 8.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.964 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 94.5 mttt -55.77 -58.15 9.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 3.8 tmtm? -47.46 -40.14 17.49 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.798 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 77.4 t -70.59 -56.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.549 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HG21 ' A' ' 66' ' ' VAL . 47.7 mt -48.19 -39.18 8.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 CA-C-O 122.814 1.292 . . . . 0.0 110.836 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 11.7 mt -53.26 -35.9 60.53 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.077 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -62.66 -46.59 87.49 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-O 123.942 1.829 . . . . 0.0 110.455 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.543 ' CG ' ' HE1' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -62.78 -49.94 72.99 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 110.335 -3.121 . . . . 0.0 111.988 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 1.2 mtpp -125.81 81.14 66.04 Favored Pre-proline 0 N--CA 1.497 1.913 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.799 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.49 -54.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 118.204 2.348 . . . . 0.0 118.204 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.36 13.65 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 64' ' ' ASP . . . -60.22 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.032 0.92 . . . . 0.0 113.293 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -82.74 72.32 9.81 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 124.567 2.127 . . . . 0.0 106.071 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.67 HD11 ' CG2' ' A' ' 39' ' ' ILE . 49.2 mt -73.63 148.95 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 110.617 -2.992 . . . . 0.0 117.37 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.87 162.08 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 112.748 -2.023 . . . . 0.0 112.84 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 133.93 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 112.06 -2.336 . . . . 0.0 105.115 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.722 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.6 mt -141.51 113.36 6.62 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-N 113.371 -1.74 . . . . 0.0 111.564 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -76.0 130.04 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 CA-C-N 121.818 1.685 . . . . 0.0 108.0 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 69' ' ' PHE . 13.1 t -39.55 130.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.61 -40.69 2.46 Favored Glycine 1 N--CA 1.518 4.144 0 CA-C-N 109.302 -3.59 . . . . 0.0 111.019 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.56 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 40.6 m -46.29 125.49 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.721 1.208 . . . . 0.0 108.778 177.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.39 152.28 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.502 HG21 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -128.62 -51.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.716 1 N-CA-C 125.002 5.186 . . . . 0.0 125.002 -175.653 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.08 99.98 5.54 Favored 'General case' 0 C--N 1.288 -2.081 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.431 ' HB2' ' NH2' ' A' ' 62' ' ' ARG . 87.9 mtp -94.11 -117.55 0.1 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 100.809 -3.775 . . . . 0.0 100.809 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.257 3.1 pp20? -76.54 -167.29 0.78 Allowed 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 111.012 -2.813 . . . . 0.0 106.251 172.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -79.68 98.73 7.08 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.975 0.893 . . . . 0.0 112.074 -173.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -85.59 58.7 5.19 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 125.758 2.694 . . . . 0.0 109.468 177.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.515 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 7.6 tp -71.47 -9.22 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 109.524 -3.489 . . . . 0.0 116.476 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 11.5 p-10 -96.87 -1.69 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.788 1.28 . . . . 0.0 108.252 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.03 144.61 50.98 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.721 HG21 HG21 ' A' ' 39' ' ' ILE . 3.1 t -116.94 145.86 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -103.66 130.79 51.18 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.746 175.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 35' ' ' ALA . 20.3 mt -103.2 83.05 2.14 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.662 -2.063 . . . . 0.0 107.398 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.722 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.5 m-85 -73.18 100.15 3.0 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 126.478 3.037 . . . . 0.0 108.485 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 68' ' ' LEU . 32.8 m -101.52 171.15 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 1 CA-C-N 106.541 -4.845 . . . . 0.0 108.211 -176.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.514 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.2 p-10 -97.35 -140.87 0.29 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 124.633 2.158 . . . . 0.0 111.689 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.514 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 37.4 tttp -85.88 -0.97 56.77 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 109.199 -3.637 . . . . 0.0 111.451 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.492 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.3 mt -136.08 38.79 2.75 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.624 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.49 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -100.08 134.38 43.09 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.616 HG21 ' HG3' ' A' ' 80' ' ' PRO . 50.8 mt -58.37 122.96 9.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-O 125.328 2.49 . . . . 0.0 109.651 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.476 . . -105.4 -38.13 6.59 Favored 'General case' 0 C--N 1.284 -2.267 2 CA-C-N 105.19 -5.459 . . . . 0.0 110.261 -172.601 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -118.71 160.08 22.49 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.069 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG22 HG21 ' A' ' 28' ' ' VAL . 95.4 t -65.55 135.99 95.95 Favored Pre-proline 0 N--CA 1.501 2.089 0 C-N-CA 114.881 -2.728 . . . . 0.0 110.107 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HG3' HG21 ' A' ' 76' ' ' ILE . 4.4 Cg_exo -83.45 142.46 10.54 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 N-CA-C 104.417 -2.955 . . . . 0.0 104.417 -176.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 22' ' ' THR . 6.9 ptm180 -156.56 163.76 39.0 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 116.522 -2.071 . . . . 0.0 113.375 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 83' ' ' GLY . 2.7 t -84.38 155.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 125.924 2.015 . . . . 0.0 111.994 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.542 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.428 0 CA-C-O 114.127 -3.596 . . . . 0.0 112.512 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.758 0 CA-C-O 120.856 0.36 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -102.19 45.63 0.96 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -98.41 31.22 2.9 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.396 -1.322 . . . . 0.0 111.384 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.63 146.29 31.28 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 111.753 -2.476 . . . . 0.0 110.913 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.637 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 24.1 m-90 -127.4 67.17 71.1 Favored Pre-proline 0 N--CA 1.498 1.966 0 CA-C-O 124.262 1.982 . . . . 0.0 111.396 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' HG22 ' A' ' 79' ' ' VAL . 40.8 Cg_endo -69.29 -41.51 4.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 CA-C-N 111.068 -2.154 . . . . 0.0 110.614 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 2.7 pm0 -67.42 -9.64 43.67 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.786 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.637 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -107.78 13.73 26.16 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.645 HG21 HG22 ' A' ' 79' ' ' VAL . 48.6 t -68.01 161.46 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.72 57.15 Favored Glycine 1 N--CA 1.518 4.147 0 C-N-CA 118.475 -1.821 . . . . 0.0 113.829 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 2.9 mtpp -106.48 166.62 10.42 Favored 'General case' 0 N--CA 1.505 2.308 0 C-N-CA 124.122 0.969 . . . . 0.0 111.655 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.8 p -85.7 154.23 21.79 Favored 'General case' 0 CA--C 1.478 -1.825 0 CA-C-O 126.249 2.928 . . . . 0.0 115.717 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.479 ' CG2' HG11 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -48.94 -57.82 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 1 CA-C-N 107.875 -4.239 . . . . 0.0 114.202 -172.081 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -53.01 -36.51 60.6 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 121.506 1.957 . . . . 0.0 113.802 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -50.68 38.83 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -46.55 -51.82 14.71 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 123.422 1.582 . . . . 0.0 107.488 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 40' ' ' LEU . 15.5 mtpp -55.16 -54.2 46.23 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -49.1 -42.03 37.66 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.341 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 85.5 t -67.57 -53.49 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.393 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.813 HG21 HG21 ' A' ' 66' ' ' VAL . 45.6 mt -60.3 -51.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.084 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 36' ' ' LYS . 1.3 mp -52.68 -27.75 18.75 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.575 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 39.4 tp60 -68.98 -23.75 64.16 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.1 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.19 -53.37 3.82 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.283 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 18.6 ttpp -116.7 76.69 7.79 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -24.24 -45.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 123.387 2.725 . . . . 0.0 117.446 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -77.25 0.7 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.6 88.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 16.3 mt-30 -77.94 60.74 2.4 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.651 ' HA ' ' HG3' ' A' ' 65' ' ' ARG . 65.6 mt -73.22 140.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 43.1 mm -115.86 175.7 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.607 1.194 . . . . 0.0 112.645 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.477 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 17.2 t -102.52 116.09 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 110.279 -3.146 . . . . 0.0 108.327 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 13.4 mt -124.04 92.18 48.68 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -54.05 127.94 27.76 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 N-CA-C 109.286 -1.082 . . . . 0.0 109.286 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.429 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -43.18 127.89 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.877 0 CA-C-O 123.613 1.673 . . . . 0.0 111.186 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.66 -21.04 35.42 Favored Glycine 1 N--CA 1.517 4.063 0 CA-C-N 109.587 -3.461 . . . . 0.0 112.778 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.626 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.333 23.7 m -68.25 62.95 0.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 173.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 mm -51.11 112.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 124.308 2.004 . . . . 0.0 116.382 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' CG2' ' HE2' ' A' ' 69' ' ' PHE . 30.2 m -103.56 167.82 2.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 110.106 -3.225 . . . . 0.0 104.394 175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 -171.68 2.3 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 108.852 -3.794 . . . . 0.0 111.958 -174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.3 tpp -92.23 23.76 3.69 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.073 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.03 166.21 16.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.631 ' CD2' ' HA2' ' A' ' 83' ' ' GLY . 8.3 t80 -145.59 154.19 41.89 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 120.072 3.36 . . . . 0.0 120.072 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.601 ' N ' ' CD2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -116.43 62.1 0.72 Allowed 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.619 HD12 HG12 ' A' ' 82' ' ' VAL . 5.3 tp -44.54 -27.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -55.07 -24.37 24.9 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 112.154 -2.294 . . . . 0.0 108.261 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HG3' ' HA ' ' A' ' 48' ' ' ILE 0.269 7.1 ttm-85 -129.38 158.77 38.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 110.375 -3.102 . . . . 0.0 114.434 -168.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 39' ' ' ILE . 3.1 t -103.8 140.86 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -81.34 115.55 20.76 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 80' ' ' PRO . 10.3 mp -113.46 84.79 2.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.518 1.136 . . . . 0.0 112.791 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 36.0 m-85 -74.41 104.77 5.27 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 127.238 3.399 . . . . 0.0 106.361 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 32' ' ' VAL . 21.3 m -99.51 172.17 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.042 1 CA-C-N 107.166 -4.561 . . . . 0.0 105.833 -177.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.6 p-10 -95.43 -142.4 0.26 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 123.793 2.997 . . . . 0.0 113.688 -176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.2 ttpp -92.02 9.4 33.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 109.732 -3.395 . . . . 0.0 110.34 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 47.4 mt -142.71 38.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 111.513 -2.585 . . . . 0.0 110.74 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.69 20.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 -176.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.5 m-20 -104.61 142.3 34.9 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.943 1.354 . . . . 0.0 108.845 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 44.7 mt -63.28 113.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-O 126.518 3.056 . . . . 0.0 112.359 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.488 . . -88.51 -51.34 5.76 Favored 'General case' 0 C--N 1.283 -2.294 2 CA-C-N 103.479 -6.237 . . . . 0.0 107.909 -173.258 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -118.02 157.84 26.06 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 28' ' ' VAL . 94.4 t -63.66 138.64 97.43 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 115.75 -2.38 . . . . 0.0 112.482 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 3.5 Cg_exo -86.63 157.13 9.09 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.58 2.186 . . . . 0.0 108.26 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.44 HH21 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -154.5 150.24 27.59 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.142 -176.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG12 HD12 ' A' ' 63' ' ' ILE 0.278 21.9 t -89.13 105.09 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.729 1.268 . . . . 0.0 107.783 175.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.631 ' HA2' ' CD2' ' A' ' 61' ' ' TYR . . . . . . . . 0 C--N 1.27 -3.121 0 C-N-CA 117.7 -2.191 . . . . 0.0 110.853 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 121.625 0.726 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.07 49.59 2.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.848 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -101.29 17.84 21.54 Favored 'General case' 0 N--CA 1.526 3.354 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -140.15 151.89 45.63 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 125.105 1.503 . . . . 0.0 114.327 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.565 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 29.4 m-90 -134.53 73.16 68.72 Favored Pre-proline 0 N--CA 1.496 1.875 0 CA-C-O 123.762 1.744 . . . . 0.0 112.944 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HA ' HG23 ' A' ' 28' ' ' VAL . 13.1 Cg_endo -77.45 -34.77 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.702 1.601 . . . . 0.0 111.576 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -62.35 -18.89 62.61 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 123.402 1.572 . . . . 0.0 109.429 -177.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HA ' ' CE ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -97.94 15.31 24.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.528 HG21 HG22 ' A' ' 79' ' ' VAL . 99.2 t -73.53 164.45 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 120.838 -1.164 . . . . 0.0 108.325 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 2.1 89.75 Favored Glycine 1 N--CA 1.518 4.112 0 C-N-CA 120.41 -0.9 . . . . 0.0 114.809 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.582 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 14.5 mtmm -130.05 168.51 16.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.312 1.045 . . . . 0.0 108.536 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 10.7 p -87.82 160.08 18.16 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 127.835 3.683 . . . . 0.0 114.319 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -45.76 -50.88 3.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 1 CA-C-N 105.277 -5.42 . . . . 0.0 116.141 -172.738 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 8.8 mm-40 -54.99 -42.41 72.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.082 -1.011 . . . . 0.0 112.162 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.98 -46.59 74.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.448 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -51.64 -49.37 62.42 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.116 -1.434 . . . . 0.0 111.336 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 57.5 mtpt -53.04 -50.2 64.78 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 52.5 mttp -50.9 -46.65 60.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.99 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 84.2 t -61.1 -56.9 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-O 124.685 2.183 . . . . 0.0 111.309 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.71 ' CG2' HG21 ' A' ' 66' ' ' VAL . 35.3 mt -54.38 -45.84 69.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.011 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 46' ' ' ALA . 91.7 mt -58.13 -36.51 73.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.728 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 55.9 tt0 -63.55 -39.33 94.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.183 -1.407 . . . . 0.0 110.933 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.41 -45.96 29.31 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.101 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 63.7 tttm -125.18 66.86 53.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.162 -0.961 . . . . 0.0 109.744 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -9.83 -57.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 1 C-N-CA 125.466 4.111 . . . . 0.0 121.233 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -82.59 1.49 37.85 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -178.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -57.74 84.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.21 111.01 7.05 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.58 HG12 ' H ' ' A' ' 66' ' ' VAL . 20.2 mt -107.77 152.37 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 50' ' ' VAL . 18.6 mm -124.58 163.06 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 123.752 1.739 . . . . 0.0 114.009 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.457 ' CB ' HG21 ' A' ' 32' ' ' VAL . 7.1 p -106.76 118.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-N 112.316 -2.22 . . . . 0.0 113.805 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 5.7 mp -128.6 136.58 29.33 Favored Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.095 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.79 135.97 20.22 Favored 'Trans proline' 0 N--CA 1.512 2.58 0 C-N-CA 123.017 2.478 . . . . 0.0 109.059 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 72.1 t -43.16 126.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 CA-C-N 120.437 1.471 . . . . 0.0 114.894 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.32 -39.82 2.47 Favored Glycine 0 N--CA 1.51 3.581 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.902 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.653 ' HB ' ' CZ ' ' A' ' 69' ' ' PHE . 22.4 m -47.61 168.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.787 1.28 . . . . 0.0 113.803 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.79 118.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.638 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -114.91 -77.23 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.362 174.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 78.6 9.77 Favored 'General case' 0 C--N 1.283 -2.326 1 N-CA-C 124.172 4.879 . . . . 0.0 124.172 -177.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.432 ' HG3' ' H ' ' A' ' 60' ' ' GLU . 1.9 tpt -98.99 -128.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 1 CA-C-N 107.153 -4.567 . . . . 0.0 104.098 176.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.545 ' CD ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.87 -169.49 2.38 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 172.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.652 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 39.3 t80 -118.04 102.56 9.14 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.72 -1.238 . . . . 0.0 112.311 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 65' ' ' ARG . 2.1 mpt_? -90.83 68.46 6.35 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 124.188 1.947 . . . . 0.0 108.739 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.749 HD12 HG11 ' A' ' 82' ' ' VAL . 4.6 tp -42.34 -29.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 112.681 -2.054 . . . . 0.0 116.026 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 2.2 p30 -57.04 -17.43 10.1 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-O 124.16 1.933 . . . . 0.0 111.448 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 62' ' ' ARG . 21.6 ttp85 -132.14 149.7 52.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.71 HG21 ' CG2' ' A' ' 39' ' ' ILE . 3.3 t -106.73 139.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' CZ ' ' HA ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -99.15 124.69 44.38 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 67' ' ' ARG . 2.7 mp -109.29 90.39 3.29 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 125.879 1.987 . . . . 0.0 110.761 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.653 ' CZ ' ' HB ' ' A' ' 55' ' ' THR . 12.8 m-85 -70.99 110.96 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 126.155 2.883 . . . . 0.0 110.475 170.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 53' ' ' VAL . 4.9 m -103.25 170.77 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-N 108.912 -3.767 . . . . 0.0 109.221 -176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.7 p-10 -93.43 -140.62 0.22 Allowed 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 124.285 1.993 . . . . 0.0 112.033 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -92.14 6.82 45.15 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 110.545 -3.025 . . . . 0.0 111.21 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 72.1 mt -136.74 32.08 2.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 112.534 -2.121 . . . . 0.0 110.061 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 34.96 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.688 1.595 . . . . 0.0 113.97 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 45.0 m-20 -108.47 137.94 45.6 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.4 mt -61.51 111.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 126.431 3.015 . . . . 0.0 112.796 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.475 . . -90.22 -47.01 8.06 Favored 'General case' 0 C--N 1.288 -2.108 2 CA-C-N 103.27 -6.332 . . . . 0.0 108.657 -173.842 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -117.14 157.15 26.42 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 111.556 -2.565 . . . . 0.0 107.765 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.528 HG22 HG21 ' A' ' 28' ' ' VAL . 94.5 t -75.4 141.03 72.89 Favored Pre-proline 0 N--CA 1.497 1.921 0 C-N-CA 115.122 -2.631 . . . . 0.0 108.74 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.573 ' HG2' HD11 ' A' ' 27' ' ' LEU . 6.5 Cg_exo -84.25 158.68 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.56 2.173 . . . . 0.0 109.121 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 156.65 32.49 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.032 -1.461 . . . . 0.0 109.195 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG11 HD12 ' A' ' 63' ' ' ILE . 23.9 t -74.93 144.79 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.258 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.652 ' HA3' ' CE1' ' A' ' 61' ' ' TYR . . . . . . . . 0 N--CA 1.509 3.53 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.63 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.178 0 CA-C-O 122.7 1.238 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -100.45 76.9 1.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 123.584 1.659 . . . . 0.0 113.241 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -98.34 1.74 47.34 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.554 ' HB2' ' NH2' ' A' ' 81' ' ' ARG . 0.6 OUTLIER -139.68 155.9 47.12 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.635 0.731 . . . . 0.0 111.736 172.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.498 ' CG ' HG12 ' A' ' 39' ' ' ILE . 30.1 m-90 -118.87 71.93 10.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -70.71 -30.54 17.72 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.054 1.169 . . . . 0.0 109.501 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -66.06 2.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.916 0.865 . . . . 0.0 109.979 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.521 HD13 ' HB1' ' A' ' 35' ' ' ALA . 31.3 mt -103.97 -8.07 19.9 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.653 -0.654 . . . . 0.0 110.902 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' HG22 ' A' ' 79' ' ' VAL . 53.2 t -66.51 107.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 123.148 1.452 . . . . 0.0 108.846 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.56 5.04 22.94 Favored Glycine 0 N--CA 1.506 3.306 0 CA-C-N 112.891 -1.958 . . . . 0.0 109.639 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' NZ ' ' CD ' ' A' ' 34' ' ' GLU . 1.5 mmmp? -111.69 167.6 10.22 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.736 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -88.28 173.18 8.92 Favored 'General case' 0 CA--C 1.443 -3.14 0 CA-C-O 123.008 1.385 . . . . 0.0 112.791 177.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.709 ' CG2' HG11 ' A' ' 70' ' ' VAL . 1.4 p -80.98 -55.62 7.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 108.903 -3.771 . . . . 0.0 115.641 -171.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 35.1 mm-40 -62.83 -21.13 65.7 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 122.362 2.346 . . . . 0.0 109.867 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 38.0 tt0 -75.9 -49.07 18.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.521 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -46.33 -52.5 12.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 82.0 tttt -48.05 -46.58 33.49 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 112.768 -2.015 . . . . 0.0 106.645 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 40.4 tttm -55.54 -54.3 45.65 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.487 -1.285 . . . . 0.0 109.891 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 69.1 t -59.02 -47.88 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 CA-C-O 124.291 1.996 . . . . 0.0 111.734 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 66' ' ' VAL . 14.7 mt -56.16 -51.8 58.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 112.764 -2.017 . . . . 0.0 109.21 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -61.93 -37.66 85.53 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 29.5 tp60 -58.92 -24.25 62.22 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.205 175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' OD2' ' NE1' ' A' ' 24' ' ' TRP . 49.5 t0 -96.2 -51.53 4.37 Favored 'General case' 0 N--CA 1.523 3.194 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.01 75.28 21.37 Favored Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -9.79 -55.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 2 C-N-CA 126.121 4.547 . . . . 0.0 122.717 -178.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -89.67 -0.29 57.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . . . -42.27 97.75 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.437 ' O ' ' NH2' ' A' ' 65' ' ' ARG . 93.4 mm-40 -87.59 65.21 8.44 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 39' ' ' ILE . 46.6 mt -72.26 127.03 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 121.456 3.873 . . . . 0.0 121.456 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.441 HD13 HH12 ' A' ' 65' ' ' ARG . 1.7 mp -123.14 128.23 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.062 -3.245 . . . . 0.0 106.085 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 51' ' ' LEU . 12.4 p -81.07 158.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 126.411 2.319 . . . . 0.0 113.129 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 HG21 ' A' ' 55' ' ' THR . 0.8 OUTLIER -141.1 151.65 62.63 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -85.48 131.83 4.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.738 1.625 . . . . 0.0 108.145 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 70' ' ' VAL . 13.3 t -42.33 133.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 106.75 -31.27 8.39 Favored Glycine 1 N--CA 1.518 4.112 0 CA-C-N 110.273 -3.149 . . . . 0.0 113.487 -178.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.624 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.312 40.2 m -48.62 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.8 1.24 . . . . 0.0 108.186 175.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' GLY . 21.1 mm -53.61 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 125.033 2.349 . . . . 0.0 112.274 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.619 HG21 ' HE2' ' A' ' 69' ' ' PHE . 7.0 m -98.75 -173.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 110.046 -3.252 . . . . 0.0 105.776 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -92.43 144.95 24.85 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 111.68 -2.509 . . . . 0.0 116.231 -174.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.11 40.14 1.06 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 123.291 1.52 . . . . 0.0 108.388 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 19.4 pt-20 -83.14 -171.97 3.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 111.511 -2.586 . . . . 0.0 113.589 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -137.47 74.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 123.614 1.673 . . . . 0.0 113.914 178.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 64' ' ' ASP . 15.5 mmt180 -89.69 68.22 7.55 Favored 'General case' 0 C--N 1.294 -1.843 1 N-CA-C 97.865 -4.865 . . . . 0.0 97.865 176.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 HG11 ' A' ' 82' ' ' VAL . 6.5 tp -43.85 -1.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' ARG . 3.1 p30 -85.67 -9.11 57.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 126.492 1.917 . . . . 0.0 108.71 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.441 HH12 HD13 ' A' ' 49' ' ' ILE . 38.9 ttm-85 -128.53 148.76 50.78 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 -172.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.723 HG21 HG21 ' A' ' 39' ' ' ILE . 4.2 t -117.27 120.63 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 1 N-CA-C 99.214 -4.365 . . . . 0.0 99.214 170.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.595 HH21 ' C ' ' A' ' 83' ' ' GLY . 3.1 tpp85 -79.92 117.14 20.5 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD23 HG23 ' A' ' 32' ' ' VAL . 10.0 mp -107.76 93.06 4.34 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 124.533 1.146 . . . . 0.0 110.633 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.624 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 26.5 m-85 -79.43 102.43 8.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 126.124 2.869 . . . . 0.0 109.93 170.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.709 HG11 ' CG2' ' A' ' 32' ' ' VAL . 2.3 m -108.93 177.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 108.475 -3.966 . . . . 0.0 109.47 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.6 p-10 -101.96 -142.77 0.35 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 124.478 2.085 . . . . 0.0 113.533 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -86.67 -2.09 58.24 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 109.021 -3.718 . . . . 0.0 113.09 -178.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 54.3 mt -135.84 37.95 2.82 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 111.5 -2.591 . . . . 0.0 108.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 37.13 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 65.6 m-20 -109.73 149.95 29.03 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -72.8 121.63 23.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 126.911 3.243 . . . . 0.0 116.983 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.462 . . -106.05 -42.58 5.06 Favored 'General case' 0 C--N 1.295 -1.796 2 CA-C-N 103.671 -6.149 . . . . 0.0 112.559 -173.213 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 27.8 mt-30 -111.46 153.97 25.37 Favored 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.524 HG22 ' CG2' ' A' ' 28' ' ' VAL . 62.8 t -75.9 139.89 70.09 Favored Pre-proline 0 N--CA 1.508 2.447 0 C-N-CA 112.547 -3.661 . . . . 0.0 106.893 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 9.7 Cg_exo -78.92 152.12 24.67 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 N-CA-C 106.673 -2.087 . . . . 0.0 106.673 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.554 ' NH2' ' HB2' ' A' ' 23' ' ' GLU . 7.7 ptp180 -160.76 159.31 29.91 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.079 -1.048 . . . . 0.0 112.041 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.55 HG11 HD12 ' A' ' 63' ' ' ILE . 5.4 t -78.24 143.66 12.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 124.265 1.983 . . . . 0.0 111.36 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.595 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C--N 1.296 -1.64 0 CA-C-N 110.014 -3.266 . . . . 0.0 110.215 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -124.9 49.57 1.84 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p -100.87 16.44 25.17 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.599 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.79 153.74 51.5 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 125.253 1.596 . . . . 0.0 110.267 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -128.49 60.44 48.41 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 123.075 1.416 . . . . 0.0 114.714 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -53.47 -35.95 77.96 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.417 2.078 . . . . 0.0 109.453 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -48.05 -31.32 5.3 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.136 1.446 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.56 HD11 HG13 ' A' ' 39' ' ' ILE . 56.0 mt -79.77 -26.85 40.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.886 -1.961 . . . . 0.0 114.847 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG2' HG22 ' A' ' 79' ' ' VAL . 14.3 t -50.92 137.83 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 117.877 -1.529 . . . . 0.0 107.59 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.23 -13.9 66.54 Favored Glycine 0 N--CA 1.505 3.238 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.305 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -111.34 166.84 10.77 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 117.438 0.619 . . . . 0.0 111.617 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.2 p -90.62 164.32 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 128.273 3.892 . . . . 0.0 115.119 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.69 -31.22 6.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 105.511 -5.313 . . . . 0.0 121.921 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -50.25 13.8 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 123.336 1.541 . . . . 0.0 107.195 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.673 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 2.2 tm-20 -50.67 -52.1 43.09 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 102.75 -3.055 . . . . 0.0 102.75 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.71 -60.16 3.14 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.952 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -48.37 -49.07 36.07 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.673 ' HE3' ' HA ' ' A' ' 34' ' ' GLU . 8.9 ttpp -53.1 -53.45 50.12 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.626 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.456 HG23 ' HZ1' ' A' ' 37' ' ' LYS . 90.5 t -60.64 -55.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 CA-C-O 123.432 1.587 . . . . 0.0 111.607 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.779 HG21 HG21 ' A' ' 66' ' ' VAL . 23.0 mt -53.54 -43.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.871 -176.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 46' ' ' ALA . 60.3 mt -64.99 -38.06 89.72 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.387 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -57.79 -48.29 80.14 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.441 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.66 -47.18 73.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 113.78 -1.555 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HE3' HG11 ' A' ' 82' ' ' VAL . 58.8 tttm -124.74 71.83 60.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 C-N-CA 124.513 1.125 . . . . 0.0 111.617 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -21.58 -50.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 124.35 3.366 . . . . 0.0 118.331 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 0.34 43.19 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -59.87 92.31 0.02 OUTLIER 'General case' 0 CA--C 1.587 2.391 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' ASP . 19.3 tt0 -75.72 70.4 2.51 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.571 HG12 ' H ' ' A' ' 66' ' ' VAL . 47.5 mt -72.68 141.22 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 111.852 -2.431 . . . . 0.0 117.135 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.451 ' HB ' ' HD3' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -125.91 156.52 35.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 123.075 1.417 . . . . 0.0 108.063 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.85 142.78 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 111.964 -2.38 . . . . 0.0 106.854 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 1.4 mt -137.17 125.29 14.57 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -67.59 135.12 35.03 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 CA-C-N 121.049 1.41 . . . . 0.0 108.857 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 70' ' ' VAL . 2.6 t -44.02 123.29 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.957 0.885 . . . . 0.0 112.742 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.22 -35.58 3.85 Favored Glycine 0 N--CA 1.513 3.803 0 O-C-N 128.075 3.359 . . . . 0.0 113.278 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.701 ' HB ' ' CE1' ' A' ' 69' ' ' PHE . 60.1 m -47.61 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.463 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mm -53.4 97.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 124.437 2.065 . . . . 0.0 112.481 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.564 HG21 ' HE2' ' A' ' 69' ' ' PHE . 14.7 m -97.26 -176.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 110.76 -2.927 . . . . 0.0 105.563 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.33 147.1 24.27 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 112.197 -2.274 . . . . 0.0 115.328 -172.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtp -91.55 34.23 0.98 Allowed 'General case' 0 N--CA 1.515 2.788 0 CA-C-O 124.929 2.299 . . . . 0.0 112.315 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.444 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 24.1 pt-20 -83.71 -163.25 0.74 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 109.134 -3.666 . . . . 0.0 115.299 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.65 67.16 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.06 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.444 ' HE ' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -89.39 66.73 7.54 Favored 'General case' 0 N--CA 1.511 2.594 0 CA-C-O 126.608 3.099 . . . . 0.0 105.865 177.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.582 HD12 HG11 ' A' ' 82' ' ' VAL . 4.9 tp -42.8 -8.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 109.717 -3.401 . . . . 0.0 119.446 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 65' ' ' ARG . 45.8 p30 -80.86 -5.7 57.67 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 119.588 1.086 . . . . 0.0 108.166 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.465 HH21 ' CG ' ' A' ' 64' ' ' ASP 0.26 15.9 ttm-85 -137.45 147.58 45.44 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 119.587 3.18 . . . . 0.0 119.587 -174.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.779 HG21 HG21 ' A' ' 39' ' ' ILE . 5.2 t -101.33 140.06 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 1 N-CA-C 99.205 -4.369 . . . . 0.0 99.205 173.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.408 ' NH2' ' C ' ' A' ' 83' ' ' GLY . 1.5 tpp180 -89.44 120.11 30.48 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.9 mt -111.33 88.15 2.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 126.066 2.104 . . . . 0.0 114.036 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.701 ' CE1' ' HB ' ' A' ' 55' ' ' THR . 38.2 m-85 -81.76 99.62 9.06 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 127.852 3.691 . . . . 0.0 107.734 170.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 5.7 m -100.19 171.52 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 1 CA-C-N 106.042 -5.072 . . . . 0.0 106.75 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.4 p-10 -87.72 -141.02 0.11 Allowed 'General case' 0 C--N 1.293 -1.874 0 O-C-N 118.818 -2.426 . . . . 0.0 110.72 -175.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 44.3 mmtm -95.88 8.2 44.25 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 110.256 -3.156 . . . . 0.0 112.683 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.1 mt -137.59 32.46 2.51 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 111.627 -2.533 . . . . 0.0 108.198 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' HA ' ' CG2' ' A' ' 70' ' ' VAL 0.322 3.9 p-10 31.9 41.71 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 22.8 m-80 -113.46 151.47 31.4 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 110.93 -2.85 . . . . 0.0 104.968 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -80.69 117.68 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 125.415 2.531 . . . . 0.0 113.695 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 71' ' ' ASP 0.416 . . -105.37 -38.71 6.4 Favored 'General case' 0 C--N 1.298 -1.644 2 CA-C-N 104.062 -5.972 . . . . 0.0 114.344 -174.049 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.94 155.87 27.23 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 100.661 -3.829 . . . . 0.0 100.661 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.533 HG22 ' CG2' ' A' ' 28' ' ' VAL . 67.2 t -75.46 147.72 82.45 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 113.628 -3.229 . . . . 0.0 109.155 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HG2' HD12 ' A' ' 27' ' ' LEU . 25.4 Cg_exo -73.05 139.35 29.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.39 153.24 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.377 -1.329 . . . . 0.0 110.281 -176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 63' ' ' ILE . 14.9 t -82.09 134.09 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 117.374 -1.731 . . . . 0.0 114.522 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.494 2.505 0 C-N-CA 118.957 -1.592 . . . . 0.0 113.968 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.803 0 CA-C-O 122.413 1.101 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HE3' ' NE1' ' A' ' 24' ' ' TRP . 4.4 tmtm? -116.16 72.93 0.83 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 68.1 p -120.95 20.02 11.62 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 109.066 -3.697 . . . . 0.0 111.028 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.566 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -153.11 159.38 42.76 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 126.327 1.851 . . . . 0.0 113.33 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.62 ' NE1' ' HE3' ' A' ' 21' ' ' LYS . 11.6 m-90 -139.32 64.91 33.45 Favored Pre-proline 0 N--CA 1.51 2.536 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.596 ' HA ' HG21 ' A' ' 79' ' ' VAL . 75.6 Cg_exo -53.85 -40.05 81.92 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.407 2.738 . . . . 0.0 111.184 -178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 14.6 mp0 -50.5 -27.88 7.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 123.767 1.746 . . . . 0.0 109.671 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.524 ' CD1' HG13 ' A' ' 39' ' ' ILE . 29.4 mt -79.46 -24.09 42.64 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 116.542 -1.694 . . . . 0.0 113.514 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.742 HG23 ' CG2' ' A' ' 79' ' ' VAL . 95.7 t -47.97 136.72 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -17.49 55.16 Favored Glycine 0 N--CA 1.51 3.591 0 C-N-CA 119.371 -1.395 . . . . 0.0 112.487 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -113.73 161.76 17.12 Favored 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.759 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 2.5 p -86.55 153.82 21.54 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 126.548 3.07 . . . . 0.0 115.102 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.298 4.3 p -38.9 -56.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 1 CA-C-N 107.128 -4.578 . . . . 0.0 117.446 -174.131 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.39 -23.8 65.61 Favored 'General case' 0 N--CA 1.51 2.558 0 CA-C-N 120.508 1.504 . . . . 0.0 113.833 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -77.46 -48.94 15.86 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.46 -44.13 62.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' CG ' HD12 ' A' ' 40' ' ' LEU . 36.7 ttmt -54.53 -47.2 73.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.084 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -54.13 -48.81 70.38 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 124.901 1.376 . . . . 0.0 110.758 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.3 t -64.99 -48.0 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 124.133 1.92 . . . . 0.0 112.029 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.78 HG21 HG21 ' A' ' 66' ' ' VAL . 31.4 mt -55.89 -55.39 18.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.961 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD12 ' CG ' ' A' ' 36' ' ' LYS . 3.8 mt -64.74 -22.86 67.08 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.131 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 17.5 tp60 -66.46 -29.04 69.08 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.742 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -97.02 -53.47 3.49 Favored 'General case' 0 N--CA 1.517 2.914 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 20.0 tptp -118.75 72.15 10.79 Favored Pre-proline 0 N--CA 1.506 2.342 0 O-C-N 120.168 -1.583 . . . . 0.0 112.04 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -20.03 -50.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 124.684 3.589 . . . . 0.0 120.144 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.1 mp0 -63.8 -22.21 66.8 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.49 84.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 120.084 3.364 . . . . 0.0 120.084 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -75.33 74.59 2.43 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.521 HD11 HG21 ' A' ' 39' ' ' ILE . 23.9 mt -76.47 121.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 50' ' ' VAL . 3.9 mp -119.29 163.05 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 173.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 49' ' ' ILE . 8.6 p -85.01 130.2 36.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 111.153 -2.748 . . . . 0.0 106.982 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.688 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -129.12 102.02 19.15 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.58 118.39 5.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 120.912 1.075 . . . . 0.0 113.686 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.495 HG23 ' C ' ' A' ' 69' ' ' PHE . 2.4 t -38.81 134.3 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 118.186 2.662 . . . . 0.0 118.186 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' ILE . . . 113.61 -37.28 3.66 Favored Glycine 0 N--CA 1.506 3.362 1 CA-C-N 108.232 -4.076 . . . . 0.0 107.13 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' VAL 0.297 80.7 m -56.07 69.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 125.91 1.684 . . . . 0.0 108.235 174.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' GLY . 11.5 mm -62.63 116.76 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 123.445 1.593 . . . . 0.0 109.832 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.469 HG21 ' HD3' ' A' ' 67' ' ' ARG . 18.4 m -98.67 -168.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 111.325 -2.671 . . . . 0.0 112.428 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.17 150.37 24.0 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 117.824 2.528 . . . . 0.0 117.824 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 89.7 mmm -91.71 47.61 1.38 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 123.044 1.402 . . . . 0.0 107.336 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' CD ' ' HB2' ' A' ' 62' ' ' ARG . 13.0 pt-20 -81.16 -179.55 7.4 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.745 -2.025 . . . . 0.0 110.488 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.559 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 1.1 t80 -127.57 41.91 3.42 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 125.479 2.561 . . . . 0.0 107.817 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 64' ' ' ASP . 3.6 mpt_? -88.43 77.42 8.1 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.744 ' HA ' HG12 ' A' ' 82' ' ' VAL . 8.7 tp -67.23 22.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.747 1 CA-C-N 107.835 -4.257 . . . . 0.0 116.931 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 62' ' ' ARG . 2.3 p-10 -95.93 -11.82 26.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 110.195 -3.184 . . . . 0.0 108.971 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 6.3 mtm180 -129.46 88.1 2.64 Favored 'General case' 0 N--CA 1.503 2.194 1 N-CA-C 128.496 6.48 . . . . 0.0 128.496 -173.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.78 HG21 HG21 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.83 83.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 121.898 2.135 . . . . 0.0 107.072 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' HD3' HG21 ' A' ' 57' ' ' VAL . 2.2 ptp180 -59.32 96.48 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 111.23 -2.714 . . . . 0.0 111.088 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.565 HD23 ' HG3' ' A' ' 80' ' ' PRO . 53.9 mt -73.99 100.17 3.49 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 116.993 -1.883 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 32.7 m-85 -74.63 98.86 3.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 127.624 3.583 . . . . 0.0 107.268 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.1 m -100.9 165.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 1 CA-C-N 107.267 -4.515 . . . . 0.0 107.21 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.485 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 8.9 p-10 -89.91 -140.61 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 115.935 -2.306 . . . . 0.0 107.973 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 11.3 mptt -95.78 8.98 42.01 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 111.12 -2.763 . . . . 0.0 113.906 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 31.1 mt -137.6 39.32 2.42 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 112.242 -2.254 . . . . 0.0 107.164 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 33.91 28.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 118.86 2.911 . . . . 0.0 118.86 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 60.0 m-20 -104.76 148.59 26.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.443 HG21 HG23 ' A' ' 79' ' ' VAL . 23.0 mt -74.93 120.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 126.446 3.022 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.48 . . -104.54 -52.81 2.82 Favored 'General case' 0 C--N 1.285 -2.227 2 CA-C-N 102.468 -6.697 . . . . 0.0 107.794 -173.592 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 69' ' ' PHE . 6.3 mp0 -119.98 84.91 2.29 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.761 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.742 ' CG2' HG23 ' A' ' 28' ' ' VAL . 1.2 t -42.2 147.71 0.55 Allowed Pre-proline 0 N--CA 1.503 2.18 0 C-N-CA 117.079 -1.848 . . . . 0.0 115.69 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -89.19 -170.79 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 124.473 3.449 . . . . 0.0 119.51 -175.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.532 HH11 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -156.46 136.35 12.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.961 -3.291 . . . . 0.0 105.556 -179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 63' ' ' ILE . 96.7 t -53.65 -63.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 125.888 2.756 . . . . 0.0 109.67 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.532 ' C ' HH11 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.291 -1.919 1 CA-C-N 107.705 -4.316 . . . . 0.0 105.459 -174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.003 0 CA-C-O 123.049 1.405 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 7.4 tmtm? -102.16 70.56 1.2 Allowed 'General case' 0 C--N 1.305 -1.368 1 N-CA-C 99.302 -4.332 . . . . 0.0 99.302 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -98.78 13.29 32.87 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 111.214 -2.721 . . . . 0.0 111.839 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.4 146.56 40.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 126.27 2.231 . . . . 0.0 113.625 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.603 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 19.6 m-90 -131.16 64.7 74.51 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 117.814 2.524 . . . . 0.0 117.814 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -60.08 -33.96 94.89 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.951 2.434 . . . . 0.0 111.234 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -58.05 -12.1 3.09 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.201 1.477 . . . . 0.0 109.336 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.603 ' CD1' ' HB3' ' A' ' 24' ' ' TRP . 17.9 mt -99.31 2.86 45.8 Favored 'General case' 0 CA--C 1.56 1.36 0 O-C-N 121.123 -0.986 . . . . 0.0 112.365 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG2' HG22 ' A' ' 79' ' ' VAL . 88.6 t -73.4 127.07 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-N 120.652 1.569 . . . . 0.0 107.068 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.6 4.04 57.18 Favored Glycine 0 N--CA 1.505 3.298 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -117.63 160.83 20.64 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -89.6 153.21 20.93 Favored 'General case' 0 CA--C 1.474 -1.967 0 CA-C-O 125.989 2.804 . . . . 0.0 114.696 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.576 ' HB ' HG11 ' A' ' 70' ' ' VAL 0.318 11.6 p -42.37 -62.38 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.415 1 CA-C-N 107.533 -4.394 . . . . 0.0 118.215 -172.265 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.23 -18.51 63.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.514 -1.674 . . . . 0.0 111.356 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 36.7 tt0 -76.61 -45.75 28.88 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.501 ' CA ' HD13 ' A' ' 27' ' ' LEU . . . -54.38 -55.64 26.58 Favored 'General case' 0 C--O 1.205 -1.251 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -48.5 -49.6 35.17 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.717 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 3.2 ttpp -52.94 -44.29 66.96 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.555 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' N ' ' HZ2' ' A' ' 37' ' ' LYS . 78.4 t -70.66 -47.08 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 CA-C-O 122.156 0.979 . . . . 0.0 112.252 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.712 HG21 HG21 ' A' ' 66' ' ' VAL . 40.5 mt -48.24 -48.27 13.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-O 122.932 1.348 . . . . 0.0 109.691 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 46' ' ' ALA . 31.1 mt -59.91 -22.27 62.18 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.186 -1.825 . . . . 0.0 113.364 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -16.16 57.31 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.451 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.39 -52.54 3.93 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.749 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mmmp? -119.08 77.99 16.76 Favored Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -19.06 -56.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.901 1 C-N-CA 125.503 4.135 . . . . 0.0 120.728 -177.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.48 8.27 19.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.494 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -52.83 87.05 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -77.24 70.71 3.67 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 176.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.527 HD11 ' CG2' ' A' ' 39' ' ' ILE . 62.1 mt -74.3 148.04 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 112.383 -2.19 . . . . 0.0 116.794 -175.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.11 152.76 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.969 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 32' ' ' VAL . 3.5 p -93.6 122.34 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 112.84 -1.982 . . . . 0.0 113.404 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.618 HD23 HG21 ' A' ' 55' ' ' THR . 1.4 mp -136.77 141.58 35.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.5 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -80.38 139.54 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.369 1.38 . . . . 0.0 108.769 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 69' ' ' PHE . 41.7 t -43.81 127.56 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.98 -34.82 4.67 Favored Glycine 1 N--CA 1.523 4.448 0 CA-C-N 111.179 -2.737 . . . . 0.0 115.613 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.618 HG21 HD23 ' A' ' 51' ' ' LEU 0.253 50.2 m -45.03 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 124.981 1.312 . . . . 0.0 112.695 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.45 106.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.775 0 CA-C-O 122.58 1.181 . . . . 0.0 111.545 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.617 HG21 ' HE2' ' A' ' 69' ' ' PHE . 1.7 m -111.38 -106.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 85.19 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 1 N-CA-C 123.297 4.554 . . . . 0.0 123.297 -173.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 18.5 mmm -95.11 -47.57 6.32 Favored 'General case' 0 N--CA 1.501 2.116 1 CA-C-N 106.874 -4.694 . . . . 0.0 105.426 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' HB2' HH21 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -82.94 -175.9 6.06 Favored 'General case' 0 C--N 1.284 -2.279 3 CA-C-N 103.161 -6.381 . . . . 0.0 112.062 179.385 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.535 ' CE2' HD13 ' A' ' 63' ' ' ILE . 20.8 t80 -157.97 85.66 0.89 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.586 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.542 HH21 ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -100.84 81.76 2.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 175.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.668 HD12 HG11 ' A' ' 82' ' ' VAL 0.262 6.0 tp -42.54 -6.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.136 1 CA-C-N 108.341 -4.027 . . . . 0.0 117.007 177.711 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.1 p30 -93.88 7.27 45.6 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.228 1.011 . . . . 0.0 110.034 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.572 ' HD2' ' CZ ' ' A' ' 67' ' ' ARG . 20.0 ttp180 -129.78 140.38 51.06 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 39' ' ' ILE . 9.6 t -111.52 150.68 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 CA-C-N 122.918 2.599 . . . . 0.0 106.073 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' CZ ' ' HD2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.77 112.77 24.48 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.326 -177.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.2 mt -103.58 85.14 2.4 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.343 1.652 . . . . 0.0 109.458 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.617 ' HE2' HG21 ' A' ' 57' ' ' VAL . 29.6 m-85 -83.54 97.42 9.02 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 127.335 3.445 . . . . 0.0 109.965 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.576 HG11 ' HB ' ' A' ' 32' ' ' VAL . 4.4 m -104.24 174.09 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 1 CA-C-N 105.746 -5.206 . . . . 0.0 109.392 -175.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.6 p-10 -99.74 -148.77 0.35 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 124.163 1.935 . . . . 0.0 109.28 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.33 17.17 14.95 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 111.26 -2.7 . . . . 0.0 113.641 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -133.8 26.16 3.99 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 111.222 -2.717 . . . . 0.0 103.715 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.28 0.0 OUTLIER 33.36 35.98 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.61 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 70.7 m-20 -113.42 154.91 26.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.6 mt -78.21 119.85 27.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 126.483 3.039 . . . . 0.0 115.423 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.474 . . -98.51 -45.61 6.04 Favored 'General case' 0 C--N 1.293 -1.874 2 CA-C-N 103.662 -6.154 . . . . 0.0 111.696 -173.668 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -117.72 160.66 20.96 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.549 HG22 ' CG2' ' A' ' 28' ' ' VAL . 89.4 t -71.68 146.56 91.2 Favored Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 114.052 -3.059 . . . . 0.0 110.282 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 8.1 Cg_exo -79.13 159.28 26.79 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.331 2.021 . . . . 0.0 109.6 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 79' ' ' VAL . 8.7 ptp85 -160.38 162.11 33.27 Favored 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 117.376 -1.297 . . . . 0.0 113.659 -176.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 63' ' ' ILE . 2.9 t -84.55 150.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 118.045 2.609 . . . . 0.0 118.045 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.197 0 C-N-CA 126.6 2.048 . . . . 0.0 114.427 176.239 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.945 0 CA-C-O 122.473 1.13 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -119.36 60.75 0.83 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -100.0 19.59 15.97 Favored 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 112.079 -2.328 . . . . 0.0 112.292 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -142.63 151.41 41.43 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.204 176.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.578 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 30.5 m-90 -127.84 75.37 78.19 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.616 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -81.2 -18.02 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.352 2.035 . . . . 0.0 111.071 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -77.58 -28.68 51.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.578 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 2.0 pp -92.27 23.48 3.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 122.391 1.091 . . . . 0.0 113.918 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 79' ' ' VAL . 55.7 t -72.53 167.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.83 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.01 36.58 20.94 Favored Glycine 0 N--CA 1.514 3.867 0 CA-C-O 123.209 1.449 . . . . 0.0 112.799 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 50.2 mttp -138.1 174.58 10.41 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-N 112.203 -1.999 . . . . 0.0 110.534 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 p -85.51 159.85 19.82 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 125.321 2.486 . . . . 0.0 114.331 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG2' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -64.25 -32.35 57.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 1 CA-C-N 108.324 -4.035 . . . . 0.0 109.719 -175.739 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 44.5 mm-40 -63.81 -46.41 85.24 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 118.315 -1.354 . . . . 0.0 112.024 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.36 -54.93 41.47 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 126.327 2.267 . . . . 0.0 105.079 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -45.69 -54.85 7.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.354 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 52.5 mtpt -49.43 -56.44 9.69 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -54.45 -48.43 71.75 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.05 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 94.2 t -57.71 -56.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.453 0 CA-C-O 124.787 2.232 . . . . 0.0 110.646 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.772 HG21 HG21 ' A' ' 66' ' ' VAL . 37.9 mt -55.32 -45.68 77.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 112.177 -2.283 . . . . 0.0 110.57 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 26.1 mt -56.49 -38.72 72.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 8.7 tt0 -59.0 -44.77 91.71 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.816 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.04 -47.74 60.81 Favored 'General case' 0 N--CA 1.503 2.222 0 CA-C-N 113.526 -1.67 . . . . 0.0 113.782 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 63.6 tttm -125.23 74.84 67.98 Favored Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -7.77 -65.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 1 C-N-CA 125.487 4.125 . . . . 0.0 120.139 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.575 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -88.34 7.12 33.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 -177.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.517 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -43.95 103.23 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -85.24 83.47 7.98 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.586 HD11 ' CG2' ' A' ' 39' ' ' ILE . 68.5 mt -80.31 135.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 111.581 -2.554 . . . . 0.0 115.809 -176.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 48' ' ' ILE . 1.8 mp -125.95 137.68 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 111.956 -2.384 . . . . 0.0 111.522 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.481 ' C ' HD12 ' A' ' 51' ' ' LEU . 12.1 p -95.81 145.51 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.62 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 5.5 mp -141.12 149.62 56.1 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -81.55 135.38 9.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 N-CA-C 105.474 -2.548 . . . . 0.0 105.474 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 69' ' ' PHE . 87.4 t -42.91 130.48 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.652 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.31 -41.1 2.11 Favored Glycine 1 N--CA 1.519 4.214 0 CA-C-N 111.528 -2.578 . . . . 0.0 112.977 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.636 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.258 11.4 m -50.02 165.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 125.279 1.432 . . . . 0.0 111.338 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mm -61.14 136.05 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.68 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -123.69 -77.92 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-N 112.16 -2.291 . . . . 0.0 114.015 176.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 83.73 6.41 Favored 'General case' 0 C--N 1.295 -1.78 1 N-CA-C 122.698 4.333 . . . . 0.0 122.698 -179.115 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 tpt -97.44 -137.11 0.27 Allowed 'General case' 0 C--N 1.29 -2.003 1 CA-C-N 107.769 -4.287 . . . . 0.0 103.273 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 60' ' ' GLU 0.277 0.1 OUTLIER -78.4 -174.07 3.6 Favored 'General case' 0 C--N 1.288 -2.105 1 N-CA-C 98.843 -4.503 . . . . 0.0 98.843 170.168 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 7.9 t80 -120.33 135.85 54.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.015 -2.303 . . . . 0.0 117.059 -173.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -115.56 64.33 0.69 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 124.074 1.892 . . . . 0.0 106.844 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.638 HD12 HG11 ' A' ' 82' ' ' VAL . 5.8 tp -42.83 -7.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 62' ' ' ARG . 1.8 p30 -81.66 -9.83 59.56 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 124.207 1.003 . . . . 0.0 110.035 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -129.07 149.3 50.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 120.562 3.541 . . . . 0.0 120.562 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.772 HG21 HG21 ' A' ' 39' ' ' ILE . 5.0 t -110.18 132.21 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 101.962 -3.347 . . . . 0.0 101.962 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.64 ' NH1' ' HA ' ' A' ' 57' ' ' VAL . 16.8 tpp85 -89.83 116.21 27.74 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.779 -2.01 . . . . 0.0 108.098 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 80' ' ' PRO . 7.6 mp -107.92 90.97 3.46 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 124.816 1.323 . . . . 0.0 113.996 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 57' ' ' VAL . 22.5 m-85 -76.34 103.52 6.4 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 125.588 2.613 . . . . 0.0 112.153 169.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 4.5 m -109.77 171.78 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 CA-C-N 109.077 -3.692 . . . . 0.0 109.074 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -93.62 -140.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.494 -2.004 . . . . 0.0 111.818 -176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.4 mmtm -88.51 0.91 55.81 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 110.911 -2.859 . . . . 0.0 112.303 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 38.5 mt -136.97 39.52 2.55 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 111.62 -2.537 . . . . 0.0 109.846 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.57 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -178.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 53.7 m-20 -105.27 142.31 35.27 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.532 HD13 ' HG2' ' A' ' 80' ' ' PRO . 79.9 mt -67.18 116.98 7.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 126.69 3.138 . . . . 0.0 114.561 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 53' ' ' VAL 0.468 . . -102.82 -40.61 6.49 Favored 'General case' 0 C--N 1.289 -2.057 1 CA-C-N 104.414 -5.812 . . . . 0.0 111.815 -172.198 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.2 163.72 15.87 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 102.266 -3.235 . . . . 0.0 102.266 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 28' ' ' VAL . 78.1 t -77.3 141.22 66.06 Favored Pre-proline 0 N--CA 1.499 1.998 0 C-N-CA 114.092 -3.043 . . . . 0.0 110.235 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.532 ' HG2' HD13 ' A' ' 76' ' ' ILE . 14.6 Cg_exo -80.84 145.49 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.544 2.829 . . . . 0.0 106.464 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -153.28 168.45 25.98 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.502 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.638 HG11 HD12 ' A' ' 63' ' ' ILE . 25.0 t -82.64 154.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 116.731 -1.987 . . . . 0.0 113.105 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.561 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.511 3.636 0 C-N-CA 125.937 1.732 . . . . 0.0 114.01 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.944 0 CA-C-O 121.453 0.644 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' NZ ' ' CG ' ' A' ' 42' ' ' ASP . 37.3 mtpt -118.68 152.3 36.36 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.517 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 45.6 p -128.94 19.26 6.04 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.331 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -156.88 150.58 24.57 Favored 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.731 178.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CE3' ' C ' ' A' ' 23' ' ' GLU . 20.3 m-90 -133.77 59.89 42.39 Favored Pre-proline 0 N--CA 1.516 2.83 0 N-CA-C 121.118 3.747 . . . . 0.0 121.118 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' N ' HG13 ' A' ' 79' ' ' VAL . 52.8 Cg_exo -48.98 -40.3 40.58 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 124.098 3.198 . . . . 0.0 110.983 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.703 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 4.8 mp0 -46.38 -30.41 2.11 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.621 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 32.6 mt -79.65 -27.37 40.88 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.775 ' CG2' HG22 ' A' ' 79' ' ' VAL . 30.8 t -48.05 137.54 3.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.85 -4.12 71.79 Favored Glycine 0 N--CA 1.508 3.446 0 CA-C-N 114.566 -1.197 . . . . 0.0 113.255 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 32.4 mtmm -114.27 178.42 4.29 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.504 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 5.7 p -85.71 171.56 11.53 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 127.518 3.533 . . . . 0.0 116.867 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.1 p -72.15 -18.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 1 CA-C-N 104.863 -5.608 . . . . 0.0 112.752 -176.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -85.42 -49.09 8.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 24.4 mt-10 -50.06 -52.78 31.73 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' CB ' HD13 ' A' ' 27' ' ' LEU . . . -50.91 -44.21 60.0 Favored 'General case' 0 C--O 1.204 -1.31 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.406 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' ILE . 61.1 mttm -62.05 -49.14 77.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.082 1.765 . . . . 0.0 108.24 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -54.97 -52.76 62.04 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 113.088 -1.869 . . . . 0.0 109.976 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 84.9 t -61.8 -54.99 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.239 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.662 ' CG2' HG21 ' A' ' 66' ' ' VAL . 32.2 mt -55.34 -51.0 60.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.095 -176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' PRO . 96.9 mt -57.37 -33.28 67.64 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 24.1 mt-30 -59.81 -43.76 94.35 Favored 'General case' 0 N--CA 1.516 2.871 0 C-N-CA 117.432 -1.707 . . . . 0.0 110.137 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' CG ' ' NZ ' ' A' ' 21' ' ' LYS . 52.0 m-20 -72.63 -53.06 12.86 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 82' ' ' VAL . 26.3 tptp -121.43 57.17 6.79 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 112.347 -2.206 . . . . 0.0 108.389 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 12.5 Cg_exo -12.48 -65.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 125.198 3.932 . . . . 0.0 120.414 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.74 24.98 1.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -71.22 124.67 25.01 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-O 122.442 1.115 . . . . 0.0 111.203 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -91.71 67.9 5.46 Favored 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.543 HG12 ' HB ' ' A' ' 66' ' ' VAL . 20.6 mt -72.37 134.4 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 119.359 3.096 . . . . 0.0 119.359 -173.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 50' ' ' VAL . 40.5 mm -103.53 175.22 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 113.385 -1.734 . . . . 0.0 111.569 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.6 p -106.4 118.19 53.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 126.516 1.926 . . . . 0.0 111.516 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.786 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 16.7 mt -136.29 119.41 12.21 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-O 117.682 -1.151 . . . . 0.0 110.399 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 27.3 Cg_exo -70.45 138.44 35.62 Favored 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 123.51 2.807 . . . . 0.0 110.465 176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.459 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 32.7 t -42.28 131.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.45 99.07 1.92 Allowed Glycine 0 N--CA 1.509 3.555 2 N-CA-C 96.215 -6.754 . . . . 0.0 96.215 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.717 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -68.24 116.2 8.57 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -171.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -83.14 -0.24 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 126.036 2.827 . . . . 0.0 111.036 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' CG2' ' HE2' ' A' ' 69' ' ' PHE . 24.9 m -110.62 -173.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 108.592 -3.913 . . . . 0.0 111.61 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.489 ' OG1' ' NH1' ' A' ' 62' ' ' ARG . 2.8 p -87.09 -178.53 6.28 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.9 tpt -91.03 -38.08 13.03 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 125.961 2.791 . . . . 0.0 115.345 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 9.5 pt-20 -49.82 -160.68 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.34 1 CA-C-N 105.061 -5.518 . . . . 0.0 117.24 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.824 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 57.8 t80 -114.76 70.84 0.74 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.695 1.247 . . . . 0.0 113.376 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.655 ' H ' ' CD ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -88.22 66.13 8.34 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 126.718 3.152 . . . . 0.0 109.602 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.824 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.23 -31.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 2 N-CA-C 125.652 5.427 . . . . 0.0 125.652 -179.079 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' CG ' HH22 ' A' ' 65' ' ' ARG . 6.4 p-10 -55.09 -18.11 5.03 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 123.458 1.599 . . . . 0.0 108.058 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.738 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 14.8 ttp-105 -135.45 104.37 5.81 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 82' ' ' VAL . 18.4 t -62.04 136.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 123.495 2.861 . . . . 0.0 104.193 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.771 ' CZ ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -96.57 134.89 39.22 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.038 -1.865 . . . . 0.0 112.577 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.771 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 80.5 mt -114.96 81.3 1.54 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 112.855 -1.975 . . . . 0.0 111.432 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.786 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 9.4 m-85 -73.7 102.93 4.1 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 126.713 3.149 . . . . 0.0 105.26 167.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -100.75 167.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 1 CA-C-N 107.481 -4.418 . . . . 0.0 106.301 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 3.5 p-10 -91.39 -141.44 0.18 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 123.386 2.812 . . . . 0.0 112.424 -177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.547 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 9.9 mptt -91.66 5.22 50.52 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 111.055 -2.793 . . . . 0.0 114.939 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 73' ' ' LEU 0.264 0.5 OUTLIER -138.6 34.52 2.23 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.6 176.893 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.62 48.03 0.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 124.665 2.174 . . . . 0.0 110.005 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -115.0 142.71 46.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 172.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.9 mt -69.63 119.55 15.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 124.359 2.028 . . . . 0.0 112.846 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.477 . . -103.21 -35.67 8.37 Favored 'General case' 0 C--N 1.297 -1.707 2 CA-C-N 104.687 -5.688 . . . . 0.0 110.726 -174.875 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -116.53 126.63 53.6 Favored 'General case' 0 N--CA 1.52 3.049 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.12 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.87 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 94.2 t -78.38 -75.83 0.07 OUTLIER Pre-proline 0 N--CA 1.516 2.831 1 N-CA-C 124.997 5.184 . . . . 0.0 124.997 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.87 ' HD3' ' HB ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -66.6 51.3 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.613 2 N-CA-C 133.547 8.249 . . . . 0.0 133.547 -171.795 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.501 HH21 ' C ' ' A' ' 83' ' ' GLY 0.262 0.0 OUTLIER -170.69 120.65 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 2 N-CA-C 131.144 7.461 . . . . 0.0 131.144 172.956 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.666 ' HA ' HG22 ' A' ' 66' ' ' VAL . 4.4 t -51.26 -23.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 111.939 -2.391 . . . . 0.0 113.853 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.501 ' C ' HH21 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.28 -2.569 0 O-C-N 128.786 3.804 . . . . 0.0 103.605 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 120.186 0.041 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 42.5 tptt -131.42 58.57 1.72 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.659 0.742 . . . . 0.0 109.341 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -112.37 24.53 12.44 Favored 'General case' 0 N--CA 1.512 2.663 0 CA-C-O 122.733 1.254 . . . . 0.0 110.601 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -136.77 146.03 45.27 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 112.729 -2.032 . . . . 0.0 108.999 175.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.585 ' CZ3' HG23 ' A' ' 82' ' ' VAL . 15.6 m-90 -129.95 62.78 65.77 Favored Pre-proline 0 N--CA 1.522 3.156 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.624 ' HA ' HG21 ' A' ' 79' ' ' VAL . 77.9 Cg_exo -53.68 -38.92 84.88 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.978 3.118 . . . . 0.0 111.586 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 30.4 mp0 -49.58 -28.65 5.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.919 1.343 . . . . 0.0 110.333 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' A' ' 35' ' ' ALA . 74.4 mt -79.92 -19.99 46.78 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.671 -177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.677 HG23 ' CG2' ' A' ' 79' ' ' VAL . 59.9 t -49.73 137.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 121.625 2.011 . . . . 0.0 107.831 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.65 -9.03 66.36 Favored Glycine 0 N--CA 1.515 3.922 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.27 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 35.0 mmtm -106.45 166.92 10.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.404 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.418 ' HB3' ' ND2' ' A' ' 75' ' ' ASN . 1.9 p -88.46 165.81 14.64 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 126.679 3.133 . . . . 0.0 116.533 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 68' ' ' LEU 0.255 0.3 OUTLIER -60.84 -50.51 80.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 1 CA-C-N 107.174 -4.557 . . . . 0.0 116.569 -174.241 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 41.1 mm-40 -68.17 -37.55 81.11 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.572 -1.651 . . . . 0.0 111.127 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -58.98 -51.09 71.58 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.406 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -49.82 -59.08 4.17 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.293 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 48' ' ' ILE 0.303 21.7 tttm -44.55 -53.78 6.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 54.5 mttp -53.47 -53.93 44.3 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.6 -2.091 . . . . 0.0 111.072 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 93.6 t -59.53 -52.3 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 123.941 1.829 . . . . 0.0 113.193 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 66' ' ' VAL . 15.8 mt -54.17 -50.94 51.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.101 -2.318 . . . . 0.0 107.864 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.64 -14.12 56.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 124.294 0.996 . . . . 0.0 112.675 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -80.27 -21.13 43.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -97.0 -52.12 3.98 Favored 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HG2' HG21 ' A' ' 82' ' ' VAL . 10.7 tptp -118.35 72.94 10.19 Favored Pre-proline 0 N--CA 1.514 2.754 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -177.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -9.76 -51.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 1 C-N-CA 125.421 4.081 . . . . 0.0 120.495 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.4 mp0 -71.89 -23.28 61.47 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.27 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.479 1.133 . . . . 0.0 113.713 -177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -87.57 71.3 9.77 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -175.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 39' ' ' ILE . 56.0 mt -74.03 142.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.35 160.92 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 1 CA-C-N 107.687 -4.324 . . . . 0.0 110.053 -179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.04 119.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 112.254 -2.248 . . . . 0.0 106.83 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.538 HD13 ' CZ ' ' A' ' 69' ' ' PHE . 1.5 mt -135.2 121.24 14.3 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 117.249 2.314 . . . . 0.0 117.249 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 51' ' ' LEU . 32.5 Cg_exo -64.66 127.84 19.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 N-CA-C 108.438 -1.408 . . . . 0.0 108.438 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' A' ' 69' ' ' PHE . 5.2 p -57.77 139.01 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-O 123.876 1.798 . . . . 0.0 113.58 177.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.19 -15.55 27.86 Favored Glycine 1 N--CA 1.521 4.309 0 CA-C-N 110.747 -2.933 . . . . 0.0 113.049 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.304 17.6 m -45.56 139.28 3.93 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.0 mm -80.54 82.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 CA-C-N 123.156 2.707 . . . . 0.0 111.773 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.675 HG21 ' CE2' ' A' ' 69' ' ' PHE . 1.5 m -127.27 156.56 38.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 109.444 -3.525 . . . . 0.0 107.986 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.57 178.05 5.73 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 109.275 -3.602 . . . . 0.0 115.049 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.584 ' SD ' ' CD ' ' A' ' 81' ' ' ARG . 1.2 tpt -89.41 67.13 7.63 Favored 'General case' 0 N--CA 1.494 1.741 1 N-CA-C 96.432 -5.396 . . . . 0.0 96.432 173.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' CD ' ' NH1' ' A' ' 62' ' ' ARG . 10.3 pt-20 -78.44 154.24 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' HE1' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -111.83 50.81 0.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 123.956 1.836 . . . . 0.0 111.783 -176.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NH1' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mpt_? -90.88 72.76 6.54 Favored 'General case' 0 N--CA 1.491 1.595 1 N-CA-C 94.973 -5.936 . . . . 0.0 94.973 175.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' HA ' HG12 ' A' ' 82' ' ' VAL . 6.6 tp -40.87 -4.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' OD2' ' NH2' ' A' ' 65' ' ' ARG . 3.9 p-10 -99.3 2.86 45.84 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HG3' ' H ' ' A' ' 67' ' ' ARG . 8.7 tpp180 -123.95 95.51 4.59 Favored 'General case' 0 N--CA 1.498 1.969 1 N-CA-C 124.97 5.174 . . . . 0.0 124.97 -170.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -89.2 52.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 115.264 -2.574 . . . . 0.0 105.62 177.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.496 HH11 ' CD ' ' A' ' 60' ' ' GLU . 9.9 ptm180 -48.0 116.46 1.52 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 123.714 1.721 . . . . 0.0 111.703 -174.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' CD2' ' HG2' ' A' ' 80' ' ' PRO . 67.3 mt -82.15 93.08 6.98 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 109.341 -3.572 . . . . 0.0 115.668 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.675 ' CE2' HG21 ' A' ' 57' ' ' VAL . 37.0 m-85 -74.39 96.06 2.81 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 126.811 3.196 . . . . 0.0 108.45 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 18.1 m -106.82 174.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.304 1 CA-C-N 106.937 -4.665 . . . . 0.0 110.422 -174.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 2.5 p-10 -95.95 -141.55 0.27 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 124.919 2.295 . . . . 0.0 112.769 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 58.6 mttp -83.98 -8.11 59.24 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 108.971 -3.741 . . . . 0.0 113.457 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' H ' ' CG ' ' A' ' 71' ' ' ASP 0.287 0.5 OUTLIER -137.41 48.13 2.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 124.924 2.297 . . . . 0.0 109.677 178.73 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.82 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 2.5 m120 -99.71 142.57 31.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.752 1.263 . . . . 0.0 108.222 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.1 mt -65.37 117.7 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 126.389 2.995 . . . . 0.0 115.279 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.459 . . -98.48 -44.27 6.56 Favored 'General case' 0 C--N 1.283 -2.306 2 CA-C-N 103.905 -6.043 . . . . 0.0 109.86 -172.273 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -117.43 118.88 33.43 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 101.073 -3.677 . . . . 0.0 101.073 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.677 ' CG2' HG23 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -73.1 137.65 79.03 Favored Pre-proline 0 N--CA 1.501 2.106 1 C-N-CA 110.947 -4.301 . . . . 0.0 109.818 -178.455 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HG2' ' CD2' ' A' ' 68' ' ' LEU . 5.8 Cg_exo -82.16 169.75 14.13 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 123.901 3.067 . . . . 0.0 113.836 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.584 ' CD ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -145.87 154.18 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.592 ' CG2' HG22 ' A' ' 66' ' ' VAL . 70.8 t -71.97 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.734 2 CA-C-N 107.048 -4.615 . . . . 0.0 102.923 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 122.975 1.369 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 31.3 tttp -106.3 136.49 45.94 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.634 -4.21 . . . . 0.0 99.634 178.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 8.3 p -106.42 -6.29 18.33 Favored 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 118.264 -1.374 . . . . 0.0 108.386 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' OE2' ' HG3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -130.69 136.01 48.37 Favored 'General case' 0 N--CA 1.523 3.214 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -176.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.721 ' CZ2' HG23 ' A' ' 39' ' ' ILE . 29.6 m-90 -126.45 71.62 72.14 Favored Pre-proline 0 N--CA 1.513 2.71 1 N-CA-C 126.553 5.76 . . . . 0.0 126.553 -176.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' TRP . 70.5 Cg_endo -68.08 -35.41 19.99 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.143 1.229 . . . . 0.0 113.828 176.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 23.0 mp0 -57.61 -37.88 74.02 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 126.344 2.973 . . . . 0.0 114.097 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.568 ' HA ' ' NZ ' ' A' ' 30' ' ' LYS . 4.2 pp -78.57 -16.06 57.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.239 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 79' ' ' VAL . 93.3 t -49.51 157.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.913 0 O-C-N 123.22 0.325 . . . . 0.0 110.554 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.74 -13.76 46.08 Favored Glycine 1 N--CA 1.518 4.151 0 O-C-N 120.347 -1.47 . . . . 0.0 113.901 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.568 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.08 167.88 10.59 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 117.203 -1.379 . . . . 0.0 112.671 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 3.5 p -86.52 159.62 19.23 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 127.039 3.304 . . . . 0.0 114.747 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.8 p -45.46 -23.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 1 CA-C-N 106.847 -4.706 . . . . 0.0 119.015 -174.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.565 ' CG ' ' H ' ' A' ' 34' ' ' GLU . 14.3 pt-20 -67.2 -58.67 4.41 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.796 0.808 . . . . 0.0 109.293 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.565 ' H ' ' CG ' ' A' ' 33' ' ' GLU . 2.5 tt0 -56.97 -50.43 72.71 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB1' ' CD1' ' A' ' 68' ' ' LEU . . . -47.77 -51.58 21.85 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 117.573 -1.651 . . . . 0.0 112.711 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.679 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 17.5 mtpp -58.36 -52.8 64.07 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 4.3 tmtm? -48.6 -41.1 29.77 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.926 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 62.3 t -69.11 -60.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.925 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.721 HG23 ' CZ2' ' A' ' 24' ' ' TRP . 42.9 mt -56.05 -53.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.186 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mp -56.92 -23.74 47.24 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.419 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 57.3 tp60 -67.65 -33.5 75.07 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.119 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 51.0 m-20 -92.59 -49.49 6.08 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.75 80.45 32.39 Favored Pre-proline 0 N--CA 1.515 2.82 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -35.19 -31.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.574 0 N-CA-C 120.408 3.195 . . . . 0.0 120.408 -173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.72 -0.23 57.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 123.843 0.714 . . . . 0.0 112.289 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.46 99.32 0.14 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.699 1.238 . . . . 0.0 111.738 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.26 113.7 25.97 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.679 ' HB ' ' HG2' ' A' ' 36' ' ' LYS . 21.8 mt -105.47 155.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.406 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 42.4 mm -125.19 169.74 16.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 110.581 -3.009 . . . . 0.0 105.899 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' CG2' HG21 ' A' ' 70' ' ' VAL . 8.7 p -107.25 142.43 20.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -139.51 122.27 10.37 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 178.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HD2' HD23 ' A' ' 51' ' ' LEU . 55.1 Cg_endo -72.7 129.14 14.15 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.27 1.98 . . . . 0.0 112.319 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 69' ' ' PHE . 6.7 t -42.2 133.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.52 -27.0 19.73 Favored Glycine 0 N--CA 1.512 3.72 0 CA-C-N 109.552 -3.476 . . . . 0.0 112.683 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.45 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.305 51.8 m -60.66 178.38 0.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 126.28 1.832 . . . . 0.0 112.928 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 57' ' ' VAL . 14.1 mt -86.46 154.18 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.226 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -140.45 -59.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.972 1 N-CA-C 122.666 4.321 . . . . 0.0 122.666 177.113 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 78.14 6.89 Favored 'General case' 0 C--N 1.288 -2.093 1 N-CA-C 123.098 4.481 . . . . 0.0 123.098 -177.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 88.9 mtp -97.13 -144.14 0.29 Allowed 'General case' 0 C--N 1.291 -1.942 1 CA-C-N 104.459 -5.791 . . . . 0.0 104.352 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.3 pm0 -60.5 -142.31 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 O-C-N 124.854 1.346 . . . . 0.0 112.393 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.673 ' CE1' ' HB ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -100.25 113.46 26.17 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.339 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.635 ' NH2' ' HB2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -105.54 39.66 1.71 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 123.925 1.821 . . . . 0.0 110.056 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.673 ' HB ' ' CE1' ' A' ' 61' ' ' TYR . 8.6 tp -56.37 -25.64 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 110.098 -3.228 . . . . 0.0 117.351 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -70.44 -11.12 60.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 62' ' ' ARG . 23.0 ttp180 -135.06 163.13 30.59 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -176.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 39' ' ' ILE . 16.1 t -117.08 128.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -102.47 110.11 21.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 114.03 -3.068 . . . . 0.0 114.207 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 39' ' ' ILE . 6.1 mt -107.49 104.79 14.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 111.515 -2.584 . . . . 0.0 106.65 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.677 ' HB3' HG22 ' A' ' 53' ' ' VAL . 8.9 m-85 -69.18 122.24 18.4 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 116.875 -1.93 . . . . 0.0 107.861 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' A' ' 50' ' ' VAL . 8.3 m -102.46 170.97 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 110.642 -2.981 . . . . 0.0 105.948 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 4.7 p-10 -96.45 -135.88 0.24 Allowed 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 117.144 -1.823 . . . . 0.0 112.129 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -91.34 3.01 55.97 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 110.405 -3.089 . . . . 0.0 112.306 177.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.433 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 73.5 mt -135.78 34.43 2.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 111.682 -2.508 . . . . 0.0 109.769 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 37.29 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 -178.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -102.98 139.05 39.05 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 13.1 mt -64.37 115.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.219 0 CA-C-O 126.491 3.043 . . . . 0.0 112.177 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.579 . . -97.98 -39.3 9.02 Favored 'General case' 0 C--N 1.281 -2.394 1 CA-C-N 105.158 -5.474 . . . . 0.0 101.979 -175.623 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 69' ' ' PHE . 33.8 mt-30 -115.95 129.24 56.3 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.638 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 98.8 t -44.6 -61.83 1.93 Allowed Pre-proline 0 N--CA 1.514 2.765 1 N-CA-C 125.148 5.24 . . . . 0.0 125.148 177.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.261 0.0 OUTLIER 4.8 -161.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 2 C-N-CA 131.114 7.876 . . . . 0.0 128.61 -168.582 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.466 ' C ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -145.78 175.19 10.59 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 -161.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 66' ' ' VAL . 21.6 t -68.22 137.34 24.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 109.099 -3.682 . . . . 0.0 108.416 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.503 3.139 0 CA-C-O 114.911 -3.16 . . . . 0.0 117.92 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 121.99 0.9 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 8.9 mtpm? -99.08 144.5 28.15 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.377 -1.283 . . . . 0.0 107.907 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -107.16 7.25 29.43 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.227 -1.389 . . . . 0.0 109.515 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -142.74 150.72 40.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 126.15 2.156 . . . . 0.0 112.096 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.617 ' CE3' HG11 ' A' ' 66' ' ' VAL . 25.4 m-90 -132.45 79.51 65.12 Favored Pre-proline 0 N--CA 1.503 2.175 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HA ' HG23 ' A' ' 28' ' ' VAL . 15.9 Cg_endo -77.48 -30.85 3.76 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 120.872 1.048 . . . . 0.0 110.021 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 21' ' ' LYS . 3.0 pm0 -51.8 -20.88 2.42 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 122.501 1.143 . . . . 0.0 113.459 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 24' ' ' TRP . 3.1 pp -107.93 16.19 23.7 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 79' ' ' VAL . 22.3 t -70.64 155.92 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.514 0 CA-C-O 122.343 1.068 . . . . 0.0 112.104 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.29 18.05 70.95 Favored Glycine 0 N--CA 1.512 3.735 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.927 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -128.69 167.48 17.17 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 116.843 -1.551 . . . . 0.0 110.278 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -91.01 166.18 13.14 Favored 'General case' 0 CA--C 1.472 -2.045 1 CA-C-O 128.573 4.035 . . . . 0.0 115.508 179.81 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' A' ' 50' ' ' VAL . 1.4 p -53.92 -29.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 1 CA-C-N 103.175 -6.375 . . . . 0.0 115.435 -174.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.03 -37.54 23.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.718 -1.239 . . . . 0.0 111.992 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 46.5 mt-10 -61.02 -48.09 83.42 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -47.14 -50.78 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.683 -1.607 . . . . 0.0 112.962 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 58.3 mttp -51.2 -51.46 53.63 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.682 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.3 -47.41 69.25 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 112.04 -2.345 . . . . 0.0 108.868 -178.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.424 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 96.2 t -59.16 -57.64 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 CA-C-O 123.555 1.645 . . . . 0.0 111.944 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.563 ' CG2' HG21 ' A' ' 66' ' ' VAL . 14.0 mt -54.98 -46.44 76.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 112.314 -2.221 . . . . 0.0 111.221 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 36' ' ' LYS . 96.0 mt -57.18 -33.55 67.59 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 38' ' ' VAL . 48.2 mt-30 -64.42 -19.6 65.62 Favored 'General case' 0 N--CA 1.519 3.023 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.457 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -96.07 -58.59 2.05 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.24 1.416 . . . . 0.0 110.457 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -121.94 67.8 24.24 Favored Pre-proline 0 N--CA 1.499 1.997 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.328 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.96 -45.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 125.107 3.872 . . . . 0.0 120.271 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -81.14 -5.26 57.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.64 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -76.44 77.74 3.17 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.626 HG12 ' H ' ' A' ' 66' ' ' VAL . 44.2 mt -74.89 133.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.7 mp -117.43 162.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 112.463 -2.153 . . . . 0.0 113.119 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 32' ' ' VAL . 7.7 p -106.02 131.47 55.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 112.913 -1.949 . . . . 0.0 114.488 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 5.1 mp -138.94 155.87 72.81 Favored Pre-proline 0 N--CA 1.508 2.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -81.38 130.49 7.11 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 121.737 1.624 . . . . 0.0 109.794 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 69' ' ' PHE . 93.7 t -40.44 132.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -42.43 1.97 Allowed Glycine 0 N--CA 1.505 3.265 0 CA-C-N 110.353 -3.112 . . . . 0.0 108.168 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.586 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.338 43.3 m -47.09 131.35 12.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.871 1.32 . . . . 0.0 109.264 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.693 ' H ' HD12 ' A' ' 56' ' ' ILE . 1.9 mp -52.01 113.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.618 HG13 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -104.1 -70.57 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.595 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.32 66.54 4.8 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 127.345 3.45 . . . . 0.0 118.757 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -99.66 -119.39 0.15 Allowed 'General case' 0 C--N 1.288 -2.095 1 CA-C-N 104.405 -5.816 . . . . 0.0 106.245 -179.085 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -72.51 -152.22 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 108.998 -3.728 . . . . 0.0 105.461 171.145 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.544 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -128.84 91.59 3.25 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -176.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.663 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -94.77 66.22 3.12 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 127.496 3.522 . . . . 0.0 105.937 175.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.588 HD12 HG11 ' A' ' 82' ' ' VAL . 2.7 tp -59.91 -25.13 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 1 CA-C-N 106.549 -4.841 . . . . 0.0 114.019 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -87.51 24.93 1.55 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.8 ttm-85 -158.16 131.64 7.66 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.626 ' H ' HG12 ' A' ' 48' ' ' ILE . 12.4 t -104.86 70.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 C-N-CA 116.543 -2.063 . . . . 0.0 105.979 173.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.615 ' HD3' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -45.98 138.11 5.3 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.119 1.914 . . . . 0.0 112.157 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -102.23 116.65 33.1 Favored 'General case' 0 C--N 1.295 -1.786 1 CA-C-N 108.304 -4.044 . . . . 0.0 112.775 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.618 ' HE2' HG13 ' A' ' 57' ' ' VAL . 42.8 m-85 -93.14 99.56 12.12 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 125.721 2.677 . . . . 0.0 110.162 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.487 HG11 ' CG2' ' A' ' 32' ' ' VAL . 1.1 m -111.01 177.1 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 1 CA-C-N 107.787 -4.279 . . . . 0.0 113.508 -174.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -106.67 -141.87 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 124.177 1.942 . . . . 0.0 113.906 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -83.99 -5.41 59.22 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 110.338 -3.119 . . . . 0.0 113.091 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.5 mt -136.12 43.18 2.54 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 111.075 -2.784 . . . . 0.0 111.171 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.3 OUTLIER 33.15 30.26 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.1 m-20 -106.83 141.0 38.76 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 123.455 1.598 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.61 93.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 127.756 3.646 . . . . 0.0 116.329 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.44 . . -74.41 -40.72 61.83 Favored 'General case' 0 C--N 1.289 -2.053 2 CA-C-N 100.718 -7.492 . . . . 0.0 110.516 -179.273 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . 9.0 tt0 -119.52 158.71 25.74 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 ' CG2' ' A' ' 28' ' ' VAL . 97.2 t -76.92 138.39 65.7 Favored Pre-proline 0 N--CA 1.503 2.196 0 C-N-CA 114.506 -2.877 . . . . 0.0 110.71 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.6 Cg_exo -75.89 165.73 29.43 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.773 2.315 . . . . 0.0 110.193 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.579 HH12 HG21 ' A' ' 57' ' ' VAL . 9.3 ptp85 -162.77 167.94 22.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.588 HG11 HD12 ' A' ' 63' ' ' ILE . 37.5 t -82.61 133.53 28.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 C-N-CA 118.964 -1.095 . . . . 0.0 109.69 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' OXT' ' HD3' ' A' ' 67' ' ' ARG . . . . . . . . 0 CA--C 1.548 2.138 0 O-C-N 125.32 1.638 . . . . 0.0 112.428 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.863 0 CA-C-O 122.326 1.06 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 81.2 tttt -114.22 86.45 2.42 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.469 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -97.41 26.55 4.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 7.5 pt-20 -138.62 156.4 47.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.822 1.326 . . . . 0.0 112.743 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.673 ' NE1' ' HA ' ' A' ' 39' ' ' ILE . 11.7 m-90 -134.56 78.61 55.9 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 119.369 3.1 . . . . 0.0 119.369 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 28' ' ' VAL . 66.8 Cg_endo -75.2 -26.21 10.82 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 120.598 0.865 . . . . 0.0 113.993 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 16.1 mp0 -51.33 -29.62 15.76 Favored 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 124.845 2.26 . . . . 0.0 110.11 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -77.98 -27.9 49.23 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 112.643 -2.071 . . . . 0.0 112.035 -177.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG2' HG22 ' A' ' 79' ' ' VAL . 58.5 t -49.02 136.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 CA-C-N 119.97 1.259 . . . . 0.0 112.335 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.83 2.01 69.92 Favored Glycine 0 N--CA 1.507 3.407 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.169 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -126.09 169.49 12.73 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 117.21 -1.376 . . . . 0.0 114.65 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -87.59 177.13 7.15 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 125.331 2.491 . . . . 0.0 113.829 176.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.58 -37.4 77.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 109.863 -3.335 . . . . 0.0 115.716 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.66 -48.32 69.74 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.509 -1.276 . . . . 0.0 111.162 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 58.5 mm-40 -60.07 -42.1 93.83 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB1' HD23 ' A' ' 27' ' ' LEU . . . -53.52 -60.94 2.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.74 -1.225 . . . . 0.0 110.419 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HG2' ' HB ' ' A' ' 48' ' ' ILE . 55.2 mtpt -45.68 -50.22 13.75 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.339 1.066 . . . . 0.0 108.806 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 34' ' ' GLU . 73.3 tttt -48.99 -47.64 44.04 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 111.031 -2.804 . . . . 0.0 109.142 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 88.5 t -76.64 -49.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 O-C-N 124.731 1.269 . . . . 0.0 112.686 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.673 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 11.1 mt -48.11 -47.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.476 0.655 . . . . 0.0 111.448 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 46' ' ' ALA 0.252 96.0 mt -63.88 -12.81 39.97 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.921 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -77.99 -47.31 18.78 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.96 -52.72 26.05 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 124.831 2.253 . . . . 0.0 110.773 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 45' ' ' GLU . 57.6 tttm -122.76 70.06 36.96 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 112.617 -2.083 . . . . 0.0 112.137 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -28.44 -45.19 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.844 3.029 . . . . 0.0 119.603 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -87.93 8.85 24.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 -178.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -64.96 113.14 3.66 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 116.953 -1.899 . . . . 0.0 115.483 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -82.44 67.77 8.62 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.735 -1.853 . . . . 0.0 106.273 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.567 HD11 HG21 ' A' ' 39' ' ' ILE . 2.8 mp -80.77 137.7 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 124.19 1.948 . . . . 0.0 115.528 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 50' ' ' VAL . 1.3 mp -120.27 177.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 109.908 -3.315 . . . . 0.0 109.628 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 12.1 p -98.33 125.26 51.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.58 1.181 . . . . 0.0 109.48 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 9.7 mt -122.47 89.06 49.46 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.422 ' HG2' ' OG1' ' A' ' 55' ' ' THR . 37.8 Cg_endo -53.39 130.39 38.29 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 O-C-N 119.005 -1.103 . . . . 0.0 113.436 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 69' ' ' PHE . 54.8 t -45.36 115.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 123.133 1.444 . . . . 0.0 111.157 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.36 8.1 Favored Glycine 0 N--CA 1.513 3.78 1 CA-C-N 107.779 -4.282 . . . . 0.0 115.039 -173.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.539 ' HB ' ' HE1' ' A' ' 69' ' ' PHE 0.284 1.4 m -56.94 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 118.945 1.372 . . . . 0.0 107.908 177.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.31 110.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 120.085 3.365 . . . . 0.0 120.085 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.63 HG21 ' HE2' ' A' ' 69' ' ' PHE . 35.3 m -124.12 177.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 108.473 -3.967 . . . . 0.0 110.672 176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -94.89 142.87 26.97 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 109.759 -3.382 . . . . 0.0 112.574 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.3 tpt -93.28 57.9 2.75 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-N 123.399 2.818 . . . . 0.0 104.419 174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 20.2 pt-20 -80.49 -169.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 111.18 -2.736 . . . . 0.0 113.208 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.642 ' CE2' ' HB ' ' A' ' 63' ' ' ILE . 12.8 t80 -140.21 63.33 1.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.634 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.28 74.61 7.0 Favored 'General case' 0 N--CA 1.486 1.331 1 N-CA-C 97.91 -4.848 . . . . 0.0 97.91 174.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.642 ' HB ' ' CE2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -43.07 -20.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 109.899 -3.319 . . . . 0.0 116.334 -179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -62.52 4.24 0.16 Allowed 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.904 1.335 . . . . 0.0 109.466 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 63' ' ' ILE . 3.5 ttm-85 -149.87 154.71 38.81 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.66 HG21 ' CG2' ' A' ' 39' ' ' ILE . 3.2 t -115.99 135.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 1 N-CA-C 99.454 -4.276 . . . . 0.0 99.454 176.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.563 ' HD3' HG21 ' A' ' 57' ' ' VAL . 8.9 ttm-85 -94.49 126.19 39.61 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.837 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 48' ' ' ILE . 11.1 mp -110.59 76.81 1.0 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.526 2.391 . . . . 0.0 112.048 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.63 ' HE2' HG21 ' A' ' 57' ' ' VAL . 26.1 m-85 -74.98 102.44 4.81 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 126.996 3.284 . . . . 0.0 105.468 168.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 53' ' ' VAL . 18.7 m -100.77 179.75 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.526 3.326 1 CA-C-N 106.055 -5.066 . . . . 0.0 109.975 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.591 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -89.43 -145.49 0.16 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 117.438 -3.289 . . . . 0.0 111.425 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.591 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.6 -4.95 59.25 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 111.336 -2.666 . . . . 0.0 115.62 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 73' ' ' LEU 0.266 0.6 OUTLIER -138.02 48.47 1.98 Allowed 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 126.875 3.226 . . . . 0.0 106.959 176.938 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 34.58 37.02 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.302 -3.135 . . . . 0.0 116.663 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -106.9 147.73 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 124.14 1.924 . . . . 0.0 107.633 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.0 mt -72.92 97.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 127.176 3.369 . . . . 0.0 116.623 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.374 . . -73.1 -48.81 32.55 Favored 'General case' 0 C--N 1.29 -2.016 2 CA-C-N 100.257 -7.701 . . . . 0.0 111.767 179.71 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -119.1 155.85 30.8 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.636 HG22 ' CG2' ' A' ' 28' ' ' VAL . 89.2 t -72.47 142.89 84.64 Favored Pre-proline 0 N--CA 1.507 2.392 0 C-N-CA 114.312 -2.955 . . . . 0.0 108.505 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 7.0 Cg_exo -82.11 159.03 17.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 123.549 2.833 . . . . 0.0 108.725 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 7.7 ptp85 -162.57 171.81 16.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.855 -1.153 . . . . 0.0 108.257 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 35.9 t -79.5 140.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' OXT' ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.15 0 CA-C-O 116.399 -2.334 . . . . 0.0 109.946 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.138 0 CA-C-O 121.24 0.543 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' A' ' 23' ' ' GLU . 81.9 tttt -139.94 118.27 12.08 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.171 1.388 . . . . 0.0 108.934 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -113.78 21.03 15.36 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.151 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -143.94 132.52 22.31 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 118.381 2.734 . . . . 0.0 118.381 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.605 ' CE2' HG23 ' A' ' 39' ' ' ILE . 21.3 m-90 -119.1 67.73 8.83 Favored Pre-proline 0 N--CA 1.504 2.234 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -61.9 -36.25 73.44 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 120.867 1.045 . . . . 0.0 110.889 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 21' ' ' LYS . 8.1 pm0 -49.8 -25.02 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.677 1.227 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.546 HD13 ' HB1' ' A' ' 35' ' ' ALA . 52.1 mt -77.07 -34.19 57.09 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.657 -177.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 79' ' ' VAL . 60.5 t -45.91 135.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.545 0 CA-C-O 121.592 0.71 . . . . 0.0 110.917 -177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.84 -15.5 59.47 Favored Glycine 0 N--CA 1.513 3.803 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.129 -176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -119.49 176.02 5.56 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -178.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -87.97 156.43 19.34 Favored 'General case' 0 N--CA 1.51 2.548 0 CA-C-O 126.787 3.184 . . . . 0.0 118.314 176.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -54.45 -46.76 70.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 1 CA-C-N 107.426 -4.443 . . . . 0.0 116.545 -175.848 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 36' ' ' LYS . 63.1 mm-40 -54.46 -49.38 70.19 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 116.883 -1.927 . . . . 0.0 111.203 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' OE2' ' NZ ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -49.88 -53.61 24.75 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 124.333 2.016 . . . . 0.0 106.012 178.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.546 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -54.02 -54.91 32.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.275 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HG2' ' CG2' ' A' ' 48' ' ' ILE . 9.5 mtpm? -46.27 -52.02 13.38 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 125.416 1.487 . . . . 0.0 107.72 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 21.1 ttpp -56.98 -57.59 11.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 110.78 -2.918 . . . . 0.0 108.98 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 72.2 t -55.0 -46.44 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 122.85 1.31 . . . . 0.0 112.955 -178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.798 HG21 HG21 ' A' ' 66' ' ' VAL . 96.9 mt -66.59 -49.41 75.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.227 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.46 -39.89 73.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 33.4 mt-30 -57.69 -37.37 73.35 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.438 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 5.1 t0 -98.16 21.57 10.68 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 126.978 2.111 . . . . 0.0 115.955 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.645 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 65.7 tttt -98.72 105.91 33.68 Favored Pre-proline 0 N--CA 1.526 3.374 1 N-CA-C 128.299 6.407 . . . . 0.0 128.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 4.0 Cg_exo -90.95 -63.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.594 3.479 0 N-CA-C 104.132 -3.064 . . . . 0.0 104.132 161.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' C ' HG11 ' A' ' 82' ' ' VAL . 19.8 mp0 -88.81 -27.0 21.39 Favored 'General case' 0 N--CA 1.509 2.514 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.645 ' N ' ' HG3' ' A' ' 43' ' ' LYS . . . -62.35 67.58 0.01 OUTLIER 'General case' 1 N--CA 1.541 4.115 1 N-CA-C 132.85 8.092 . . . . 0.0 132.85 -179.064 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 60.7 tp60 -89.81 113.08 24.59 Favored 'General case' 1 N--CA 1.541 4.078 0 CA-C-N 124.965 3.53 . . . . 0.0 108.21 178.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 48' ' ' ILE . 1.1 mp -78.48 144.65 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 48' ' ' ILE . 42.9 mm -139.3 142.11 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 110.433 -3.076 . . . . 0.0 105.402 174.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.8 141.59 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-O 121.605 0.717 . . . . 0.0 109.858 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.64 HD13 ' CE2' ' A' ' 69' ' ' PHE . 5.9 mt -132.0 128.66 21.55 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 116.88 -1.533 . . . . 0.0 107.675 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.27 135.89 23.36 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 104.058 -3.093 . . . . 0.0 104.058 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.589 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 2.2 t -41.41 124.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.12 -20.21 38.64 Favored Glycine 0 N--CA 1.505 3.256 0 CA-C-N 109.055 -3.702 . . . . 0.0 118.172 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.481 ' OG1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -48.79 143.94 4.91 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.466 2.133 . . . . 0.0 112.587 -175.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.3 121.83 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.613 HG21 ' HE2' ' A' ' 69' ' ' PHE . 1.8 m -115.89 -87.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -175.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.47 107.64 16.09 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 119.487 3.143 . . . . 0.0 119.487 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.6 mtm -96.14 -58.56 2.05 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 127.649 3.595 . . . . 0.0 108.82 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.619 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -84.36 -145.92 0.09 Allowed 'General case' 0 C--N 1.273 -2.743 1 CA-C-N 104.05 -5.977 . . . . 0.0 105.7 175.173 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.576 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -126.07 94.61 4.14 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.438 172.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.626 ' HB3' ' NH2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -77.84 50.97 0.9 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 124.911 2.291 . . . . 0.0 112.466 175.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.576 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 10.4 tp -76.66 31.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-O 125.234 2.445 . . . . 0.0 117.321 -176.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -98.5 -30.63 12.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 111.212 -2.722 . . . . 0.0 109.386 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.626 ' NH2' ' HB3' ' A' ' 62' ' ' ARG . 3.8 ttp85 -127.5 158.62 36.92 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 118.923 2.934 . . . . 0.0 118.923 -171.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.798 HG21 HG21 ' A' ' 39' ' ' ILE . 2.2 t -107.09 127.34 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.555 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.6 ttp180 -87.1 102.03 14.04 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 108.693 -3.867 . . . . 0.0 104.917 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 80' ' ' PRO . 10.9 mp -103.09 90.47 3.75 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 125.398 1.686 . . . . 0.0 111.307 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.64 ' CE2' HD13 ' A' ' 51' ' ' LEU . 13.0 m-85 -73.28 105.75 4.82 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 124.762 2.22 . . . . 0.0 109.744 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -106.69 173.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 109.062 -3.699 . . . . 0.0 107.829 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.575 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.7 p-10 -98.39 -139.19 0.3 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 124.575 2.131 . . . . 0.0 111.885 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.575 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 22.6 mtmm -83.79 -13.52 53.62 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 109.477 -3.511 . . . . 0.0 114.83 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 73' ' ' LEU 0.323 0.3 OUTLIER -136.35 51.13 2.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-O 124.447 2.07 . . . . 0.0 107.197 -178.661 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 35.75 25.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 178.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 2.4 m120 -102.73 156.98 17.27 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.4 mt -78.86 116.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 126.465 3.031 . . . . 0.0 115.563 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 53' ' ' VAL 0.478 . . -94.53 -47.29 6.61 Favored 'General case' 0 C--N 1.287 -2.135 2 CA-C-N 103.381 -6.282 . . . . 0.0 110.065 -174.18 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -114.7 159.62 20.32 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.486 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 94.6 t -72.29 132.44 84.11 Favored Pre-proline 0 N--CA 1.499 2.018 0 C-N-CA 114.022 -3.071 . . . . 0.0 110.12 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 24' ' ' TRP . 38.0 Cg_exo -67.05 144.25 68.9 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.811 2.341 . . . . 0.0 107.88 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.86 153.07 31.43 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.246 -1.359 . . . . 0.0 112.134 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 66' ' ' VAL . 13.1 t -82.32 102.64 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.55 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.286 -2.22 0 C-N-CA 118.767 -1.683 . . . . 0.0 110.056 176.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.766 0 CA-C-O 122.716 1.246 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -122.36 65.97 0.94 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 102.686 -3.079 . . . . 0.0 102.686 177.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -114.89 9.27 16.14 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.255 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' CD ' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.38 150.4 45.26 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.528 -179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.433 ' HZ3' HG23 ' A' ' 82' ' ' VAL . 16.3 m-90 -127.86 65.78 69.2 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-O 123.477 1.608 . . . . 0.0 112.444 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 27' ' ' LEU . 54.2 Cg_endo -67.74 -32.95 28.94 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.596 1.531 . . . . 0.0 109.481 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -65.5 0.49 1.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.598 HD11 HG13 ' A' ' 39' ' ' ILE . 40.9 mt -99.17 -17.68 18.04 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.986 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' CG2' HG22 ' A' ' 79' ' ' VAL . 64.0 t -63.11 116.06 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 116.821 -1.952 . . . . 0.0 108.596 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.46 -5.68 24.76 Favored Glycine 0 N--CA 1.508 3.479 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.8 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 27' ' ' LEU . 35.7 mmtm -101.63 171.72 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.47 1.108 . . . . 0.0 108.564 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -87.19 168.75 12.95 Favored 'General case' 0 CA--C 1.445 -3.079 0 CA-C-O 124.942 2.306 . . . . 0.0 111.688 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.726 HG23 HG11 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -70.39 -39.57 76.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 108.566 -3.925 . . . . 0.0 109.066 -178.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 2.1 pp20? -65.32 -49.74 68.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.287 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' N ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 tt0 -58.82 -46.08 88.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 27' ' ' LEU . . . -50.44 -58.51 5.58 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 116.721 -1.609 . . . . 0.0 109.809 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -47.69 -55.17 10.06 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 120.994 1.724 . . . . 0.0 107.481 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 34' ' ' GLU . 14.0 ttpt -48.04 -51.33 24.58 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 110.394 -3.094 . . . . 0.0 109.894 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.49 -52.92 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.066 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.709 ' CG2' HG21 ' A' ' 66' ' ' VAL . 22.5 mt -51.34 -47.79 34.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 123.021 1.391 . . . . 0.0 109.832 -177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.2 mt -55.6 -28.79 57.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.01 -34.81 79.33 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 123.313 1.53 . . . . 0.0 109.679 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 21' ' ' LYS . 36.8 m-20 -88.82 -49.53 6.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 119.661 3.208 . . . . 0.0 119.661 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 24.1 tptp -116.06 72.1 4.46 Favored Pre-proline 0 N--CA 1.515 2.819 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 71.6 Cg_exo -10.98 -38.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 2 C-N-CA 127.289 5.326 . . . . 0.0 122.773 -178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 1.9 mp0 -91.42 -25.11 19.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 48' ' ' ILE . . . -38.17 80.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 1 N-CA-C 123.353 4.575 . . . . 0.0 123.353 -171.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -76.64 69.88 3.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.607 HG12 ' HB ' ' A' ' 66' ' ' VAL . 4.6 mt -72.46 131.69 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.352 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.57 162.01 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 p -85.77 113.19 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.36 1.076 . . . . 0.0 109.803 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.767 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -114.16 100.85 53.42 Favored Pre-proline 0 N--CA 1.501 2.1 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.616 -178.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.3 131.83 29.56 Favored 'Trans proline' 0 N--CA 1.509 2.416 0 CA-C-N 122.035 1.763 . . . . 0.0 108.926 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 78.1 t -46.57 121.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 120.371 -1.455 . . . . 0.0 113.223 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.07 -30.19 6.42 Favored Glycine 1 N--CA 1.517 4.098 0 CA-C-N 110.512 -3.04 . . . . 0.0 114.849 -176.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.552 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.289 91.6 m -47.21 92.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 124.742 1.217 . . . . 0.0 109.205 176.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mm -52.06 101.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 124.046 1.879 . . . . 0.0 115.804 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.492 HG21 ' HE2' ' A' ' 69' ' ' PHE . 28.2 m -103.65 -178.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.44 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -91.16 158.76 16.44 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -174.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.459 ' N ' ' SD ' ' A' ' 59' ' ' MET . 3.6 mpp? -92.13 37.26 0.98 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 123.876 1.798 . . . . 0.0 108.237 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 58' ' ' THR . 18.2 pt-20 -81.89 -171.67 3.49 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.757 -2.928 . . . . 0.0 111.773 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.524 ' CE1' HD13 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -133.98 82.42 1.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.738 1.256 . . . . 0.0 108.771 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 6.8 mmm180 -88.3 78.21 8.05 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 101.291 -3.596 . . . . 0.0 101.291 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.536 ' HA ' HG12 ' A' ' 82' ' ' VAL . 7.4 tp -69.77 -3.61 3.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 109.412 -3.54 . . . . 0.0 112.659 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.5 -6.7 58.83 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 110.047 -3.252 . . . . 0.0 106.755 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.292 5.3 ttm-85 -145.33 150.83 37.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 120.265 3.432 . . . . 0.0 120.265 -171.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.709 HG21 ' CG2' ' A' ' 39' ' ' ILE . 4.4 t -111.67 108.64 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -63.15 125.35 23.77 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -177.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.1 tp -115.12 74.55 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 O-C-N 124.905 1.378 . . . . 0.0 111.641 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.767 ' CE1' ' HB3' ' A' ' 51' ' ' LEU . 24.4 m-85 -72.76 104.94 4.13 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 126.593 3.092 . . . . 0.0 111.344 169.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.726 HG11 HG23 ' A' ' 32' ' ' VAL . 3.6 m -107.36 171.8 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 CA-C-N 108.724 -3.853 . . . . 0.0 112.156 -175.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 1.1 p-10 -83.0 -147.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 123.738 2.972 . . . . 0.0 112.889 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.538 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 1.8 ttpp -91.55 8.5 36.29 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.389 -3.096 . . . . 0.0 112.031 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.479 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 26.7 mt -141.7 36.45 1.63 Allowed 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 111.458 -2.61 . . . . 0.0 110.245 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.531 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 36.13 26.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 -177.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -103.62 135.47 45.15 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.64 118.89 5.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 127.542 3.544 . . . . 0.0 114.039 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.443 . . -94.68 -51.24 4.81 Favored 'General case' 0 C--N 1.288 -2.105 2 CA-C-N 103.159 -6.382 . . . . 0.0 112.064 -173.023 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.41 161.78 18.55 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 104.805 -2.295 . . . . 0.0 104.805 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.5 HG22 ' CG2' ' A' ' 28' ' ' VAL . 95.0 t -73.46 137.68 77.84 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 113.819 -3.152 . . . . 0.0 108.757 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 13.1 Cg_exo -78.36 152.71 27.07 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.421 ' NH2' ' O ' ' A' ' 82' ' ' VAL . 2.6 ptm180 -156.43 157.83 36.23 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 117.748 -1.581 . . . . 0.0 112.391 -176.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 63' ' ' ILE . 3.5 t -81.49 131.5 33.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.401 -1.319 . . . . 0.0 108.104 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.593 0 CA-C-O 114.538 -3.368 . . . . 0.0 112.804 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 22' ' ' THR . . . . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 120.923 0.392 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -57.75 73.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 125.736 2.684 . . . . 0.0 115.041 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LEU . 17.1 p -111.94 33.77 4.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 100.458 -3.904 . . . . 0.0 100.458 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -142.31 156.08 45.24 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 126.671 2.482 . . . . 0.0 113.56 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 27' ' ' LEU . 22.4 m-90 -140.77 62.78 18.47 Favored Pre-proline 0 N--CA 1.509 2.522 0 CA-C-O 123.73 1.729 . . . . 0.0 115.09 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -63.3 -13.02 33.31 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.293 1.995 . . . . 0.0 113.125 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 12.0 mp0 -77.43 -20.43 54.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.686 HD13 ' HB1' ' A' ' 35' ' ' ALA . 69.8 mt -87.46 -19.62 27.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 79' ' ' VAL . 45.4 t -49.51 130.57 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.22 -10.88 60.08 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.637 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -110.11 161.7 15.29 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.7 p -74.5 162.7 28.56 Favored 'General case' 0 CA--C 1.463 -2.368 0 CA-C-O 126.867 3.222 . . . . 0.0 110.961 177.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HA ' HD23 ' A' ' 68' ' ' LEU 0.279 9.1 p -62.89 -47.39 93.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 1 CA-C-N 107.199 -4.546 . . . . 0.0 112.163 -173.573 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 36' ' ' LYS . 3.7 mm-40 -68.42 -34.2 75.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.343 -1.743 . . . . 0.0 110.954 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -62.94 -51.1 68.21 Favored 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB1' HD13 ' A' ' 27' ' ' LEU . . . -62.41 -44.19 97.02 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.398 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 85.7 mttt -45.85 -50.49 14.24 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.236 1.017 . . . . 0.0 108.518 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.559 ' HZ3' ' HB3' ' A' ' 37' ' ' LYS . 5.7 ttpm? -48.14 -54.19 14.16 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 111.876 -2.42 . . . . 0.0 110.932 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 41' ' ' GLN . 71.4 t -65.76 -47.34 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 112.768 -2.015 . . . . 0.0 111.898 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 66' ' ' VAL . 17.1 mt -52.92 -53.57 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.886 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.257 34.7 mt -58.2 -19.62 34.92 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 125.154 1.534 . . . . 0.0 110.999 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -75.54 -25.88 57.55 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -96.45 -53.86 3.45 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -118.87 55.05 2.46 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.671 -0.643 . . . . 0.0 110.844 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -17.91 -40.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 125.131 3.888 . . . . 0.0 119.507 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.51 -30.37 68.53 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.518 0.675 . . . . 0.0 112.301 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.0 76.32 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 120.86 3.652 . . . . 0.0 120.86 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -78.43 74.84 4.96 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 39' ' ' ILE . 55.6 mt -73.03 141.84 15.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.645 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 50' ' ' VAL . 11.7 mm -108.36 170.43 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.047 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 49' ' ' ILE . 39.8 t -84.11 122.65 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.67 HD22 ' CZ ' ' A' ' 69' ' ' PHE . 40.9 mt -118.51 77.47 13.98 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -50.79 129.88 28.87 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 106.927 -1.99 . . . . 0.0 106.927 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.628 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 1.3 t -40.86 130.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 123.885 1.802 . . . . 0.0 115.725 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.75 -29.61 12.14 Favored Glycine 0 N--CA 1.508 3.489 0 CA-C-N 110.652 -2.976 . . . . 0.0 113.811 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.618 ' HB ' ' CE1' ' A' ' 69' ' ' PHE 0.298 3.2 m -45.76 162.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.4 mm -84.03 136.63 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.582 HG21 ' CD ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -141.79 -70.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.873 0 N-CA-C 121.249 3.796 . . . . 0.0 121.249 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 93.33 8.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -98.64 -86.97 0.35 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 108.922 -3.763 . . . . 0.0 102.35 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' HG2' ' NE ' ' A' ' 62' ' ' ARG . 20.2 pt-20 -81.73 -167.91 1.69 Allowed 'General case' 0 C--N 1.277 -2.557 1 CA-C-N 107.263 -4.517 . . . . 0.0 106.321 173.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -96.37 95.99 8.44 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.412 ' NE ' ' HG2' ' A' ' 60' ' ' GLU . 3.0 mpt_? -83.74 66.24 8.95 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 125.088 2.375 . . . . 0.0 104.863 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.664 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.6 tp -74.8 -23.46 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.922 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.56 6.4 5.9 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 109.445 -3.525 . . . . 0.0 108.583 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.303 12.6 ttm-85 -154.87 149.38 26.31 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 -170.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 39' ' ' ILE . 2.9 t -117.17 126.44 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-N 120.647 1.567 . . . . 0.0 112.393 174.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.582 ' CD ' HG21 ' A' ' 57' ' ' VAL . 2.3 mtp180 -56.25 104.04 0.13 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 117.1 -1.429 . . . . 0.0 113.035 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.601 HD23 ' HA ' ' A' ' 32' ' ' VAL . 10.3 mp -106.48 74.27 1.01 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 123.208 2.731 . . . . 0.0 104.496 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.67 ' CZ ' HD22 ' A' ' 51' ' ' LEU . 16.7 m-85 -72.82 108.64 5.89 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 127.42 3.486 . . . . 0.0 109.262 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 68' ' ' LEU . 32.7 m -106.03 170.33 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 1 CA-C-N 106.647 -4.797 . . . . 0.0 110.088 -173.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 5.3 p-10 -94.83 -138.15 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 124.096 1.903 . . . . 0.0 111.082 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 30.0 mmtp -83.57 -11.83 56.88 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 109.74 -3.391 . . . . 0.0 112.447 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 ' CD1' HD22 ' A' ' 75' ' ' ASN 0.302 0.4 OUTLIER -136.53 52.2 1.97 Allowed 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 124.144 1.926 . . . . 0.0 108.955 -179.202 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' C ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.47 15.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 110.735 -2.938 . . . . 0.0 118.547 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.513 HD22 ' CD1' ' A' ' 73' ' ' LEU . 56.3 m-20 -99.38 134.56 42.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.641 1.21 . . . . 0.0 110.274 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 mt -52.28 117.9 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 126.326 2.965 . . . . 0.0 111.877 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.435 . . -102.37 -39.19 7.28 Favored 'General case' 0 C--N 1.286 -2.168 1 CA-C-N 104.633 -5.712 . . . . 0.0 112.348 -170.913 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -114.47 160.25 19.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 102.831 -3.025 . . . . 0.0 102.831 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 28' ' ' VAL . 88.3 t -76.88 145.03 73.54 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 114.273 -2.971 . . . . 0.0 109.405 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 14.5 Cg_exo -78.42 151.33 25.86 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 108.297 -1.463 . . . . 0.0 108.297 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.568 HH22 ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -153.63 155.73 36.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 66' ' ' VAL . 45.2 t -75.53 -83.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 124.01 1.862 . . . . 0.0 108.454 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.568 ' C ' HH22 ' A' ' 81' ' ' ARG . . . . . . . . 0 C--N 1.285 -2.276 1 N-CA-C 102.304 -4.318 . . . . 0.0 102.304 -175.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.657 0 CA-C-O 121.609 0.719 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.616 ' NZ ' ' O ' ' A' ' 23' ' ' GLU . 14.6 pttp -102.23 165.77 10.95 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 124.397 2.046 . . . . 0.0 107.874 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' CB ' ' A' ' 81' ' ' ARG . 36.2 p -106.92 -3.7 19.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 110.596 -3.002 . . . . 0.0 111.034 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.616 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -129.77 142.84 50.63 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 -179.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.625 ' CZ2' HG23 ' A' ' 39' ' ' ILE . 25.5 m-90 -134.23 76.55 62.86 Favored Pre-proline 0 N--CA 1.52 3.068 1 N-CA-C 123.363 4.579 . . . . 0.0 123.363 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . 7.4 Cg_endo -79.84 -35.69 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.873 1.716 . . . . 0.0 111.985 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -56.13 -18.19 9.23 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -176.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 1.2 pp -104.09 2.05 31.59 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.282 1.433 . . . . 0.0 114.389 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.56 HG21 HG22 ' A' ' 79' ' ' VAL . 49.0 t -70.55 141.67 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.754 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.84 7.6 59.83 Favored Glycine 0 N--CA 1.515 3.941 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -125.96 167.38 15.37 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 117.333 -1.318 . . . . 0.0 112.525 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 3.2 p -88.17 155.01 19.99 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 126.354 2.978 . . . . 0.0 114.033 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 33' ' ' GLU . 5.3 p -40.97 -49.62 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 1 CA-C-N 106.411 -4.904 . . . . 0.0 120.14 -175.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' N ' HG13 ' A' ' 32' ' ' VAL . 57.6 mm-40 -59.88 -49.02 79.35 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.211 -1.395 . . . . 0.0 109.605 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -51.3 -51.82 50.86 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 76' ' ' ILE . . . -52.6 -58.02 8.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.547 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 33' ' ' GLU . 49.1 mtpt -45.99 -52.45 11.74 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 123.364 1.554 . . . . 0.0 107.107 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.8 -54.05 43.81 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.324 -2.671 . . . . 0.0 111.483 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.4 t -54.33 -54.94 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-O 124.896 2.284 . . . . 0.0 109.778 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.656 HD13 HG11 ' A' ' 66' ' ' VAL . 9.3 mt -54.26 -43.88 63.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 110.526 -3.033 . . . . 0.0 112.216 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 46' ' ' ALA . 57.7 mt -73.22 -32.87 65.02 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 125.655 1.847 . . . . 0.0 110.866 175.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -64.81 -18.54 65.2 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 10.9 t70 -96.36 -64.15 1.08 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.277 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -104.65 62.62 0.11 Allowed Pre-proline 0 C--N 1.29 -1.979 0 C-N-CA 127.873 2.469 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -18.86 -49.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 123.983 3.122 . . . . 0.0 120.052 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.53 14.91 13.59 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 48' ' ' ILE . . . -59.56 97.87 0.04 OUTLIER 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.762 1.268 . . . . 0.0 113.626 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 64' ' ' ASP . 3.3 tt0 -73.59 77.33 1.49 Allowed 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.632 HD11 ' CG2' ' A' ' 39' ' ' ILE . 66.8 mt -74.52 135.06 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 123.153 1.454 . . . . 0.0 113.524 -177.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.51 137.58 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 111.514 -2.585 . . . . 0.0 108.758 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.27 141.37 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 123.117 1.437 . . . . 0.0 110.541 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.604 ' CD2' HG22 ' A' ' 55' ' ' THR . 2.5 mp -137.43 140.19 29.77 Favored Pre-proline 0 C--N 1.301 -1.537 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.01 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 55' ' ' THR . 32.3 Cg_endo -74.82 141.79 27.63 Favored 'Trans proline' 0 CA--C 1.551 1.364 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.505 ' HA ' ' HD1' ' A' ' 69' ' ' PHE . 8.4 t -42.14 128.24 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.12 20.63 Favored Glycine 0 N--CA 1.507 3.396 0 CA-C-N 111.213 -2.721 . . . . 0.0 112.543 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.604 HG22 ' CD2' ' A' ' 51' ' ' LEU 0.28 0.9 OUTLIER -69.02 177.05 2.82 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 123.76 1.743 . . . . 0.0 112.428 179.106 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.3 mm -59.18 105.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.822 1 N-CA-C 124.037 4.829 . . . . 0.0 124.037 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.716 HG22 ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -105.18 -50.84 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.613 0 CA-C-N 111.207 -2.724 . . . . 0.0 111.682 173.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.2 62.95 4.53 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 128.284 3.897 . . . . 0.0 119.156 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.66 ' HG2' ' H ' ' A' ' 60' ' ' GLU . 3.5 ttt -98.65 -162.38 0.95 Allowed 'General case' 0 C--N 1.279 -2.475 1 CA-C-N 103.038 -6.437 . . . . 0.0 108.687 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.66 ' H ' ' HG2' ' A' ' 59' ' ' MET . 0.4 OUTLIER -73.87 -141.69 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.868 -1.969 . . . . 0.0 108.226 172.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.566 ' CE2' HD13 ' A' ' 63' ' ' ILE . 12.1 t80 -136.49 83.35 2.0 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 6.6 mmp_? -87.41 76.61 9.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.582 HD12 HG11 ' A' ' 82' ' ' VAL . 5.9 tp -52.2 -19.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 110.952 -2.84 . . . . 0.0 112.808 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.625 ' O ' ' HB3' ' A' ' 47' ' ' GLN 0.263 2.2 p30 -81.43 15.96 1.85 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.975 177.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.482 HH21 ' C ' ' A' ' 83' ' ' GLY . 53.0 ttp180 -153.64 122.65 6.46 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 82' ' ' VAL . 24.0 t -91.12 146.79 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 C-N-CA 114.467 -2.893 . . . . 0.0 105.016 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.653 HH21 ' C ' ' A' ' 83' ' ' GLY . 14.9 tpp85 -99.94 114.08 27.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 111.076 -2.784 . . . . 0.0 105.527 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 39' ' ' ILE . 84.3 mt -113.74 105.21 13.03 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.46 -1.296 . . . . 0.0 114.094 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.716 ' CE2' HG22 ' A' ' 57' ' ' VAL . 25.7 m-85 -80.14 102.91 9.66 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 125.697 2.665 . . . . 0.0 112.174 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.99 173.99 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 108.593 -3.912 . . . . 0.0 110.018 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -99.72 -141.75 0.33 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 124.53 2.109 . . . . 0.0 111.935 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.596 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.64 8.54 43.11 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 112.01 -2.359 . . . . 0.0 115.054 177.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 75' ' ' ASN . 65.2 mt -135.46 39.95 2.84 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 111.075 -2.784 . . . . 0.0 108.627 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.78 28.0 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 64.0 m-20 -104.8 146.9 28.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.174 1.94 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 35' ' ' ALA . 15.6 mt -77.8 95.33 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-O 127.245 3.403 . . . . 0.0 114.402 -177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.507 . . -72.3 -45.47 59.87 Favored 'General case' 0 C--N 1.289 -2.045 2 CA-C-N 100.608 -7.542 . . . . 0.0 102.437 178.838 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -119.19 135.14 54.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.716 ' N ' ' HD2' ' A' ' 80' ' ' PRO . 87.2 t -42.72 -56.19 6.27 Favored Pre-proline 0 N--CA 1.519 2.98 1 N-CA-C 124.623 5.046 . . . . 0.0 124.623 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.716 ' HD2' ' N ' ' A' ' 79' ' ' VAL 0.255 0.0 OUTLIER 7.01 -152.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 2 C-N-CA 130.714 7.609 . . . . 0.0 127.837 -168.309 . . . . . . . . 5 4 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -155.53 -173.23 4.45 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -158.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 66' ' ' VAL . 5.0 t -81.88 148.55 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.289 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.653 ' C ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 N--CA 1.501 2.988 0 O-C-N 126.392 2.307 . . . . 0.0 114.464 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.632 0 CA-C-O 120.991 0.424 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.544 ' HE3' ' CD1' ' A' ' 24' ' ' TRP . 1.7 tmtm? -14.2 76.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -123.75 16.51 9.46 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 111.56 -2.564 . . . . 0.0 106.846 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -133.74 150.12 51.48 Favored 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 175.085 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.582 ' HB3' ' CG ' ' A' ' 27' ' ' LEU . 26.8 m-90 -133.22 74.56 72.47 Favored Pre-proline 0 N--CA 1.507 2.388 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' HA ' HG23 ' A' ' 28' ' ' VAL . 42.0 Cg_endo -74.14 -33.91 5.43 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.704 2.269 . . . . 0.0 110.486 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -48.43 -34.85 11.66 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.739 2.209 . . . . 0.0 109.945 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' CG ' ' HB3' ' A' ' 24' ' ' TRP . 3.7 pp -98.51 23.08 8.96 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.588 ' CG2' HG22 ' A' ' 79' ' ' VAL . 64.5 t -73.32 163.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.85 17.17 60.33 Favored Glycine 0 N--CA 1.512 3.709 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.949 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.23 163.89 25.74 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-O 116.568 -1.682 . . . . 0.0 109.59 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 75' ' ' ASN . 5.5 p -88.42 158.13 18.47 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 126.575 3.083 . . . . 0.0 113.908 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.49 -27.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 1 CA-C-N 106.41 -4.905 . . . . 0.0 114.76 -176.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.605 ' HG3' ' N ' ' A' ' 34' ' ' GLU . 16.8 pt-20 -66.67 -52.16 47.92 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 123.87 1.795 . . . . 0.0 109.429 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.605 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 9.6 tm-20 -62.48 -51.04 69.02 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -50.72 -48.92 58.73 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.06 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.3 mttm -57.95 -53.12 61.81 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.524 ' HD3' ' C ' ' A' ' 37' ' ' LYS . 3.8 tmtm? -48.2 -35.91 12.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 113.382 -1.736 . . . . 0.0 114.775 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.455 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 66.1 t -85.25 -59.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.229 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 66' ' ' VAL . 40.2 mt -49.25 -48.91 17.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.679 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 46' ' ' ALA . 9.8 mt -70.94 -23.18 62.19 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.126 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -71.48 -21.58 61.92 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -96.38 -63.27 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 45' ' ' GLU . 8.2 tptp -111.13 67.23 0.59 Allowed Pre-proline 0 N--CA 1.499 2.007 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -18.62 -46.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.035 0 C-N-CA 124.599 3.533 . . . . 0.0 120.096 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' GLN . 3.3 mp0 -59.28 -35.07 73.07 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' A' ' 66' ' ' VAL . . . -44.86 79.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.678 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 43.9 tt0 -78.09 65.37 3.46 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 123.875 1.797 . . . . 0.0 107.269 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 39' ' ' ILE . 32.6 mt -70.46 142.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 50' ' ' VAL . 32.9 mm -125.86 -166.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-N 110.668 -2.969 . . . . 0.0 106.418 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.8 p -106.02 142.05 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 0.0 112.56 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.39 102.81 7.24 Favored Pre-proline 0 N--CA 1.513 2.723 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.55 129.06 15.17 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 122.799 2.035 . . . . 0.0 109.435 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 4.1 t -41.94 130.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 123.383 1.563 . . . . 0.0 114.476 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.62 -21.49 45.83 Favored Glycine 0 N--CA 1.503 3.144 0 CA-C-N 111.095 -2.775 . . . . 0.0 114.613 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -58.24 156.36 9.98 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 119.261 1.531 . . . . 0.0 113.416 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.04 127.46 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.488 -1.285 . . . . 0.0 112.124 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 69' ' ' PHE . 30.0 m -131.21 -152.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 112.645 -2.071 . . . . 0.0 109.473 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.73 -155.67 0.31 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.556 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 50.2 mtp -58.1 -149.91 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -81.47 -18.68 44.36 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 125.27 2.462 . . . . 0.0 116.318 175.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.639 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -116.54 107.15 14.38 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 109.488 -3.506 . . . . 0.0 106.706 178.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.703 ' H ' ' C ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -107.45 43.72 1.16 Allowed 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 125.277 2.465 . . . . 0.0 109.758 179.073 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.639 ' HB ' ' CD1' ' A' ' 61' ' ' TYR . 6.2 tp -42.73 -27.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.444 1 CA-C-N 107.295 -4.502 . . . . 0.0 120.058 -177.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.23 -17.62 20.45 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 47' ' ' GLN 0.255 0.1 OUTLIER -142.81 -170.84 3.32 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 111.863 -2.426 . . . . 0.0 114.017 -176.973 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.696 HG21 HG21 ' A' ' 39' ' ' ILE . 3.0 t -115.64 111.49 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 1 N-CA-C 88.032 -8.507 . . . . 0.0 88.032 169.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HD3' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -81.04 101.83 9.82 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 122.515 2.416 . . . . 0.0 111.013 -176.164 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.9 mp -79.9 80.18 6.33 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.556 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 13.6 m-85 -70.12 106.67 3.35 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 125.96 2.79 . . . . 0.0 108.95 166.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 74' ' ' ASP . 14.9 m -105.9 175.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.766 1 CA-C-N 108.234 -4.075 . . . . 0.0 109.607 -176.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.486 ' CG ' ' N ' ' A' ' 72' ' ' LYS . 6.5 p-10 -91.89 -140.21 0.18 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.232 -2.167 . . . . 0.0 113.194 -177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 43.8 mtmt -89.3 0.87 56.47 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 110.673 -2.967 . . . . 0.0 112.072 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.1 mt -135.77 32.66 2.98 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.874 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 37.16 28.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -177.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 55.9 m-80 -103.2 148.83 25.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.0 mt -74.88 106.46 4.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 126.843 3.211 . . . . 0.0 114.18 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 71' ' ' ASP 0.399 . . -81.34 -51.88 7.88 Favored 'General case' 0 C--N 1.287 -2.152 2 CA-C-N 101.692 -7.049 . . . . 0.0 110.042 -177.744 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -115.49 148.33 39.59 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.588 HG22 ' CG2' ' A' ' 28' ' ' VAL . 88.8 t -70.45 141.73 88.47 Favored Pre-proline 0 N--CA 1.502 2.132 0 C-N-CA 114.193 -3.003 . . . . 0.0 108.113 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 6.2 Cg_exo -89.27 159.16 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.765 2.31 . . . . 0.0 108.26 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -154.29 157.27 38.41 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -177.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' CH2' ' A' ' 24' ' ' TRP . 55.6 t -75.26 109.79 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 176.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.703 ' C ' ' H ' ' A' ' 62' ' ' ARG . . . . . . . . 0 C--N 1.276 -2.768 0 CA-C-N 110.869 -2.878 . . . . 0.0 107.032 -178.854 . . . . . . . . 1 1 . 1 stop_ save_